<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-HEADER AEXT-CLASS="Y">
<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20210122">4.2</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="00962922">(주)팬젠</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">N</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">131111-0248194</EXTRACTION>
</SUMMARY>
</DOCUMENT-HEADER>

<BODY>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 정정문서 작성시 『정오표』 삽입</COMMENT>
<LIBRARYLIST>정정신고(보고)-대표이사등의확인.LCommon</LIBRARYLIST>
</INSERTION>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P>&cr;&cr;&cr;</P>
<P USERMARK="F-16">                                    (제 11 기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20200101">2020.01.01</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20201231">2020.12.31</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2021년    3  월   19일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">(주)팬젠</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">김영부,윤재승</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="53">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="53">경기도 수원시 영통구 신원로 306 (원천동, 영통이노플렉스 2동 4층)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 031-733-9165</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://www.pangen.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책) 전무이사               (성  명)장재홍</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 031-733-9165</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TOC>
<TITLE ATOC="N">목     차</TITLE>
<P></P>
<PGBRK></PGBRK>
</TOC>

<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">확인서(2021.03.19).jpg</IMG>
<IMG-CAPTION ATOC="N">확인서(2021.03.19)</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『연결재무제표를작성하는주권상장법인』 삽입</COMMENT>
<LIBRARYLIST>11011#*연결재무제표를작성하는주권상장법인.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<P>
<SPAN USERMARK=" B">가. 회사의 법적/상업적 명칭</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>당사의 명칭은 "주식회사 팬젠"이라고 표기합니다. 영문으로는 PanGen Biotech, Inc.라고 하며 약식으로 표기할 때는 PanGen이라고 합니다. &cr;&cr;</SPAN>
<SPAN USERMARK=" B">나. 설립일자 </SPAN>
<SPAN>&cr;</SPAN>
<SPAN>당사는 바이오시밀러 EPO의약품의 생산 및 판매등을 주요사업으로 하고 있습니다. &cr;2010년 1월 29일에 분할설립 되었고 2016년 3월 11일에 기술성장기업으로 코스닥 시장에 상장되었습니다. &cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">다. 본사 주소, 전화번호 및 홈페이지</SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="426"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">본사</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">주      소</TD>
<TD WIDTH="435" HEIGHT="53">경기도 수원시 영통구 신원로 306 &cr;(원천동, 영통이노플렉스 2동 4층)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전화번호</TD>
<TD WIDTH="435" HEIGHT="30">(031)733-9165</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">홈페이지</TD>
<TD WIDTH="435" HEIGHT="30">www.pangen.com</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">라. 중소기업 해당 여부</SPAN>
<SPAN>&cr;당사는 보고서 작성 기준일 현재 중소기업기본법 제2조에 의거 중소기업에 해당합니다. &cr;&cr;</SPAN>
<SPAN USERMARK=" B">마. 주요사업의 내용</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>당사는 바이오의약품 생산용 GMP시설과, 당사의 원천기술인 PanGen CHO-TECH</SPAN>
<SPAN>™ </SPAN>
<SPAN>기술, 바이오의약품 제품화 기술을 활용하여 바이오시밀러 EPO의약품 생산 및 판매, 바이오의약품 개발 사업, 바이오의약품(전임상,임상시료포함) 위탁생산(CMO) 및  개발기술 이전서비스</SPAN>
<SPAN>(CDO)</SPAN>
<SPAN> 사업을 수행하고 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> - 바이오시밀러 의약품  생산  및 판매사업 :&cr;   · EPO의약품(만성 신부전 환자의 빈혈치료제)&cr;&cr; - 바</SPAN>
<SPAN>이오 의약품 개발사업 :&cr;   ·혈우병A치료제 Factor VIII&cr;  </SPAN>
<SPAN> </SPAN>
<SPAN>·항암치료보조제 G-CSF</SPAN>
<SPAN>&cr;   </SPAN>
<SPAN>·황반변성,황반부종등 치료제 Aflibercept</SPAN>
<SPAN>&cr;   </SPAN>
<SPAN>·중증열성 혈소판 감소 증후군 치료제  항SFTS</SPAN>
<SPAN>V항체&cr;&cr;</SPAN>
<SPAN> - 바이오 의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산</SPAN>
<SPAN></SPAN>
<SPAN>(CMO) 및 개발 기술 이전 서비스&cr;   사업(CDO) :&cr;  · CDMO</SPAN>
<SPAN>(Contract Development and Manufacturing Organization)&cr;</SPAN>
<SPAN></SPAN>
</P>
<P>당사의 주요 사업에 대한 자세한 사항은 본 사업보고서의  "II. 사업의 내용"을 참조 하시기 바랍니다.</P>
<P></P>
<P USERMARK=" B">바. 회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="731" BORDER="1">

<COLGROUP>
<COL WIDTH="161"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="229"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="238" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;여부</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="SPC_CHK">코스닥시장</TE>
<TU WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="SPC_DATE" AUNITVALUE="20160311">2016년 03월 11일</TU>
<TE WIDTH="238" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="SPC_CHP">기술성장기업의 코스닥시장 상장</TE>
<TE WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="SPC_LAW">코스닥시장상장규정&cr;제7조2항</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>
<P></P>
<P></P>

<P>
<SPAN USERMARK=" B">가. 회사의 본점 소재지 및 그 변경&cr;</SPAN>
<SPAN>회사의  본점 소재지는 경기도 수원시 영통구 신원로 306 (원천동, 영통이노플렉스 2동 4층) 이며 공시대상기간중 소재지 변경은 없습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">나. 경영진의 중요한 변동</SPAN>
<SPAN>&cr;당사 경영진의 주요변동사항은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="592" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="485"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일  자</TD>
<TD WIDTH="494" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">변동내용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2016.03.25</TD>
<TD WIDTH="494" HEIGHT="53">사내이사 김영부, 윤재승, 장재홍 중임&cr;감사 김두표 중임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.04.12</TD>
<TD WIDTH="494" HEIGHT="30">사외이사 황창석 사임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">2017.03.24</TD>
<TD WIDTH="494" HEIGHT="37">기타비상무이사 백광희, 레오나르드아리프빈압둘샤타 중임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019.03.26</TD>
<TD WIDTH="494" HEIGHT="53">사내이사 김영부, 윤재승, 장재홍 중임&cr;감사 김두표 중임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.03.24</TD>
<TD WIDTH="494" HEIGHT="53" VALIGN="MIDDLE">기타비상무이사 백광희, 레오나르드아리프빈압둘샤타 중임</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">다. 최대주주의 변동</P>
<P>당사의 최대주주는 김영부로 최근 5년간  최대주주의 변동은 없습니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">라. 그 밖에 경영활동과 관련된 중요한 사항의 발생내용</SPAN>
</P>

<TABLE BORDER="1" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="501"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>일  자</P>
</TD>

<TD WIDTH="510" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내      용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2016.03.11</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">코스닥시장 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2016.03.25</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">벤처기업인증 (한국벤처캐피탈협회, 제20160300045호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2016.04.26</TD>

<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">특허등록(동물세포발현벡터, 일본 제5931174호)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2016.07.22</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="53">바이오시밀러 EPO제품에 대한 상업생산규모의 바이오의약품 제조소 PIC/S cGMP인증[말레이시이아 식약청(NPCB)(NO.:272/16)]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2016.08.16</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="53">재조합 Factor VIII 제품에 대한 마케팅 및 상업화 계약체결&cr;(멕시코 Medicamentos Naturales사)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2016.11.30</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">특허등록(동물세포발현벡터, 유럽 제2692867호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2017.03.29</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">EPO 바이오시밀러 말레이시아 NDA 제출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2017.09.04</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">EPO 임상3상시험 종료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2018.03.25</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">벤처기업인증 (한국벤처캐피탈협회, 제20180300124호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2018.04.26</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="53">특허등록(인간및마우스 Sema3에교차결합하는항체및 그의 용도,&cr;한국 제 10-1854529호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2018.05.21</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">EPO 바이오시밀러 한국 NDA 제출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2018.10.12</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">Factor VIII 한국 임상1상 IND 제출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2019.01.31</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">EPO바이오시밀러 말레이시아 식약청 품목등록(제품명:에리사)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2019.03.25</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">Factor VIII 한국 임상 1상 IND승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2019.04.03</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">사우디아라비아  SAUDI VAX사와  EPO 판권계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2019.06.11</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">특허등록(항-혈액응고 제Ⅷ인자 항체 및 그 용도,한국 제 10-1989779호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2019.07.04</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">특허등록(동물세포발현벡터, 인도 제314687호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2019.10.08</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">특허등록(동물세포발현벡터, 말레이시아 MY-171316-A)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2019.11.11</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="53">특허등록(인간및마우스 Sema3에교차결합하는항체및 그의 용도,&cr;호주 제 2016346595호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2019.11.28</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">EPO바이오시밀러 한국 식약처 품목등록(제품명:팬포틴)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2020.01.06</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">중헌제약과 국내 EPO의약품 판권계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2020.02.13</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">베트남  Khuong Duy사와  EPO의약품 판권계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2020.02.13</TD>

<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="53">
<SPAN>특허등록(인간및마우스 Sema3에교차결합하는항체및 그의 용도,&cr;미국 제 15/964,463호,</SPAN>
<SPAN>미국 제 15/964,648호</SPAN>
<SPAN> ,</SPAN>
<SPAN>미국 제 15/964,763호</SPAN>
<SPAN></SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2020.02.20</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">바이오시밀러 EPO의약품(제품명:팬포틴,Erysaa) 할랄인증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2020.03.25</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">벤처기업인증 (한국벤처캐피탈협회, 제20200300176호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2020.09.28</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="53">특허등록(인간및마우스 Sema3에교차결합하는항체및 그의 용도,&cr;인도네시아)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P></P>
<P></P>
<P USERMARK=" B">증자(감자)현황</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="598" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="882" BORDER="1">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="278"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행&cr;(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)&cr;형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="637" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당&cr;액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행&cr;(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="287" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160308">2016.03.08</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="01">유상증자(일반공모)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">1,699,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">16,500</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160314">2016.03.14</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">501,254</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-우선주 501,254주의 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160314">2016.03.14</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="06">신주인수권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">62,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,800</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-제1회,제3회BW 각 1.5억원행사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160328">2016.03.28</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">451,610</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-우선주 451,610주의 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160620">2016.06.20</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="06">신주인수권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">83,333</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,800</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-제1회BW 1.5억, 제3회BW 2.5억원행사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160620">2016.06.20</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">226,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">2,750</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160620">2016.06.20</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">16,100</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">3,350</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160620">2016.06.20</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">6,400</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,350</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20161102">2016.11.02</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">2,750</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170206">2017.02.06</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="06">신주인수권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">250,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,800</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-제1회BW 12억원 행사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170414">2017.04.14</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">6,900</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">3,350</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170414">2017.04.14</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">4,800</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,350</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170414">2017.04.14</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">8,800</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,750</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170707">2017.07.07</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="06">신주인수권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">93,750</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,800</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-제3회BW 4.5억원 행사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170713">2017.07.13</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="06">신주인수권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">135,416</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,800</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30">-제3회BW 6.5억원 행사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170720">2017.07.20</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">67,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">7,500</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180628">2018.06.28</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">1,200</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,350</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180628">2018.06.28</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">3,300</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,750</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180723">2018.07.23</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">3,300</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">4,750</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180723">2018.07.23</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">13,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">7,500</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180724">2018.07.24</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">7,500</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180822">2018.08.22</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">1,200</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">7,500</TE>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환사채 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환사채발행현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">2_미상환전환사채발행현황</FILENAME>

<TABLE-GROUP ACLASS="CB" ADELETETABLE="N">
<TITLE ATOC="N">미상환 전환사채 발행현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="685" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="379"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="388" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1219" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="93" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">종류＼구분</TH>
<TH WIDTH="56" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">회차</TH>
<TH WIDTH="92" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">발행일</TH>
<TH WIDTH="92" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">만기일</TH>
<TH WIDTH="150" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">권면(전자등록)총액</TH>
<TH WIDTH="98" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환대상&cr;주식의 종류</TH>
<TH WIDTH="161" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환청구가능기간</TH>
<TH WIDTH="156" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환조건</TH>
<TH WIDTH="273" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">미상환사채</TH>
<TH WIDTH="48" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환비율&cr;(%)</TH>
<TH WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환가액</TH>
<TH WIDTH="150" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">권면(전자등록)총액</TH>
<TH WIDTH="123" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환가능주식수</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="93" HEIGHT="53" ACODE="CB_KND" ALIGN="CENTER" VALIGN="MIDDLE">무기명사모&cr;전환사채</TE>
<TE WIDTH="56" HEIGHT="53" ACODE="CB_SEQ" ALIGN="CENTER" VALIGN="MIDDLE">제2회</TE>
<TU WIDTH="92" HEIGHT="53" AUNIT="CB_DT" AUNITVALUE="20180221" ALIGN="CENTER" VALIGN="MIDDLE">2018.02.21</TU>
<TU WIDTH="92" HEIGHT="53" AUNIT="CB_FDT" AUNITVALUE="20230221" ALIGN="CENTER" VALIGN="MIDDLE">2023.02.21</TU>
<TE WIDTH="150" HEIGHT="53" ACODE="CB_EN" ALIGN="RIGHT" VALIGN="MIDDLE">18,000,000,000</TE>
<TE WIDTH="98" HEIGHT="53" ACODE="CB_KN" ALIGN="CENTER" VALIGN="MIDDLE">보통주식</TE>
<TE WIDTH="161" HEIGHT="53" ACODE="CB_PE" ALIGN="CENTER" VALIGN="MIDDLE">2019.2.21~2023.1.20</TE>
<TE WIDTH="78" HEIGHT="53" ACODE="CB_RAT" ALIGN="RIGHT" VALIGN="MIDDLE">100</TE>
<TE WIDTH="78" HEIGHT="53" ACODE="CB_PR" ALIGN="RIGHT" VALIGN="MIDDLE">12,107</TE>
<TE WIDTH="150" HEIGHT="53" ACODE="CB_AMN" ALIGN="RIGHT" VALIGN="MIDDLE">18,000,000,000</TE>
<TE WIDTH="123" HEIGHT="53" ACODE="CB_CN" ALIGN="RIGHT" VALIGN="MIDDLE">1,486,743</TE>
<TE WIDTH="48" HEIGHT="53" ACODE="NOTE" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">합 계</TD>
<TD WIDTH="56" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TE WIDTH="150" HEIGHT="30" ACODE="CB_ENT" ALIGN="RIGHT" VALIGN="MIDDLE">18,000,000,000</TE>
<TE WIDTH="98" HEIGHT="30" ACODE="CB_KNT" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TE WIDTH="78" HEIGHT="30" ACODE="CB_RATT" ALIGN="RIGHT" VALIGN="MIDDLE">100</TE>
<TE WIDTH="78" HEIGHT="30" ACODE="CB_PRT" ALIGN="RIGHT" VALIGN="MIDDLE">12,107</TE>
<TE WIDTH="150" HEIGHT="30" ACODE="CB_AMNT" ALIGN="RIGHT" VALIGN="MIDDLE">18,000,000,000</TE>
<TE WIDTH="123" HEIGHT="30" ACODE="CB_CNT" ALIGN="RIGHT" VALIGN="MIDDLE">1,486,743</TE>
<TE WIDTH="48" HEIGHT="30" ACODE="NOTET" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 신주인수권부사채 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환신주인수권부사채등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환형 조건부자본증권 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환형조건부자본증권등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P></P>
<P></P>
<P>주식의 총수 현황</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N">우선주</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="34" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="ISU_STK1">47,500,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="ISU_STK1">2,500,000</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ACODE="SUM_ISU_STK1">
<P USERMARK="F-GL11"> 50,000,000</P>
</TE>

<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ALIGN="CENTER" ACODE="NOTE">
<P USERMARK="F-GL11">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="34" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="ISU_STK2">9,641,781</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="ISU_STK2">
<P USERMARK="F-GL11">952,864</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ACODE="SUM_ISU_STK2">10,594,645</TE>

<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ALIGN="CENTER" ACODE="NOTE1">
<P USERMARK="F-GL11">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="34" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="TOT_RST">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="TOT_RST">
<P USERMARK="F-GL11">952,864</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ACODE="SUM_RST">
<P USERMARK="F-GL11">952,864</P>
</TE>

<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ALIGN="CENTER" ACODE="NOTE2">
<P USERMARK="F-GL11">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="155" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="34" AUPDATECONT="N"> 1. 감자</TD>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="RDC_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="RDC_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ACODE="SUM_RDC_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ALIGN="CENTER" ACODE="NOTE3">
<P USERMARK="F-GL11">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="34" AUPDATECONT="N"> 2. 이익소각</TD>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="DST_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="DST_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ACODE="SUM_DST_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ALIGN="CENTER" ACODE="NOTE4">
<P USERMARK="F-GL11">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="34" AUPDATECONT="N"> 3. 상환주식의 상환</TD>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="RFD_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="RFD_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ACODE="SUM_RFD_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ALIGN="CENTER" ACODE="NOTE5">
<P USERMARK="F-GL11">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="53" AUPDATECONT="N"> 4. 기타</TD>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="53" ACODE="ETC_CNT">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="53" ACODE="ETC_CNT">
<P USERMARK="F-GL11">952,864 </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="53" ACODE="SUM_ETC_CNT">
<P USERMARK="F-GL11">952,864</P>
</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="53" ALIGN="CENTER" ACODE="NOTE6">2016.3월보통주전환</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="34" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="ISU_STK3">9,641,781</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="ISU_STK3">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ACODE="SUM_ISU_STK3">9,641,781</TE>

<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ALIGN="CENTER" ACODE="NOTE7">
<P USERMARK="F-GL11">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="34" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="TRS_STK">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="TRS_STK">
<P USERMARK="F-GL11">- </P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ACODE="SUM_TRS_STK">
<P USERMARK="F-GL11">- </P>
</TE>

<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ALIGN="CENTER" ACODE="NOTE8">
<P USERMARK="F-GL11">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="34" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="FLT_STK">9,641,781</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="34" ACODE="FLT_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ACODE="SUM_FLT_STK">9,641,781</TE>

<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="34" ALIGN="CENTER" ACODE="NOTE9">
<P USERMARK="F-GL11">-</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『자기주식 취득 및 처분 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*자기주식취득및처분현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『종류주식(명칭) 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*종류주식발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 의결권 현황</TITLE>
<P></P>
<P></P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="65" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">9,641,781</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISU_STK_KND">
<P USERMARK="F-GL"> 우선주</P>
</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISU_STK">-</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE">
<P USERMARK="F-GL">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="70" AUPDATECONT="N">의결권없는 주식수(B)</TD>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISN_STK_KND">
<P USERMARK="F-GL"> 보통주</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISN_STK">
<P USERMARK="F-GL"> -</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE1">
<P USERMARK="F-GL">-</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISN_STK_KND">
<P USERMARK="F-GL"> 우선주</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISN_STK">
<P USERMARK="F-GL"> -</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE1">
<P USERMARK="F-GL">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="70" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISQ_STK_KND">
<P USERMARK="F-GL"> 보통주</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISQ_STK">
<P USERMARK="F-GL">-</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE2">
<P USERMARK="F-GL"> -</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISQ_STK_KND">
<P USERMARK="F-GL"> 우선주</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISQ_STK">
<P USERMARK="F-GL">-</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE2">
<P USERMARK="F-GL"> -</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="70" AUPDATECONT="N">기타 법률에 의하여&cr;의결권 행사가 제한된 주식수(D)</TD>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISJ_STK_KND">
<P USERMARK="F-GL"> 보통주</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISJ_STK">
<P USERMARK="F-GL">-</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE3">
<P USERMARK="F-GL"> -</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISJ_STK_KND">
<P USERMARK="F-GL"> 우선주</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISJ_STK">
<P USERMARK="F-GL"> -</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE3">
<P USERMARK="F-GL"> -</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="70" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISB_STK_KND">
<P USERMARK="F-GL"> 보통주</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISB_STK">
<P USERMARK="F-GL">-</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE4">
<P USERMARK="F-GL"> -</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISB_STK_KND">
<P USERMARK="F-GL"> 우선주</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISB_STK">
<P USERMARK="F-GL">-</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE4">
<P USERMARK="F-GL">-</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="70" AUPDATECONT="N">의결권을 행사할 수 있는 주식수&cr;(F = A - B - C - D + E)</TD>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISH_STK_KND">
<P USERMARK="F-GL"> 보통주</P>
</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISH_STK">9,641,781</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="35" ACODE="ISH_STK_KND">
<P USERMARK="F-GL"> 우선주</P>
</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="35" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-6-0">6. 배당에 관한 사항 등</TITLE>
<P></P>
<P USERMARK=" B">주요배당지표</P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="607" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제11기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제10기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제09기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">500</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">500</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">500</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">-4,356</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">-8,938</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-4,630</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">-452</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">-927</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">-481</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『과거배당이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*과거배당이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">48_과거배당이력</FILENAME>
<P USERMARK=" B">과거 배당 이력</P>

<TABLE-GROUP ACLASS="DIVIDEND_BCK" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 회, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">연속 배당횟수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">평균 배당수익률</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">분기(중간)배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">결산배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 3년간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 5년간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_QUA" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_END" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_THR" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="149" HEIGHT="30" ACODE="DIV_FIV" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>최근 5년간 배당을 지급한 사실이 없어 배당 이력 산출을 하지 않았습니다.</P>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-7-0">7. 정관에 관한 사항</TITLE>

<P USERMARK=" 0X0000FF">&cr;
<SPAN USERMARK=" 0X000000">사업보고서에 첨부된 정관의 최근 개정일은 2019.3.26이며, 제11기 정기주주총회(2021.3.29개최) 안건중 정관 변경 안건(우선주발행한도변경, 제3자유상증자 발행한도변경등)이 포함 되어 있습니다.&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『정관변경이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*정관변경이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">49_정관변경이력</FILENAME>
<P>정관 변경 이력</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="923" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="334"></COL>
<COL WIDTH="324"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="154" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="343" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="333" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="99" AUNIT="ART_DATE" AUNITVALUE="20190326" VALIGN="MIDDLE">2019.03.26</TU>
<TE ALIGN="CENTER" WIDTH="154" HEIGHT="99" ACODE="ART_NAME" VALIGN="MIDDLE">제9기정기주주총회</TE>
<TE WIDTH="343" HEIGHT="99" ACODE="ART_CHN" VALIGN="MIDDLE">- 주권의 종류(삭제)&cr;- 주식등의 전자등록(신설)&cr;- 주주등의 주소, 성명 및 인감 또는 서명등&cr;   신고등(삭제)</TE>
<TE WIDTH="333" HEIGHT="99" ACODE="ART_RSN" VALIGN="MIDDLE">- 주식 사채등의 전자등록에 관한 법률 개정반영</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="99" AUNIT="ART_DATE" AUNITVALUE="20180330" VALIGN="MIDDLE">2018.03.30</TU>
<TE ALIGN="CENTER" WIDTH="154" HEIGHT="99" ACODE="ART_NAME" VALIGN="MIDDLE">제8기정기주주총회</TE>
<TE WIDTH="343" HEIGHT="99" ACODE="ART_CHN" VALIGN="MIDDLE">- 신주인수권 제3자 배정한도 확대(20%=>50%)&cr;- 전환사채,신주인수권부 사채  제3자 발행한도&cr;   확대(200억→1,000억)&cr;- 이사의 책임감경</TE>
<TE WIDTH="333" HEIGHT="99" ACODE="ART_RSN" VALIGN="MIDDLE">- 제3자유상증자등 배정한도 및 발행한도확대&cr;- 제3자 CB, BW 발행한도 확대 &cr;&cr;- 상법 400조 제2항 반영</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P USERMARK=" 0X0000FF"></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P USERMARK="F-16 0XFF1200 B">1. 사업의 개요</P>
<P></P>

<P>
<SPAN> </SPAN>
<SPAN>당사는 설립초기부터 </SPAN>
<SPAN>바이오의약품 생산용 GMP시설을 구축하였고, GMP 시설과당사의 원천기술인 PanGen CHO-TECH</SPAN>
<SPAN>™ </SPAN>
<SPAN>기술, 바이오의약품 제품화 기술을 활용하여 아래와 같이 바이오시밀러 EPO의약품의 생산 및 판매, 바이오의약품 개발 사업, 바이오의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산</SPAN>
<SPAN>(CMO)</SPAN>
<SPAN> 및 개발기술 이전서비스</SPAN>
<SPAN></SPAN>
<SPAN> (CDO)사업을 수행하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> - 바이오시밀러 의약품  생산  및 판매사업 :&cr;   · </SPAN>
<SPAN>EPO의약품</SPAN>
<SPAN>(만성 신부전 환자의  빈혈치료제)</SPAN>
<SPAN>&cr;&cr; - 바</SPAN>
<SPAN>이오 의약품 개발사업 : &cr;    ·혈우병</SPAN>
<SPAN>A</SPAN>
<SPAN>치료제 Factor VIII&cr;    ·</SPAN>
<SPAN>항암치료보조제 G-CSF</SPAN>
<SPAN>&cr;    ·황반변성,황반부종등 치료제 Aflibercept&cr;    </SPAN>
<SPAN>·중증열성 혈소판 감소 증후군치료제 </SPAN>
<SPAN></SPAN>
<SPAN>항SFTS</SPAN>
<SPAN>V항체</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;&cr; - 바이오 의약품</SPAN>
<SPAN></SPAN>
<SPAN> 위탁생산(CMO) 및 개발 기술 이전 사업(CDO) :&cr;   ·CDMO</SPAN>
<SPAN>(Contract Development and Manufacturing Organization)&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>자체 개발에 성공한 만성 신부전 환자의 빈혈 치료제인 바이오시밀러 EPO의약품은 </SPAN>
<SPAN>2019년 1월에 말레이시아 식약청으로부터 </SPAN>
<SPAN>제품명 Erysaa로</SPAN>
<SPAN></SPAN>
<SPAN> 품목허가를 받아  2019년 3월부터 말레이시아 시장에 판매중에 있으며</SPAN>
<SPAN>,</SPAN>
<SPAN> </SPAN>
<SPAN> </SPAN>
<SPAN>한국은</SPAN>
<SPAN> </SPAN>
<SPAN>2019년 11월에 제품명 팬포틴으로 품목허가를 받</SPAN>
<SPAN>아  </SPAN>
<SPAN></SPAN>
<SPAN>2020년 2월부터 국내 판매를 시작 하였습니다&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>* PanGen CHO-TECH</SPAN>
<SPAN>™ </SPAN>
<SPAN>기술이란 바이오의약품 개발을 위한 기반기술인 생산용 세포주 개발기술과 생산공정개발 기술을 포함하는 CHO세포에 특화된 단백질 발현기술로 당사에서 명명한 기술입니다. &cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">가. 바이오 의약품 산업 특성&cr;</SPAN>
</P>
<P>의약품은 일반적으로 화학합성 의약품과 바이오 의약품으로 구분할 수 있는데, 바이오 의약품은 사람이나 생물체에서 유래된 것을 원료 또는 재료로 하여 제조한 의약품으로서 생물학제제, 유전자 재조합 의약품, 세포배양 의약품, 세포치료제, 유전자 치료제, 기타 식약처장이 인정하는 제제 등을 말합니다. </P>
<P> </P>

<TABLE BORDER="1" WIDTH="903" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="44"></COL>
<COL WIDTH="493"></COL>
<COL WIDTH="339"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">구 분</P>
</TH>

<TH WIDTH="502" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">바이오의약품</P>
</TH>

<TH WIDTH="348" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">화학합성의약품</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">정 의</P>
</TD>

<TD WIDTH="502" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">- 사람이나 생물체에서 유래된 것을 원료 또는 재료로 하여 제조한 의약품</P>
</TD>

<TD WIDTH="348" HEIGHT="28">
<P USERMARK="F-10">- 화학적 방법으로 약효 성분을 추출하여 만들어낸 의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">특징</P>
</TD>

<TD WIDTH="502" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">- 분자량이 매우 크고 복잡한 3차원 복잡한 구조를 가짐 </P>
<P USERMARK="F-10">- 살아있는 세포를 통해 매우 복잡한 생물학적 공정</P>
<P USERMARK="F-10">- 주로 유전자재조합 기술을 통해 형질도입된 숙주세포를 배양하고 필요한 물질을 &cr;   추출하는 복잡한 생산공정</P>
</TD>

<TD WIDTH="348" HEIGHT="91">
<P USERMARK="F-10">- 분자량이 매우 작음(500 Dalton이하)</P>
<P USERMARK="F-10">- 화학적 구조가 잘 밝혀져 있음</P>
<P USERMARK="F-10">- 화학물질의 화학반응을 통해 비교적 간단한 &cr;   화학 생산공정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">투약법</P>
</TD>

<TD WIDTH="502" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">- 정맥 / 피하 주사</P>
</TD>

<TD WIDTH="348" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">- 경구 투약(먹는 약)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">가 격</P>
</TD>

<TD WIDTH="502" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">- 고가/높음</P>
</TD>

<TD WIDTH="348" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">- 상대적으로 저가/낮음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49">
<P USERMARK="F-10">부작용</P>
</TD>

<TD WIDTH="502" HEIGHT="49">
<P USERMARK="F-10">- 부작용 경미함</P>
<P USERMARK="F-10">(특정부위 부작용, 작용기전에 의한 국소 부작용)</P>
</TD>

<TD WIDTH="348" VALIGN="MIDDLE" HEIGHT="49">
<P USERMARK="F-10">- 부작용 높음</P>
<P USERMARK="F-10">(인체의 전 부분에 작용, 예상불가능 부작용)</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>화학합성의약품은 새로운 작용 기전 개발이 어려워지고 막대한 연구개발비가 소요되는 관계로 혁신적인 신약 개발 건수가 점차 낮아지고 있고, 기존의 블록버스터 의약품들의 특허가 점차 만료됨에 따라 경쟁 카피제품(제네릭)의 개발이 쉬워지면서 가격이 하락하는 등 시장 성장에 어려움을 겪고 있는 반면, 바이오의약품은 생명공학기술을 기반으로 개발되어 생체내에 존재하는 특정 단백질을 타깃으로 하는 효과적이고 부작용이 적은 의약품으로 1980년대 유전자재조합 기술이 획기적으로 발전되면서 인슐린과 성장호르몬 같이 질환으로 인해 체내에 부족한 단백질을 보충하여 질병을 치료하는 1세대 바이오의약품이 처음으로 등장하게 되었습니다.</P>
<P> </P>
<P>1세대 바이오의약품은 주로 세균, 효모 등을 숙주로 활용하여 생산한 것으로 인슐린과 성장 호르몬 등을 들 수 있으며, 2세대 바이오의약품은 주로 동물세포를 이용하여생산한 것으로 치료용 항체, 퓨전단백질, EPO, 인터페론 등을 들 수 있습니다. 최근에는 바이오의약품 대비 효능이나 편의성 등이 증가된 개량형 바이오베터(biobetter)개발을 위한 제약사 간의 경쟁이 진행되고 있으며, 오리지널 제품보다 인체 내 약효지속성이 증가된 제품들이 일부 출시되어 판매되고 있습니다. 또한, 최근에는 차세대바이오의약품으로서 세포치료제, 유전자치료제, 치료용 백신 등에 대한 연구개발이 활발해 지고 있는 상황이지만, 기술이 상용화되어 본격적으로 시장이 형성되기까지는 시간이 조금 더 필요한 상태입니다.</P>
<P> </P>
<P>바이오의약품 산업에서 획기적인 변화는 2000년부터 블록버스터 바이오의약품의 특허가 만료됨에 따라 바이오신약에 비해 R&D비용과 기간을 획기적으로 줄일 수 있는바이오시밀러 제품 개발이 시작되었습니다. 합성의약품의 복제품 (generic)은 오리지널 합성의약품과 동일한 화학반응으로 생산하지만, 바이오시밀러 의약품은 살아있는숙주세포의 생물학적 반응을 이용하여 생산하기 때문에 100% 동일한 제품으로 생산할 수 없으며, 오리지널 바이오의약품과 생물학적 동등성을 입증해야만 바이오시밀러로 인정받을 수 있게됩니다. 이런 차이로 합성의약품의 복제약은 제너릭(generic)으로, 바이오의약품의 복제약은 바이오시밀러(biosimilar)라는 용어로 구분하게 됩니다. 특히 일반인들이 혼동하여 이해하고 있는 바이오시밀러의 개념을 다시 정리해 보면, 기존의 오리지널 의약품을 대체할 목적으로 개발되는 바이오 의약품으로는  바이오 시밀러와 Stand-alone으로 나눌 수 있는데 바이오시밀러는 오리지널 의약품과 품질의 비교 동등성이 확보된 후 등록된 제품을 말하며, Stand-alone은 오리지널 바이오의약품과 비교하지 않고 등록된 제품을 말합니다. 따라서 두 가지 제품은 서로 품질의 수준이 다르고, 서로 다른 허가 규정의 적용을 받게되며, 시장 진출시에도 서로 다른 시장을 형성할 수 있게 됩니다. </P>
<P> </P>
<P>전 세계적으로 고령화 추세에 따라 치매 중풍 파킨스병 등 노인성 질환에 대한 치료 수요가 빠르게 증가하고 소득증대 및 생활 패턴의 변화에 따른 삶의 질 향상으로 건강증진 및 유지를 위한 의료분야의 지출이 크게 확대되고 있습니다. 이에 각국의 의료비가 가파르게 상승하고 있어 의료보험 지출 등 의료비 절감을 위한 방안을 찾고 있는 많은 국가들이 기존의 블록버스터 오리지널 바이오 의약품과 효능은 동일하면서 상대적으로 낮은 가격의 바이오시밀러 개발을 권장함과 동시에 이의 개발을 촉진하기 위한 규정 및 가이드라인을 제정하고 있습니다. 이에 전 세계적으로 많은 제약사들이 경쟁적으로 바이오시밀러 개발을 추진하고 있습니다. </P>
<P>  </P>

<TABLE ACLASS="NORMAL" WIDTH="655" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="646"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="655" HEIGHT="30">[ 바이오시밀러 주요 규정/가이드라인 현황]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="658" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="356"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="365" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제목</P>
</TH>

<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>발표연월</P>
</TH>

<TH WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>발표기관</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="30">
<P>동등생물의약품 평가 가이드라인</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2009. 7.</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30">
<P>식품의약품안전청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="53">
<P>에리스로포이에틴 동등생물의약품의 전임상 및 임상 평가 가이드라인</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2011.12</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="53">
<P>식품의약품안전청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="53">
<P>소마트로핀 동등생물의약품의 전임상 및 임상 평가 가이드라인</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2011.12</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="53">
<P>식품의약품안전청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="53">
<P>유전자재조합 과립구 집락 자극인자 (G-CSF) 동등생물의약품의 전임상 및 임상 평가 가이드라인</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2012.10</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="53">
<P>식품의약품안전청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="53">
<P>단클론항체 동등생물의약품의 전임상 및 임상 평가 가이드라인</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2013. 9.</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="53">
<P>식품의약품안전처</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="30">
<P>동등생물의약품 평가 가이드라인 (Rev. 1)</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2014.12</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30">
<P>식품의약품안전처</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="30">
<P>동등생물의약품 허가 및 심사를 위한 질의 응답집</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2014.12</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30">
<P>식품의약품안전처</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="76">
<P>Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (revision 1)</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>2014. 5</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="76">
<P>European Medicines Agency</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="53">
<P>Guideline on similar biological medicinal products&cr; (rev 1)</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2014.10</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="53">
<P>European Medicines Agency</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="76">
<P>Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues (rev 1)</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>2014.12</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="76">
<P>European Medicines Agency</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="30">
<P>Guideline on similar biological medicinal products</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2015. 4</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30">
<P>European Medicines Agency</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="53">
<P>Guidelines on evaluation of similar biotherapeutic products (SBPs)</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2009.10</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="53">
<P>World Health Organization</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="76">
<P>Guidelines on evaluation of similar biotherapeutic products (SBPs), Annex 2. Technical Report Series &cr;No. 977</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>2009.10</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="76">
<P>World Health Organization</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="76">
<P>Guidelines on evaluation on monoclonal antibodies as similar biotherapeutic products (SBPs), Annex 2, Technical Report Series No. 1004</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>2016.10</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="76">
<P>World Health Organization</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="53">
<P>Guidance for Industry Scientific Considerations in Demonstrating Biosimilarity to a Reference Product</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2012. 2</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="53">
<P>FDA</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="53">
<P>Quality considerations in demonstrating biosimilarity of a therapeutic protein product to a reference product</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2015. 4</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="53">
<P>FDA</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="53">
<P>Scientific considerations in demonstrating biosimilarity to a reference product</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2015. 4</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="53">
<P>FDA</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="365" VALIGN="MIDDLE" HEIGHT="76">
<P>Development of Therapeutic Protein Biosimilars: Comparability Analytical Assessment and Other Quality-Related Considerations</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>2019. 5</P>
</TD>

<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="76">
<P>FDA</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> (출처: 자체조사)</P>
<P>&cr;국내 바이오시밀러 관련 허가는 2009년 고시된 ‘동등생물의약품(바이오시밀러) 허가 심사를 위한 규정’에 따라 품질평가, 전임상평가, 임상평가, 적응증 외삽의 단계를 거쳐 이루어집니다.</P>
<P>다른 의약품과 마찬가지로 바이오시밀러의 판매를 위해서는 각국의 의약품 관련 허가기관으로부터 승인을 받아야 하며, 바이오시밀러의 승인을 위해서는 다른 신약이나 복제의약품과는 다른 승인 절차가 필요합니다.</P>

<P>
<SPAN>이러한 승인을 위한 기준 및 절차 등을 명시한 규정을 가이드라인이라 하며, 바이오시밀러에 대한 가이드라인은 2004년 유럽에서 최초로 바이오시밀러에 대한 가이드라인을 제정한 후 2006년에 최초의 바이오시밀러 시판 허가를 내주었고, 이후 2009년 일본, 한국을 비롯한 많은 전 세계 국가들이 자국 내 바이오시밀러의 도입을 위해 가이드라인을 제정하였습니다. 미국은 2012년에 바이오시밀러에 대한 가이드라인을제정하였고</SPAN>
<SPAN> </SPAN>
<SPAN> </SPAN>
<SPAN>미국 FDA는 2018년 7월에  바이오시밀러의 처방 활성화를 목적으로 하는 바이오시밀러 시장강화정책(Biosimilars Action Plan, BAT)을, 2019년 5월에는 바이오시밀러 관련 가이드라인을  발표 하</SPAN>
<SPAN>였습니다.&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="628" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="619"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="628" HEIGHT="30">[바이오시밀러 승인 평가과정과 기준]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="626" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="393"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="131" VALIGN="MIDDLE" HEIGHT="304">
<P>① 품질평가</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="145">
<P>특성분석</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="145">
<SPAN>대조약과의 1차 및 고차구조 분석과 </SPAN>
<SPAN>당화를 포함한 번역 후 변형, 물리화학적 성질, 생물학적 활성, 함량, 순도와 불순물, 불용성 미립자 등과 가속 및/또는 가혹조건 (온도, 빛, pH, 습도, 산화 등)에서 분해산물 비교시험을 통해 해당 단백질의 특성에 따른 불순물과 제조공정에서 발생하는 불순물에 대한 순도시험, 면역학적 </SPAN>
<SPAN>동등성 평가.</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">
<P>기준규격</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="53">
<P>관련 규정에 적합하고 제품 특이적인 품질항목이 대조약과 동등성이 확보될 수 있는 규격 선정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">
<P>분석방법</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="53">
<P>최신 기술을 이용한 광범위한 특성 분석방법과 한 가지 품질항목에 한 가지 이상의 분석방법 사용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">
<P>안정성시험</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="53">
<P>유효기간과 저장조건 설정을 위한 장기보존시험, 대조약과 비교한 가속 및 가혹 시험</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="131" VALIGN="MIDDLE" HEIGHT="182">

<P>
<SPAN>② </SPAN>
<SPAN>비임상</SPAN>
<SPAN> 평가</SPAN>
</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="76">
<P>독성시험</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="76">
<P>단회 및/도는 반복투여 독성시험 자료 필요하며, 대조약과 비교동등성 입증하도록 디자인되어야 하고 독성동태시험 포함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">
<P>in vitro 시험</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="53">
<P>수용체 결합시험, 세포증식 시험 등을 통해 대조약과의 동등성 평가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">
<P>in vivo 시험</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="53">
<P>약동학, 약력학, 및 반복투여 독성시험 등을 통하여 대조약과의 동등성 평가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="131" VALIGN="MIDDLE" HEIGHT="83">
<P>③ 임상 1상 평가</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">
<P>약동학 시험</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="53">
<P>대조약의 권장 용량 범위 내의 용량을 사용하여 대조약과 동등성 비교</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">
<P>약력학 시험</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="30">
<P>임상 효과와의 상관성에 근거한 약력학 변수 설정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="131" VALIGN="MIDDLE" HEIGHT="143">
<P>④ 임상 3상 평가</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">
<P>유효성 시험</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="30">
<P>임상적 동등성 시험</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">
<P>확증적 약동력학 시험</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="53">
<P>대조약과 동등성 비교</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">
<P>안전성</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="30">
<P>이상반응에 대해 대조약과 비교</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">
<P>면역원성</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="30">
<P>면역반응에 의한 임상적 영향 비교</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="53">
<P>⑤ 적응증 외삽</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">
<P>-</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="53">
<P>대조약과의 잠재적 차이를 증명하는 경우 적응증 외삽 가능</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> &cr;</P>
<P USERMARK=" B">나. 시장 현황</P>
<P> </P>
<P>(1) 바이오의약품 시장</P>
<P> </P>

<P>
<SPAN> 바이오의약품 전체 시장은 다양한 제품군들로 구성되는데, 주로 단백질 치료제, 항체치료제, 백신, 줄기세포 치료제 및 유전자 치료제 </SPAN>
<SPAN>등으로 지칭됩니다. </SPAN>
<SPAN>복잡한 구조로 이뤄진 바이오의약품은 합성의약품에 비해 상대적으로 효능은 높고 부작용은 적어서 일반적으로 합성의약품보다 바이오 의약품이 고가임에도 불구하고 다양한 만성질환, 중증 질환, 주요 질병등을 치료하고자 하는 환자들에게 사용되고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN>세계 바이오의약품 시장규모는 조사기관 및 발표 시점에 따라 다소 차이가 존재하는데 Evaluate Pharma의  "Word Preview 2020.Outlook to 2026"에 의하면 2019년 기준 전체 의약품 시장(처방전의약품 + 일반의약품)은 9,100억달러로 이 중 바이오 의약품 시장이 2,660억 달러로 전체 의약품 시장의 29%를 차지하고 있으며, 매출액 상위 100위 의약품 품목의 53% 를 바이오 의약품이 차지하는 것으로 추정하고 있습니다.  세계 바이오의약품 시장은 2012~2019년 까지 연 8.6%로 성장한데 이어 향후 2020~2026년까지는 연 10.1%의 성장을 지속하여 2026년의 시장규모가 5,050억 달러에 달할 것으로 전망하고 있고 이에 따라 전체 의약품 시장에서 바이오 의약품이 차지하는 비중이 2010년 18%에서 2019년 29%, 2026년 35%로 지속적인 증가를 예상하고 있습니다. </SPAN>
<SPAN> 바이오의약품은 합성 의약품에 비하여 매우 높은 부가가치를 가지고 있는 산업이므로 미래 의약품시장의 성장은 바이오 의약품에 의하여 주도될 것입니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<IMAGE>
<IMG WIDTH="518" HEIGHT="309" ALIGN="CENTER" HSPACE="0">글로벌바이오의약품시장규모및전망(2012년~2026년).jpg</IMG>
<IMG-CAPTION ATOC="N">글로벌바이오의약품시장규모및전망(2012년~2026년)</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;&cr;</SPAN>
</P>
<P>이러한 바이오의약품의 시장 성장은 주로 항체치료제 또는 항체치료제 바이오시밀러제품들이 속속 개발되면서 성장을 주도하게 되겠지만, 이머징 마켓을 중심으로 만성신부전환자, 혈우병환자 등 만성질환 환자수가 크게 증가하고 있어 단백질치료제 시장도 지속적으로 증가하면서 바이오의약품 시장의 성장에 기여하게 될 전망입니다. </P>
<P> </P>
<P>역사적으로 국내 바이오의약품 시장은 stand alone 시장이라고 할 수 있습니다. 1980년대 중반 국내제약사에서 시작한 유전자재조합 제품들은 모두 기존의 바이오의약품을 복제하는 것을 기반으로 시작하였고 성장호르몬, EPO, G-CSF 등 1세대 바이오의약품들이 국산화되어 이 제품들이 국내바이오의약품 시장을 선도하였습니다. 그러나 이들 제품들은 품질 수준에서 선진국 제품과 격차가 있었으며 허가 등록 자료 미비 등으로 선진국 시장으로 진출하지 못하고 제3세계에서 저가 제품들과 경쟁하면서 시장을 크게 성장시키지 못하였습니다.</P>
<P> </P>

<P>
<SPAN>그러나 2009년부터 국내 식약처가 바이오시밀러 개발을 위한 가이드라인을 만들기 시작하였고</SPAN>
<SPAN>, ㈜팬젠, 셀트리온, 삼성바이오에피스등 여러 회사들이 바이오시밀러 항체 및 단백질 치료제를 개발하기 시작하였습니다. 최근 들어서는 블록버스터 항체의약품들에 대한 바이오시밀러가 국제적인 관심을 끌게 되자 국내 대기업에서도 개발경쟁이 치열하게 전개되었습니다.  그 결과 셀트리온, 삼성바이오에피스등 국내 여러회사들이 미국과 EU 인허가를 획득하며 선진국 시장 판매를 본격화하였고 </SPAN>
<SPAN> 바</SPAN>
<SPAN>이오의약품 개발에 대한 연구개발이 지속적으로 이루어지고 있으며, 이로 인한 바이오의약품 시장의 확대가 예상됩니다.&cr;</SPAN>
</P>
<P>(2) 바이오시밀러 시장</P>
<P> </P>

<P>
<SPAN>바이오시밀러는 오리지널 의약품과 품질비교, 임상시험 비교등을 통해 유사성이 확인되어 허가받은 제품을 의미하며 </SPAN>
<SPAN>바이오신약에 비해 상대적으로 개발비용 </SPAN>
<SPAN>절감 및</SPAN>
<SPAN> 개발기간을 </SPAN>
<SPAN>단축할</SPAN>
<SPAN> 수 있고 이미 검증된 제품을 생산하기 때문에 단기간에 </SPAN>
<SPAN>빠른</SPAN>
<SPAN>성장이 가능합니다. 또한 세계 각국의 의료비 재정부담 축소와  블룩버스터 오리지널 바이오 의약품 특허가 2020년 까지 대거 만료, 의약품에 대한 환자 접근성 개선을 위한 신약대비 저렴한 복제약 사용</SPAN>
<SPAN> 장려등에 따라 바이오시밀러 시장은 급격히 확대될 전망입니다</SPAN>
<SPAN>.</SPAN>
</P>

<P>
<SPAN> &cr;</SPAN>
<SPAN>Forst & Sullivan의 바이오시밀러 시장 전망에 따르면  세계 바이오시밀러 시장은 2017 ~ 2023년동안 연평균 30.6%의  급격한 성장을 예측하고 있습니다.  시장규모는 2017년 97억달러에서 2023년 481억달러에 이를 전망이며  전체 바이오의약품중 바이오시밀러 의약품이 차지하는 비중은 2017년 4.2%에서 2023년 12.9%로 급격히 증가할 것으로 예측하고 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="239" ALIGN="CENTER" HSPACE="0">글로벌 바이오신약 및 바이오시밀러 전망(2017~2023).jpg</IMG>
<IMG-CAPTION ATOC="N">글로벌 바이오신약 및 바이오시밀러 전망(2017~2023)</IMG-CAPTION>
</IMAGE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">출처: Forst & Sullivan(2019)&cr;</SPAN>
</P>
<P>이와 같은 바이오시밀러 시장의 높은 성장세는 바이오시밀러 의약품이 오리지널 바이오의약품과의 동등한 효능 대비 저렴한 약가, 오리지널 바이오의약품의 특허만료, 선진시장의 만성질환 환자의 지속적인 증가, 정부 보건의료 재정의 압박등에 따른  신규 바이오시밀러 제품 개발에 주로 기인한 것으로 판단됩니다.</P>
<P> </P>
<P>또한 지역 특성상 풍부한 구매력을 보유한 이머징 마켓 내 인구의 노화, 만성질환의 확대, 소득증가에 따른 수요 증가 등은 바이오시밀러 시장 성장에 긍정적 요소로 작용할 것으로 전망됩니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(3) </SPAN>
<SPAN>위탁생산(CMO)</SPAN>
<SPAN> 시장&cr;&cr;</SPAN>
<SPAN> 바이오 의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산(CMO: </SPAN>
<SPAN>Contract  Manufacturing Organization</SPAN>
<SPAN> ) 사</SPAN>
<SPAN>업은 자체 생산역량이 부족한 바이오</SPAN>
<SPAN>회</SPAN>
<SPAN>사, 의약품 R&D 및 의약품 판매에 사업역량을 집중하기 위해 생산을 전략적으로 아웃소싱하는 바이오 제약사들을 고객으로하는 위탁생산 사업 입니다.  CMO 업체</SPAN>
<SPAN>들은 One stop shop 솔루션 제공업체로 거듭나기 위해 의약품 제조 서비스와 후보물질 개발등 위탁개발 서비스를 통합한 CDMO 서비스를 제공하는 비즈니스 모델로 전환하는 추세 입니다&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> Forst & Sullivan의 시장 전망에 따르면  글로벌 CMO 시장은 2015 ~ 2020년동안 연평균 8.4%의  성장을 예측하고 있으며 시장규모는 2016년 788억달러에서 2020년 1,087억달러에 이를 것으로 전망하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="269" ALIGN="CENTER" HSPACE="0">글로벌cro시장전망(2012~2020).jpg</IMG>
<IMG-CAPTION ATOC="N">글로벌CRO시장전망(2012~2020)</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>출처: Forst & Sullivan(2016)&cr;</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">다. 시장 규모 및 전망</SPAN>
</P>
<P> </P>

<P>
<SPAN> (1) </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> 바</SPAN>
<SPAN>이오시밀러 의약품 시장 규모 및 성장전망</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>Forst & Sullivan(2019)의 바이오시밀러 시장 전망에 따르면  세계 바이오시밀러 시장은 2017 ~ 2023년동안 연평균 30.6%의  급격한 성장을 예측하고 있습니다.  시장규모는 2017년 97억달러에서 2023년 481억달러에 이를 전망이며  전체 바이오의약품중 바이오시밀러 의약품이 차지하는 비중은 2017년 4.2%에서 2023년 12.9%로 급격히 증가할 것으로 예측하고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN>(2) 타겟시장 </SPAN>
<SPAN>  EPO 시장 규모 </SPAN>
<SPAN> 및 전망   </SPAN>
<SPAN>     &cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"> </SPAN>
<SPAN USERMARK=" 0X0000FF">신</SPAN>
<SPAN>장 투석 환자 (만성 신부전)의 투석 중 일어나는 급성 빈혈</SPAN>
<SPAN>치료제인 EPO의 2020년 국내시장 규모은 </SPAN>
<SPAN>약 917억원이며, 말레이시아  EPO 시장규모는 약 1.1억RM 입니다.</SPAN>
<SPAN>  대한신장학회에 따르면 2018년말 기준 국내</SPAN>
<SPAN> 만성콩팥병 환자수가 10만명(말기신부전 77,617명, 신장이식 20,119명, 복막투석 6,248명)으로 최근 5년간 26% 증가하였고 만성콩팥병 환자 증가로 투석기관도 같은기간 39% 증가 하였습니다.  환자수 증가 및 투석기관 증가에 따라  EPO시장도 증가가 예상됩니다.</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="454" ALIGN="CENTER" HSPACE="0">만성콩팥병환자수.jpg</IMG>
<IMG-CAPTION ATOC="N">만성콩팥병환자수</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;타켓시장 EPO 시장 규모</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">구    분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2020년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2019년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2018년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">한    국</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">917억원</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">920억원</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">913억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">말레이시아</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">1.10억RM</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">1.05억RM</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">1.04억RM</TD>
</TR>
</TBODY>
</TABLE>
<P> &cr;</P>
<P USERMARK=" B">라. 개발 및 경쟁현황</P>
<P> </P>

<P>
<SPAN>당사가 </SPAN>
<SPAN>개발하였거나 개발 중인</SPAN>
<SPAN> 바이오</SPAN>
<SPAN>의약품</SPAN>
<SPAN> 제품에는 바이오시밀러 EPO의약품, 재조합 Factor VIII, </SPAN>
<SPAN> </SPAN>
<SPAN>바이오시밀러 G-CSF, </SPAN>
<SPAN>바이오시밀러 </SPAN>
<SPAN>Aflibercept</SPAN>
<SPAN></SPAN>
<SPAN>, </SPAN>
<SPAN></SPAN>
<SPAN>항SFTS</SPAN>
<SPAN>V항체</SPAN>
<SPAN> 제품등이 있으며 그 외에 </SPAN>
<SPAN>사업</SPAN>
<SPAN>으로 바이오의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산(CMO) 및 바이오의약품 개발 기술 이전 </SPAN>
<SPAN>서비스(CDO)등이</SPAN>
<SPAN> 있습니다. 이 제품별 경쟁업체는 당사가 개발 중인 제품과 유사한 기술을 적용시킨 제품 및 </SPAN>
<SPAN>사업을 주로하고 있는</SPAN>
<SPAN> 회사들 가운데 대표적인 회사를 선정하였으며 </SPAN>
<SPAN>주요 경쟁업체 현황은 다음과 같습니다.</SPAN>
</P>
<P> </P>

<TABLE BORDER="1" WIDTH="796" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="246"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="428" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">기  술 (제품)</P>
</TH>

<TH WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">국내경쟁사</P>
</TH>

<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">해외경쟁사</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">

<P USERMARK="F-10">
<SPAN USERMARK="F-11">바이오시밀러 </SPAN>
<SPAN USERMARK="F-11">EPO의약품</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11">(만성 신부전 환자의 빈혈 치료제)</SPAN>
</P>
</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">사업화</TD>

<TD WIDTH="165" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">

<P>
<SPAN>LG화학</SPAN>
<SPAN>,HK이노</SPAN>엔
</P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Sandoz사, Janssen사</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">

<P>
<SPAN>재조합 Factor VIII&cr;</SPAN>
<SPAN>(혈우병A치료제)</SPAN>
</P>
</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">임상1상완료</TD>

<TD WIDTH="165" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>녹십자</P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Pfizer사, Baxter사</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">

<P>
<SPAN>바이오시밀러 G-CSF&cr;</SPAN>
<SPAN>(항암치료보조제)</SPAN>
</P>
</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전임상완료</TD>

<TD WIDTH="165" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>제일기린, JW중외 </P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Roche/Chugai사, Sandoz사</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<SPAN>바이오시밀러 </SPAN>
<SPAN>Aflibercept</SPAN>
<SPAN>&cr;(황반변성,황반부종등 치료제)</SPAN>
</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전임상완료</TD>
<TD WIDTH="165" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">바이엘코리아,</TD>
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Bayer사, Roche사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<SPAN>항SFTSV항체&cr;(</SPAN>
<SPAN>중증열성혈소판감소증후군치료제</SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">생산세포주,공정개발&cr;완료</TD>
<TD WIDTH="165" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<SPAN>바이오의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산(CMO)</SPAN>
</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">사업화</TD>
<TD WIDTH="165" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">삼성바이오로직스</TD>
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Lonza사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>바이오의약품 &cr;개발 기술 이전 서비스(CDO)</P>
</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">사업화</TD>
<TD WIDTH="165" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">삼성바이오로직스</TD>

<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Selexis사, Lonza사</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P> </P>
<P USERMARK=" B">마. 회사 사업 개요</P>
<P> </P>

<P>
<SPAN> </SPAN>
<SPAN>당</SPAN>
<SPAN>사의 주요사업은 </SPAN>
<SPAN>바이오시밀러 EPO의약품 생산 및 판매, 바이오의약품 개발사업과</SPAN>
<SPAN> 바이오의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산(CMO) 및 바이오의약품 개발 기술이전(CDO) 서비스가 있습니다. </SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>만성 신부전 환자의 빈혈 치료제인 바이오시밀러  EPO의약품 사업은 자체 제품개발에 성</SPAN>
<SPAN>공하여  현재 국내(제품명:팬포틴) 및 말레이시아(제품명:Erysaa) 시장에서 판매중에 있으며, 개발중인 바이오의약품 제품에는</SPAN>
<SPAN>  혈우병A 치료제인</SPAN>
<SPAN> FactorVIII(</SPAN>
<SPAN>임상1상 완료)</SPAN>
<SPAN>, </SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>황반변성,황반부종등</SPAN>
<SPAN> 치료제인 바이오시밀러 </SPAN>
<SPAN>Aflibercept(</SPAN>
<SPAN>전임상완료)</SPAN>
<SPAN>, 항암치료 보조제인 바이오시밀러 G-CSF (전임상 완료), </SPAN>
<SPAN>중증열성혈소판감소증후군치료제</SPAN>
<SPAN>인 항SFTSV항</SPAN>
<SPAN>체(</SPAN>
<SPAN>생산세포주 및 공정기술 개발완료)</SPAN>
<SPAN>등이 있으며 </SPAN>
<SPAN>순차적으로 제품개발 중에 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>바이오의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산 및 바이오의약품 개발 기술 이전 서비스는 생산용 세포주 및 생산 공정 기술 이전 서비스(CDO)와 위</SPAN>
<SPAN>탁생산</SPAN>
<SPAN>서비스(</SPAN>
<SPAN>(</SPAN>
<SPAN>CMO)</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>등으로 설립 이후부터</SPAN>
<SPAN> </SPAN>
<SPAN>현재까지 </SPAN>
<SPAN>항체 치료제 13종을 포함한 바이오의약품 생산용 세포주를 50종 구축하였고</SPAN>
<SPAN> </SPAN>
<SPAN>수십건의 항체치료제 및 단백질 치료제 기술이전</SPAN>
<SPAN>과  </SPAN>
<SPAN>위탁생산(CM</SPAN>
<SPAN>O)</SPAN>
<SPAN>사업을 </SPAN>
<SPAN>성공적으로 수행하였습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="628" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="619"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="628" HEIGHT="30">[팬젠의 주요 사업 개황]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="987" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="207"></COL>
<COL WIDTH="246"></COL>
<COL WIDTH="244"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="263" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>사업부분</P>
</TH>

<TH WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>해당기술</P>
</TH>

<TH WIDTH="255" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요(개발)제품 및 서비스</P>
</TH>
<TH WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">진행사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">바이오시밀러의약품생산및판매</TD>

<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">
<P>PanGen CHO-TECH™기술 및</P>

<P>
<SPAN>바이오의약품,</SPAN>
<SPAN>제품화 기술</SPAN>
<SPAN>등</SPAN>
</P>
</TD>

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">
<P>바이오시밀러 EPO</P>
<P>(만성 신부전 환자의 빈혈치료제)</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">

<P>
<SPAN>자</SPAN>
<SPAN>체제</SPAN>
<SPAN>품개</SPAN>
<SPAN>발성공&cr;한</SPAN>
<SPAN>국,말레이시아 제품판매중</SPAN>
<SPAN>&cr;필리핀,베트남,태국,사우디아라비아</SPAN>
<SPAN> </SPAN>
<SPAN>품목허가신청</SPAN>
<SPAN></SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="263" VALIGN="MIDDLE" HEIGHT="258" ALIGN="CENTER">
<P>바이오의약품</P>

<P>
<SPAN></SPAN>
<SPAN>개발사업등</SPAN>
</P>
</TD>

<TD ROWSPAN="4" WIDTH="216" VALIGN="MIDDLE" HEIGHT="258" ALIGN="CENTER">
<P>PanGen CHO-TECH™기술 및</P>

<P>
<SPAN>바이오의약품,</SPAN>
<SPAN>제품화 기술</SPAN>
<SPAN>등</SPAN>
</P>
</TD>

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">
<P>재조합 Factor VIII</P>
<P>(혈우병A 치료제) </P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">

<P>
<SPAN>전임상완료(17년 7월)&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>한국 IND제출 (18년10월)&cr;한국임상1상 시험승인(19년 3월)&cr;</SPAN>
<SPAN></SPAN>
<SPAN>한국 임상1상 완료</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>바이오시밀러 G-CSF</P>
<P>(항암치료 보조제)</P>
</TD>
<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전임상 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<SPAN>바이오시밀러 </SPAN>
<SPAN> </SPAN>
<SPAN>Aflibercept</SPAN>
<SPAN>&cr;(황반변성,황반부종등 치료제)</SPAN>
</TD>
<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전임상 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">항SFTSV항체&cr;(중증열성혈소판감소증후군치료제)</TD>
<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">생산세포주 및 공정기술개발완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="263" VALIGN="MIDDLE" HEIGHT="106" ALIGN="CENTER">
<P>바이오의약품 위탁생산 및 개발 기술</P>

<P>
<SPAN>이전 서비스(CDMO)</SPAN>
</P>
</TD>

<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>PanGen CHO-TECH™기술</P>
</TD>

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>생산용세포주 및 </P>

<P>
<SPAN>생산공정 기술이전 서비스&cr;</SPAN>
<SPAN>(CDO)</SPAN>
</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>사업화</P>
<P>(기술이전)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>바이오의약품 제품화 기술</P>
</TD>

<TD WIDTH="255" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>위탁생산서비스(CMO)</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>사업화</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(1) 바이오시밀러 의약품 생산 및 판매사업&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>바</SPAN>
<SPAN>이</SPAN>
<SPAN>오시밀러 의약품 생산 및 판매사업은 자체 제품개발에 성공한  만성 신부전 환자의 빈혈치료제인 바이오시밀러 EPO 의약품의 생산 및 판매 사업으로, 바이오시밀러 EPO 의약품은 세계 2번째로 epoetin alfa 성분의 바이오시밀러 의약품으로 </SPAN>
<SPAN>개발하였으며</SPAN>
<SPAN>, 오리지널의약품은 Amgen사의 Eprex 입니다.  &cr;&cr;</SPAN>
<SPAN> </SPAN>
<SPAN>한국과 말레이시아에서 다국가 임상을 진행하여 20</SPAN>
<SPAN>19년 </SPAN>
<SPAN>1월에 말레이시아 식약청으로부터 </SPAN>
<SPAN></SPAN>
<SPAN>품목허가(제품명:Erysaa)를 받았으며 2019년 11월에는 한국 식약처로부터 품목허가(제품명:팬포틴)를 </SPAN>
<SPAN>받아 말레이시아 시장과 국내 시장에 판매하고 있습니다. </SPAN>
<SPAN></SPAN>
<SPAN> 시장 다변화를 위해 필리핀, 베트남, 태국등 주요 아세안 국가와 </SPAN>
<SPAN>사우디아라비아</SPAN>
<SPAN>에</SPAN>
<SPAN> 품목허가 신청을 </SPAN>
<SPAN>하였으며</SPAN>
<SPAN>, 2020년 2월에 한국이슬람교중</SPAN>
<SPAN>앙회(KMF)로 부터 할랄인증을 취득하여 향후 아세안시장의 주요 이슬람국가와 사우디아라비아 시장진출에  크게 도움이 될 수 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>EP</SPAN>
<SPAN>O의</SPAN>
<SPAN>약품 판권과 관련하여 2014년에</SPAN>
<SPAN> </SPAN>
<SPAN>Duopharma Sdn Berhad</SPAN>
<SPAN></SPAN>
<SPAN>사와 말레이시아외 2개국 판권계약을 체결하였고</SPAN>
<SPAN> </SPAN>
<SPAN>2015년에 ONKO사와 터키 판권을, S.Charoen사와</SPAN>
<SPAN> </SPAN>
<SPAN> 태국 판권을, 2019년에 Saudi Vax사와 사우디아라비아외</SPAN>
<SPAN> </SPAN>
<SPAN>GCC 5개국</SPAN>
<SPAN>의 판권계약을,</SPAN>
<SPAN> 2020년에는</SPAN>
<SPAN> </SPAN>
<SPAN>중헌제약과 국내 판권계약을, </SPAN>
<SPAN> Khuong Duy Pharma사와 베트남 판권계약을 체결하였습니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN>(2) 바이오의약품  개발 사업 </SPAN>
</P>
<P> </P>

<P USERMARK=" 0X54AF00">
<SPAN USERMARK=" 0X000000">바이오의약품 개발 사업은 당사가 보유한 바이오의약품 개발에 필수적인 PanGen CHO-TECH™ 원천기술과 바이오의약품 제품화 기술을 활용하여 재조합 Factor VIII (혈우병A치료제) 및 </SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000"> 바이오시밀러G-CSF(항암치료보조제), </SPAN>
<SPAN USERMARK=" 0X000000">바이오시밀러 </SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
<SPAN USERMARK=" 0X000000">Aflibercept</SPAN>
<SPAN USERMARK=" 0X000000">(황반변성,황반부종등 치료제), 항SFTSV항체(중증열성혈소판감소증후군 치료제)등의 제품을 개발하는 사업입니다</SPAN>
<SPAN USERMARK=" 0X000000">.</SPAN>
</P>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="521" ALIGN="CENTER" HSPACE="0">개발중인 바이오시밀러 제품의 개요2.jpg</IMG>
<IMG-CAPTION ATOC="N">개발중인 바이오시밀러 제품의 개요2</IMG-CAPTION>
</IMAGE>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN>혈우병A치료제인 </SPAN>
<SPAN>재조합 Factor VIII 제품의 경우 단백질의 크기가 크고 구조가 복잡하여 바이오</SPAN>
<SPAN>시밀러 개발이 불가능하므로 일반적인 바이오제네릭 제품으로 개발하고 있습니다. 당사가 </SPAN>
<SPAN>개발</SPAN>
<SPAN>중인</SPAN>
<SPAN> 재조합 Factor VIII 제품은 세계 세 번째 B도메인 결손 재조합 Factor VIII 제품으로 첫 번째 제품은 Pfizer사가 보유한 Xyntha/ReFacto 제품이고 두번째 제품은 녹십자의 그린</SPAN>
<SPAN>진-F입니다. </SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>Factor VIII은 </SPAN>
<SPAN>2017년</SPAN>
<SPAN> 7월에 전임상시험을 완료 하</SPAN>
<SPAN>였으며</SPAN>
<SPAN>,</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>2018년 10월에 한국식약처에 임상 IND제출</SPAN>
<SPAN>하였고 2019년 3월에 한국임상1상 시험승인</SPAN>
<SPAN>을</SPAN>
<SPAN> 받</SPAN>
<SPAN>았</SPAN>
<SPAN>습니다. </SPAN>
<SPAN> </SPAN>
<SPAN>국</SPAN>
<SPAN>내</SPAN>
<SPAN> 을지대 병원에서</SPAN>
<SPAN> 임상1상 시험을 진행하</SPAN>
<SPAN>여, 2019년 11월에 첫 환자 </SPAN>
<SPAN></SPAN>
<SPAN>투여를 시작하였고,</SPAN>
<SPAN>  2020년 7월에 마지막 환자의 임상약 투여가 </SPAN>
<SPAN>완료되어</SPAN>
<SPAN>  현재 임상1상 시험이  종료되었습니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>항암치료 보조제인</SPAN>
<SPAN> 바이오시밀러 G-CSF 제품의 경우  lenograstim 성분의 세계 최초 바이오시밀러 제품으로 개발하고 있습니다. 오리지널 제품은 Roche/Chugai사가 보유한 Neutrogin 제품이며</SPAN>
<SPAN>, 당사의 제품은 동물세포배양 방식으로 생산되어 미생물 배양으로 생산되는 filgrastim 성분의 제품보다 효능이 우수하고 안전성이 높은 장점이 있습니다</SPAN>
<SPAN>.</SPAN>
<SPAN> 현재 전임상 시험을 </SPAN>
<SPAN>완료하였습니다.&cr;&cr;</SPAN>
<SPAN>황반변성, 황반부종등의</SPAN>
<SPAN> 치</SPAN>
<SPAN>료</SPAN>
<SPAN>제</SPAN>
<SPAN>인</SPAN>
<SPAN> Aflibercept</SPAN>
<SPAN> 바이오시밀러 제품은 바이오시밀러 제품으로 개발하고 있으며, 오리지널 제품은 Regeneron(판매사 </SPAN>
<SPAN>Baye</SPAN>
<SPAN>r)사의 아일리아 (Eylea)입니다. 오리지널 제품의 특허가 아직 만료되지 않아 전세계적으로 바이오시밀러 제품은 현재 시장에 없는 상황입니다. 오리지널 제품에 대한 특허가 국내 2024년, 미국 2023년, 유럽 2025년</SPAN>
<SPAN>에 만료될 예정이므로 당사의 제품개발이 완료될 시점에는 대부</SPAN>
<SPAN>분의 주요국가에서 특허가 만료되므로 </SPAN>
<SPAN>충분한 시장이 확보될 것으로 보고 있습니다.</SPAN>
<SPAN> 당사의 제품은 세포주의 생산성이 높으면서 단백질 품질이 오리지널 제품과 상당히</SPAN>
<SPAN> 유사하여 제품생산시 생산 단가를 크게 낮출 수 있게 됨으로써 시장경쟁력 있는 약가가 책정될 수 있을 것으로 예상됩니다. </SPAN>
<SPAN>현재 전임상 시험을 완</SPAN>
<SPAN>료</SPAN>
<SPAN>하였습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>그 밖에  중증 열성 혈소판 감소증후군(Severe fever with thrombocytopenia syndrome) 치료제인 항SFTSV항체 제품이 있습니다. 현</SPAN>
<SPAN>재 전세계적으로 치료제가 없으며  2011년 중국에서 처음 환자발생이 보고된 신종감염병으로 국내는 2012년 처음 감염환자 발생이 보고되었고 해마다 환자수가 증가하고 있으며 국내의 </SPAN>
<SPAN>경우 </SPAN>
<SPAN>최근 7년간(2013~2019년) 치사율이 19.7%에</SPAN>
<SPAN>  이를 정도로 매우 높습니다</SPAN>
<SPAN>.  당</SPAN>
<SPAN>사는 2020년 1월에 중국의 와이클론메티칼 사이언스가 보유한 기술을 도입해 </SPAN>
<SPAN> 현재 생산세포주 개발 및 공정기술 개발을 완료하였습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(3) 바이오의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산 및 개발 기술이전 서비스 사업</SPAN>
</P>
<P> </P>

<P>
<SPAN>당사의 바이오의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산 및 개발 기술이전 서비스 사업은 당사가 보유하고 있는 원천기술인 PanGen CHO-TECH™기술과 바이오의약품 제품화 기술 중 대량생산 기술 및 GMP 운영기술 등이 활용된 사업입니다. 국내외 기업들이 개발하고자 하는 바이오의약품 아이템 별로 우수한 생산용 세포주를 미리 개발한 후 로열티를 부가하여 판매하는 생산용 세포주 기술이전 및 생산공정 기술이전 서비스</SPAN>
<SPAN>(CDO:Contract Development Organization)</SPAN>
<SPAN>와  전임상시료, 임상시료, </SPAN>
<SPAN>원료의약품</SPAN>
<SPAN> 위탁생산 (CMO; Contract Manufacturing Organization) 등의 사업형태로 이루어져 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN>생산용 세포주 기술 이전 서비스 : 이 사업은 PanGen CHO-TECH™ 기술을 이용하여 타 경쟁사 대비 빠른 기간 내에 고 생산성, 고 안정성 바이오 의약품 생산용 CHO(Chinese Hamster Ovary)세포주를 개발하여 관련기술과 함께 세포주를 이전 하는 서비스로  upfront 수익 및 </SPAN>
<SPAN>로열티를 부가로  판매하고</SPAN>
<SPAN> 있는 사업입니다. </SPAN>
</P>
<P> </P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="165" ALIGN="CENTER" HSPACE="0">세포주 개발 및 기술이전 서비스 공정기간.jpg</IMG>
<IMG-CAPTION ATOC="N">세포주 개발 및 기술이전 서비스 공정기간</IMG-CAPTION>
</IMAGE>
<P></P>
<P>생산공정 기술 이전 서비스는 당사가 보유한 PanGen CHO-TECH™ 기술 외에도 우수한 공정개발 인력의 기술 노하우와 우수한 성능의 첨단 보유 설비들(아래 그림 참조)을 활용하여 우수하고 안정적인 공정개발 기술을 확립하여 고객에게 제공하는 기술이전 서비스입니다. &cr;&cr;최근에는 세포주 기술이전 과 공정 기술 이전 계약이 동시에 이루어지고 있습니다.</P>
<P> </P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="307" ALIGN="CENTER" HSPACE="0">공정개발 기술이전 서비스에 활용되는 설비.jpg</IMG>
<IMG-CAPTION ATOC="N">공정개발 기술이전 서비스에 활용되는 설비</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>위탁생산(CMO)서비스는 당사가 보유한 바이오의약품 제품화 기술의 </SPAN>
<SPAN>일부와 PanGen CHO-TECH™ 기술, 바이오의약품 GMP 생산시설을 활용하여 </SPAN>
<SPAN>국내외 기업들의 전임상 및 임상시험용 시료, </SPAN>
<SPAN>원료의약품</SPAN>
<SPAN> 생산을 대행해 주는 서비스 사업입니다. &cr;&cr;당사는 바이오의약품 생산용 세포주 개발부터 시작하여 이를 이용한 최적의 공정기술 개발 그리고 마지막 대량생산까지 전 개발 분야에서 원스톱 서비스가 가능한 회사로 타사 대비 경쟁력 있는 사업으로 꾸준히 사업화 실적을 보여주고 있습니다.&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="586" HEIGHT="255" ALIGN="CENTER" HSPACE="0">gmp시설 내에서의 위탁생산 공정과정.jpg</IMG>
<IMG-CAPTION ATOC="N">GMP시설 내에서의 위탁생산 공정과정</IMG-CAPTION>
</IMAGE>
<P></P>
<P>(4) 주요시설 현황&cr;</P>
<P>당사는 바이오의약품의 대량생산(제품생산)을 위한 바이오의약품 GMP공장을 아래와 같이 구축하여 한국 GMP 뿐만 아니라 ICH 규정에 따르는 GMP 공장을 2011년 2월에 완공하였습니다.</P>

<P>
<SPAN>현재 확보된 GMP 생산시설에서 캠페인 생산 기법으로 첫 번째 제품인 바이오시밀러</SPAN>
<SPAN>EPO의약품 </SPAN>
<SPAN>생산과 </SPAN>
<SPAN>위탁생산(CMO)</SPAN>
<SPAN> 사업을 병행해서 추진하고 있습니다.</SPAN>
</P>

<P>당사의 GMP 생산시설은 자체적
<SPAN>으로 </SPAN>
<SPAN>주사용</SPAN>
<SPAN>수의</SPAN>
<SPAN> 제조 및</SPAN>
<SPAN> 관리를 </SPAN>
<SPAN>하고 있으며, 일회용 바이오리엑터 장비 운용이라는 </SPAN>
<SPAN>당사의 생산시설 특성에 따라</SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>교차생산 방식으로 다품목의 생산이 가능하여 생산시설의 가동율을 극대화 할 수 있습니다. &cr;
</P>

<TABLE ACLASS="NORMAL" WIDTH="628" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="619"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="628" HEIGHT="30">[주요시설 현황]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="181"></COL>
<COL WIDTH="206"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>시설명</P>
</TH>

<TH WIDTH="215" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주소</P>
</TH>

<TH WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>규모(평)</P>
</TH>

<TH WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="190" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>본  사</P>
</TD>

<TD WIDTH="215" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>경기도 수원시 신원로 306</P>
<P>영통 이노플렉스 1동 612호</P>
</TD>
<TD WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">79</TD>

<TD WIDTH="112" HEIGHT="214" VALIGN="MIDDLE" ROWSPAN="4">
<P>&cr;&cr;&cr;&cr;&cr;&cr;&cr;&cr;</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="190" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>연구소</P>
</TD>

<TD WIDTH="215" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>경기도 수원시 신원로 306</P>
<P>영통 이노플렉스 1동 510호외</P>
</TD>
<TD WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">276</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="108" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2">GMP공장 및 사무소</TD>

<TD WIDTH="215" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>경기도 수원시 신원로 306</P>
<P>영통 이노플렉스 2동 4층</P>
</TD>
<TD WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">719</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="215" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P>경기도 수원시 신원로 306</P>
<P>영통 이노플렉스 2동 501호</P>
</TD>
<TD WIDTH="105" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">119</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(5) 수익창출 전략</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>국내 바이오벤처회사의 사업 전략은 일반적으로 R&D 기반의 기술이전 사업 전략과 바이오의약품 제품생산 사업 전략으로 구별할 수 있습니다. </SPAN>
</P>

<P>
<SPAN>당사는 바이오의약품 상업화를 위한 GMP공장을 갖추고 직접 </SPAN>
<SPAN>바이오의약품 제품의  생산</SPAN>
<SPAN> 및 판매, 개발사업과 국내외 기업들이 개발하고자 하는 바이오의약품 아이템 별로우수한 생산용 세포주를 미리 개발한 후 로열티를 부가하여 판매하는 생산용 세포주 기술이전 서비스(CDO)와 생산 공정 개발 서비스, 전임상시료 및 임상시료 위탁생산(CMO) 사업을 병행하며 수익 창출을 하고 있습니다.</SPAN>
</P>
<P></P>

<TABLE ACLASS="NORMAL" WIDTH="587" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="578"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="587" HEIGHT="30">[팬젠 수익창출 모델]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="930" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="237"></COL>
<COL WIDTH="237"></COL>
<COL WIDTH="247"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="246" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수익모델</P>
</TH>

<TH WIDTH="246" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요(개발)제품 및 서비스</P>
</TH>
<TH WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">진행단계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="182" VALIGN="MIDDLE" HEIGHT="380">
<P>바이오의약품 제품 생산 및 판매, 개발사업전략</P>
</TD>

<TD ROWSPAN="5" WIDTH="246" VALIGN="MIDDLE" HEIGHT="380">
<P>바이오의약품 제품 개발-> 품목허가후 의약품 판매를 통한 수익창출</P>
</TD>

<TD WIDTH="246" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">

<P>
<SPAN>바이오시밀러 EPO</SPAN>
<SPAN>의약품</SPAN>
</P>
<P>(만성신부전환자의빈혈 치료제)</P>
</TD>

<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">
<SPAN>자체개발성공&cr;</SPAN>
<SPAN>한국,말레이시아 </SPAN>
<SPAN>제품</SPAN>
<SPAN>판매중&cr;</SPAN>
<SPAN>필리핀,베트남,태국,사우디아라비아 </SPAN>
<SPAN>품목허가신청</SPAN>
<SPAN></SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="246" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">
<P>재조합 Factor VIII</P>
<P>(혈우병A 치료제) </P>
</TD>

<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">

<P>
<SPAN>전임상완료(17년 7월)&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>한국 IND제출(18년 10월)&cr;한국임상1상 시험승인(19년 3월) &cr;</SPAN>
<SPAN></SPAN>
<SPAN>한국 임상1상 완료(20년 9월)</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="246" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>바이오시밀러 G-CSF</P>
<P>(항암치료 보조제)</P>
</TD>
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전임상완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="246" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<SPAN>바이오시밀러 </SPAN>
<SPAN> </SPAN>
<SPAN>Aflibercept</SPAN>
<SPAN>&cr;(황반변성,황반부종등 치료제)</SPAN>
</TD>
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전임상 완료(20년 9월)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">항SFTSV항체&cr;(중증열성혈소판감소증후군치료제)</TD>
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">생산세포주 및 공정기술개발완료&cr;(20년 8월)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="182" VALIGN="MIDDLE" HEIGHT="106">
<P> R&D 기반 바이오의약품&cr;개발기술이전 사업전략</P>
</TD>

<TD ROWSPAN="2" WIDTH="246" VALIGN="MIDDLE" HEIGHT="106">
<P>바이오의약품 개발 기술&cr;이전 서비스->upfront 및 제품출시&cr;매출에 따른 로열티 수익창출</P>
</TD>

<TD WIDTH="246" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>생산용세포주 및 </P>
<P>생산공정 기술이전 서비스&cr;(CDO)</P>
</TD>

<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>사업화</P>
<P>(기술이전)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="246" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>위탁생산서비스(CMO)</P>
</TD>

<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>사업화</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-16 B">&cr;
<SPAN USERMARK=" 0XFF1200">2. 주요 제품, 서비스 등</SPAN>
</P>
<P> </P>

<P USERMARK=" B">
<SPAN>가. 주요 제품</SPAN>
<SPAN> 등에 </SPAN>
<SPAN>관한 사항</SPAN>
</P>

<P>
<SPAN> &cr;</SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>당사는 바이오의약품 개발 기술(PanGen CHO-TECH™ 기술) 및 바이오 의약품 제품화 기술, GMP 생산설비를  활용하여 다음과 같은 서비스등를 제공하고 있습니다.</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN> -의약품 생산 및 판매 : </SPAN>
<SPAN>&cr; ·만</SPAN>
<SPAN>성 신부전 환자의 빈혈치료제인</SPAN>
<SPAN> </SPAN>
<SPAN>바이오시밀러 EPO의약품&cr;</SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>·말레이시아 (제품명:Erysaa)  : 품목허가 (2019.1월), 제품판매(2019.3월~)&cr; </SPAN>
<SPAN>·한국(제품명:팬포틴) :  품목허가(2019.11월), 제품판매 (2020.2월~) &cr;</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>·필리핀, 베트남, 태국, 사우디아라비아에 품목허가 신청&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN> </SPAN>
<SPAN>-바</SPAN>
<SPAN>이오 의약품 개발사업 :&cr;</SPAN>
<SPAN>  ·혈우병</SPAN>
<SPAN>A</SPAN>
<SPAN>치료제 Factor VIII&cr;  ·</SPAN>
<SPAN>항암치료보조제 G-CSF</SPAN>
<SPAN>&cr;  ·황반변성,황반부종등 치료제 Aflibercept&cr;  </SPAN>
<SPAN>·중증열성 혈소판 감소 증후군치료제 </SPAN>
<SPAN></SPAN>
<SPAN>항SFTS</SPAN>
<SPAN>V항체</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>- 바이오 의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN>  </SPAN>
<SPAN>위탁생산</SPAN>
<SPAN></SPAN>
<SPAN> 및 </SPAN>
<SPAN>개발 기술 이전 서비스등:&cr;  ·우수한 성능의 재조합 CHO 생산 세포주 구축,</SPAN>
<SPAN> 기술이전 </SPAN>
<SPAN>(CDO)</SPAN>
<SPAN>(로열티부과)&cr;</SPAN>
<SPAN>  ·바이오 의약품 개발에 필요한 생산공정 </SPAN>
<SPAN>기술이전</SPAN>
<SPAN>(CDO</SPAN>
<SPAN>)</SPAN>
<SPAN>&cr;  ·전임상 또는 임상시험용 시료 및 </SPAN>
<SPAN>바이오의약품 </SPAN>
<SPAN>위탁생산(CMO) &cr; </SPAN>
</P>

<TABLE BORDER="1" WIDTH="646" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="484"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="69" VALIGN="MIDDLE" HEIGHT="413" ALIGN="CENTER">
<P USERMARK="F-10">바이오시밀러 EPO</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" HEIGHT="154" ALIGN="CENTER">
<P USERMARK="F-10">주요 사용&cr;범위</P>
</TD>

<TD WIDTH="493" HEIGHT="154">
<P USERMARK="F-10">-적혈구 형성 자극 인자(Erythropoietin, EPO)로 만성 신부전 환자의 빈혈 치료제임. 즉, 만성 신부전 환자들이 혈액투석이나 복막 투석 중에 일어나는 급성 빈혈을 치료하는 데 사용됨.</P>
<P USERMARK="F-10">-그 외에도 증후성 빈혈이나 수혈이 필요한 빈혈에도 활용 가능함.</P>
<P USERMARK="F-10">-화학요법을 받는 암 환자에게 나타나는 빈혈치료</P>
<P USERMARK="F-10">-자기혈액 채혈량 증가를 위한 적혈구 생성 촉진 및 대수술이 예정되어 있고 수술전 필요량의 자기 혈액 채혈이 어려운 환자의 헤모글로빈 농도 저하 방지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" HEIGHT="259" ALIGN="CENTER">
<P USERMARK="F-10">주요 기능 및 특징</P>
</TD>

<TD WIDTH="493" HEIGHT="259">
<P USERMARK="F-10">-적혈구 형성 자극 인자는 신장에서 생성되는 당 단백질 성 호르몬으로 신체의 산소요구량에 따라 적혈구 생성을 조절하는 생체물질로 신장기능이 비정상인 만성 신부전 환자에서는 이 자극인자가 생성되지 않아 빈혈이 나타나게 됨.</P>
<P USERMARK="F-10">-본 제품은 유전자 재조합 기술을 이용하여 생산된 제제로 골수 중 조혈 조직의 전구세포에 작용 하여 적혈구 원시세포의 분열과 분화를 자극함으로써 적혈구 생성을 유도하게 됨.</P>

<P USERMARK="F-10">
<SPAN>-만성 신부전 환자 대상으로 초기 투여량은 1회 50 IU/kg을 주 3회, 정맥주사 또는 피하주사 함. 헤모글로빈의 농도 증감에 따라 투여횟수 변경 또는 투여용량 증감이 가능함. 최적 헤모글로빈의 수준은 10-12 g/dL가 가장 적절한 것으로 알려져 있음.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>-</SPAN>
<SPAN> </SPAN>
<SPAN>Malaysia 품목허가(19년 1월)</SPAN>
<SPAN>, </SPAN>
<SPAN> </SPAN>
<SPAN>Malaysia </SPAN>
<SPAN>판매개시(19년 3월)&cr;- 한국</SPAN>
<SPAN>품목허가(19년</SPAN>
<SPAN> 11월), 한국 판매개시(20년 2월)&cr;- </SPAN>
<SPAN>필리핀,베트남,태국,사우디아라비아에 </SPAN>
<SPAN>품목허가신청</SPAN>
<SPAN></SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="69" VALIGN="MIDDLE" HEIGHT="476" ALIGN="CENTER">
<P USERMARK="F-10">재조합 혈액응고 8인자 (Factor VIII)</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" HEIGHT="49" ALIGN="CENTER">
<P USERMARK="F-10">주요 사용&cr;범위</P>
</TD>

<TD WIDTH="493" HEIGHT="49">
<P USERMARK="F-10">-혈우병 A (선천성 혈액응고 8인자 결핍증) 환자에서의 출혈의 조절 및 예방.</P>
<P USERMARK="F-10">-일상생활 및 수술 시 출혈 예방.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" HEIGHT="427" ALIGN="CENTER">
<P USERMARK="F-10">주요 기능 및 특징</P>
</TD>

<TD WIDTH="493" HEIGHT="427">
<P USERMARK="F-10">-Factor VIII은 인체의 간세포 (Hepatocyte)에서 생성되어 혈관 내를 순환하며, 혈액응고가 필요할 때 활성화 됨.</P>
<P USERMARK="F-10">-혈우병은 혈액응고인자 결핍으로 인한 출혈성 질환인데, 혈액 내 응고인자들은 1번 ~ 13번 인자들로 구성되어 있으며, 혈우병은 해당 인자의 유전적 결함으로 발생됨.  혈우병 A는 8인자 결핍이 원인이며, 출생 남아 5,000명당 1명 정도에서 발생하는 것으로 알려짐.  혈우병 B는 9인자 결핍이 원인이며, 출생 남아 20,000명당 1명 정도에서 발생하는 것으로 알려짐.</P>
<P USERMARK="F-10">-혈우병의 치료는 부족한 항 응고 인자를 보충해 주는 것으로 8인자와 9인자 제제가 사용되고 있으며, 항체가 생긴 경우에는 우회인자를 투여함.  투여방법에도 출혈이 있을 때 마다 투여하는 보충요법(on-demand)과 평소에 출혈이 발생되지 않더라도 부족한 응고인자를 정기적으로 투여해 출혈을 예방하는 유지요법(prophylaxis)이 있음.</P>

<P USERMARK="F-10">
<SPAN>-재조합 Factor VIII 제품은 신생아를 포함하여, 성인 및 소아에게 적합하며, 투여용량과 투여기간은 8인자 결핍정도, 출혈 부위 및 정도, 환자의 임상적 상태에 따라 결정됨. 8인자의 투여 단위수는 8인자 활성에 대한 WHO 국제 기준인 International Units (IU)로 표시됨.  보통 재조합 Factor VIII 제품의 예방용 투여용량은 30 ± 5 IU/kg의 용량을 주 3회 예방적으로 투여하는 용법용량을 가짐.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>-개발현황: 전임상 완료(17년 7월</SPAN>
<SPAN>), </SPAN>
<SPAN>한국 IND제출 (18년 10월)</SPAN>
<SPAN>,&cr; </SPAN>
<SPAN> 한국</SPAN>
<SPAN>임상1상시험승인(19년 3월), </SPAN>
<SPAN>임상1상 첫환자 투여(19년 11월)&cr;  </SPAN>
<SPAN>임상1상 마지막환자 투여완료(20년 7월)</SPAN>
<SPAN>, 임상1상시험 완료(20년 9월)</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="69" HEIGHT="490" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러&cr; G-CSF</P>
</TD>

<TD WIDTH="84" HEIGHT="97" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">주요 사용&cr;범위</P>
</TD>

<TD WIDTH="493" HEIGHT="97">
<P USERMARK="F-10">-항암치료 환자의 백혈구 증진(항암치료보조제)</P>
<P USERMARK="F-10">-고형암(악성임파종, 소세포폐암, 배세포종양(고환종양, 난소종양 등), 신경아세포종, 소아암, 기타암종)에 대해 항암화학요법을 받고 있는 환자의 호중구 감소증</P>
<P USERMARK="F-10">-혈액종양에 대해 항암화학요법을 받고 있는 환자의 호중구 감소증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" HEIGHT="393" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">주요 기능 및 특징</P>
</TD>

<TD WIDTH="493" HEIGHT="393">
<P USERMARK="F-10">-G-CSF는 골수에 있는 호중구 전구세포에 작용하여 호중구의 기능을 강화시키는 성장 인자이며 각종 고형암 치료를 위한 화학요법 치료시와 면역억제요법에 수반되는 호중구 감소증의 치료와 재생불량성 빈혈환자에 나타나는 호중구 감소증의 치료 그리고 골수 세포와 조혈모세포 이식 시 호중구 증가 촉진 및 조혈모세포의 말초조혈모세포의 동원 등에 사용하고 있는 치료용 단백질임.</P>
<P USERMARK="F-10">-G-CSF는 골수의 monocyte, fibroblast, endothelial cell에서 생산되는 조혈성장인자로서 감염과 염증부위에서 neutrophil의 대식작용을 증강시키는 기능을 함.</P>
<P USERMARK="F-10">-레노그라스팀은 재조합 당화 G-CSF로서 Chinese Hamster Ovary 세포에서 생산된 분자량이 20 kDa이고, 사람 G-CSF와 당화 형태와 생물학적 활성이 유사하며, 비골수성 악성종양 (nonmyelogenous malignacy)의 치료에 있어서 항암요법의 보조치료제로 이용됨.</P>
<P USERMARK="F-10">-레노그라스팀은 항암요법의 보조제로 사용될 때의 용량은 150 mcg/m2/day (5 mcg/kg/day)로 항암제 투여를 종료한 다음 날 피하주사로 시작함. 국내에서는 골수이식, 골수이식형성 증후군, 재생불량성 빈혈로 인한 호중구 감소증일 때는 5 mcg/kg/day를 정맥으로 투여하며, chemotheraphy로 인한 호중구 감소증일 때는 2 mcg/kg/day를 피하주사 또는 5 mcg/kg/day를 정맥으로 투여하며, 선천성 또는 특발성 호중구 감소증일 대는 2 mcg/kg/day를 정맥 내 (IV) 또는 피하 (SC)로 투여함.</P>
<P USERMARK="F-10">-개발현황: 전임상 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="69" HEIGHT="560" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-10">바이오시밀러 </SPAN>
<SPAN USERMARK="F-10">Aflibercept</SPAN>
</TD>

<TD WIDTH="84" HEIGHT="112" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">주요 사용&cr;범위</P>
</TD>

<TD WIDTH="493" HEIGHT="112">
<P USERMARK="F-10"> - 신생혈관성 (습성) 연령 관련 황반변성의 치료&cr; - 망막정맥폐쇄성 황반부종에 의한 시력 손상의 치료(망막중심정맥폐쇄 또는 망막     분지정맥폐쇄)&cr; - 당뇨병성 황반부종에 의한 시력 손상의 치료&cr; - 병적근시로 인한 맥락막 신생혈관 형성에 따른 시력 손상의 치료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" HEIGHT="448" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">주요 기능 및 특징</P>
</TD>

<TD WIDTH="493" HEIGHT="448">
<P USERMARK="F-10">- Aflibercept는 혈관내피인자 수용체 (VEGFR)와 항체의 Fc가 결합된 단백질로 신생혈관성 (습성) 연령관련 황반변성 (AMD) 치료제로 사용되고 있는 약품임.</P>
<P USERMARK="F-10">- 연령관련 황반변성은 50세 이상 고령에서 망막 중심부 신경조직인 황반 부위에 변성이 나타나는 질환으로 드루젠(drusen)과 색소이상, 지도모양위축이 나타나는 건성과 맥락막 신생혈관이 동반되는 습성으로 구분됨. </P>
<P USERMARK="F-10">- 맥락막에 산소가 부족하고 노폐물로 막히게 되면 신생혈관이 생성되기 쉽고, 신생혈관은 쉽게 터져 황반에 손상을 일으키게 됨.</P>
<P USERMARK="F-10">- 습성 연령관련 황반변성은 VEGF에 의해 황반부에 비정상적으로 생성되는 신생혈관과 이로부터 발생하는 출혈, 부종 때문에 시력저하가 발생하므로, 항혈관내피성장인자를 눈 내부에 직접 주사하여 VEGF를 비활성화시킴으로써 이상 혈관의 생성과 체액의 누출을 막는 치료법이 주로 사용되고 있음.</P>
<P USERMARK="F-10">- 현재 사용되는 약물로는 아일리아, 루센티스 그리고 아바스틴이 사용되고 있는데, 아일리아와 루센티스는 습성 황반변성 치료제로 FDA 허가를 받은 약물이고, 아바스틴은 다른 질환에 사용되는 약물을 안구 내 주사치료에 사용하고 있음.</P>
<P USERMARK="F-10">- 항혈관내피성장인자 주사법은 다른 치료법들보다 습성 황반변성에서 시력의 향상과 보존에 효과가 좋은 것으로 보고되고 있으나 주사 후 효과가 지속되는 기간이 짧아 1 ~ 수개월 간격으로 재치료를 받아야함. </P>
<P USERMARK="F-10">-  습성 연령관련 황반변성 치료의 권장용량은 2 mg으로 첫 3개월 동안 매월 1회 주사하고 이후 2개월마다 1회 주사함. 장기 사용 (처음 12개월 사용 이후)시 계속해서 2개월마다 주사하는 것이 권장됨.</P>
<P USERMARK="F-10">- 개발현황: 전임상 완료(2020.09)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="69" HEIGHT="565" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">항 SFTSV 항체</P>
</TD>

<TD WIDTH="84" HEIGHT="54">
<P USERMARK="F-10">주요 사용 &cr;범위</P>
</TD>

<TD WIDTH="493" HEIGHT="54">
<P USERMARK="F-10">- 중증열성혈소판감소증후군의 치료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" HEIGHT="511">
<P USERMARK="F-10">주요 기능 및 특징</P>
</TD>

<TD WIDTH="493" HEIGHT="511">
<P USERMARK="F-10">- 중증열성혈소판감소증후군 (Severe Fever with Thrombocytopenia Syndrome, SFTS)은 SFTS 바이러스 (SFTSV)에 의해 발생하는 중증의 감염성 질환임.</P>
<P USERMARK="F-10">- SFTS는 주로 작은 소피참진드기 (Haemaphysalis longicornis)에 의해 매개되어 발생함.</P>
<P USERMARK="F-10">- 이 진드기는 중국, 한국, 일본, 러시아, 호주 등에 주로 분포하는 것으로 알려져 있으며, 해마다 사례 보고가 증가하고 있고, 사망률도 지속적으로 증가하는 추세임.</P>
<P USERMARK="F-10">- 인체 감염은 SFTS 바이러스에 감염된 진드기가 사람의 피부에 붙어 흡혈할 때 인체 내로 바이러스가 주입되어 SFTS를 일으키는 것으로 알려져 있음.</P>
<P USERMARK="F-10">- SFTS 바이러에 감염되면 발열, 위장관 증상, 호중구 감소증 및 혈소판 감소증 등의 임상증상 및 검사소견을 보이며 회복되지 않는 경우 빠르게 다발성 장기기능 장애로 진행하여 사망에 이름.</P>
<P USERMARK="F-10">- 진드기에 물린 후 바이러스의 체내 잠복기는 약 6일에서 14일로, 대부분 사망하는 환자는 증상 발생 후 평균 9일에서 14일 이내에 사망함.</P>
<P USERMARK="F-10">- 임상적인 진단은 고열, 혈소판과 백혈구감소증이 동반되면 SFTS 가능성을 의심하고, 실험실적인 진단은 환자의 혈액에서 RT-PCR 유전자 검출 검사를 수행하여 SFTSV RNA를 확인함.</P>
<P USERMARK="F-10">- SFTS에 대해서 확실히 효과가 증명된 치료법이 없으므로 경과를 지켜보면서 리바비린 등의 항바이러스제, 고농도의 스테로이드제 치료 및 혈장교환술 등이 시도되고 있음. </P>
<P USERMARK="F-10">- 개발중인 항 SFTSV 항체는 혈소판감소증후군을 일으키는 바이러스 (SFTSV)의 외막 당단백질에 특이적으로 결합하여 바이러스를 중화시키는 항체 치료제임.</P>

<P USERMARK="F-10">
<SPAN>- 동물모델을 통해 그 효과가 검증된 항체 치료제로 향후 비임상 시험을 통해 SFTS에 대한 항체 치료제의 사용량 및 사용주기에 대한 연구가 진행될 예정임.&cr;</SPAN>
<SPAN>- 개발현황 : </SPAN>
<SPAN>생산세포주 및 공정기술완</SPAN>
<SPAN>료(2020.08)</SPAN>
</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN> &cr;&cr;</SPAN>
<SPAN USERMARK=" B">나. 주요제품 매출현황</SPAN>                                                       (단위: 백만원, %)
</P>

<TABLE BORDER="1" WIDTH="703" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="216"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">
<P>품 목</P>
</TH>

<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">
<P>2020년&cr;(11기)</P>
</TH>

<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">
<P>2019년&cr;(10기)</P>
</TH>

<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">
<P>2018년&cr;(9기)</P>
</TH>

<TH WIDTH="225" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">
<P>제 품 설 명</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비율</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비율</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">EPO의약품</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,548</TD>
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">57.3</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">810</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28.1</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10">
<SPAN>만성신부전환자의 빈</SPAN>
<SPAN>혈치료제</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">기술이전(CDO)</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,163</TD>
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18.8</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">956</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33.1</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">730</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12.9</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">

<P USERMARK="F-10">
<SPAN>바이오의약품 </SPAN>
<SPAN>개발기술</SPAN>
<SPAN> 이전매출</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>위탁생산(CMO)</P>
</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">899</TD>
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14.5</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">863</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30.0</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,233</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">74.5</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">

<P USERMARK="F-10">
<SPAN>전임상 및 임상시료 </SPAN>
<SPAN>위탁</SPAN>
<SPAN>생산 서비스</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>로열티</P>
</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">450</TD>
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.3</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.0</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">95</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.7</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">

<P USERMARK="F-10">
<SPAN>바이오의약품 </SPAN>
<SPAN>개발기술</SPAN>
<SPAN> 이전 로열티</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>기타</P>
</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131</TD>
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.1</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.7</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">607</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10.7</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-10">연구용역,Protein 및 KIT판매등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>소계</P>
</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,191</TD>
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.0</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,878</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99.9</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,665</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99.8</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-10">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>상품</P>
</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.1</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.2</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-10">연구용 시약(Polysciences사 제품)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>합계</P>
</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,191</TD>
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.0</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,881</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.0</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,679</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.0</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-10">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">&cr;&cr;다. 주요 제품 등의 가격 변동 추이</P>
<P> </P>

<P>
<SPAN>현재 </SPAN>
<SPAN>당사의 매출중</SPAN>
<SPAN> 바이오의약품 개발 기술 이전 </SPAN>
<SPAN>서비스(CDO)의 경우</SPAN>
<SPAN> 생산세포주 및 생산공정 기술 이전 서비스</SPAN>
<SPAN> 가격은 건당 5~7억원(로열티 별도)의 가격이 형성되어 있고, 위탁생산(CMO) 서비스 가격은 </SPAN>
<SPAN>생산batch수,</SPAN>
<SPAN> 생산기간, 생산공정등의 여러 계약조건에 에 따라 </SPAN>
<SPAN>결정되며, </SPAN>
<SPAN> EPO제품은 각 국</SPAN>
<SPAN>가별, 용량별 가격이 상이하며 국내의 경우 최근 약 2년간 2~3%의 의료보험약가 인하가 있었습니다.  &cr;&cr;</SPAN>
</P>
<P USERMARK="F-16 0XFF1200 B">3. 주요 원재료에 관한 사항</P>
<P> </P>

<P USERMARK=" B">가. 매입현황                                                           
<SPAN USERMARK=" !B"> (단위: 천원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="576" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="175" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" COLSPAN="2" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년 </P>
</TH>

<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년 </P>
</TH>

<TH WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년  </P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(제11기)</P>
</TH>

<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(제10기)</P>
</TH>

<TH WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(제9기)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>상    품</P>
</TD>

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국 내</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수 입</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,698</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,089</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소 계</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,698</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,089</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">재료비등</TD>

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국 내</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,636,219</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">534,751</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,132,787</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수 입</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">690</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소 계</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,636,219</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">534,751</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,133,477</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>외주시험비,용역비등</P>
</TD>

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국 내</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,657,896</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">442,110</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,820</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수 입</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소 계</P>
</TD>

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">1,657,896</SPAN>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">442,110</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,820</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>합 계</P>
</TD>

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국 내</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,294,115</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">976,861</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,235,607</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수 입</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,698</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,779</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,294,115</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">978,559</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,243,386</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>주1) </SPAN>
<SPAN>재료비 및 외주시험비는 당사의 GMP 설비</SPAN>
<SPAN>를 활용하여 </SPAN>
<SPAN>EPO의약품 및 </SPAN>
<SPAN>CDMO</SPAN>
<SPAN>위탁</SPAN>
<SPAN> 생산</SPAN>
<SPAN></SPAN>
<SPAN>등을 하는데 소요되는 </SPAN>
<SPAN>원료 및 시약</SPAN>
<SPAN>, 소모품, 실험도구와 이에 대한 </SPAN>
<SPAN>위탁 시험비 등 입니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P USERMARK=" B">
<SPAN>나. 원재료 가격변동추이</SPAN>
<SPAN USERMARK=" !B">                                                       (단위 : 천원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="604" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="280"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품    목</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년&cr;(제11기)</P>
</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년&cr;(제10기)</P>
</TH>

<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년&cr;(제9기)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="30">
<P>PowerCHO-2 CD Medium (1 L/병)</P>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">103</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">91</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">74</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="30">
<P>PowerCHO-2 CD Medium (20 L bag)</P>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,225</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,200</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,160</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="30">
<P>200 mM L-Glutamine (500 mL/병)</P>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">142</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="30">
<P>HyCell CHO Medium</P>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">113</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="30">
<P>Kinetic-QCL Lysate</P>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">110</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">107</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">105</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="30">
<P>LAL Reagent Water, 30 mL</P>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,152</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,080</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,056</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="30">
<P>resDNASEQTM Quantitative CHO DNA kit</P>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,200</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,132</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,047</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;바이오의약품 </SPAN>
<SPAN>생산 및 연구개발에</SPAN>
<SPAN> 사용되는 </SPAN>
<SPAN>원재료, 부재료, 시약 및 실험소모</SPAN>
<SPAN>품 등은 대부분 장기간 동안 지속적인 반복 구매를 하게 됩니다. 국내 대리업체를 통해 수입되는 품목이 많아 해외 제조사의 제조원가 상승에 따른 가격 인상 정책 또는 환율 변동에 따라 가격이 변동하게 되며, 구입시마다 거래처와의 협의를 통해 가격을 결정하게 됩니다. </SPAN>
</P>
<P> &cr;</P>
<P USERMARK="F-16 0XFF1200 B">4. 생산 및 생산 설비에 관한 사항</P>
<P> </P>
<P USERMARK=" B">가. 생산능력과 생산 실적</P>
<P> </P>

<P>
<SPAN>당사는 </SPAN>
<SPAN>만성 신부전 환자의 빈혈치료제인 </SPAN>
<SPAN>바이오시밀러 </SPAN>
<SPAN>EPO의약품</SPAN>
<SPAN>을 </SPAN>
<SPAN>자체</SPAN>
<SPAN> 개발하여 직접 </SPAN>
<SPAN>의약품을 생산, 판매하고</SPAN>
<SPAN> 있습니다.  기 확보한 GMP 생산시설에서 캠페인 생산 기법으로 첫 번째 제품인 바이오시밀러 </SPAN>
<SPAN>EPO의약품</SPAN>
<SPAN> 생산과 판매 그리고 </SPAN>
<SPAN>위탁생산(CMO)</SPAN>
<SPAN> 사업을 병행해서 GMP생산시설을 가동하고 있습니다.</SPAN>
<SPAN>. &cr;</SPAN>
</P>

<P>
<SPAN> </SPAN>
<SPAN>당사가 </SPAN>
<SPAN>자체 개발에 성공한</SPAN>
<SPAN> 바이오시밀러 EPO의약품의 경우 원료의약품의 유효기간을 5년으로 </SPAN>
<SPAN>확보함에 따라 제품의 </SPAN>
<SPAN>생산 및 판매 </SPAN>
<SPAN>계획을 장기적으로 수립할 수 있고  </SPAN>
<SPAN>판매 계획에 따라 생산계획을 보다 신축적으로 운영할 수 있습니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>당사는 </SPAN>
<SPAN>GMP내</SPAN>
<SPAN>에서</SPAN>
<SPAN> 일회용 바이오리엑터 장비를</SPAN>
<SPAN> 운용중에</SPAN>
<SPAN> 있으며  일회용 바이오리엑터 장비 </SPAN>
<SPAN>운용으로</SPAN>
<SPAN> 인해 다품목의 생산이 가능하여 GMP</SPAN>
<SPAN>생산시설의 가동율을 극대화 할 수 있습니다. 당사가 보유한 GMP 생산시설에서 바이오시밀러</SPAN>
<SPAN> EPO의약품</SPAN>
<SPAN>의 생산능력은 아래 표와 같습니다.</SPAN>
</P>
<P></P>

<TABLE ACLASS="NORMAL" WIDTH="622" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="613"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="622" HEIGHT="30">[바이오시밀러 EPO 연간 생산능력]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">사업부문</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">품    목</TH>
<TH WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연간생산능력(배치)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">200L</TH>
<TH WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">500L</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<SPAN>의약품</SPAN>
<SPAN>생산</SPAN>
</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">바이오시밀러 EPO</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">48배치</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">48배치</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;연간생산능력 산출근거&cr; - 연간 가동일수 : 320일(설비유지보수 45일 제외)&cr; - 작업성공율 : 90%(작업자 실수 및 기계장치 오류에 따른 실패율 10% 추정)&cr; - 1배치당 생산 소요일수(200L,500L) : 6일&cr; - 연간생산능력  &cr;    200L 배양기  (320일 / 6일) X 90%  = 48배치&cr;    500L 배양기  (320일 / 6일) X 90%  = 48배치&cr; - 상기 연간 생산능력은  각 배치별 생산시간 간격, 성공율,  생산제품의 수 등,&cr;    다양한 요인에 의해 변동될 수 있습니다&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">나. 생산 및 연구소등 설비에 관한 사항</SPAN>
</P>
<P>&cr;(1) 현황                                                                               (단위 : 천원) </P>

<TABLE BORDER="1" WIDTH="888" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="81" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="81" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유&cr;형태</TH>
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="81" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="81" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">용도</TH>

<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="81" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">자산별</P>
</TH>
<TH ROWSPAN="2" WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="81" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년 기초장부가액</TH>
<TH COLSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년 &cr;증감액</TH>
<TH ROWSPAN="2" WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="81" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년&cr; 상각액</TH>
<TH ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="81" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년말 &cr;장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">증가</P>
</TH>

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">감소</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="12" WIDTH="63" VALIGN="MIDDLE" HEIGHT="360" ALIGN="CENTER">
<P>본사</P>
</TD>
<TD ROWSPAN="12" WIDTH="48" VALIGN="MIDDLE" HEIGHT="360" ALIGN="CENTER">자가</TD>
<TD ROWSPAN="12" WIDTH="63" VALIGN="MIDDLE" HEIGHT="360" ALIGN="CENTER">수원&cr;(영통)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="120" ALIGN="CENTER" ROWSPAN="4">제조공장</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>토지</P>
</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">636,662</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">636,662</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>건물</P>
</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,977,294</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,193</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,929,101</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>생산설비등</P>
</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,740,382</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">192,210</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">561,508</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,371,084</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소계</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,354,338</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>192,210</SPAN>
</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">609,701</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,936,847</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="120" ALIGN="CENTER" ROWSPAN="4">연구소</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">토지</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">285,544</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">285,544</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">건물</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">778,839</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,254</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">762,585</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">연구설비등</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">382,894</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">218,543</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">88,974</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">512,463</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소계</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,447,277</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>218,543</SPAN>
</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">105,228</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,560,592</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="90" ALIGN="CENTER" ROWSPAN="3">본사사무실</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">토지</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">209,469</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">127,244</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">82,225</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">건물</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">571,061</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">346,786</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,681</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">219,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소계</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">780,530</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">474,030</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,681</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">301,819</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="186" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="2">합    계</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,582,145</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">410,753</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">474,030</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">719,610</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,799,258</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>주) 본사사무실 토지,건물 감소분(금액 474,030천원)은  건물 임대로 인해  유형자산(토지,건물) 에서 투자부동산으로 계정 대체하</SPAN>
<SPAN>였고 현황에서 제외.</SPAN>
<SPAN>&cr;</SPAN>
</P>
<P>(2)설비의 투자 계획</P>
<P> </P>

<P>
<SPAN>당사는 바이오 의약품 개발단계에서 사전에 생산시설(GMP설비, 생산설비, 자가</SPAN>
<SPAN>공장)을 </SPAN>
<SPAN>조기에 </SPAN>
<SPAN>확보하여 </SPAN>
<SPAN>제품 생산에 필요한</SPAN>
<SPAN> 대규모 투자는 필요하지 않</SPAN>
<SPAN>고 일부 </SPAN>
<SPAN>생산 및 </SPAN>
<SPAN>시험장비등의 보완 투자가 발생할 수 있습니다.  </SPAN>
</P>
<P> &cr;</P>
<P USERMARK="F-16 0XFF1200 B">5. 매출에 관한 사항</P>
<P> </P>

<P USERMARK=" B">가. 매출 실적                                             
<SPAN USERMARK=" !B">        (단위 : 백만원) </SPAN>
</P>

<TABLE BORDER="1" WIDTH="584" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>매출유형</P>
</TH>

<TH COLSPAN="2" ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품 목</P>
</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>

<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년</P>
</TH>

<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(제11기)</P>
</TH>

<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(제10기)</P>
</TH>

<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(제9기)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">제   조</TD>
<TD ROWSPAN="3" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">EPO의약품</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수출</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,541 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">810</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,007 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,548 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">810</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="12" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="360">기술이전&cr;서비스등</TD>

<TD ROWSPAN="3" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>기술이전&cr;(CDO)</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수출</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,163 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">956</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">645</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,163 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">956</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">730</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>위탁생산&cr;(CMO)</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수출</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">899 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">863</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,233</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">899 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">863</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,233</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>로열티</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수출</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">429 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">450 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>기타</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수출</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">580</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">143</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">607</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="3" WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>상  품</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수출</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="3" WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>합    계</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수출</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,621 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">861</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">705</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,570 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,020</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,974</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,191 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,881</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,679</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
</P>
<P USERMARK=" B">나. 판매경로 및 판매방법</P>
<P> </P>
<P>(1) 판매조직</P>
<P> </P>

<P>
<SPAN>당사는 자체적인 판매조직은 없으며  공동임상에 참여한 파트너사에게 해당 국가의 판권을 부여하고  있으며 기타 국가의 경우 해당 국가의 주요 제약사들과 판권계약을 통해 판매를 담당하도록 할 계획입니다.&cr;</SPAN>
</P>

<P>
<SPAN>현재</SPAN>
<SPAN> 바이오시밀러 EPO 제품과 관련하여</SPAN>
<SPAN> 당사와 </SPAN>
<SPAN>판권계</SPAN>
<SPAN></SPAN>
<SPAN>약 체결을 완료</SPAN>
<SPAN>(예정포함)</SPAN>
<SPAN>한 </SPAN>
<SPAN>파트너사는 아래와 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="443"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="175" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제품</P>
</TH>

<TH WIDTH="452" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>판매 파트너사 </P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="175" VALIGN="MIDDLE" HEIGHT="145">
<P>바이오시밀러 EPO</P>
</TD>

<TD WIDTH="452" VALIGN="MIDDLE" HEIGHT="145">

<P>
<SPAN></SPAN>
<SPAN>말레이시아,브루나이,싱가폴</SPAN>
<SPAN>: </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>Duopharma Sdn Berhad</SPAN>
<SPAN>&cr;한국 : 중헌제약</SPAN>
</P>
<P>태국: S.Charoen 사, 터키: ONKO사</P>

<P>
<SPAN>필리핀:</SPAN>
<SPAN>Duopharma Sdn Berhad</SPAN>
<SPAN>(예정)</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>사우디아라비아, </SPAN>
<SPAN>GCC 5개국</SPAN>
<SPAN> : </SPAN>
<SPAN></SPAN>
<SPAN>Saudi Vax</SPAN>
<SPAN>사&cr;</SPAN>
<SPAN>베트남 : </SPAN>
<SPAN></SPAN>
<SPAN>Khuong Duy Pharma</SPAN>
<SPAN></SPAN>
</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>(2)판매경로</P>

<P>
<SPAN> &cr;</SPAN>
<SPAN>바이오시밀러 EPO의약품 및 위탁생산(CMO)의 경우 판매경로는  고객사와의 계약에 의거 생산된 제품 또는 시료를 고객사가 지정한 장소에 운송을 통하여 전량 고객사에 판매하고 있으며, 대리점 등 별도의 판매경로를 이용하고 있지 않습니다. </SPAN>
</P>
<P> </P>

<P USERMARK="F-16 B">
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK="F-12 !B">(3) 판매방</SPAN>
<SPAN USERMARK="F-12 !B">법 및 조건&cr;&cr;당사의 </SPAN>
<SPAN USERMARK="F-12 !B">바이오시밀러 EPO의약품</SPAN>
<SPAN USERMARK="F-12 !B"> 및 </SPAN>
<SPAN USERMARK="F-12 !B">CDMO의 수주시 판매 방법, 판매 조건은 </SPAN>
<SPAN USERMARK="F-12 !B">고객사와의 계약을 통해 개별적으로 결정됩니다. </SPAN>
<SPAN USERMARK="F-12 !B">EPO의약품의</SPAN>
<SPAN USERMARK="F-12 !B"> 경우 고객사의 구매요청(PO)한 제품에 대하여 고객사가 </SPAN>
<SPAN USERMARK="F-12 !B">지정한 기일, 지정한 장소에</SPAN>
<SPAN USERMARK="F-12 !B"> 인도하고,  대금은 </SPAN>
<SPAN USERMARK="F-12 !B">청구(인도)</SPAN>
<SPAN USERMARK="F-12 !B">후 30일~90일 이내에 회수하고 있습니다.  CDMO 사업은 고객과 계약후 약 1년내외에 관련 용역의 개발 및 생산을 진행하며 대금은 진행 단계별로 청구하여 청구후 30~60일 이내에 현금으로 회수하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-12 !B">&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200 !B"></SPAN>
<SPAN USERMARK=" 0XFF1200">6. 수주현황&cr;</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN USERMARK="F-12 !B">당사의 </SPAN>
<SPAN USERMARK="F-12 !B">바이오시밀러 EPO의약품</SPAN>
<SPAN USERMARK="F-12 !B"> 및 바이오의약품</SPAN>
<SPAN USERMARK="F-12 !B"></SPAN>
<SPAN USERMARK="F-12 !B"></SPAN>
<SPAN USERMARK="F-12 !B">(전임상,임상시료포함)</SPAN>
<SPAN USERMARK="F-12 !B"> 위탁생산(CMO) 및 개발기술 이전 서비스(CDO)등과 관련된 주요 수주</SPAN>
<SPAN USERMARK="F-12 !B">현황은 다음과 같습니다.</SPAN>
</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="700" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(2020.12.31 현재)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="400" HEIGHT="30">      (단위 :천원,천￥,$)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="761" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">품목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="76" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">수주&cr;일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="76" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">납기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">수주총액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">기납품액(주1)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">수주잔고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="31" VALIGN="MIDDLE">CDO</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="31" VALIGN="MIDDLE">19.01.25</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="31" VALIGN="MIDDLE">20.01.24</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="31" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="31" VALIGN="MIDDLE">200,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="31" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="31" VALIGN="MIDDLE">200,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="31" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="31" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">CDO</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">19.05.07</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">20.04.30</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">180,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">180,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">CMO</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">19.05.16</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">20.05.15</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">850,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">850,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">CMO</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">19.08.22</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">20.08.21</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">911,600</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">911,600</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">CDO</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">19.08.26</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">20.06.25</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">180,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">180,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">CDO</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">19.11.01</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">20.09.30</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">400,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">400,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">CDO</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">19.12.10</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">20.12.09</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">200,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">200,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">CDO</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">19.12.10</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">21.05.09</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">450,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">326,853</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">123,147</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="136" HEIGHT="53" VALIGN="MIDDLE">
<SPAN>CMO</SPAN>
</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="53" VALIGN="MIDDLE">20.01.20</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="53" VALIGN="MIDDLE">21.10.31</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="53" VALIGN="MIDDLE">1,960,924&cr;￥186,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>

<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="53" VALIGN="MIDDLE" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">-&cr;</SPAN>
<SPAN USERMARK=" 0X000000">-</SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>

<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="53" VALIGN="MIDDLE" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">1,960,924&cr;￥186,000</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">CDO</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">20.08.11</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">21.10.10</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">480,000</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">148,930</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">331,070</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="53" VALIGN="MIDDLE">EPO의약품(수출)</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="53" VALIGN="MIDDLE">2,928,536&cr;$2,490,099.55</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>

<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="53" VALIGN="MIDDLE">
<SPAN>2,540,860&cr;</SPAN>
<SPAN>$2,133,779.55</SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="53" VALIGN="MIDDLE">387,676&cr;$356,320</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">EPO의약품(내수)</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">1,417,609</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">1,007,319</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">410,290</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="53" VALIGN="MIDDLE">기타(수출)</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="53" VALIGN="MIDDLE">58,803&cr;$48,300</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="53" VALIGN="MIDDLE">58,803&cr;$48,300</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="53" VALIGN="MIDDLE">-&cr;-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>기타(내수</SPAN>
<SPAN>)</SPAN>
</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="76" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">90,500</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">66,750</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">23,750</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="288" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">10,307,972</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">7,071,115</TD>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30" VALIGN="MIDDLE">3,236,857</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>주1) 기납품액은 수</SPAN>
<SPAN>주일로부터 </SPAN>
<SPAN>2020년 12월 31</SPAN>
<SPAN>일까</SPAN>
<SPAN>지 매출인식 완료한 합계금액 입니다.&cr;</SPAN>
<SPAN>주2) 수주잔고 외화평가시 적용환율은</SPAN>
<SPAN> 1$=1,088, 100￥=1,054.26원</SPAN>
<SPAN> 입니다.</SPAN>
<SPAN>(2020.12.31 서울외국환중개고시)&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>주3) EPO의약품은 수시 발주가 이루어져 수주일자 및 납기일을 생략 했습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-16 0XFF1200 B">7. 시장위험과 위험관리&cr;</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-12">당사의 주요 금융부채는 매입채무및기타채무와 전환사채 및 기타비유동금융부채로 구성되어 있으며, 이러한 금융부채는 영업활동 및 재무활동으로 발생하였습니다. 또한 당사는 영업활동에서 발생하는 현금및현금성자산, 매출채권및기타채권 등과 같은 금융자산도 보유하고 있습니다.&cr;&cr;당사의 금융자산 및 금융부채에서 발생할 수 있는 주요 위험은 시장위험, 신용위험 및 유동성위험입니다. 당사의 주요 경영진은 아래에서 설명하는 바와 같이, 각 위험별 관리절차를 검토하고 정책에 부합하는지 검토하고 있습니다. 또한 당사는 투기 목적의 파생상품거래를 실행하지 않는 것이 기본적인 정책입니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12 B"></SPAN>
<SPAN USERMARK="F-12 B">가. 시장위험</SPAN>
<SPAN USERMARK="F-12">&cr;&cr;시장위험은 시장가격의 변동으로 인하여 금융상품의 공정가치가 변동할 위험입니다.시장위험은 이자율위험, 환위험 및 기타 가격위험의 세가지 유형으로 구성됩니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
</P>

<P>
<SPAN>다음의 민감도 분석은 당기말과 전기말에 관련되어 있습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>(1) 이자율위험&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
</P>

<P>
<SPAN>이자율위험은 시장이자율의 변동으로 인하여 금융상품의 공정가치나 미래현금흐름이 변동할 위험입니다. 당사는 내부적으로 이자율 1% 변동을 기준으로 이자율위험을 측정하고 있으며, 상기의 변동비율은 합리적으로 발생가능한 이자율변동위험에 대한 경영진의 평가를 반영하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-12">당기말 현재 변동이자율이 적용되는 차입금은 없으므로, 이자율변동이 금융부채의 현금흐름에 미치는 영향은 없습니다.&cr;</SPAN>
</P>

<P>
<SPAN>(2) 환위험&cr;환위험은 환율의 변동으로 금융상품의 공정가치나 미래현금흐름이 변동할 위험입니다. 당기말과 전기말 현재 기능통화 이외의 외화로 표시된 화폐성자산 및 부채의 장부금액은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-12 0X0000FF"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="610">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT12"></TD>
<TD WIDTH="308" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT12">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="613">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="62">구   분</TH>

<TH COLSPAN="2" WIDTH="246" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">
<SPAN USERMARK="F-GL">당기</SPAN>
<SPAN USERMARK="F-GL">말</SPAN>
</TH>
<TH COLSPAN="2" WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">자산</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">부채</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">자산</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER">USD</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">657,988 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">- </TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">175,369 </TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">451,848 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P USERMARK="F-11">
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">당사는 내부적으로 원화 환율 변동에 대한 환위험을 정기적으로 측정하고 있습니다. </SPAN>
<SPAN USERMARK="F-12">당기말과 전기말</SPAN>
<SPAN USERMARK="F-12"> 현재 각 외화에 대한 기능통화의 환율 5% 변동시 환율변동이 </SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">당기</SPAN>
<SPAN USERMARK="F-12"> 및 전기 손익에 미치는 영향은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-12"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="612">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT12"></TD>
<TD WIDTH="310" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT12">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="62">구   분</TH>
<TH COLSPAN="2" WIDTH="246" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">당   기</TH>
<TH COLSPAN="2" WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">전   기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">5% 상승시</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">5% 하락시</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">5% 상승시</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">5% 하락시</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER">USD</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">32,899 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">(32,899)</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">(13,824)</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">13,824 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-12">&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">상기 민감도 분석은 </SPAN>
<SPAN USERMARK="F-12">당기말과 전기말</SPAN>
<SPAN USERMARK="F-12"> 현재 기능통화 이외의 외화로 표시된 화폐성 자산 및 부채를 대상으로 하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
</P>

<P>
<SPAN>(3) 기타 가격위험&cr;</SPAN>
<SPAN></SPAN>
<SPAN>기타 가격위험은 이자율위험이나 환위험 이외의 시장가격의 변동으로 인하여 금융상품의 공정가치나 미래현금흐름이 변동할 위험이며, 당사는 </SPAN>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN>말 현재 금융상품 중 상장지분상품 등을 보유하고 있지 않습니다.</SPAN>
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-12">&cr;&cr;</SPAN>
<SPAN USERMARK="F-12 B"></SPAN>
<SPAN USERMARK="F-12 B">나. </SPAN>
<SPAN USERMARK="F-12 B">신용위험&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN>신용위험은 거래상대방이 의무를 이행하지 않아 당사에 재무손실이 발생할 위험입니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">당사는 신용위험을 관리하기 위하여 금융자산의 신용보강을 위한 정책과 절차를 마련하여운영하고 있으며, 회수가 지연되는 금융자산에 대하여는 회수지연 현황 및 회수대책이 보고된 후 지연사유에 따라 적절한 조치를 취하고 있습니다. 또한, 거래상대방의 신용에 따라 필요한 경우 담보 및 기타 신용보강을 요구하고 있습니다.</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN USERMARK="F-12">당기말과 전기말</SPAN>
<SPAN USERMARK="F-12"> 현재 당사의 신용위험에 대한 최대노출정도는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="618" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="618" HEIGHT="31" USERMARK="F-BT12">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="618" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="268"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="161"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="277" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31">
<P USERMARK="F-12">구   분</P>
</TH>

<TH WIDTH="171" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31">

<P USERMARK="F-BT">
<SPAN USERMARK="F-GL12">당기</SPAN>
<SPAN USERMARK="F-GL12">말</SPAN>
</P>
</TH>

<TH WIDTH="170" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31">
<P USERMARK="F-12">전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="277" HEIGHT="31">
<P USERMARK="F-12">현금및현금성자산</P>
</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">8,139,296 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">4,363,335 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="277" HEIGHT="31">
<P USERMARK="F-12">매출채권및기타채권</P>
</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">684,265 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">100,983 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="277" HEIGHT="31" USERMARK="F-12">계약자산</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">49,734 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">78,732 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="277" HEIGHT="31">
<P USERMARK="F-12">기타유동금융자산</P>
</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">10,640,908 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">20,161,200 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="277" HEIGHT="31" USERMARK="F-12">기타비유동금융자산</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">206,988 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">295,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="277" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">합   계</P>
</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">19,721,192 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">24,999,407 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당사는 매출채권과기타수취채권에 대해 손실충당금을 인식하였으며(주석 8. 참조), 이외의 금융자산에 대해서는 채무불이행위험이 없다고 판단하여 기대신용손실을 인식하지 않았습니다.</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-12"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">다. 유동성위험&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN>유동성위험은 만기까지 모든 금융계약상의 약정사항들을 이행할 수 있도록 자금을 조달하지 못할 위험입니다.&cr;&cr;당사는 유동성 전략 및 계획을 통하여 자금부족에 따른 위험을 관리하고 있으며, 금융상품의 만기와 영업현금흐름의 추정치를 고려하여 금융자산과 금융부채의 만기를 대응시키고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN>보</SPAN>
<SPAN>고기간말 현재 금융부채별 상환계획으로서 할인되지 않은 계약상의 금액은 다음과 같습니다.&cr;</SPAN>
<SPAN>&cr;<</SPAN>
<SPAN>당기</SPAN>
<SPAN>말></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="298"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="307" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT12">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="47"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12" COLSPAN="2">구   분</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">1년 이내</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">1년~5년</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">5년 이후</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="56" VALIGN="MIDDLE" HEIGHT="86" USERMARK="F-12" ROWSPAN="2" ALIGN="CENTER">유동</TD>
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-12">매입채무및기타채무</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-12">679,716 </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-12">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-12">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-12">679,716 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-12">전환사채(*)</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">18,398,863 </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">18,398,863 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="56" VALIGN="MIDDLE" HEIGHT="55" ALIGN="CENTER" USERMARK="F-12">비유동</TD>
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-12">기타비유동금융부채</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-12">- </TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK="F-GL12 0X000000">77,306 </SPAN>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-12">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-12">77,306 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-12" ALIGN="CENTER" COLSPAN="2">합   계</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK="F-GL12 0X000000">679,716 </SPAN>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12"> 18,476,169 </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">19,155,886 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-12">(</SPAN>
<SPAN USERMARK="F-12">*) 상기 전환사채의 만기구조는 계약 만기까지 사채권자의 전환권이 행사되지 않을 경우를 가정한 것입니다.</SPAN>
<SPAN USERMARK="F-12">&cr;</SPAN>
</P>

<P>
<SPAN><</SPAN>
<SPAN>전기</SPAN>
<SPAN>말></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="298"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="307" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT12">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">구   분</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">1년 이내</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">1년~5년</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">5년 이후</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-12">매입채무및기타채무</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">878,296 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">- </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">- </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">878,296 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-12">전환사채</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">18,921,708 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">- </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">18,921,708 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-12" ALIGN="CENTER">합   계</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">878,296 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">18,921,708 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">- </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">19,800,004 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-12">&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-12 B">라. 자본관리&cr;</SPAN>
</P>

<P>
<SPAN>자본관리의 주 목적은 당사의 영업활동을 유지하고 주주가치를 극대화하기 위하여 높은 신용등급과 건전한 자본비율을 유지하기 위한 것입니다.&cr;&cr;당사는 자본구조를 경제환경의 변화에 따라 수정하고 있으며, 이를 위하여 배당정책을 수정하거나 자본감소 혹은 신주발행을 검토하도록 하고 있습니다. 한편, </SPAN>
<SPAN>당기</SPAN>
<SPAN> 중 자본관리의 목적, 정책 및 절차에 대한 어떠한 사항도 변경되지 않았습니다.&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-12">당사는 총부채를 자기자본으로 나눈 부채비율을 사용하고 있으며,</SPAN>
<SPAN USERMARK="F-12"> </SPAN>
<SPAN USERMARK="F-12">당기</SPAN>
<SPAN USERMARK="F-12">말</SPAN>
<SPAN USERMARK="F-12">과 전기말 현재 총부채 및 자기자본은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="605">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="303" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT12">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-12">구   분</TH>

<TH WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">
<SPAN USERMARK="F-GL12">당기</SPAN>
<SPAN USERMARK="F-GL12">말</SPAN>
</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-12">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-12" ALIGN="CENTER">총 부 채</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">22,097,719 </TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">20,656,553 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-12" ALIGN="CENTER">자기자본</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">14,211,163 </TD>

<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT">
<SPAN USERMARK="F-GL12">18,426,386 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-12" ALIGN="CENTER">부채비율</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">155.50%</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-12">112.10% </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">마. 위험관리 조직</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>당사는 보고서 작성 기준일 현재 벤처기업으로서, 상기 위험 관리는 당사의 관리조직및 해당 위험과 연관성이 높은 현업 부서에서 자체적으로 담당하고 있습니다. 다만, 향후 회사의 파이프라인 개발 성공 및 제품 매출이 지속적으로 시현되여 회사의 규모가 커지게 되면, 별도의 위험관리조직을 구축하여 상기 위험을 적극적으로 관리할 예정입니다. &cr;</SPAN>
</P>
<P USERMARK="F-16 0XFF1200 B">8. 경영상의 주요 계약 등</P>
<P> </P>
<P>당사는 보고서 작성 기준일 현재  경영상의 주요계약은 다음과 같습니다.&cr;</P>
<P USERMARK=" B">주요 라이선스-아웃(License-out) 계약</P>

<TABLE BORDER="1" WIDTH="897" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="188"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">품목</P>
</TD>

<TD WIDTH="197" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약상대방</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">대상지역</P>
</TD>

<TD WIDTH="93" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약체결일</P>
</TD>

<TD WIDTH="189" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약종료일</P>
</TD>

<TD WIDTH="116" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">총계약금액</P>
</TD>

<TD WIDTH="116" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">진행단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">빈혈치료제</P>
<P USERMARK="F-BT">(EPO)</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">Labortorios Cryopharma</P>
<P USERMARK="F-BT">(멕시코)</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">멕시코</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">2003.01.28</P>
</TD>

<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">N/A</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P USERMARK="F-BT">USD80,000</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">상업화</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">

<P USERMARK="F-BT">
<SPAN>혈우병</SPAN>
<SPAN>A</SPAN>
<SPAN>치료제</SPAN>
</P>
<P USERMARK="F-BT">(Factor VIII)</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">Beijing Northland Biotech</P>
<P USERMARK="F-BT">(중국)</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">중국</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">2012.07.20</P>
</TD>

<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">매출발생시점부터 10년간</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P USERMARK="F-BT">CNY4,500,000</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">IND제출준비중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">단백질치료제</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">Beijing Tide Pharmaceutical</P>
<P USERMARK="F-BT">(중국)</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">중국</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">2013.11.28</P>
</TD>

<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">매출발생시점부터 7년간</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P USERMARK="F-BT">USD667,000</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">임상1상&cr;IND승인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">항체치료제</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">Beijing Tide Pharmaceutical</P>
<P USERMARK="F-BT">(중국)</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">중국</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">2014.05.30</P>
</TD>

<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">매출발생시점부터 7년간</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P USERMARK="F-BT">USD778,000</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">IND제출</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">혈우병치료제</P>
<P USERMARK="F-BT">(Factor VII)</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">Beijing Northland Biotech</P>
<P USERMARK="F-BT">(중국)</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">중국</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">2015.03.26</P>
</TD>

<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">매출발생시점부터 10년간</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P USERMARK="F-BT">CNY3,000,000</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">전임상</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(1) 품목: 빈혈치료제(EPO)</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="93"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">계약상대방</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">Laboratorios Cryopharma(멕시코)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">계약내용</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">EPO 생산세포주 기술이전 계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">대상지역</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">멕시코</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="53">
<P USERMARK="F-BT">계약기간</P>
</TD>

<TD WIDTH="513" HEIGHT="53">
<P USERMARK="F-BT">계약체결일: 2003.01.28</P>
<P USERMARK="F-BT">로열티 계약종료일: 없음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">총계약금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">USD 80,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">수취금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">USD 80,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">계약조건</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">로열티는 순매출액의 2% (로열티수령 중)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">회계처리방법</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">계약금 수취금액 수익인식</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">대상기술</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">PanGen CHO-Tech 기술(바이오의약품 개발기술)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">개발진행경과</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">상업화</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">기타사항</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<P>
<SPAN>(2) 품목: 혈우</SPAN>
<SPAN>병</SPAN>
<SPAN>A</SPAN>
<SPAN>치료</SPAN>
<SPAN>제(Factor VIII)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="93"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약상대방</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">Beijing Northland Biotech(중국)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약내용</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">혈우병치료제인 Factor VIII인자 생산세포주 기술이전계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">대상지역</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">중국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="53">
<P USERMARK="F-BT">계약기간</P>
</TD>

<TD WIDTH="513" HEIGHT="53">
<P USERMARK="F-BT">계약일:2012.07.20</P>
<P USERMARK="F-BT">로열티 계약종료일: 매출발생시점으로부터 10년간</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">총계약금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">CNY 4,500,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">수취금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">CNY 3,150,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약조건</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">로열티는 순매출액의 2%로 10년간</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">회계처리방법</P>
</TD>

<TD WIDTH="513" HEIGHT="30">

<P USERMARK="F-BT">
<SPAN>계약금,</SPAN>
<SPAN> 중도금 수취금액 수익인식 </SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">대상기술</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">PanGen CHO-Tech 기술(바이오의약품 개발기술)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">개발진행경과</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">IND제출 준비중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">기타사항</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">잔금 미수령액 CNY1,350,000은 중국 임상환자 50% 모집 시 수령</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(3) 품목: 단백질 치료제</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="93"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약상대방</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">Beijing Tide Pharmaceutical(중국)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약내용</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">단백질 치료제 생산세포주 기술이전계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">대상지역</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">중국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="53">
<P USERMARK="F-BT">계약기간</P>
</TD>

<TD WIDTH="513" HEIGHT="53">
<P USERMARK="F-BT">계약일:2013.11.28</P>
<P USERMARK="F-BT">로열티 계약종료일: 매출발생시점으로부터 7년간</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">총계약금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">USD 667,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">수취금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">USD 667,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약조건</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">로열티는 순매출액의2%로 7년간</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">회계처리방법</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">계약금 수취금액 수익인식</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">대상기술</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">PanGen CHO-Tech 기술(바이오의약품 개발기술)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">개발진행경과</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">임상 1상 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">기타사항</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(4) 품목: 항체 치료제</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="93"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약상대방</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">Beijing Tide Pharmaceutical(중국)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약내용</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">항체 치료제 생산세포주 기술이전계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">대상지역</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">중국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="53">
<P USERMARK="F-BT">계약기간</P>
</TD>

<TD WIDTH="513" HEIGHT="53">
<P USERMARK="F-BT">계약일:2014.05.30</P>
<P USERMARK="F-BT">로열티 계약종료일: 매출발생시점으로부터 7년간</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">총계약금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">USD 778,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">수취금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">USD 778,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약조건</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">로열티는 순매출액의2%로 7년간</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">회계처리방법</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">계약금 수취금액 수익인식</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">대상기술</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">PanGen CHO-Tech 기술(바이오의약품 개발기술)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">개발진행경과</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">IND제출</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">기타사항</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(5) 품목: 혈우병치료제(Factor VII)</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="93"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약상대방</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">Beijing Northland Biotech(중국)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약내용</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">혈우병치료제인 Factor VII인자 생산세포주 기술이전계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">대상지역</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">중국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="53">
<P USERMARK="F-BT">계약기간</P>
</TD>

<TD WIDTH="513" HEIGHT="53">
<P USERMARK="F-BT">계약일:2015.03.26</P>
<P USERMARK="F-BT">로열티 계약종료일: 매출발생시점으로부터 10년간</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">총계약금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">CNY 3,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">수취금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">CNY 2,700,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">계약조건</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">로열티는 순매출액의 2%로 10년간</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">회계처리방법</P>
</TD>

<TD WIDTH="513" HEIGHT="30">

<P USERMARK="F-BT">
<SPAN>계약금, </SPAN>
<SPAN>중도금 수취금액 수익인식 </SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">대상기술</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">PanGen CHO-Tech 기술(바이오의약품 개발기술)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">개발진행경과</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">전임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" HEIGHT="30">
<P USERMARK="F-BT">기타사항</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">잔금 미수령액 CNY 300,000은 중국 임상 IND 승인 시 수령</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> &cr;</P>
<P USERMARK=" B">주요 라이선스-인(License-in) 계약</P>

<TABLE BORDER="1" WIDTH="1012" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="187"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="212"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">품목</P>
</TD>

<TD WIDTH="196" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약상대방</P>
</TD>

<TD WIDTH="84" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">대상지역</P>
</TD>

<TD WIDTH="99" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약체결일</P>
</TD>

<TD WIDTH="99" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약종료일</P>
</TD>

<TD WIDTH="104" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">총계약금액</P>
</TD>

<TD WIDTH="221" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">진행단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">중증열성혈소판감소&cr;증후군치료제(항SFTSV항체)</P>
</TD>

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">Y-Clone Medical Science&cr;(중국)</P>
</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">전세계</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.01.20</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P USERMARK="F-BT">USD555,600</P>
</TD>

<TD WIDTH="221" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">생산세포주 및 공정기술완료</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
</P>
<P>(1) 중증열성혈소판 감소증후군 치료제(항SFTSV항체)</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="93"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">계약상대방</P>
</TD>
<TD WIDTH="513" HEIGHT="30" USERMARK="F-BT">Y-Clone Medical Science(중국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">계약내용</P>
</TD>
<TD WIDTH="513" HEIGHT="30" USERMARK="F-BT">중증열성혈소판 감소증후군 치료제(항SFTSV항체) 공동 개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">대상지역</P>
</TD>
<TD WIDTH="513" HEIGHT="30" USERMARK="F-BT">전세계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">계약기간</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">계약체결일: 2020.01.20</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">총계약금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<P USERMARK="F-BT">USD 555,600</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">지급금액</P>
</TD>

<TD WIDTH="513" HEIGHT="30">

<P USERMARK="F-BT">
<SPAN>USD </SPAN>
<SPAN>555,600</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="32">
<P USERMARK="F-BT">계약조건</P>
</TD>
<TD WIDTH="513" HEIGHT="32" USERMARK="F-BT">특허 공동소유, 공동개발 및 전세계 독점 상업화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="53">
<P USERMARK="F-BT">회계처리방법</P>
</TD>

<TD WIDTH="513" HEIGHT="53">
<P USERMARK="F-BT">계약금 지급액은 건설중인자산으로 처리. 향후 특허권 등록시 무형자산(특허권)으로 대체 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">대상기술</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<SPAN USERMARK="F-BT">중증열성혈소판 감소증후군 치료용 항체</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">개발진행경과</P>
</TD>

<TD WIDTH="513" HEIGHT="30">
<SPAN USERMARK="F-BT">생산세포주 및 공정기술완료(2020.08)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="53">
<P USERMARK="F-BT">기타사항</P>
</TD>

<TD WIDTH="513" HEIGHT="53">

<P USERMARK="F-BT">
<SPAN>특허 출원 중이며( 중국(201980001738.0), 한국(10-2020-7022152), 일본) 팬젠과 </SPAN>
<SPAN>Y-Clone사 공동특허임 </SPAN>
</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>*판권계약</P>

<TABLE BORDER="1" WIDTH="1019" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">품목명</P>
</TD>

<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약상대방</P>
</TD>

<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">대상지역</P>
</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약체결일자</P>
</TD>

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약종료일</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약금액</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">지급금액</P>
</TD>

<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계약의 내용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">

<P USERMARK="F-BT">
<SPAN>바이오시밀러&cr;</SPAN>
<SPAN> EPO의약품</SPAN>
</P>
</TD>

<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">Duopharma Sdn Berhad</P>
</TD>

<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">말레이시아,외2개국</P>
</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">2012.06.19</P>
</TD>

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">N/A</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">-</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">-</P>
</TD>

<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">

<P USERMARK="F-BT">
<SPAN>EPO의약품 유통계약</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">ONKO </P>
</TD>

<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">터키</P>
</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">2015.11.27</P>
</TD>

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">등록 후 5년,</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">-</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">-</P>
</TD>

<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT">EPO의약품 유통계약</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">S. Charoen</P>
</TD>

<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">태국</P>
</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">2015.08.31</P>
</TD>

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">등록 후 5년,</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">-</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">-</P>
</TD>

<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT">EPO의약품 유통계약</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<SPAN USERMARK="F-BT"> </SPAN>
<SPAN USERMARK="F-BT">Saudi Vax</SPAN>
</TD>

<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X1814FF">
<SPAN USERMARK="F-BT 0X000000">Saudi외GCC 5개국</SPAN>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">2019.04.03</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">등록 후 5년,</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>

<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT"></SPAN>
<SPAN USERMARK="F-BT">EPO의약품 유통계약</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">(주)중헌제약</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">한국</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">2020.01.06</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">체결일로부터2년</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>

<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT">EPO의약품 유통계약</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">Khuong Duy Pharma</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">베트남</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">2020.02.10</TD>

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">등록 후 5년,</SPAN>
</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>

<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT">EPO의약품 유통계약</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<PGBRK></PGBRK>

<P USERMARK="F-16 B">&cr;
<SPAN USERMARK=" 0XFF1200">9. 연구 개발 활동</SPAN>
</P>
<P> </P>
<P USERMARK=" B">가. 연구개발 조직</P>
<P> </P>
<P>(1) 연구개발 조직 개요</P>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="450" ALIGN="CENTER" HSPACE="0">연구개발조직도(2020.10).jpg</IMG>
<IMG-CAPTION ATOC="N">연구개발조직도(2020.10)</IMG-CAPTION>
</IMAGE>
<P></P>

<P>
<SPAN>당사의 연구개발조직은 COO 아래 </SPAN>
<SPAN>연구소와 개발부서로 구성되어 있으며</SPAN>
<SPAN>  </SPAN>
<SPAN>연구소의 </SPAN>
<SPAN>3개</SPAN>
<SPAN> 팀과</SPAN>
<SPAN> </SPAN>
<SPAN>개발부서의 </SPAN>
<SPAN>3개 팀에서</SPAN>
<SPAN> 바이오의약품 개발에 필수적인 원천기술 및 연구프로젝트 사업화를 수행하고 있습니다. 연구소에서는 바이오의약품 개발관련 원천기술을 이용하여 주로 치료용 항체 및 치료용 단</SPAN>
<SPAN>백질 바이오의약품을 대</SPAN>
<SPAN>상으로 생산용 세포주를 개발하고 생산공정(배양, 정제 및 품질관리) 기술 개발을 수행하여 바이오의약품 개발 기술이전 서비스를 수행하는 한편 당사가 추진 중인 </SPAN>
<SPAN>바이오의약품</SPAN>
<SPAN> 제품의 공정을 개발하고 있습니다. 개발부서에서는 개발된 바이오의약품의 허가 등록, 전임상, 임상 진행, 신규품목 선정 및 기술이전 사업화 기능을 수행합니다.</SPAN>
</P>
<P> </P>

<TABLE BORDER="1" WIDTH="629" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="377"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>조 직</P>
</TH>

<TH WIDTH="386" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>역 할</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="243" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">

<P>
<SPAN>최고운영책임자</SPAN>
<SPAN>(COO), &cr;</SPAN>
<SPAN>Site manager</SPAN>
</P>
</TD>

<TD WIDTH="386" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>연구개발 운영 총괄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="243" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>연구소장</P>
</TD>

<TD WIDTH="386" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>연구 개발 총괄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="101" VALIGN="MIDDLE" HEIGHT="162" ALIGN="CENTER">
<P>연구소</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">공정개발팀</TD>

<TD WIDTH="386" VALIGN="MIDDLE" HEIGHT="99">
<P> - 바이오의약품 생산 세포주 개발&cr; - 바이오의약품 배양공정기술 개발&cr; - 바이오의약품 정제공정기술 개발&cr; - 바이오의약품 분석법 개발</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="33" ALIGN="CENTER">제품개발팀</TD>

<TD WIDTH="386" VALIGN="MIDDLE" HEIGHT="33">
<P> - 바이오의약품 개발 및 제품화</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">연구지원팀</TD>
<TD WIDTH="386" VALIGN="MIDDLE" HEIGHT="30"> - 연구지원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="101" VALIGN="MIDDLE" HEIGHT="90" ALIGN="CENTER">
<P>개발 부서</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>RA팀</P>
</TD>

<TD WIDTH="386" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>허가등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>사업개발팀</P>
</TD>

<TD WIDTH="386" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>신규 바이오시밀러 전임상, 임상관련 발굴 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>아이템개발팀</P>
</TD>

<TD WIDTH="386" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>신규아이템(신약) 개발품목 발굴 등</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(2) 연구개발 인력현황&cr;</SPAN>
<SPAN>당사는 보고서 작성 기준</SPAN>
<SPAN>일 현재  연구개발 인력현황은  아래와 같습니다.&cr;</SPAN>
<SPAN>                                                                                        (단위:명)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="100"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" COLSPAN="2" ALIGN="CENTER">구   분</TD>
<TD WIDTH="386" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="4" ALIGN="CENTER">인원수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">박사</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">석사</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기타</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="109" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2" ALIGN="CENTER">연구개발&cr;인력현황</TD>
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">제1부설연구소</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">3</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">16</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">8</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">27</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">개발부서</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">3</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">5</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" ALIGN="CENTER">합    계</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">3</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">18</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">11</TD>
<TD WIDTH="96" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">32</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(3) 핵심연구인력 현황&cr; 당사의 핵심 연구 인력은</SPAN>
<SPAN> </SPAN>
<SPAN>COO인  변태호 부사장, 연구소장인 박정수</SPAN>
<SPAN></SPAN>
<SPAN> 상무</SPAN>
<SPAN> 그리고 바이오시밀러 </SPAN>
<SPAN>EPO의약품 및 FACTORⅧ</SPAN>
<SPAN> 개발과 관련하여 프로젝트 매니저 역활을 수행하고 있는 개발부 이종민 </SPAN>
<SPAN>상무</SPAN>
<SPAN> 이며 주요 경력 및 연구 실적은 아래와  같습니다.&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="930">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="235"></COL>
<COL WIDTH="234"></COL>
<COL WIDTH="278"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직위</TH>
<TH WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH WIDTH="244" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담당업무</TH>
<TH WIDTH="243" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요경력</TH>
<TH WIDTH="287" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요연구실적</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" HEIGHT="428" VALIGN="MIDDLE" ALIGN="CENTER">
<SPAN>COO</SPAN>
<SPAN>&cr;(부사장)</SPAN>
</TD>
<TD WIDTH="63" HEIGHT="428" VALIGN="MIDDLE" ALIGN="CENTER">변태호</TD>
<TD WIDTH="244" HEIGHT="428" VALIGN="MIDDLE" ALIGN="CENTER">연구개발운영총괄</TD>
<TD WIDTH="243" HEIGHT="428" VALIGN="MIDDLE">고려대 축산학과 박사(92)&cr;녹십자 수석연구원(94~01)&cr;삼성정밀화학 수석연구원(02~05)</TD>

<TD WIDTH="287" HEIGHT="428" VALIGN="MIDDLE" USERMARK=" 0XBD6F00">
<P>1.특허</P>
<P>-Serum free medium for suspension culture of mammalian cells(KR1005252540000)</P>
<P>-Production Method of Human Coagulation Factor Ⅷ from Recombinant CHO Cell line with Heavy and light Chain of Factor Ⅷ and von Willibrand Factor.(KR251286)</P>
<P>-Purification Method of Factor Ⅷ Using Kimera antibody of von willibrand Factor.(KR254574)</P>
<P>-동물세포발현벡터(KR101385223)</P>
<P>2.대표논문</P>
<P>-Continuous stable production of von Willebrand factor monoclonal antibody in spin filter bioreactor with bleeding technology. Biotechnol. Bioprocess Eng.2000; 5:130-135 외 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" HEIGHT="260" VALIGN="MIDDLE" ALIGN="CENTER">
<SPAN>연구소장&cr;</SPAN>
<SPAN>(상무)</SPAN>
</TD>
<TD WIDTH="63" HEIGHT="260" VALIGN="MIDDLE" ALIGN="CENTER">박정수</TD>

<TD WIDTH="244" HEIGHT="260" VALIGN="MIDDLE" ALIGN="CENTER">
<SPAN>연구개발총괄&cr;</SPAN>
<SPAN>(바이오의약품 생산세포주개발등)</SPAN>
</TD>
<TD WIDTH="243" HEIGHT="260" VALIGN="MIDDLE">경희대 유전공학과 박사(01)&cr;아주대 의대 연구실(95~00)</TD>

<TD WIDTH="287" HEIGHT="260" VALIGN="MIDDLE" USERMARK=" 0XBD6F00">
<P>1.특허</P>
<P>-RNA molecule biding to Anti-DNA autoantibody specifically, (KR1020010076989)</P>
<P>-동물세포발현벡터(KR1020120033467)</P>
<P>2. 대표논문</P>
<P>-Unstable expression of recombinant antibody during long-term culture of CHO cells is accompanied by histone H3 hypoacetylation. Biotechnol. Lett. 2013; 35(7):987-993외</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" HEIGHT="311" VALIGN="MIDDLE" ALIGN="CENTER">
<SPAN>개발부&cr;</SPAN>
<SPAN>(상무)</SPAN>
</TD>
<TD WIDTH="63" HEIGHT="311" VALIGN="MIDDLE" ALIGN="CENTER">이종민</TD>

<TD WIDTH="244" HEIGHT="311" VALIGN="MIDDLE" ALIGN="CENTER">
<SPAN>EPO, FACTOR</SPAN>
<SPAN>Ⅷ</SPAN>
<SPAN> 임상 및 허가등록</SPAN>
</TD>

<TD WIDTH="243" HEIGHT="311" VALIGN="MIDDLE">
<SPAN>고려대 유전공학과 석사(91)&cr;</SPAN>
<SPAN>녹십자 책임연구원(93~03)&cr;삼성정밀화학 책임연구원(03~05)</SPAN>
</TD>

<TD WIDTH="287" HEIGHT="311" VALIGN="MIDDLE" USERMARK=" 0XBD6F00">
<P>1.특허</P>
<P>-Purification method of factor VIII by using chimeric antibody against von Willebrand factor, (KR1002545740000)</P>
<P>-Mutein of human Interferon-beta and its preparation method(PCT/KR2004/000738) </P>
<P>2. 대표논문</P>
<P>-Purification of Recombinant Human B-Domain-Deleted Factor VIII Using Anti-factor VIII Monoclonal Antibody Selected by the surface plasmon Resonance Biosensor. Biotechnol. Prog. 17, 1119-1127외</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;&cr;</SPAN>
<SPAN USERMARK=" B">나. 연구개발비용&cr;</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>당사의 최근 3년간 연구개발비용은 아래와 같습니다.</SPAN>
<SPAN></SPAN>
<SPAN>&cr;                                                                                              (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="292" HEIGHT="60" COLSPAN="3" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구 분</P>
</TH>
<TH WIDTH="103" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>

<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">2019년</P>
</TH>

<TH WIDTH="109" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">2018년</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="103" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">(제11기)</P>
</TH>

<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">(제10기)</P>
</TH>

<TH WIDTH="109" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">(제9기)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" HEIGHT="540" ROWSPAN="18" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">연구개발품목</TD>
<TD WIDTH="83" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">EPO&cr;의약품</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">재료비등</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">97,150</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">10,477</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">위탁용역+시험비등</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">84,213</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">153,363</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">513,591</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">기    타</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">8,299</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">69,516</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">소계</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">84,213 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">258,812</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">593,584</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="83" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">FactorⅧ</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">재료비등</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,005 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">512,918</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">134,672</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">위탁용역+시험비등</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">395,708 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">268,420</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">5,090</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">기    타</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,000 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">4,535</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">소계</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">442,713 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">785,873</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">140,162</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-BT10">Aflibercept</SPAN>
</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">재료비등</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">115,719 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">222,265</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">46,046</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">위탁용역+시험비등</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,170,282 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,256,701</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">6,250</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">기    타</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">10,535 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">15,721</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">소계</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,296,536 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,494,687</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">52,296</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="83" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">기타</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">재료비등</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">840,918 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">718,462</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">660,030</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">위탁용역+시험비등</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">131,292 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">30,416</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">134,033</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">기    타</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">3,632 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">0</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">소계</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">975,842 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">748,878</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">795,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">인건비등(공통)</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,467,982 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,442,524</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,136,691</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">연구개발비용 합계</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">4,267,286 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">4,730,774</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">2,717,796</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="150" COLSPAN="2" ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">회계처리내역</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">판매비와관리비</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,675,570 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">4,522,537</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">2,579,786</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">개발비(무형자산)</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">0</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">회계처리금액 계</TD>

<TD USERMARK="F-BT 0X0000FF" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000">3,675,570</SPAN>
</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">4,522,537</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">2,579,786</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">정부보조금</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">591,716 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">208,237</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">138,010</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">연구개발비용 합계</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,267,286 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">4,730,774</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">2,717,796</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="53" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">연구개발비 / 매출액 비율&cr;[연구개발비용합계 / 당기매출액 X 100)</TD>
<TD USERMARK="F-BT" WIDTH="103" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">68.93% </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">164.19% </TD>
<TD WIDTH="109" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">47.85% </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>2018년에 금융위원회에서 발표한  "제약 바이오 기업의 연구개발비 회계처리 관련 감독지침"에 따라  </SPAN>
<SPAN>처리하고</SPAN>
<SPAN> </SPAN>
<SPAN>있으며</SPAN>
<SPAN> </SPAN>
<SPAN>2018년~2020년중에 </SPAN>
<SPAN>자산화한 연구개발비는 없습니다.  </SPAN>
<SPAN>연구개발비에 대한 세부내역은 </SPAN>
<SPAN> </SPAN>
<SPAN>III. 재무에 관한 사항</SPAN>
<SPAN> </SPAN>
<SPAN> </SPAN>
<SPAN>5.재무제표주석</SPAN>
<SPAN> 중 </SPAN>
<SPAN></SPAN>
<SPAN>15</SPAN>
<SPAN>. </SPAN>
<SPAN>무형자산</SPAN>
<SPAN>을</SPAN>
<SPAN> 참조하여 주시기 바랍니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
</P>
<P USERMARK=" B">다. 연구개발실적</P>

<P>
<SPAN>&cr;당사는 바이오의약품 개발기술인 PanGen CHO-TECH™기술과 바이오의약품 제품화 기술을 활용하여 다음과 같은 제품들을 개발하고 있습니다. </SPAN>
<SPAN></SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN>(1) 연구개발 진행 현황 &cr;&cr; 공시서류 작성기준일 현재 당사가 연구개발 진행중인 현황은 아래와 같습니다</SPAN>
</P>

<TABLE BORDER="1" WIDTH="996" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="171"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="228"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">핵심기술</P>
</TH>

<TH WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">개발 제품</P>
</TH>

<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">적응증</P>
</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">연구시작일</TH>

<TH WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">개발결과</P>
</TH>

<TH WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">현 개발단계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="434">
<P USERMARK="F-10">PanGen CHO-TECH™</P>
<P USERMARK="F-10">기술 및 </P>
<P USERMARK="F-10">바이오의약품</P>
<P USERMARK="F-10">제품화 기술</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">바이오시밀러 EPO의약품</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">

<P USERMARK="F-10">
<SPAN>만성신부전환자의</SPAN>
<SPAN>&cr;빈혈치료제</SPAN>
</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133" USERMARK="F-10">2010.01</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">세포주 개발</P>
<P USERMARK="F-10">공정/분석법 개발</P>
<P USERMARK="F-10">Scale-up</P>
<P USERMARK="F-10">전임상/임상1,3상완료</P>
</TD>

<TD WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<SPAN USERMARK="F-10">임상 3상 </SPAN>
<SPAN USERMARK="F-10">시</SPAN>
<SPAN USERMARK="F-10">험종료(17년 9월)</SPAN>
<SPAN USERMARK="F-10">&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">Malaysia 품목허가(19년 1월)</SPAN>
<SPAN USERMARK="F-10">&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">Malaysia 판매개시(19년 3월)</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">한국 품목허가(19년 11월)&cr;한국 판매개시(20년 2월)&cr;</SPAN>
<SPAN USERMARK="F-10">상업생산중</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">재조합 Factor VIII</P>
<P USERMARK="F-10">(PGA40)</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">혈우병A치료제</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">2014.02</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">개발후보 선정</P>
<P USERMARK="F-10">세포주 개발</P>
<P USERMARK="F-10">공정개발</P>
<P USERMARK="F-10">전임상시험완료</P>
</TD>

<TD WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">

<P USERMARK="F-10">
<SPAN>전임상완료(17년 7월)&cr;</SPAN>
<SPAN>한국 IND제출(18년 10월)&cr;한국임상1상 시험승인(19년 3월)&cr;</SPAN>
<SPAN></SPAN>
<SPAN>한국 임상1상 완료(20년 09월)</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">바이오시밀러 G-CSF</P>
<P USERMARK="F-10">(PHA30)</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">항암치료보조제</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">2013.01</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">개발후보 선정</P>
<P USERMARK="F-10">세포주 개발</P>
<P USERMARK="F-10">공정 개발</P>
<P USERMARK="F-10">전임상시험완료</P>
</TD>

<TD WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">전임상완료(15년 2월)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">바이오시밀러 Aflibercept&cr;(PCH250)</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">황반변성,황반부종등&cr;치료제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">2018.11</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">개발후보 선정</P>
<P USERMARK="F-10">세포주 개발</P>
<P USERMARK="F-10">공정 개발</P>
</TD>
<TD WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">전임상 완료(20년09월)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">항SFTSV항체&cr;(PAK255)</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">중증열성혈소판감소&cr;증후군치료제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">2020.01</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">-</TD>
<TD WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">생산세포주 및 공정 기술개발진행중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49">
<P USERMARK="F-10">PanGen CHO-TECH™ 기술</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49">
<P USERMARK="F-10">바이오의약품 개발기술이전서비스</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49">
<P USERMARK="F-10">-</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49">-</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49">
<P USERMARK="F-10">특허출원 14</P>
<P USERMARK="F-10">특허등록 21</P>
</TD>

<TD WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49">
<P USERMARK="F-10">사업화</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN> &cr;&cr; </SPAN>
<SPAN>가) 품  목 : 바이오시밀러 </SPAN>
<SPAN>EPO의약품</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="591">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="461"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">구      분</TH>

<TH WIDTH="470" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">바이오 시밀러</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">적 응 증</TD>
<TD WIDTH="470" HEIGHT="70" VALIGN="MIDDLE" USERMARK="F-10"> - 신장 투석 환자 (만성 신부전)의 투석 중 일어나는 급성 빈혈&cr; - 화학항암 요법 중 나타나는 빈혈&cr; - 그 외 수혈이 필요한 환자 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="133" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">작용기전</TD>

<TD WIDTH="470" HEIGHT="133" VALIGN="MIDDLE" USERMARK="F-10">
<P USERMARK="F-10">- 적혈구 형성 자극 인자는 신장에서 생성되는 당 단백질 성 호르몬으로 신체의   산소요구량에 따라 적혈구 생성을 조절하는 생체물질로 신장기능이 비정상인    만성 신부전 환자에서는 이 자극인자가 생성되지 않아 빈혈이 나타나게 됨.</P>
<P USERMARK="F-10">- 본 제품은 유전자 재조합 기술을 이용하여 생산된 제제로 골수 중 조혈 조직의  전구세포에 작용 하여 적혈구 원시세포의 분열과 분화를 자극함으로써 적혈구   생성을 유도하게 됨.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="91" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">제품의 특성</TD>
<TD WIDTH="470" HEIGHT="91" VALIGN="MIDDLE" USERMARK="F-10">- 오리지널 EPREX 와 약동학, 약력학, 독성 동등성 확보 &cr;- 세계 2번째 Epoetin alfa 성분의 바이오시밀러 제품(대조약 EPREX)&cr;- 세계 최초 바이오시밀러 제품인 Binocrit? 에 비해 대조약과의 품질비교에서   동등성이 뛰어남</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="154" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">진행경과</TD>

<TD WIDTH="470" HEIGHT="154" VALIGN="MIDDLE" USERMARK="F-10">
<SPAN>- 말</SPAN>
<SPAN></SPAN>
<SPAN>레이시아 국영제약사인</SPAN>
<SPAN> </SPAN>
<SPAN>DUOPHARMA BIOTECH BERHAD사의</SPAN>
<SPAN> 자회사인&cr; DUOPHARMA</SPAN>
<SPAN>(</SPAN>
<SPAN>M)사와</SPAN>
<SPAN> 공동으로 한국과 말레이시아에서 임상3상시험을 진행  하여 2017년 9월에  임상 3상을 종료하였습니다. </SPAN>
<SPAN> </SPAN>
<SPAN>2017년 3월에 말레이시아 식  약청에, </SPAN>
<SPAN> </SPAN>
<SPAN>2018년 5월에는 한국 식약처에 품목허가(NDA)를 신청하였</SPAN>
<SPAN></SPAN>
<SPAN>고,</SPAN>
<SPAN> </SPAN>
<SPAN>2</SPAN>
<SPAN>019년 1월에 말레이시아 식약청으로 부터 품목허가를 받았고 </SPAN>
<SPAN>2019년 11월에 한국 식약처로부터 품목허가를 받아 </SPAN>
<SPAN> 말레이시아 시장은 2019년 3월부터, 한국 시장은 2020년 2월부터 판매를 시작 하였습니다.</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="154" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">향후계획</TD>

<TD WIDTH="470" HEIGHT="154" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<SPAN USERMARK=" 0X000000">- 말레이시아 품목허가 후  당사와 공동임상 및 판권을 계약한 말레이시아 국영 제약사인</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
<SPAN USERMARK=" 0X000000">DUOPHARMA BIOTECH BERHAD사의</SPAN>
<SPAN USERMARK=" 0X000000"> 자회사인 DUOPHARMA</SPAN>
<SPAN USERMARK=" 0X000000">(</SPAN>
<SPAN USERMARK=" 0X000000">M)    사와</SPAN>
<SPAN USERMARK=" 0X000000"> 말레이시아외 </SPAN>
<SPAN USERMARK=" 0X000000">2개국과 필리핀</SPAN>
<SPAN USERMARK=" 0X000000"> 판매를,</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
<SPAN USERMARK=" 0X000000">한국은 중헌제약이</SPAN>
<SPAN USERMARK=" 0X000000">, 터키는 ONKO사, 태국은 S.Charoen사, </SPAN>
<SPAN USERMARK=" 0X000000">베트남은 </SPAN>
<SPAN USERMARK="F-BT 0X000000">Khuong Duy Pharma</SPAN>
<SPAN USERMARK=" 0X000000">사, </SPAN>
<SPAN USERMARK=" 0X000000"> 사우디아라비아와 </SPAN>
<SPAN USERMARK=" 0X000000">GCC 5개국</SPAN>
<SPAN USERMARK=" 0X000000">은 SAUDI VAX사가 </SPAN>
<SPAN USERMARK=" 0X000000"> 판매를 담당할 계획이며,</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
<SPAN USERMARK=" 0X000000">기타 다 른 </SPAN>
<SPAN USERMARK=" 0X000000">판매 국가</SPAN>
<SPAN USERMARK=" 0X000000">등은 해당 지역에서 의약품 마케팅 인력, 조직, 영업망 및 know-how 등을 확보하고 있는</SPAN>
<SPAN USERMARK=" 0X000000"> 중대형제약사</SPAN>
<SPAN USERMARK=" 0X000000"> 들을 상대로 판권계약을 계획 중입니다.</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">경쟁제품</TD>

<TD WIDTH="470" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<SPAN USERMARK=" 0X000000">- 국내 : EPOKINE</SPAN>
<SPAN USERMARK=" 0X000000">(HK이노엔)</SPAN>
<SPAN USERMARK=" 0X000000">, E</SPAN>
<SPAN USERMARK=" 0X000000">POGEN</SPAN>
<SPAN USERMARK=" 0X000000">(LG화학 )&cr;</SPAN>
<SPAN USERMARK=" 0X000000">- 해외 : EPREX(Janssen), BINOCRIT(</SPAN>
<SPAN USERMARK=" 0X000000">Sandoz), </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="91" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">관련논문등</TD>

<TD WIDTH="470" HEIGHT="91" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<SPAN USERMARK=" 0X000000">- Pharmacokinetic and Pharmacodynamic Comparison of Two Recombinant Human Erythropoietin Formulations, PDA10 and Eprex, in Healthy Korean Male Volunteers: A Randomized,Double-Blinded, Single-Dose, Two-Period Crossover Study, </SPAN>
<SPAN USERMARK=" 0X000000">Clin. Drug Investig. (2015) 35:659-664</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">시장규모</TD>
<TD WIDTH="470" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10">- EPO 시장 규모 : 71억달러(2015년 기준 , 컨설팅업체 BBC 리서치)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">기타사항</TD>

<TD WIDTH="470" HEIGHT="70" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">- 말레이시아 판매개시(19년 3월), </SPAN>
<SPAN USERMARK=" 0X000000">한국 판매개시(20년 2월)</SPAN>
<SPAN USERMARK=" 0X000000">&cr;</SPAN>
<SPAN USERMARK=" 0X000000">- 필리핀,베트남,태국,</SPAN>
<SPAN USERMARK=" 0X000000">사우디아라비아</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">에 품목허가신청&cr;</SPAN>
<SPAN USERMARK=" 0X000000">- 한국 한국이슬람교 중앙회(KMF)로 부터 할랄인증(20년 2월)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN> </SPAN>
<SPAN>나) 품  목 : 재조합 Factor VIII</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="605">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="475"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">구      분</TH>
<TH WIDTH="484" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">Stand alone</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">적 응 증</TD>
<TD WIDTH="484" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">- 혈우병 A (선천성 혈액응고 8인자 결핍증) 환자에서의 출혈의 조절 및 예방&cr;- 일상생활 및 수술 시 출혈 예방 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="236" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">작용기전</TD>

<TD WIDTH="484" HEIGHT="236" VALIGN="MIDDLE" USERMARK="F-10">
<P USERMARK="F-10">-혈우병의 치료는 부족한 항 응고 인자를 보충해 주는 것으로 8인자와 9인자 제제   가 사용되고 있으며, 항체가 생긴 경우에는 우회인자를 투여함.  투여방법에도 출  혈이 있을 때 마다 투여하는 보충요법(on-demand)과 평소에 출혈이 발생되지     않더라도 부족한 응고인자를 정기적으로 투여해 출혈을 예방하는 유지요법(prop  hylaxis)이 있음.</P>
<P USERMARK="F-10">-재조합 Factor VIII 제품은 신생아를 포함하여, 성인 및 소아에게 적합하며, 투여 용량과 투여기간은 8인자 결핍정도, 출혈 부위 및 정도, 환자의 임상적 상태에 따라 결정됨. 8인자의 투여 단위수는 8인자 활성 에 대한 WHO 국제 기준인 International Units (IU)로 표시됨.  보통 재조합 Factor VIII 제품의 예방용 투여용량은 30 ± 5 IU/kg의 용량을 주 3회 예방적으로 투여하는 용법용량을 가짐.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="112" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">제품의 특성</TD>
<TD WIDTH="484" HEIGHT="112" VALIGN="MIDDLE" USERMARK="F-10"> - 세계 3번째 B도메인 결손 재조합 Factor Ⅷ 제품으로 개발 중 (주)1 &cr; - 재조합 제품은 혈장유래 제품들에 비해 안전성이 높으며, B도메인이 결손된 제     품이 생산성이 높고 생산공정이 안정적 &cr;- 유럽 Factor VIII 가이드라인을 준수하여 신약에 준하는 Stand alone 으로 개발&cr;  (주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="154" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">진행경과</TD>

<TD WIDTH="484" HEIGHT="154" VALIGN="MIDDLE" USERMARK="F-10">
<SPAN>- 2017년 7월에 전임상시험을 완료하였으며</SPAN>
<SPAN> </SPAN>
<SPAN>2</SPAN>
<SPAN>018년 10월에 한국식약처에 임상&cr;  IND를  제출하였고</SPAN>
<SPAN> </SPAN>
<SPAN>2019년 3월에 한국임상1상 시험승인을</SPAN>
<SPAN>  받았습니다.</SPAN>
<SPAN>&cr;-</SPAN>
<SPAN> 2019년 11월에 을지대학교 병원에서 임상1상 첫환자 투여 개시</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>- 2020년 7월 임상1상 마지막 환자 투여 완료</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>- 한국 임상1상 완료(2020.09)&cr;</SPAN>
<SPAN></SPAN>
<SPAN>- </SPAN>
<SPAN>글로벌 파트너사들과 다수의 국가에서 공동 임상3상 및 판권계약을  진행할 계획임 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">향후계획</TD>
<TD WIDTH="484" HEIGHT="70" VALIGN="MIDDLE" USERMARK="F-10">- 당사는 개발 중인 바이오 제품의 다국가 공동 임상시 공동임상 계약을 맺은 파트    너사에게  해당지역의  판권 계약도 함께 체결 함으로  마케팅 네트웍을 조기에      구축할 계획임  </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">경쟁제품</TD>
<TD WIDTH="484" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">- 국내, 해외 : 그린진-F(녹십자), ADVATE (BAXTER), KOGENATE FS (BAYER),&cr;   Xyntha(Pfizer)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">관련논문등</TD>

<TD WIDTH="484" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<SPAN USERMARK=" 0X000000">- 한국특허(</SPAN>
<SPAN USERMARK=" 0X000000">제 10-1989779호</SPAN>
<SPAN USERMARK=" 0X000000">), 항-혈액응고 제Ⅷ인자 항체 및 그 용도</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">시장규모</TD>

<TD WIDTH="484" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<SPAN USERMARK=" 0X000000">- Factor VIII 시장규모:67억달러(2016년 기준 , 시장조사기관 : 글로벌데이터)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">기타사항</TD>
<TD WIDTH="484" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10"> -</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-10">
<SPAN>주1) 첫 번째 제품은 Pfizer사가 보유한 Xyntha?/Refactor , 두 번째 제품은 녹십자의 그린진-F &cr;</SPAN>
<SPAN>주2) 재조합 Factor VIII 제품의 경우 단백질의 크기가 크고 구조가 복잡하여 바이오시밀러 개발이&cr;       불가능 &cr;</SPAN>
</P>

<P>
<SPAN> </SPAN>
<SPAN>다) 품  목 : 바이오시밀러 G-CSF</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="474"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">구      분</TH>
<TH WIDTH="483" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">바이오시밀러</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="72" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">적 응 증</TD>

<TD WIDTH="483" HEIGHT="72" VALIGN="MIDDLE" USERMARK="F-10">
<P USERMARK="F-10">- 화학항암 요법 중 나타나는 호중구 감소</P>
<P USERMARK="F-10">- 골수이형성성 증후군, 재생불량성 빈혈 등에 수반되는 호중구 감소</P>
<P USERMARK="F-10">- 그 외 여러 질병에 의하여 수반되는 호중구 감소</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="112" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">작용기전</TD>
<TD WIDTH="483" HEIGHT="112" VALIGN="MIDDLE" USERMARK="F-10">- G-CSF는 골수에 있는 호중구 전구세포에 작용하여 호중구의 기능을 강화시키     는 성장 인자이며 각종 고형암 치료를 위한 화학요법 치료시와 면역억제요법에     수반되는 호중구 감소증의 치료와 재생불량성 빈혈환자에 나타나는 호중구 감소   증의 치료 그리고 골수 세포와 조혈모세포 이식 시 호중구 증가 촉진 및 조혈모세  포의 말초조혈모세포의 동원 등에 사용하고 있는 치료용 단백질임.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">제품의 특성</TD>

<TD WIDTH="483" HEIGHT="70" VALIGN="MIDDLE" USERMARK="F-10">
<SPAN>- 오리지널 Lenograstim 바이오 시밀러&cr;- 동물세포배양 방식으로 생산되어 미생물 배양으로 생산되는 filgrastim 성분의       제품보다 우수한 효능과 높은 안전성 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">진행경과</TD>

<TD WIDTH="483" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10">
<SPAN>- </SPAN>
<SPAN>전임상시험 완료(2015. 02)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">향후계획</TD>

<TD WIDTH="483" HEIGHT="70" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<SPAN USERMARK=" 0X000000">- 당사는 개발 중인 바이오 제품의 다국가 공동 임상시 공동임상 계약을 맺은 파트   너사에게  해당지역의  판권 계약도 함께 체결을 함으로  마케팅 네트웍을 조기     에 구축할 계획임  </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">경쟁제품</TD>
<TD WIDTH="483" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">- 국내 : 제일기린, JW중외&cr;- 해외 : Roche/Chugai사, Sandoz사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">관련논문등</TD>
<TD WIDTH="483" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10"> -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">시장규모</TD>
<TD WIDTH="483" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10">- G-CSF 시장규모 : 77억달러(2016년 기준 , 시장조사기관 : 크리던스리서치)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">기타사항</TD>
<TD WIDTH="483" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10"> -</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN>라) 품  목 : 바이오시밀러 Aflibercept</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="474"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">구      분</TH>
<TH WIDTH="483" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">바이오시밀러</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="91" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">적 응 증</TD>

<TD WIDTH="483" HEIGHT="91" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">-  신생혈관성 (습성) 연령 관련 황반변성 </P>
<P USERMARK="F-10">-  망막정맥폐쇄성 황반부종에 의한 신력 손상의 치료</P>
<P USERMARK="F-10">-  당뇨병성 황반부종에 의한 시력 손상의 치료</P>
<P USERMARK="F-10">-  병적근시로 인한 맥락막 신생혈관 형성에 따른 시력 손상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="112" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">작용기전</TD>

<TD WIDTH="483" HEIGHT="112" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">- 습성 연령관련 황반변성은 VEGF에 의해 황반부에 비정상적으로 생성되는&cr;   신생혈관과 이로부터 발생하는 출혈, 부종 때문에 시력저하가 발생하는 질병임.</P>
<P USERMARK="F-10">- Aflibercept는 혈관내피인자 수용체(VEGFR)와 항체의 Fc가 결합된 항-혈관내피   성장인자 단백질로 눈 내부에 직접 주사하여VEGF를 비활성화시킴으로써 비정     상적인 혈관의 생성과 체액의 누출을 막는 치료용 단백질임.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">제품의 특성</TD>

<TD WIDTH="483" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">- 오리지널 아일리아 제품에 대한 바이오시밀러 </P>
<P USERMARK="F-10">- 오리지널 의약품과 단백질 품질에서 동등성 확보</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">진행경과</TD>
<TD WIDTH="483" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-  전임상 시험 완료(2020.09)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">향후계획</TD>
<TD WIDTH="483" HEIGHT="70" VALIGN="MIDDLE" USERMARK="F-10">- 2020.9월에 전임상 시험을 완료 하였으며  향후 해외 또는 국내 바이오기업에 기술이전이나 다국가 공동 임상을 진행한 후 공동임상 계약을  맺은 파트너사에게 해당지역의 판권계약을 함께 체결하여 마케팅 네트웍을 구축할 계획임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">경쟁제품</TD>

<TD WIDTH="483" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<SPAN USERMARK=" 0X000000">- </SPAN>
<SPAN USERMARK=" 0X000000">Eylea</SPAN>
<SPAN USERMARK=" 0X000000">(Bayer사),</SPAN>
<SPAN USERMARK=" 0X000000">Lucentis</SPAN>
<SPAN USERMARK=" 0X000000">(Roche사)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">관련논문등</TD>
<TD WIDTH="483" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">시장규모</TD>
<TD WIDTH="483" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">- Eylea 63억달러(2017년), Lucentis 33억달러(2017년)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">기타사항</TD>

<TD WIDTH="483" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<SPAN USERMARK=" 0X000000">- 국</SPAN>
<SPAN USERMARK=" 0X000000">내특허</SPAN>
<SPAN USERMARK=" 0X000000"> 출원 : 안과용 액상 조성물 및 이의 안정화용 조성물</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN>마) 품  목 : 항 SFTSV 항체 </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="474"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">구      분</TH>
<TH WIDTH="483" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">신약 항체</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">적응증</P>
</TD>

<TD WIDTH="483" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">- 중증열성혈소판감소증후군 (SFTS)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="194" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">작용기전</P>
</TD>

<TD WIDTH="483" HEIGHT="194" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">- SFTS는 SFTS바이러스(SFTSV)에 감염된 진드기에 의해 매개되는 감염병 질환으로 SFTSV에 감염되면 발열, 위장관 증상, 호중구 감소증 및 혈소판 감소증 등의 임상증상을 보이며 회복되지 않는 경우 빠르게 다발성 장기기능 장애로 진행하여 사망에 이름.</P>
<P USERMARK="F-10">- 항 SFTSV항체는 나노바디 (Nanobody) 구조로 일반항체에 비해 크기가 작아 안정성이 높고, 면역원성이 낮은 장점을 보유하고 있음. </P>
<P USERMARK="F-10">- 항SFTSV항체는 SFTS 바이러스의 외막 당단백질에 특이적으로 결합하여 바이러스를 중화시키는 항체 치료제임. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">제품의 특징</P>
</TD>

<TD WIDTH="483" HEIGHT="99" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">- 세계 최초의 진드기 매개 중증열성혈소판감소증후군 치료제</P>
<P USERMARK="F-10">- 동물모델을 이용한 효력 검증완료</P>
<P USERMARK="F-10">- 한국, 중국, 일본에서 발견되는 모든 SFTS 바이러스를 중화시킬 수 있는 항체 치료제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">진행경과 </P>
</TD>

<TD WIDTH="483" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">- 생산 세포주 개발 및 대량생산을 위한 공정개발 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">향후계획</P>
</TD>

<TD WIDTH="483" HEIGHT="122" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">-  당사가 개발중인 항 SFTSV 항체 치료제는 비임상시료 생산이 완료되면 동물모델을 이용한 비임상 효력시험 및 독성시험을 수행하여 안정성을 확보한 후 가장 많은 환자가 발생하는 중국 시장내 기술력을 가진 기업과 함께 치료제 공동개발을 추진하여 제품 출시에 박차를 가할 예정임.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">경쟁제품</P>
</TD>

<TD WIDTH="483" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">-   </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">관련 논문등</P>
</TD>

<TD WIDTH="483" HEIGHT="122" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">- Severe Fever with Thrombocytopenia Syndrome, South Korea, 2012. Emerging Infectious Diseases (2013),19, 1892 ~ 1894.</P>
<P USERMARK="F-10">- An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus. PLOS Pathogens (2019), 15(2), 1 ~ 21. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">시장규모</P>
</TD>

<TD WIDTH="483" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">-     </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">기타사항</P>
</TD>

<TD WIDTH="483" HEIGHT="70" VALIGN="MIDDLE" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">한국, 중국, 일본 특허출원(공동특허 ,팬젠, Y-Clone Medical sciences)</P>
<P USERMARK="F-10"> SFTSV에 결합 가능한 나노항체 및 이의응용</P>
<P USERMARK="F-10">(Nano-antibody capable of binding to SFTSV and application thereof)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN></SPAN>
<SPAN>(2) 연구개발 완료 실적&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="789" BORDER="1">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="40"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="178"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="51"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="171" HEIGHT="53">구분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="49" HEIGHT="53">품목</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="138" HEIGHT="53">적응증</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="187" HEIGHT="53">개발완료일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="184" HEIGHT="53">현재현황</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="112">바이오</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="112">바이오시밀러</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="49" HEIGHT="112">EPO</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="138" HEIGHT="112">
<SPAN>만성신부전환자의</SPAN>
<SPAN>&cr;빈혈치료제</SPAN>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="187" HEIGHT="112">
<SPAN USERMARK="F-10">임상 3상 </SPAN>
<SPAN USERMARK="F-10">시</SPAN>
<SPAN USERMARK="F-10">험종료</SPAN>
<SPAN USERMARK="F-10">(17년9월)&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">Malaysia 품목허가(19년 1월)</SPAN>
<SPAN USERMARK="F-10">&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">Malaysia 판매개시(19년 3월)</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">한국 품목허가(19년 11월)&cr;한국 판매개시(20년 2월)</SPAN>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="184" HEIGHT="112">한국,말레이시아판매중&cr;필리핀,베트남,태국,사우디아라비아품목허가신청</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="112"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;&cr;(</SPAN>
<SPAN>3) 연구개발 향후 계획</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr; </SPAN>
<SPAN>혈우병A치료제인 재조합</SPAN>
<SPAN> Factor VIII은 전임상 시험을 완료(2017.7월) 하였으며 </SPAN>
<SPAN> </SPAN>
<SPAN>2018년 10월에</SPAN>
<SPAN> 한국식약처에 임상 IND를 제출하였고  </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>2</SPAN>
<SPAN>0</SPAN>
<SPAN>1</SPAN>
<SPAN>9</SPAN>
<SPAN>년</SPAN>
<SPAN> 3월에 한국 임상1상 시험승인을 받아</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>을</SPAN>
<SPAN>지대병원에서</SPAN>
<SPAN> 임상1상 시험를 진행 하였습니다.</SPAN>
<SPAN>  임상1상 시험은 총 12명의 환자를 대상으로 </SPAN>
<SPAN>진행하였으며</SPAN>
<SPAN>  </SPAN>
<SPAN>2019년 11월에 임상1상 첫환자 투여가 </SPAN>
<SPAN>시작 되었</SPAN>
<SPAN>고</SPAN>
<SPAN>  2020년 7월에 마지막 환자의 임상약 투여가 </SPAN>
<SPAN>완료되어</SPAN>
<SPAN> 현</SPAN>
<SPAN>재 임상1상 시험을 완료 하였습니다</SPAN>
<SPAN>. 2021년도에 다국가 공동 임상을 진행할 계획 입니다.&cr;&cr; </SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>황반변성,황반부종등 치료제인 바이오시밀러 </SPAN>
<SPAN>Aflibercept</SPAN>
<SPAN>는 현재 전임상 시험을 완</SPAN>
<SPAN>료하였고, </SPAN>
<SPAN>향후 해외,국내 바이오기업에 공동임상 또는 </SPAN>
<SPAN>기술이전을 추진할 계획입니다.</SPAN>
<SPAN> &cr;&cr; 중증열성혈소판감소증후군 </SPAN>
<SPAN>치료제</SPAN>
<SPAN>인 항SFTSV항체는 생산세포주 및 공정기술 개발을 완료 하였고</SPAN>
<SPAN> 2021년 전임상 시험을 진행할 계획입니다.</SPAN>
</P>
<P>&cr;</P>
<P>(4) 연구개발을 위한 정부출연과제 수행 실적</P>
<P>                                                                                            </P>

<TABLE BORDER="1" WIDTH="646" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="61"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">개발 제품</P>
</TH>

<TH WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">사업명</P>
</TH>

<TH WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">과제명</P>
</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">연구기간</P>
</TH>

<TH WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">비고 </P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">바이오시밀러 </P>
<P USERMARK="F-10">G-CSF</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">경기도기술개발사업</P>
<P USERMARK="F-10">(경기과학기술진흥원)</P>
</TD>

<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">동물세포 유래의 바이오시밀러 G-CSF (과립구 콜로니 자극인자) 의약품 개발</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">13.07.01 ~</P>
<P USERMARK="F-10">15.06.30</P>
</TD>

<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">전임상&cr;완료 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">바이오의약품개발</P>
<P USERMARK="F-10">기술이전서비스</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">중소기업기술혁신개발사업(중소기업청)</TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">대상포진백신 개발을 위한 항원생산기술및면역증진기술개발</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">15.10.12 ~&cr;17.10.11.</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">바이오의약품개발기술이전서비스</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">감영병위기대응&cr;기술개발</TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">차세대재조합&cr;대상포진백신개발</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">
<SPAN>18.04.30 ~&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>21.12.31</SPAN>
</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">진행중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">고성능 맞춤형 배지&cr; 첨가물 </TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">바이오산업&cr;핵심기술개발</TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">바이오의약품 생산용 배지&cr;첨가물 개발</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">20.04.01~&cr;22.12.31</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">진행중</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P USERMARK="F-16 0XFF1200 B">10. 그 밖에 투자의사결정에 필요한 사항</P>
<P> </P>
<P USERMARK=" B">가. 지적재산권 보유현황</P>
<P> </P>
<P>당사는 보고서 작성 기준일 현재 바이오시밀러 및 바이오의약품 개발기술 관련 당사가 보유하고 있는 상표권 및 특허권을 다음과 같습니다. </P>
<P> </P>

<TABLE BORDER="1" WIDTH="669" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="22"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="185"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">번호</P>
</TH>

<TH WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">구분</P>
</TH>

<TH WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">내용</P>
</TH>

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">권리자</P>
</TH>

<TH WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">출원국</P>
</TH>

<TH WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">출원일</P>
</TH>

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">등록일</P>
</TH>

<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-10">적용&cr;제품</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">1</P>
</TD>

<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">상표</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">PANGEN</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">팬젠</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">대한민국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">00.02.18</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">01.06.07</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="28" ALIGN="CENTER">
<P USERMARK="F-10">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">2</P>
</TD>

<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">상표</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">PANGENEPO</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">팬젠</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">대한민국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">11.12.21</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.01.15</P>
</TD>

<TD ROWSPAN="4" WIDTH="102" VALIGN="MIDDLE" HEIGHT="112" ALIGN="CENTER">
<P USERMARK="F-10">바이오시밀러&cr;EPO</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">3</P>
</TD>

<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">상표</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">PANPOTIN</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">팬젠</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">대한민국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">11.12.21</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.03.05</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">4</P>
</TD>

<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">상표</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">판제네포</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">팬젠</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">대한민국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">11.12.21</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.03.05</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">5</P>
</TD>

<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">상표</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="28">
<P USERMARK="F-10">팬포틴</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">팬젠</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">대한민국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">11.12.21</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.03.05</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">6</P>
</TD>

<TD ROWSPAN="7" WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="196">
<P USERMARK="F-10">특허</P>
</TD>

<TD ROWSPAN="7" WIDTH="194" VALIGN="MIDDLE" HEIGHT="196">
<P USERMARK="F-10">동물세포발현벡터</P>
<P USERMARK="F-10">Expression vector using for &cr;animal cell</P>
</TD>

<TD ROWSPAN="7" WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="196">
<P USERMARK="F-10">팬젠/</P>
<P USERMARK="F-10">목암연구소</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">대한민국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">00.07.29</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">03.11.26</P>
</TD>

<TD ROWSPAN="7" WIDTH="102" VALIGN="MIDDLE" HEIGHT="196" ALIGN="CENTER">
<P USERMARK="F-10">바이오의약품개발기술</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">7</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">중국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">03.01.29</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">06.07.05</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">8</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">일본</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">03.01.29</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">08.06.13</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">9</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">미국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">03.01.27</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">08.09.09</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">10</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">유럽</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">03.02.23</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">09.10.14</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">11</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">말레이시아</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">03.01.21</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">11.03.31</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">12</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">인도</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">03.01.27</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">11.11.14</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35">
<P USERMARK="F-10">13</P>
</TD>

<TD ROWSPAN="3" WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="140">
<P USERMARK="F-10">특허</P>
</TD>

<TD ROWSPAN="3" WIDTH="194" VALIGN="MIDDLE" HEIGHT="140">
<P USERMARK="F-10">인터페론 베타 MAR인자를 포함하는 동물세포발현벡터</P>
<P USERMARK="F-10">Expression vector for animal cell containing nuclear matrixattachment region of &cr;interferon beta</P>
</TD>

<TD ROWSPAN="3" WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="140">
<P USERMARK="F-10">팬젠</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">한국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">00.12.14</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">05.11.10</P>
</TD>

<TD ROWSPAN="3" WIDTH="102" VALIGN="MIDDLE" HEIGHT="140" ALIGN="CENTER">
<P USERMARK="F-10">바이오의약품개발기술</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">미국</P>
</TD>

<TD ROWSPAN="2" WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">03.06.13</P>
</TD>

<TD ROWSPAN="2" WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">07.08.21</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="105">
<P USERMARK="F-10">14</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">15</P>
</TD>

<TD ROWSPAN="8" WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="224">
<P USERMARK="F-10">특허</P>
</TD>

<TD ROWSPAN="8" WIDTH="194" VALIGN="MIDDLE" HEIGHT="224">
<P USERMARK="F-10">동물세포발현벡터</P>
<P USERMARK="F-10">Expression vector for animal &cr;cells</P>
</TD>

<TD ROWSPAN="8" WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="224">
<P USERMARK="F-10">팬젠</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">한국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">12.03.30</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">14.04.08</P>
</TD>

<TD ROWSPAN="8" WIDTH="102" VALIGN="MIDDLE" HEIGHT="224" ALIGN="CENTER">
<P USERMARK="F-10">바이오의약품 개발기술</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">16</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">미국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.09.27</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">15.06.23</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">17</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">인도</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.09.27</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">19.07.04</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">18</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">말레이시아</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.09.30</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">19.10.08</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">19</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">일본</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.09.30</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">16.04.26</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">20</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">유럽</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.09.30</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">16.10.13</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">21</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">브라질</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.09.30</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">22</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">중국</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28">
<P USERMARK="F-10">13.10.25</P>
</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">15.10.07</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">23</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">특허</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">인간 및 마우스 Sema3A에 교차 결합하는 항체 및  그의용도 </TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">팬젠/삼성생명공익재단</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">한국</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">16.09.26</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">18.04.26</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">신약항암항체개발기술</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">24</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="118" USERMARK="F-10" ROWSPAN="4">특허</TD>
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="118" USERMARK="F-10" ROWSPAN="4">항-혈액응고 제Ⅷ인자 항체 및 그 용도</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="118" USERMARK="F-10" ROWSPAN="4">팬젠</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">한국</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">16.12.14</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">19.06.11</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="118" USERMARK="F-10" ROWSPAN="4">혈우병치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">25</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">미국</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">19.05.27</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">26</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">중국</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">19.06.14</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">27</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">인도</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">19.06.03</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">28</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="288" USERMARK="F-10" ROWSPAN="10">특허</TD>

<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="288" USERMARK="F-10" ROWSPAN="10">
<SPAN>인간 및 마우스 Sema3A에 교차 결합하는 항체 및  그의용도&cr;(Antibody to be cross-linked to human and mouse Sema3, and use thereof) </SPAN>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="288" USERMARK="F-10" ROWSPAN="10">
<SPAN>팬젠/삼성생명공익재단</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">브라질</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">2018.04.26</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">-</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="288" USERMARK="F-10" ROWSPAN="10">
<SPAN>신약항암항체개발기술</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">29</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">멕시코</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">2018.04.26</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">30</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">인도</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">2018.05.25</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">31</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">인도네시아</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">2018.05.25</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">20.09.28</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">32</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">유럽</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">2018.04.26</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">33</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">호주</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">2018.05.25</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">19.11.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">34</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">일본</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">2018.04.26</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">35</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">미국</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">2018.04.27</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">20.02.13</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">36</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">중국</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">2018.04.26</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">37</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">말레이시아</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">2018.04.26</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="51">38</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="51" USERMARK="F-10">특허</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="51" USERMARK="F-10">안과용 액상 조성물 및 이의 안정화용 조성물</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="51" USERMARK="F-10">팬젠</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="51" USERMARK="F-10">한국</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="51" USERMARK="F-10">202.07.24</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="51" USERMARK="F-10">-</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="51" USERMARK="F-10">바이오시밀러&cr;aflibercept</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="116" ROWSPAN="3" USERMARK="F-10">39</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="116" USERMARK="F-10" ROWSPAN="3">특허</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="116" ROWSPAN="3">
<P USERMARK="F-10">SFTSV에 결합 가능한 나노항체 및 이의응용</P>
<P USERMARK="F-10">(Nano-antibody capable of binding to SFTSV and application thereof)</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="116" USERMARK="F-10" ROWSPAN="3">
<P USERMARK="F-10"></P>
<P USERMARK="F-10">팬젠</P>
<P USERMARK="F-10">Y-Clone Medical sciences</P>
</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="39" USERMARK="F-10">한국</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="39" USERMARK="F-10">2020.07.29</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="39" USERMARK="F-10">-</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="116" USERMARK="F-10" ROWSPAN="3">신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="43" USERMARK="F-10">중국</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="43" USERMARK="F-10">2019.07.23</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="43" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="34" USERMARK="F-10">일본</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="34" USERMARK="F-10">2020.07.06</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="34" USERMARK="F-10">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『수주상황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_수주상황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>

<P>                                                                                                    
<SPAN USERMARK="F-10">  (단위:백만원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="213"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제11기</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제10기</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제9기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년12월말</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년12월말</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018년12월말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">[유동자산]</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,092</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,607</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,871</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">ㆍ당좌자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,328</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,807</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,388</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">ㆍ재고자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,764</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">800</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">483</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">[비유동자산]</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,217</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,475</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,739</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">ㆍ기타비유동금융자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">207</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">295</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">255</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">ㆍ투자자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">466</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">ㆍ유형자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,028</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,011</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,979</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">ㆍ무형자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,516</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,169</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,505</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">자산총계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,309</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">39,082</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,610</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">[유동부채]</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,091</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,907</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,431</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">[비유동부채]</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,007</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,749</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,238</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">부채총계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,098</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,656</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,669</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">[자본금]</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,821</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,821</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,821</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">[자본잉여금]</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,237</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,237</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,237</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">[기타자본]</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">833</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">804</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">96</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">[결손금]</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(38,680)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(34,436)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(25,213)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">자본총계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,211</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,426</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,941</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="53" VALIGN="MIDDLE"></TD>
<TD WIDTH="126" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(2020.01.01~&cr;2020.12.31)</TD>
<TD WIDTH="133" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(2019.01.01~&cr;2019.12.31)</TD>
<TD WIDTH="130" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(2018.01.01~&cr;2018.12.31)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">매출액</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,191</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,881</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,679</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">매출총이익(매출총손실)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,373</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,097)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">517</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">영업이익(영업손실)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,700)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,978)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,044)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">당기순이익(손실)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,356)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(8,938)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,630)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">총포괄이익(손실)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,356)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,223)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,733)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30" VALIGN="MIDDLE">기본및희석주당이익(손실)(원)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(452)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(927)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(481)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>본 요약재무제표는 정기주주총회 승인전 재무제표이며  2021년 3월 29일 정기 주주총회에서 재무제표에 대한 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유등을 반영할 예정입니다.&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>&cr;
</P>
<WARNING>※ 아래 『재무제표』단위서식을 클릭하여 해당사항을 선택하면,&cr;    2.연결재무제표 ~ 5.재무제표주석 항목을 삽입할 수 있습니다.</WARNING>
</SECTION-2>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『재무제표』 삽입</COMMENT>
<LIBRARYLIST>11011#*재무제표_*.*</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dslx:1615783330">(최종본)(xbrl)2020년도 재무제표_00962922_(주)팬젠.ixd</FILENAME>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>
<P>&cr;당사는 보고서 작성 기준일 현재 해당사항 없습니다.</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P>&cr;당사는 보고서 작성 기준일 현재 해당사항 없습니다.&cr;</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>

<TABLE-GROUP ACLASS="{XBRL}BS_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">재무상태표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 11 기          2020.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 10 기          2019.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 9 기          2018.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 11 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 10 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 9 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>24,091,720,496</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>25,607,392,586</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>30,870,784,518</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,139,296,426</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,363,336,600</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>6,927,290,611</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　정부보조금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,364)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,871)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매출채권 및 기타채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>684,265,378</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,982,909</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,096,129,984</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　계약자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>49,733,716</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>78,732,386</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>46,043,955</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>10,640,907,794</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>20,161,200,183</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>22,255,365,806</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>764,366,619</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,158,657</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,852,909</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　당기법인세자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>49,263,920</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>95,202,600</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>58,359,280</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,763,886,643</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>799,780,615</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>482,746,844</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>12,217,161,684</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>13,475,546,560</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,738,927,161</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>206,988,493</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>295,157,059</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>254,547,300</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　투자부동산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>466,027,251</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,028,514,573</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,011,125,975</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,979,038,960</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,515,631,367</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,169,263,526</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,505,340,901</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자산총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>36,308,882,180</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>39,082,939,146</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>45,609,711,679</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>20,090,911,860</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,907,482,590</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,431,298,035</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매입채무 및 기타채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>679,716,373</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>878,295,994</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>383,610,199</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　계약부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>978,201,900</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>586,186,610</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>16,575,343</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　전환사채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,398,863,067</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,385,925,616</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>16,171,516,608</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　파생상품부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>836,244,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>34,130,520</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>57,074,370</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>23,351,885</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,006,807,110</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,749,070,154</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,237,615,470</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동금융부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>77,306,491</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　순확정급여부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,929,500,619</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,749,070,154</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,237,615,470</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>22,097,718,970</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>20,656,552,744</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,668,913,505</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자본</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자본금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,820,890,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,820,890,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,820,890,500</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　주식발행초과금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>47,237,256,118</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>47,237,256,118</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>47,237,256,118</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　기타자본구성요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>832,709,972</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>804,719,604</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>95,820,168</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　이익잉여금(결손금)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(38,679,693,380)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(34,436,479,820)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(25,213,168,612)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자본총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,211,163,210</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,426,386,402</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,940,798,174</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>부채와자본총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>36,308,882,180</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>39,082,939,146</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>45,609,711,679</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN></SPAN>
<SPAN>본 재무제표는 정기주주총회 승인전 재무제표이며  2021년 3월 29일 정기 주주총회에서 재무제표에 대한 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유등을 반영할 예정입니다.&cr;</SPAN>
</P>

<TABLE-GROUP ACLASS="{XBRL}IS_S1" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">포괄손익계산서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 11 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 10 기 2019.01.01 부터 2019.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 9 기 2018.01.01 부터 2018.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 11 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 10 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 9 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,191,154,710</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,881,328,518</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,679,471,336</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,818,049,409</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,978,689,191</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,161,896,456</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출총이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,373,105,301</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,097,360,673)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>517,574,880</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>판매비와관리비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,073,455,963</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,880,662,237</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,561,128,224</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>영업이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,700,350,662)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(7,978,022,910)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,043,553,344)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>영업외손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(655,629,653)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(956,332,274)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,589,727,283</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>192,890,151</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>75,906,357</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>65,296,443</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,062,371</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>590,318,691</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,153,755</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>291,104,238</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>775,546,806</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,044,573,203</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>금융원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,131,561,671</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,217,466,746</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>516,988,608</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>법인세비용차감전순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(4,355,980,315)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(8,934,355,184)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,453,826,061)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,215,496</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,176,299,495</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,355,980,315)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(8,937,570,680)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,630,125,556)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>112,766,755</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(285,740,528)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(102,809,379)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　후속적으로 당기손익으로 재분류되지 않는 항목</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>112,766,755</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(285,740,528)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(102,809,379)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　순확정급여부채의재측정요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>112,766,755</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(285,740,528)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(102,809,379)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,243,213,560)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,223,311,208)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,732,934,935)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주당손실</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　기본주당손실 (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(452)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(927)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(481)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　희석주당손실 (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(452)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(927)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(481)</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN>본 재무제표는 정기주주총회 승인전 재무제표이며  2021년 3월 29일 정기 주주총회에서 재무제표에 대한 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유등을 반영할 예정입니다.&cr;</SPAN>
</P>

<TABLE-GROUP ACLASS="{XBRL}EF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1200" BORDER="0">

<COLGROUP>
<COL WIDTH="1191"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1200" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">자본변동표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1200" HEIGHT="30" AUPDATECONT="N">
<P>제 11 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1200" HEIGHT="30" AUPDATECONT="N">
<P>제 10 기 2019.01.01 부터 2019.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1200" HEIGHT="30" AUPDATECONT="N">
<P>제 9 기 2018.01.01 부터 2018.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1200" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1200" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="83" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="450" ROWSPAN="2" COLSPAN="3">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="750" COLSPAN="5">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>자본금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>자본잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>기타자본</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>미처분이익잉여금(미처리결손금)</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>자본  합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>2018.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,807,890,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>47,070,973,011</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>65,460,299</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(20,635,071,263)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>31,309,252,547</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>회계정책변경에 따른 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>154,837,586</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>154,837,586</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="203" AUPDATECONT="N" WIDTH="150" ROWSPAN="6">
<P>자본의 변동</P>
</TD>

<TD VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N" WIDTH="150" ROWSPAN="3">
<P>포괄손익</P>
</TD>

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,630,125,556)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,630,125,556)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>순확정급여부채의재측정요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(102,809,379)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(102,809,379)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,732,934,935)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,732,934,935)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="300" COLSPAN="2">
<P>주식매수선택권의 행사</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>13,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>166,283,107</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(7,569,107)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>171,714,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="300" COLSPAN="2">
<P>전환권대가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="300" COLSPAN="2">
<P>주식선택권의부여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>37,928,976</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>37,928,976</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>13,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>166,283,107</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>30,359,869</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,578,097,349)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,368,454,373)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>2018.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,820,890,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>47,237,256,118</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>95,820,168</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(25,213,168,612)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,940,798,174</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>2019.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,820,890,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>47,237,256,118</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>95,820,168</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(25,213,168,612)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,940,798,174</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>회계정책변경에 따른 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="203" AUPDATECONT="N" WIDTH="150" ROWSPAN="6">
<P>자본의 변동</P>
</TD>

<TD VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N" WIDTH="150" ROWSPAN="3">
<P>포괄손익</P>
</TD>

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(8,937,570,680)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(8,937,570,680)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>순확정급여부채의재측정요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(285,740,528)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(285,740,528)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,223,311,208)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,223,311,208)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="300" COLSPAN="2">
<P>주식매수선택권의 행사</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="300" COLSPAN="2">
<P>전환권대가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>602,820,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>602,820,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="300" COLSPAN="2">
<P>주식선택권의부여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>106,079,436</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>106,079,436</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>708,899,436</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,223,311,208)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(8,514,411,772)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>2019.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,820,890,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>47,237,256,118</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>804,719,604</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(34,436,479,820)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,426,386,402</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>2020.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,820,890,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>47,237,256,118</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>804,719,604</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(34,436,479,820)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,426,386,402</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>회계정책변경에 따른 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="203" AUPDATECONT="N" WIDTH="150" ROWSPAN="6">
<P>자본의 변동</P>
</TD>

<TD VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N" WIDTH="150" ROWSPAN="3">
<P>포괄손익</P>
</TD>

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,355,980,315)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,355,980,315)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>순확정급여부채의재측정요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>112,766,755</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>112,766,755</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,243,213,560)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,243,213,560)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="300" COLSPAN="2">
<P>주식매수선택권의 행사</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="300" COLSPAN="2">
<P>전환권대가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="300" COLSPAN="2">
<P>주식선택권의부여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>27,990,368</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>27,990,368</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>27,990,368</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,243,213,560)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,215,223,192)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="450" COLSPAN="3">
<P>2020.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,820,890,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>47,237,256,118</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>832,709,972</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(38,679,693,380)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,211,163,210</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN></SPAN>
<SPAN>본 재무제표는 정기주주총회 승인전 재무제표이며  2021년 3월 29일 정기 주주총회에서 재무제표에 대한 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유등을 반영할 예정입니다.</SPAN>
<SPAN USERMARK=" 0X1814FF">&cr;</SPAN>
</P>

<TABLE-GROUP ACLASS="{XBRL}CF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">현금흐름표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 11 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 10 기 2019.01.01 부터 2019.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 9 기 2018.01.01 부터 2018.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 11 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 10 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 9 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>영업활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,680,879,592)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,662,195,914)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(5,610,441,456)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　영업활동으로부터창출된현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(5,044,560,498)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(4,238,559,937)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(5,969,217,575)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　이자의수취</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>317,742,226</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>616,422,839</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>378,964,457</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　이자의지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　법인세납부</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>45,938,680</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(40,058,816)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(20,188,338)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>투자활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,417,232,862</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,099,442,235</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(14,417,237,513)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　투자활동으로인한현금유입액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>65,298,385,571</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>43,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>24,000,100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동금융자산의감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>65,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>43,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>24,000,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동금융자산의감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>298,385,571</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　투자활동으로인한현금유출액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(56,881,152,709)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(41,900,557,765)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(38,417,337,513)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동금융자산의증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>55,500,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>41,013,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>37,050,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동금융자산의증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>255,985,571</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>46,227,811</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>50,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동자산의증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>268,040,721</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유형자산의취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>755,644,666</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>819,078,746</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,055,471,363</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산의취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>16,734,641</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>19,601,208</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,402,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타채무의감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>84,747,110</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,650,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>252,464,150</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>재무활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>77,306,491</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,507)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,171,718,871</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　재무활동으로인한현금유입액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>710,359,256</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>208,233,980</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>18,311,085,367</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　주식매수선택권의행사</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>173,070,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　전환사채의발행</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,000,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동금융부채의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>77,306,491</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　정부보조금의수취</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>633,052,765</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>208,233,980</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>138,015,367</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　재무활동으로인한현금유출액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(633,052,765)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(208,237,487)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(139,366,496)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　정부보조금의상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>633,052,765</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>208,237,487</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>138,010,496</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　신주발행비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,356,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>현금및현금성자산의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,813,659,761</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,562,757,186)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,855,960,098)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>외화표시 현금및현금성자산의 환율변동효과</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(37,699,935)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(1,196,825)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>873,634</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>기초현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,363,336,600</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>6,927,290,611</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,782,377,075</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>기말현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,139,296,426</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,363,336,600</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>6,927,290,611</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN>본 재무제표는 정기주주총회 승인전 재무제표이며  2021년 3월 29일 정기 주주총회에서 재무제표에 대한 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유등을 반영할 예정입니다.&cr;</SPAN>
</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P></P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="603" BORDER="0">

<COLGROUP>
<COL WIDTH="594"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="603" HEIGHT="30" USERMARK="F-BT">제 11 (당)기   2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="603" HEIGHT="30" USERMARK="F-BT">제 10 (전)기   2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="603" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="603" HEIGHT="30" USERMARK="F-BT B">주식회사  팬 젠</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-11 B">1. 회사의 개요&cr;</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11">주식회사 팬젠(이하 "당사")는 2010년 1월 11일에 분할ㆍ신설되</SPAN>
<SPAN USERMARK="F-11">어,</SPAN>
<SPAN USERMARK="F-11"> </SPAN>
<SPAN USERMARK="F-11">바이오의약품</SPAN>
<SPAN USERMARK="F-11"> 생산용 GMP시설과 당사의 원천기술인 PanGen CHO-TECH™ 기술, 바이오의약품 제품화 기술을 활용하여 바이오시밀러 EPO의약품 생산 및 판매, 바이오의약품 개발 사업, 바이오의약품 위탁생산 및 개발기술 이전서비스 사업을 수행하고 있으며,</SPAN>
<SPAN USERMARK="F-11"> </SPAN>
<SPAN USERMARK="F-11">경기도 수원시 영통구 신원로 306 영통이노플렉스 2동 4층에 본사를 두고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">보고기간말 현재 당사의 최대주주는 김영부이고 당사의 자본금은 </SPAN>
<SPAN USERMARK="F-11">4,820,891</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">천원</SPAN>
<SPAN USERMARK="F-11">(발행주식총수 </SPAN>
<SPAN USERMARK="F-11">9,641,781</SPAN>
<SPAN USERMARK="F-11">주)이며, 2016년 03월 11일 코스닥시장에 상장하였고 주요 주주의 구성</SPAN>
<SPAN USERMARK="F-11">내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="606" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="597"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="606" HEIGHT="30" USERMARK="F-BT">(단위: 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="313"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="322" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">주 주 명</TH>
<TH WIDTH="143" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">주식수</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">지분율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="322" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">
<SPAN>김영부외 </SPAN>
<SPAN>4</SPAN>
<SPAN>인</SPAN>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">1,690,820 </SPAN>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">17.54 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="322" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">윤재승</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">846,360 </TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>8.78</SPAN>
<SPAN> </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="322" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">백광희</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">448,440 </SPAN>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>4.65</SPAN>
<SPAN> </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="322" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">DUOPHARMA BIOTECH BERHAD</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">806,450 </TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>8.36 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="322" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">기타</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">5,849,711</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>60.67</SPAN>
<SPAN> </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="322" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN> </SPAN>
<SPAN>9,641,781</SPAN>
<SPAN> </SPAN>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">100.00 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11 B">2. 중요한 회계처리방침의 요약</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>
<P USERMARK="F-11">2-1 재무제표 작성기준&cr;당사는 주식회사등의외부감사에관한법률 제5조1항1호에서 규정하고 있는 국제회계기준위원회의 국제회계기준을 채택하여 정한 회계처리기준인 한국채택국제회계기준에 따라 재무제표를 작성하였습니다.&cr;&cr;당사의 재무제표는 금융상품 등 아래 회계정책에서 별도로 언급하고 있는 사항을 제외하고는 역사적원가를 기준으로 작성되었습니다. 본 재무제표는 원화로 표시되어 있으며 다른 언급이 있는 경우를 제외하고는 원 단위로 표시되어 있습니다.&cr;&cr;2-2 중요한 회계정책&cr;2-2-1 유동성/비유동성분류&cr;당사는 자산과 부채를 유동/비유동으로 재무상태표에 구분하여 표시하고 있습니다.&cr;&cr;자산은 다음의 경우에 유동자산으로 분류하고 있습니다.&cr;- 정상영업주기 내에 실현될 것으로 예상되거나, 정상영업주기 내에 판매하거나 소비할 의도가 있다.&cr;- 주로 단기매매목적으로 보유하고 있다.&cr;- 보고기간 후 12개월 이내에 실현될 것으로 예상한다.&cr;- 현금이나 현금성자산으로서, 교환이나 부채 상환목적으로의 사용에 대한 제한 기간이 보고기간 후 12개월 이상이 아니다.&cr;그 밖의 모든 자산은 비유동자산으로 분류하고 있습니다.&cr;</P>
<P USERMARK="F-11">부채는 다음의 경우에 유동부채로 분류하고 있습니다.&cr;- 정상 영업주기 내에 결제될 것으로 예상하고 있다.&cr;- 주로 단기매매목적으로 보유하고 있다.&cr;- 보고기간 후 12개월 이내에 결제하기로 되어 있다.&cr;- 보고기간 후 12개월 이상 부채의 결제를 연기할 수 있는 무조건의 권리를 가지고 있지 않다.&cr;그 밖의 모든 부채는 비유동부채로 분류하고 있습니다.&cr;</P>
<P USERMARK="F-11">이연법인세자산(부채)은 비유동자산(부채)으로 분류하고 있습니다.</P>
<PGBRK></PGBRK>
<P USERMARK="F-11">2-2-2 공정가치 측정&cr;당사는 매도가능금융자산 등과 같은 금융상품을 보고기간말 현재의 공정가치로 평가하고 있습니다. 공정가치로 측정되거나 공정가치가 공시되는 금융상품과 비금융상품의 공정가치에 대한 공시는 다음의 주석에 설명되어 있습니다.&cr;</P>
<P USERMARK="F-11">공정가치는 측정일에 시장참여자 사이의 정상거래에서 자산을 매도하면서 수취하거나 부채를 이전하면서 지급하게 될 가격입니다. 공정가치측정은 자산을 매도하거나 부채를 이전하는 거래가 다음 중 어느 하나의 시장에서 이루어지는 것으로 가정하고 있습니다.&cr;</P>
<P USERMARK="F-11">- 자산이나 부채의 주된 시장</P>
<P USERMARK="F-11">- 자산이나 부채의 주된 시장이 없는 경우에는 가장 유리한 시장&cr;</P>
<P USERMARK="F-11">당사는 주된 (또는 가장 유리한) 시장에 접근할 수 있어야 합니다.</P>
<P USERMARK="F-11">&cr;자산이나 부채의 공정가치는 시장참여자가 경제적으로 최선의 행동을 한다는 가정하에 시장참여자가 자산이나 부채의 가격을 결정할 때 사용하는 가정에 근거하여 측정하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">비금융자산의 공정가치를 측정하는 경우에는 시장참여자가 경제적 효익을 창출하기 위하여 그 자산을 최고 최선으로 사용하거나 혹은 최고 최선으로 사용할 다른 시장참여자에게 그 자산을 매도하는 시장참여자의 능력을 고려하고 있습니다.&cr;</P>
<P USERMARK="F-11">당사는 상황에 적합하며 관련된 관측가능한 투입변수의 사용을 최대화하고 관측가능하지 않은 투입변수의 사용을 최소화하면서 공정가치를 측정하는 데 충분한 자료가 이용가능한가치평가기법을 사용하고 있습니다.&cr;</P>
<P USERMARK="F-11">재무제표에서 공정가치로 측정되거나 공시되는 모든 자산과 부채는 공정가치 측정에 유의적인 가장 낮은 수준의 투입변수에 근거하여 다음과 같은 공정가치 서열체계로 구분됩니다.&cr;</P>
<P USERMARK="F-11">수준 1 - 동일한 자산이나 부채에 대한 접근가능한 활성시장의 (조정되지 않은) 공시가격</P>
<P USERMARK="F-11">수준 2 - 공정가치측정에 유의적인 가장 낮은 수준의 투입변수가 직접적으로 또는 간접적으로 관측가능한 투입변수를 이용한 공정가치</P>
<P USERMARK="F-11">수준 3 - 공정가치측정에 유의적인 가장 낮은 수준의 투입변수가 관측가능하지 않은 투입변수를 이용한 공정가치</P>
<P USERMARK="F-11">  </P>
<P USERMARK="F-11">재무제표에 반복적으로 공정가치로 측정되는 자산과 부채에 대하여 당사는 매 보고기간 말 공정가치측정에 유의적인 가장 낮은 수준의 투입변수에 기초한 분류에 대한 재평가를 통해 서열체계의 수준 간의 이동이 있는지 판단합니다.</P>
<P USERMARK="F-11">&cr;공정가치 공시 목적상 당사는 성격과 특성 및 위험에 근거하여 자산과 부채의 분류를 결정하고 공정가치 서열체계의 수준을 결정하고 있습니다.&cr;&cr;2-2-3 외화환산&cr;당사는 재무제표를 기능통화인 원화로 표시하고 있습니다.&cr;&cr;(1) 거래와 잔액&cr;당사의 재무제표 작성에 있어서 기능통화 외의 통화로 이루어진 거래는 거래일의 환율을 적용하여 기록하고 있습니다.&cr;</P>
<P USERMARK="F-11">화폐성 외화자산 및 부채는 보고기간말 현재의 기능통화 환율로 환산하고 있습니다. 이에 따라 발생하는 환산차이는 당기손익에 반영하고 있습니다. 다만, 해외사업장 순투자위험회피를 위한 항목에서 발생하는 환산차이는 해당 순투자의 처분시점까지 자본에 직접 반영하고 처분시점에 당기손익에 반영하고 있습니다. 관련 법인세효과 역시 동일하게 자본항목으로 처리하고 있습니다.&cr;</P>
<P USERMARK="F-11">한편, 역사적원가로 측정하는 외화표시 비화폐성 항목은 최초 거래 발생일의 환율을, 공정가치로 측정하는 외화표시 비화폐성 항목은 공정가치 측정일의 환율을 적용하여 인식하고있습니다. 비화폐성 항목의 환산에서 발생하는 손익은 해당 항목의 공정가치 변동으로 인한 손익의 인식항목과 동일하게 기타포괄손익 또는 당기손익으로 인식하고 있습니다.&cr;</P>
<P USERMARK="F-11">2-2-4 고객과의 계약에서 생기는 수익&cr;(1) 수익인식모형</P>
<P USERMARK="F-11">당사의 고객과의 계약에서 생기는 수익은 제품매출, 상품매출, 용역수익 및 로열티수익으로 구성되어 있습니다. 당사는 고객과의 계약이 개시되는 단계에서부터 통제가 고객에게 이전되는 시점 또는 통제가 고객에게 이전되는 기간에 걸쳐 다음의 5단계 수익인식모형에따라 수익을 인식하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">① 계약의 식별</P>
<P USERMARK="F-11">당사는 고객과의 사이에서 집행가능한 권리와 의무가 생기게 하는 합의를 계약으로 식별하고 계약으로 식별된 경우에는 수행의무의 식별 등 이후 단계를 추가 검토하여 수익인식여부를 판별하며, 계약으로 식별되지 못하였으나 고객에게서 대가를 받은 경우에는 부채로 인식하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">② 수행의무의 식별</P>
<P USERMARK="F-11">수행의무는 고객과의 계약에서 '구별되는 재화나 용역'이나 '실질적으로 서로 같고 고객에게 이전하는 방식도 같은 일련의 구별되는 재화나 용역'을 고객에게 이전하기로 한 약속을의미합니다. 당사는 계약 개시시점에 고객과의 계약에서 약속한 재화나 용역을 검토하여 수행의무를 식별하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">③ 거래가격의 산정</P>
<P USERMARK="F-11">거래가격은 고객에게 약속한 재화나 용역을 이전하고 그 대가로 기업이 받을 권리를 갖게 될 것으로 예상하는 금액으로서 추정치의 제약을 고려한 변동대가, 유의적인 금융요소, 비현금대가 및 고객에게 지급할 대가 등을 고려하여 산정하고 있습니다. 당사는 반품가능성을 과거의 경험률에 근거하여 합리적으로 추정하여 변동대가에 반영하고, 수행의무를 이전하는 시점과 고객이 그에 대한 대가를 지급하는 시점 간의 기간이 12개월 이내이므로 유의적인 금융요소는 없다고 판단하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">④ 거래가격의 배분</P>
<P USERMARK="F-11">당사는 하나의 계약에서 식별된 여러 수행의무에 상대적 개별판매가격을 기초로 거래가격을 배분하고 있습니다. 각 수행의무의 개별판매가격이 없는 경우에는 시장평가조정접근법등을 고려하여 개별판매가격을 적절하게 추정하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">⑤ 수익인식</P>
<P USERMARK="F-11">당사는 계약개시 시점에 해당 계약과 관련하여 수행의무를 이행할 때 수익을 인식할지 또는 수행의무를 이행하는 기간에 걸쳐 수익을 인식할지 여부를 판단하고 있습니다. 당사가 의무를 수행하는 대로 고객이 동시에 효익을 얻고 소비하는 경우, 당사가 의무를 수행하여자산이 만들어지거나 가치가 높아지는 것과 비례하여 고객이 그 자산을 통제하는 경우, 또는 의무를 수행하여 만든 자산이 당사 자체에는 대체용도가 없으나 현재까지 수행을 완료한 부분에 대해 집행가능한 지급청구권이 있는 경우에는 수행의무를 이행하는 기간에 걸쳐 수익을 인식합니다.</P>
<P USERMARK="F-11"> &cr;용역수익은 고객과의 계약에 따라 시험용역을 제공하는 것으로서 당사가 의무를 수행하는대로 고객이 동시에 효익을 얻고 소비하는 경우에 해당하여 수행의무를 이행하는 기간에 걸쳐 수익을 인식합니다. 제품매출 및 상품매출은 자산에 대한 통제가 고객에게 이전되는 시점(국내거래의 경우 인도시점, 해외수출의 경우 선적시점)에 수익을 인식하고 있습니 다.&cr;</P>
<P USERMARK="F-11">수행의무를 이행하는 기간에 걸쳐 수익을 인식하는 경우에는 투입법에 따라 산정된 진행률을 적용하여 수익과 원가를 측정하고 당사의 수행정도를 나타내지 못하는 투입물의 영향은 투입법에서 적절히 제외하고 있습니다.&cr;</P>
<P USERMARK="F-11">(2) 본인과 대리인의 구분</P>
<P USERMARK="F-11">당사는 상품 및 제품매출 관련된 거래에서는 '본인'의 역할을 수행하므로 수행의무의 이행결과로 이전되는 대가의 총액을 수익으로 인식하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">(3) 환불부채와 반환자산</P>
<P USERMARK="F-11">당사는 수행의무이행의 대가로서 받을 금액 중 반품에 의해 받을 권리가 상실되는 부분은 고객에게 제품을 이전할 때 수익으로 인식하지 않고 환불부채로 인식하며 매 보고기간말 반품 예상량의 변동에 따라 환불부채를 재측정하고 있습니다. </P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">한편, 반품으로 회수되는 반환자산은 판매시점의 재고자산의 장부금액에서 그 재고자산의회수에 예상되는 원가를 차감하여 측정하고 매 보고기간말 재측정하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">(4) 계약체결 증분원가와 계약이행원가</P>
<P USERMARK="F-11">당사는 회수가 가능한 계약체결 증분원가 및 조건을 충족하는 계약이행원가에 대해 자산으로 인식하고 있습니다. 이러한 자산은 관련된 재화나 용역을 고객에게 이전하는 방식과 일치하는 체계적 기준으로 상각하며, 자산과 관련된 재화나 용역의 대가로 당사가 받을 것으로 예상하는 잔액과 향후 비용으로 인식될 직접원가와의 차액이 당해 자산의 장부가액보다 작은 경우 그 장부금액과의 차이를 손상차손으로 인식하고 있습니다.</P>
<PGBRK></PGBRK>
<P USERMARK="F-11">2-2-5 법인세&cr;(1) 당기법인세&cr;당기 및 과거기간의 당기법인세부채(자산)는 보고기간말까지 제정되었거나 실질적으로 제정된 세율(및 세법)을 적용하여, 과세당국에 납부할(과세당국으로부터 환급받을) 것으로 예상되는 금액으로 측정하고 있습니다.&cr;</P>
<P USERMARK="F-11">자본에 직접 반영되는 항목과 관련된 당기 법인세는 자본에 반영되며 손익계산서에 반영되지 않고 있습니다. 경영진은 주기적으로 관련 세법 규정의 해석과 관련해서 법인세 환급액에 대한 회수가능성을 평가하여 필요한 경우 충당금을 설정하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">(2) 이연법인세&cr;당사는 자산 및 부채의 재무보고 목적상 장부금액과 세무기준액의 차이인 일시적차이에 대하여 이연법인세자산과 이연법인세부채를 인식하고 있습니다.&cr;</P>
<P USERMARK="F-11">당사는 다음의 경우를 제외하고 모든 가산할 일시적차이에 대하여 이연법인세부채를 인식하고 있습니다.&cr;- 영업권을 최초로 인식할 때 이연법인세부채가 발생하는 경우&cr;- 자산 또는 부채를 최초로 인식하는 거래로서 사업결합거래가 아니고, 거래 당시 회계이익이나 과세소득에 영향을 미치지 아니하는 거래에서 이연법인세부채가 발생하는 경우</P>
<P USERMARK="F-11">- 종속기업, 관계기업, 조인트벤처에 대한 투자지분과 관련한 가산할 일시적차이로서 동 일시적차이의 소멸시점을 통제할 수 있고, 예측가능한 미래에 일시적 차이가 소멸하지 않을 가능성이 높은 경우</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">또한, 다음의 경우를 제외하고는 차감할 일시적차이, 미사용 세액공제와 세무상결손금이 사용될 수 있는 과세소득의 발생가능성이 높은 경우 이연법인세자산을 인식하고 있습니 다.&cr;- 자산 또는 부채를 최초로 인식하는 거래로서 사업결합거래가 아니고 거래 당시 회계이익이나 과세소득에 영향을 미치지 아니하는 거래에서 이연법인세자산이 발생하는 경우</P>
<P USERMARK="F-11">- 종속기업, 관계기업, 조인트벤처에 대한 투자지분과 관련한 차감할 일시적차이로서 동 일시적차이가 예측가능한 미래에 소멸할 가능성이 높지 않거나 동 일시적차이가 사용될 수 있는 과세소득이 발생할 가능성이 높지 않은 경우</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">이연법인세자산의 장부금액은 매 보고기간말에 검토하며, 이연법인세자산의 일부 또는 전부에 대한 혜택이 사용되기에 충분한 과세소득이 발생할 가능성이 더 이상 높지 않다면 이연법인세자산의 장부금액을 감액시키고 있습니다. 한편, 감액된 금액은 사용되기에 충분한 과세소득이 발생할 가능성이 높아지면 그 범위내에서 다시 환입하고 있습니다. 또한, 매 보고기간말마다 인식되지 않은 이연법인세자산에 대하여 재검토하여, 미래과세소득에 의해 이연법인세자산이 회수될 가능성이 높아진 범위까지 과거 인식되지 않은 이연법인세자산을 인식하고 있습니다.&cr;&cr;이연법인세자산 및 부채는 보고기간말까지 제정되었거나 실질적으로 제정된 세율(및 세법)에 근거하여 당해 자산이 실현되거나 부채가 결제될 회계기간에 적용될 것으로 기대되는 세율을 사용하여 측정합니다.&cr;&cr;당기손익 이외로 인식되는 항목과 관련된 당기법인세와 이연법인세는 당기손익 이외의 항목으로 인식하고 있습니다. 이연법인세 항목은 해당 거래에 따라서 기타포괄손익으로 인식하거나 자본에 직접 반영하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">당기법인세자산과 당기법인세부채를 상계할 수 있는 법적으로 집행가능한 권리를 가지고 있고, 이연법인세자산과 이연법인세부채가 동일한 과세대상기업과 동일한 과세당국과 관련이 있는 경우에만 이연법인세자산과 이연법인세부채를 상계하여 표시하고 있습니다.</P>
<P USERMARK="F-11">&cr;2-2-6 정부보조금&cr;정부보조금은 부수되는 조건의 이행에 대한 합리적인 확신이 있는 경우에 인식하고 있습니다. 수익관련 보조금은 보조금으로 보전하려 하는 관련원가와 대응시키기 위해 필요한 기간에 걸쳐 체계적인 기준에 따라 보조금을 수익으로 인식하며, 자산관련 보조금은 이연수익으로 인식하여 관련 자산의 내용연수동안 매년 동일한 금액을 수익으로 인식하고 있습니다.&cr;&cr;당사는 비화폐성자산을 보조금으로 수취한 경우 자산과 보조금을 명목금액으로 기록하고 관련자산의 추정내용연수에 걸쳐 정액으로 손익계산서에 수익으로 인식하고 있습니다. 시장이자율보다 낮은 이자율의 대여금 혹은 유사한 지원을 제공받은 경우, 낮은 이자율로 인한 효익은 추가적인 정부보조금으로 인식하고 있습니다.&cr;</P>
<PGBRK></PGBRK>
<P USERMARK="F-11">2-2-7 금융상품&cr;(1) 금융자산의 인식 및 측정</P>
<P USERMARK="F-11">당사는 금융자산의 관리를 위한 사업모형과 금융자산의 계약상 현금흐름 특성에 따라 금융자산을 상각후원가측정금융자산, 기타포괄손익-공정가치측정금융자산 및 당기손익-공정가치측정금융자산의 세가지 범주로 분류하고 분류 명칭에 따라 후속적으로 측정하고 있습니다. 내재파생상품은 주계약이 기준서 제1109호의 적용범위에 해당되는 경우에는 분리하지 않고 복합금융상품 전체에 대해 위 세가지 범주 중의 하나로 분류합니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">유의적인 금융요소를 포함하지 않는 매출채권은 최초인식시점에 거래가격으로 측정하고 이외에는 공정가치로 측정하며, 당기손익-공정가치측정금융자산이 아닌 경우 금융자산의취득과 직접 관련되는 거래원가는 최초 인식시점에 공정가치에 가산하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">① 상각후원가측정금융자산</P>
<P USERMARK="F-11">계약상 현금흐름의 수취를 목적으로 하는 사업모형하에서 계약조건에 따라 특정일에 원금과 원금잔액에 대한 이자지급만으로 구성되는 현금흐름이 발생하는 금융자산을 상각후원가측정금융자산으로 인식하고 있습니다. 원금은 최초 인식시점의 공정가치이며 이자는 화폐의 시간가치에 대한 대가 및 신용위험에 대가 등을 포함합니다. 상각후원가측정금융자산은 유효이자율법에 따라 측정하고 이자수익은 당기손익에 반영하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">② 기타포괄손익-공정가치측정금융자산</P>
<P USERMARK="F-11">계약상 현금흐름의 수취와 매도를 목적으로 하는 사업모형하에서 계약조건에 따라 특정일에 원금과 원금잔액에 대한 이자지급만으로 구성되는 현금흐름이 발생하는 금융자산을 기타포괄손익-공정가치측정금융자산으로 인식하고 있습니다. 공정가치의 변동으로 인한 차이는 기타포괄손익에 반영하고 처분시 당기손익으로 재순환시키며 이자수익은 당기손익의 금융수익에, 손상차손(환입) 및 외환손익은 기타손익에 반영하고 있습니다. </P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">한편, 당사는 단기매매목적으로 보유하지 않는 지분상품은 최초 인식시점에 기타포괄손익-공정가치측정금융자산으로 취소불가능한 선택을 할 수 있습니다. 이러한 선택을 하는 경우에는 배당금을 제외하고 해당 지분상품으로부터 발생하는 모든 손익은 기타포괄손익으로 인식하고 후속적으로 당기손익으로 재순환시키지 않습니다.&cr;</P>
<P USERMARK="F-11">③ 당기손익-공정가치측정금융자산</P>
<P USERMARK="F-11">금융자산이 상각후원가 또는 기타포괄손익-공정가치로 측정하지 않는 경우에는 당기손익-공정가치측정금융자산으로 분류하며 단기매매목적의 지분증권, 파생상품 등을 포함하고있습니다. 기준서 1109호의 분류기준에 따라 상각후원가 또는 기타포괄손익-공정가치로 측정하는 금융자산으로 분류되더라도 회계불일치를 해소하기 위해 당기손익-공정가치측정금융자산으로 취소불가능한 지정을 할 수 있습니다. 당기손익-공정가치측정금융자산과관련된 손익은 당기손익의 기타손익에 인식하고 있습니다.&cr;</P>
<P USERMARK="F-11">(2) 금융부채의 분류 및 측정</P>
<P USERMARK="F-11">당사는 계약의 실질에 따라 금융부채를 상각후원가측정금융부채, 당기손익-공정가치측정금융부채로 분류하고 있습니다. 한편, 당사가 복합금융상품을 발행한 경우에는 자본요소와 부채요소를 분리하고 부채요소의 공정가치를 측정하여 최초 장부금액을 부채요소에 먼저 배부하고 있습니다.&cr;</P>
<P USERMARK="F-11">금융부채는 최초인식시점에 공정가치로 측정하며, 당기손익-공정가치측정금융부채가 아닌 경우 금융부채의 발행과 직접 관련되는 거래원가는 최초 인식시점에 공정가치에 가산하고 있습니다. 후속적으로는 상각후원가측정금융부채는 유효이자율을 적용하여 측정하고 관련 이자비용은 당기손익으로 인식하며, 당기손익-공정가치측정금융부채는 공정가치로 측정하고 공정가치의 변동액을 당기손익으로 인식합니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">(3) 금융자산의 손상</P>
<P USERMARK="F-11">당사는 상각후원가측정금융자산과 기타포괄손익-공정가치로 측정하는 채무상품에 대해 기대신용손실모형을 적용하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">당사는 신용손상측정대상 금융자산에 대해 최초 인식 후 신용위험의 유의적 증가가 있는지에 대한 개별평가 및 대상금융자산의 경제적 성격을 고려한 집합평가를 매 보고기간말에 수행하고 있습니다. 신용위험의 유의적인 증가가 있는지를 평가할 때 신용등급(외부평가기관 및 내부에서의 평가결과 모두 참고), 재무구조, 연체정보 및 현재 및 미래의 예측가능한 경제적 상황의 변동 등을 종합적으로 고려하여 판단하고 있습니다. 당사는 보고기간말 신용위험이 낮다고 판단되는 경우에는 최초인식 후 신용위험이 유의적으로 증가하지않은 것으로 하고 연체일수가 30일을 초과하는 경우에는 명백한 반증이 없는 한 신용위험이 유의적으로 증가한 것으로 회계처리하고 있습니다.&cr;</P>
<P USERMARK="F-11">매 보고기간말에 매출채권은 전체기간 기대신용손실에 해당하는 금액을 손실충당금으로 측정하고 최초인식시점에 신용이 손상된 금융자산은 최초 인식 후 전체기간 기대신용손실의 누적변동분만을 손실충당금으로 계상합니다. 이외의 상각후원가측정금융자산 및 기타포괄손익-공정가치측정금융자산(지분증권 제외)에 대해서는 12개월 기대신용손실로 측정한 손실충당금을 인식하며 최초 인식 후 신용위험의 유의적 증가가 있거나 신용손상이 있는 경우에는 전체기간 기대신용손실에 해당하는 금액을 손실충당금으로 측정하고 있습니다. 보고기간말에 측정한 손실충당금과 장부금액과의 차이는 손상차손(환입)으로 당기손익에 반영하고 있습니다.&cr;&cr;2-2-8 복합금융상품&cr;당사가 발행한 복합금융상품은 보유자의 선택에 의해 자본으로 전환될 수 있는 전환사채로, 발행할 주식수는 보통주의 공정가치에 따라 변동될 수 있습니다. 따라서 전환권을 부채로 분류하고 파생상품으로 회계처리하였으나, 전기 중 계약 조건에 따라 전환권 행사로 발행될 주식수가 고정되어 자본으로 재분류하였습니다.&cr;</P>
<P USERMARK="F-11">최초 인식 시 복합금융상품의 부채요소는 금융부채의 공정가치로 인식하였으며, 특정일에의무적으로 상환하여야 하는 부채요소와 특정일 이전에 전환권을 행사할 수 있는 부채요소로 이루어져 있습니다. 복합금융상품의 발행과 직접적으로 관련된 거래원가는 부채요소의 최초 인식 금액에 비례하여 배분하였습니다.&cr;&cr;최초 인식 이후 복합금융상품 중 특정일에 의무적으로 상환하여야 하는 부채요소는 현금흐름에 대해 유효이자율법을 이용하여 상각후원가로 측정합니다. 한편, 전환권을 행사할 수 있는 자본요소는 후속적으로 공정가치로 재측정하지 않고 있습니다.&cr;</P>
<P USERMARK="F-11">2-2-9 유형자산&cr;유형자산은 취득원가에서 감가상각누계액과 손상차손누계액을 차감한 잔액으로 표시하고있으며 이러한 원가에는 자산의 인식요건을 충족한 대체원가 및 장기건설 프로젝트의 차입원가를 포함하고 있습니다. 유형자산의 주요 부분이 주기적으로 교체될 필요가 있는 경우 당사는 그 부분을 개별자산으로 인식하고 해당 내용연수동안 감가상각하고 있습니다.&cr;&cr;또한, 종합검사원가와 같이 자산의 인식요건을 충족하는 경우에는 유형자산의 장부금액에포함되어 있으며 모든 수선 및 유지비용은 발생시점에 당기손익에 반영하고 있습니다.&cr;</P>
<P USERMARK="F-11">당사는 유형자산에 대하여 아래의 내용연수에 따라 정액법으로 상각하고 있습니다.</P>
<P USERMARK="F-11"></P>

<TABLE BORDER="1" WIDTH="585" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="284"></COL>
<COL WIDTH="283"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT BC0XD7D7D7">구   분</TD>
<TD WIDTH="292" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT BC0XD7D7D7">내용연수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">건         물</TD>
<TD WIDTH="292" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">50년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">기 계 장 치</TD>
<TD WIDTH="292" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">6년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">차량운반구</TD>
<TD WIDTH="292" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">공구와기구</TD>
<TD WIDTH="292" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">비         품</TD>
<TD WIDTH="292" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">5년</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">유형자산은 처분하거나 사용 또는 처분을 통하여 미래경제적 효익이 기대되지 않을 경우 제거하고 있으며 이로 인하여 발생하는 순처분가액과 장부금액의 차이는 제거시점의 당기손익에 반영하고 있습니다.&cr;</P>
<P USERMARK="F-11">당사는 매 보고기간말에 유형자산의 잔존가치, 내용연수 및 감가상각방법의 적정성을 검토하고 변경이 필요한 경우 전진적으로 적용하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">2-2-10 차입원가&cr;의도된 용도로 사용하거나 판매가능한 상태에 이르게 하는 데 상당한 기간을 필요로 하는 자산의 취득, 건설 또는 생산과 직접 관련된 차입원가는 당해 자산 원가의 일부로 자본화하고 있으며, 기타 차입원가는 발생시 비용으로 계상하고 있습니다.</P>
<P USERMARK="F-11">&cr;2-2-11 리스&cr;당사는 대가와 교환하여 일정 기간 동안 식별되는 자산의 사용통제권을 이전하는 계약을 리스로 분류하고 있으며 임직원 숙소와 창고를 리스하고 있습니다. 리스기간은 자산별로 다양하며 해지불능기간과 리스이용자의 연장선택권 및 종료선택권의 행사가능성 등 다양한 계약조건을 고려하여 리스기간을 적용합니다. &cr;</P>
<P USERMARK="F-11">당사가 리스를 이용하는 경우, 기초자산을 사용할 권리를 나타내는 사용권자산(리스자산)과 리스료를 지급할 의무를 나타내는 리스부채를 인식하고 있습니다. 다만, 단기리스(리스개시일에, 리스기간이 12개월 이하인 리스)와 소액자산 리스의 경우에는 동 기준서의 예외규정을 선택하여 관련 리스료를 리스기간에 걸쳐 정액기준으로 비용을 인식합니다. 사용권자산은 유형자산의 감가상각에 대한 요구사항을 적용하여 리스개시일부터 사용권자산의 내용연수 종료일과 리스기간 종료일 중 이른 날까지 감가상각하며, 리스부채는 내재이자율(또는 증분차입이자율)에 따라 리스기간에 걸쳐 금융비용과 리스부채를 인식하고 지급한 리스료를 리스부채에서 차감합니다. </P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">리스부채는 리스개시일 현재 지급되지 않은 리스료의 현재가치로 측정하며 리스료는 다음의 금액을 포함합니다.&cr;- 고정리스료(실질적인 고정리스료 포함하고 받을 리스 인센티브는 차감)&cr;- 지수나 요율(이율)에 따라 달라지는 변동리스료&cr;- 잔존가치보증(리스이용자가 지급할 금액)&cr;- 매수선택권의 행사가격(리스이용자의 행사가능성이 상당히 확실한 경우)&cr;- 리스종료위약금(리스기간이 리스이용자의 종료선택권 행사를 반영하는 경우)&cr;</P>
<P USERMARK="F-11">리스의 내재이자율을 쉽게 산정할 수 있는 경우 그 이자율로 리스료를 할인합니다. 내재이자율을 쉽게 산정할 수 없는 경우에는 리스이용자가 비슷한 경제적 환경에서 비슷한 기간에 걸쳐 비슷한 담보로 사용권자산과 가치가 비슷한 자산을 획득하는 데 필요한 자금을 차입한다면 지급해야 할 이자율인 리스이용자의 증분차입이자율을 사용합니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">사용권자산은 리스개시일의 원가로 측정하며 다음 항목들로 구성되어 있습니다. 한편, 당사는 리스기간이 12개월 이하인 단기리스료와 소액리스료는 인식 면제규정을 적용하여 당기비용으로 인식하고 있습니다.&cr;- 리스부채의 최초 측정금액&cr;- 리스개시일이나 그 전에 지급한 리스료(받은 인센티브는 차감)&cr;- 리스이용자가 부담하는 리스개설직접원가&cr;- 기초자산의 해체, 복구 등에 대한 계약상 부담하는 원가&cr;</P>
<P USERMARK="F-11">2-2-12 무형자산&cr;당사는 개별적으로 취득한 무형자산은 취득원가로 계상하고 사업결합으로 취득하는 무형자산은 매수시점의 공정가치로 계상하며 최초 취득 이후 상각누계액과 손상차손누계액을 직접 차감하여 표시하고 있습니다. 한편, 개발비를 제외한 내부적으로 창출된 무형자산은 발생시점에 비용항목으로 하여 당기손익에 반영하고 있습니다.&cr;&cr;무형자산은 유한한 내용연수를 가진 무형자산과 비한정 내용연수를 가진 무형자산으로 구분되는 바, 유한한 내용연수를 가진 무형자산은 해당 내용연수에 걸쳐 상각하고 손상징후가 파악되는 경우 손상여부를 검토하고 있습니다. 또한, 내용연수와 상각방법은 매 보고기간말에 그 적정성을 검토하고 있으며, 예상 사용기간의 변경이나 경제적 효익의 소비형태 변화 등으로 인하여 변경이 필요한 경우에는 추정의 변경으로 회계처리하고 있습니다. 무형자산상각비는 해당 무형자산의 기능과 일관된 비용항목으로 하여 당기손익에 반영하고 있습니다.&cr;&cr;한편, 비한정 내용연수를 가진 무형자산은 상각하지 아니하되, 매년 개별적으로 또는 현금창출단위에 포함하여 손상검사를 수행하고 있습니다. 또한 매년 해당 무형자산에 대하여 비한정 내용연수를 적용하는 것이 적절한지를 검토하고 적절하지 않은 경우 전진적인 방법으로 유한한 내용연수로 변경하고 있습니다. 당사는 무형자산 제거시 순매각금액과 장부금액의 차이로 인한 손익은 제거시점의 당기손익에 반영하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">당사는 연구 또는 내부프로젝트의 연구단계에 대한 지출을 발생시점에 비용으로 인식하고있습니다. 다만, 개별 프로젝트와 관련된 개발비의 경우, i) 무형자산을 사용하거나 판매하기 위해 그 자산을 완성할 수 있는 기술적 실현가능성을 제시할 수 있고, ii) 무형자산을 완성하여 사용하거나 판매하려는 의도와 능력이 있으며, iii) 이를 위한 충분한 자원이 확보되어 있고, iv) 무형자산이 어떻게 미래경제적효익을 창출할 수 있는 지를 제시할 수 있으며,v) 개발단계에서 발생한 무형자산 관련 지출을 신뢰성 있게 측정할 수 있는 경우에 한하여무형자산으로 계상하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">한편, 자산으로 인식한 개발비는 원가모형을 적용하여 취득원가에서 상각누계액과 손상차손누계액을 직접 차감하여 표시하고 있으며 개발이 완료되어 사용가능한 시점부터 경제적효익의 예상 지속기간에 걸쳐 상각하고 매출원가 또는 판매비와관리비로 계상하고 있습니다. 당사는 자산으로 인식한 개발비에 대하여 개발기간동안 매년 손상검사를 실시하고 있습니다.&cr;</P>
<P USERMARK="F-11">당사의 무형자산 관련 회계정책을 요약하면 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="147"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT BC0XD7D7D7">구  분</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT BC0XD7D7D7">상각방법</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT BC0XD7D7D7">내용연수</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT BC0XD7D7D7">내부창출 또는 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">산업재산권</TD>
<TD WIDTH="157" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">정액법</TD>
<TD WIDTH="157" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">5년~10년</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">소프트웨어</TD>
<TD WIDTH="157" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">정액법</TD>
<TD WIDTH="157" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">5년</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">개   발   비</TD>
<TD WIDTH="157" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">정액법</TD>
<TD WIDTH="157" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">10년</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">내부창출</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11">&cr;2-2-13 비금융자산의 손상&cr;당사는 매 보고기간말에 자산의 손상을 시사하는 징후가 존재하는지 검토하고 있습니다. 그러한 징후가 존재하는 경우 또는 매년 자산에 대한 손상검사가 요구되는 경우, 당사는 자산의 회수가능액을 추정하고 있습니다. 자산의 회수가능액은 자산 또는 현금창출단위의순공정가치와 사용가치 중 큰 금액이며, 개별자산별로 결정하나 해당 개별자산의 현금유입이 다른 자산이나 자산집단의 현금유입과 거의 독립적으로 창출되지 않는 경우, 해당 개별자산이 속한 현금창출단위별로 결정됩니다. 자산의 장부금액이 회수가능액을 초과하는 경우, 자산은 손상된 것으로 보며 자산의 장부금액을 회수가능액으로 감소시키게 됩니다. 사용가치는 해당 자산의 기대 미래현금흐름의 추정치를 화폐의 시간가치와 해당 자산의 위험에 대한 시장의 평가를 반영한 세전할인율로 할인한 현재가치로 평가하고 있습니다. 순공정가치는 공개시장에서 거래되는 기업들의 주가 또는 다른 이용가능한 공정가치 평가지표 등을 사용한 적절한 평가모델을 사용하여 결정하고 있습니다.&cr;&cr;손상차손은 손상된 자산의 기능과 일관된 비용항목으로 하여 당기손익에 반영하고 있습니다.&cr;&cr;영업권을 제외한 자산에 대하여 매 보고기간말에 과거에 인식한 자산의 손상차손이 더 이상 존재하지 않거나 또는 감소하였다는 것을 시사하는 징후가 있는지 여부를 평가하며, 그러한 징후가 있는 경우 회수가능액을 추정하고 있습니다. 과거에 인식한 영업권을 제외한 자산의 손상차손은 직전 손상차손의 인식시점 이후 해당 자산의 회수가능액을 결정하는데사용된 추정치에 변화가 있는 경우에 한하여, 손상차손을 인식하지 않았을 경우의 자산의 상각 후 잔액을 한도로 장부금액을 회수가능액으로 증가시키고 이러한 손상차손환입은 당기손익에 반영하고 있습니다.</P>
<P USERMARK="F-11">&cr;2-2-14 전환사채&cr;당사가 발행한 전환사채는 보유자의 선택에 의해 자본으로 전환될 수 있는 전환사채로, 발행할 주식수는 보통주의 공정가치에 따라 변동될 수 있습니다. 따라서 전환권을 부채로 분류하고 파생상품으로 회계처리하였으나, 전기 중 계약 조건에 따라 전환권 행사로 발행될 주식수가 고정되어 자본으로 재분류하였습니다.&cr;&cr;최초 인식 시 내재파생상품인 전환권은 동일한 파생상품에 대한 시장가격 또는 합리적인 평가모형에 따라 산출된 공정가치를 이용하여 공정가치로 인식하였고, 전기 이전까지의 기간의 공정가치 변동은 당기손익으로 인식하였으나, 전기 중 자본으로 재분류됨에 따라 후속적으로 재측정하지 않고 있습니다. 사채요소는 최초 인식 시의 전체 전환사채의 공정가치에서 전환권의 공정가치를 차감하여 인식하고, 전환으로 인한 소멸 또는 만기까지 유효이자율법을 적용한 상각후원가로 측정하고 있습니다. 최초 인식 시점의 전환권 공정가치를 별도로 신뢰성 있게 측정할 수 없는 경우, 최초 인식 시의 전환사채의 공정가치와 사채의 공정가치의 차이금액을 전환권의 공정가치로 결정합니다.&cr;</P>
<P USERMARK="F-11">2-2-15 종업원급여 및 퇴직급여&cr;(1) 단기종업원급여&cr;종업원이 회계기간에 근무용역을 제공한 때 근무용역과 교환하여 지급이 예상되는 단기종업원급여를 할인되지 않은 금액으로 인식하고 있습니다.&cr;</P>
<P USERMARK="F-11">(2) 확정급여형 퇴직급여&cr;당사는 확정급여제도를 운영하고 있으며, 당기근무원가는 예측단위적립방식을 이용하여 매 보고기간말에 보험수리적 평가를 통하여 별도로 결정됩니다. 확정급여제도에 대한 보험수리적손익은 기타포괄손익으로 자본에 직접 반영하고 있습니다.&cr;&cr;과거근무원가는 관련 급여가 가득되기까지의 평균기간에 걸쳐 정액법을 적용하여 비용으로 인식합니다. 한편, 확정급여제도를 새로 도입하거나 개정하는 즉시 관련 급여가 가득된다면, 해당 과거근무원가는 즉시 인식합니다.&cr;</P>
<P USERMARK="F-11">확정급여자산 또는 부채는 확정급여채무의 현재가치에서 미인식 과거근무원가를 차감하고 관련 확정급여채무를 결제하는 데 사용할 수 있는 사외적립자산의 공정가치를 차감하여 산정합니다. 사외적립자산은 장기종업원급여기금이 보유하고 있는 자산 또는 적격보험계약으로 구성됩니다. 사외적립자산은 당사의 채권자에게 이용가능하지 않으며 당사에게 직접 지급될 수 없습니다. 공정가치는 시장가격정보에 근거하며 상장된 유가증권의 경우 공표된 매입호가입니다. 확정급여자산은 미인식 과거근무원가와 제도로부터 환급받거나 미래 기여금이 절감되는 방식으로 이용가능한 경제적 효익의 현재가치의 합계액으로 제한됩니다.&cr;</P>
<P USERMARK="F-11">2-2-16 주식기준보상거래&cr;당사는 임직원의 근로용역에 대해 주식기준에 따른 보상을 제공하고 있는데 임직원에게 주식선택권을 부여하는 제도를 운영하고 있습니다.&cr;</P>
<P USERMARK="F-11">주식결제형 주식기준보상거래</P>
<P USERMARK="F-11">보상원가는 이에 대응하여 자본을 증가시키며 용역제공조건(또는 성과조건)이 성취되는 기간에 걸쳐 인식되며 관련 임직원이 보상을 받을 자격이 되는 시점까지 인식하고 있습니다. 매 보고기간말에 누적 보상원가의 측정에는 가득기간의 완료 여부와 최종적으로 부여될 지분상품의 수에 대한 추정이 반영됩니다. 보고기간 초와 보고기간 말의 누적 보상원가의 변동분은 당기 손익계산서에 가감됩니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">궁극적으로 가득되지 않는 주식기준보상에 대해서는 비용을 인식하지 않고 있습니다. 다만 시장조건이나 비가득조건이 있는 주식결제형 거래로서 다른 모든 성과조건이나 서비스조건을 충족한다면 시장조건이나 비가득조건의 충족여부와 관계없이 가득된 것으로 회계처리하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">주식결제형 주식기준보상의 조건이 변경될 경우 지정된 가득조건이 충족되지 않아 지분상품이 가득되지 못하는 경우를 제외하고는 조건이 변경되지 않았을 경우에 인식하였어야 할 원가를 최소한으로 하여 인식하고 있습니다. 주식기준보상약정의 총공정가치를 증가시키거나 종업원에게 유리하게 조건을 변경하는 경우에는 추가로 조건변경의 효과를 인식하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">주식결제형 보상이 취소될 경우 취소일에 가득된 것으로 보고 인식되지 않은 보상원가는 즉시 인식하고 있습니다. 이 경우 기업이나 종업원의 통제하에 있는 비가득조건이 충족되지 않은 주식기준보상을 포함하고 있습니다. 그러나, 만약 새로운 보상을 부여하고 그 새 지분상품을 부여한 날에 새로운 지분상품이 취소한 지분상품을 대체하는 것으로 식별하는경우 취소된 보상과 새로운 보상은 상기 문단에서 설명하고 있는 것처럼 기존 보상의 변경으로 보아 회계처리하고 있습니다.</P>
<P USERMARK="F-11">발행된 옵션의 희석효과는 희석주당이익을 계산할 때 희석주식으로 반영하고 있습니다.</P>
<P USERMARK="F-11">&cr;2-2-17 주당이익&cr;당사는 보통주 기본주당이익과 희석주당이익을 계속영업손익과 당기순손익에 대하여 계산하고 포괄손익계산서에 표시하고 있습니다. 기본주당이익은 보통주에 귀속되는 당기순손익을 회계기간 동안에 유통된 보통주식수를 가중평균한 주식수로 나누어 계산하고 있습니다. 희석주당이익은 전환사채와 종업원에게 부여한 주식기준보상 등 모든 희석효과가 있는 잠재적 보통주의 영향을 고려하여 보통주에 귀속되는 당기순손익 및 가중평균유통보통주식수를 조정하여 계산하고 있습니다.</P>
<PGBRK></PGBRK>
<P USERMARK="F-11">2-2-18 현금및현금성자산&cr;재무상태표상의 현금및현금성자산은 보통예금과 소액현금 및 취득 당시 만기가 3개월 이내인 단기성 예금으로 구성되어 있습니다. 현금흐름표상의 현금은 이러한 현금및현금성자산을 의미합니다.&cr;&cr;2-2-19 재고자산&cr;재고자산의 단위원가는 이동평균법으로 결정하고 있으며, 취득원가는 매입원가, 전환원가및 재고자산을 이용가능한 상태로 준비하는데 필요한 기타 원가를 포함하고 있습니다. 제품이나 재공품의 원가에 포함되는 고정제조간접원가는 생산설비의 정상조업도에 기초하여 배부하고 있습니다.&cr;</P>
<P USERMARK="F-11">재고자산의 판매에 따른 수익을 인식하는 기간에 재고자산의 장부금액을 매출원가로 인식하고 있습니다. 재고자산은 취득원가와 순실현가능가치 중 낮은 금액으로 측정하고 있습니다. 재고자산을 순실현가능가치로 감액한 평가손실과 모든 감모손실은 감액이나 감모가발생한 기간에 비용으로 인식하고 있으며, 재고자산의 순실현가능가치의 상승으로 인한 재고자산평가손실의 환입은 환입이 발생한 기간의 비용으로 인식된 재고자산의 매출원가에서 차감하고 있습니다.&cr;</P>

<P USERMARK="F-11 0XEEAE00">
<SPAN USERMARK=" 0X000000">2-3 회계정책 및 공시사항의 변경&cr;</SPAN>
<SPAN USERMARK=" 0X000000">당사의 회계정책은 당기부터 시행되는 다음 기업회계기준서의 제ㆍ개정내용을 제외하고는 전기 연차재무제표 작성시 적용한 회계정책과 동일하게 적용되었습니다.&cr;</SPAN>
<SPAN USERMARK=" 0X000000">&cr;</SPAN>
<SPAN USERMARK=" 0X000000">2-3-1 기업회계기준서 제1103호 '사업결합' 개정&cr;</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">개정 기준서에 따르면, 사업의 필수요소 중 하나인 산출물의 정의가 '투입물과 그 투입물에 적용하는 과정의 결과물로 고객에게 재화나 용역을 제공하거나 투자수익을 창출하거나통상적인 활동에서 기타수익을 창출하는 것'으로 명확하게 정리되었습니다. 한편, 취득한 대상의 사업여부를 간단하게 평가할 수 있는 '집중테스트'를 신설하여 취득한 총자산 공정가치의 대부분이 식별 가능한 단일자산 또는 비슷한 자산집합에 집중되어 있는 경우에는 사업결합이 아닌 것으로 결정할 수 있도록 개정되었습니다. 해당 집중테스트의 적용여부는 선택사항이며 거래별로 적용가능합니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.</SPAN>
</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">2-3-2 기업회계기준서 제1001호 '재무제표 표시' 및 제1008호 '회계정책, 회계추정의 변경 및 오류' 개정&cr;개정 기준서에 따르면, 기준서 제1001호의 '중요성'에 대한 정의가 개정되고 기준서 제1008호의 '중요성'의 정의는 삭제되었습니다. 중요성의 정의가 '특정 보고기업에 대한 재무정보를 제공하는 일반목적 재무제표에 정보를 누락하거나 잘못 기재하거나 불분명하게 하여, 이를 기초로 내리는 주요 이용자의 의사결정에 영향을 줄 것으로 합리적으로 예상할 수 있다면 그 정보는 중요하다'로 개정됨에 따라, 정보와 이용자 및 해당 정보의 영향의 범위가 보다 명확화 되었습니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">2-3-3 기준서 제1109호 '금융상품', 제1039호 '금융상품: 인식과 측정', 제1107호 '금융상품: 공시' 개정&cr;개정 기준서에서는 이자율 지표 개혁 움직임으로 인한 불확실성이 존재하는 동안 위험회피회계 적용과 관련하여 미래 전망 분석 시 예외규정을 적용토록 하고 있습니다. 예외규정에서는 기존 이자율지표를 준거로 하는 예상현금흐름의 발생가능성이 매우 높은지, 위험회피대상항목과 위험회피수단 사이의 경제적 관계가 있는지, 양자간에 높은 위험회피효과가 있는지를 평가할 때, 위험회피대상항목과 위험회피수단이 준거로 하고 있는 이자율지표는 이자율지표 개혁의 영향으로 바뀌지 않는다고 가정합니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.</P>

<P USERMARK="F-11 0XEEAE00">
<SPAN USERMARK=" 0X000000"></SPAN>
</P>
<P USERMARK="F-11">2-3-4 기업회계기준서 제 1116호 '리스' 개정 - 코로나19 (Covid-19) 관련 임차료 면제ㆍ할인ㆍ유예에 대한 실무적 간편법&cr;</P>
<P USERMARK="F-11">실무적 간편법으로, 리스이용자는 코로나19의 직접적인 결과로 발생한 임차료 할인 등(rent concession)이 리스변경에 해당하는지 평가하지 않을 수 있습니다. 이러한 선택을 한 리스이용자는 임차료 할인 등으로 인한 리스료 변동을 그러한 변동이 리스변경이 아닐 경우에 이 기준서가 규정하는 방식과 일관되게 회계처리하여야 합니다. 동 개정사항은 2020년6월 1일 이후 시작하는 회계연도부터 적용되며, 조기도입이 가능합니다. 회사는 동 개정으로 인해 당사의 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">동 실무적 간편법은 코로나19의 직접적인 결과로 발생한 임차료 할인 등에만 적용되며 아래의 조건을 모두 충족하는 경우에 적용합니다.</P>
<P USERMARK="F-11">- 리스료의 변동으로 수정된 리스대가가 변경 전 리스대가와 실질적으로 동일하거나 그 보다 작음</P>
<P USERMARK="F-11">- 리스료 감면이 2021년 6월 30일 이전에 지급하여야 할 리스료에만 영향을 미침(예를 들어 임차료 할인 등이 2021년 5월 30일 이전에 지급하여야 할 리스료를 감소시키고 2021년5월 30일 후에 리스료를 증가시키는 경우 이러한 조건을 충족함).</P>
<P USERMARK="F-11">- 그 밖의 리스기간과 조건은 실질적으로 변경되지 않음</P>

<P USERMARK="F-11 0XEEAE00">
<SPAN USERMARK=" 0X000000">&cr;</SPAN>
</P>
<P USERMARK="F-11">3. 중요한 회계적 판단, 추정 및 가정&cr;</P>
<P USERMARK="F-11">당사의 경영자는 재무제표 작성시 보고기간말 현재 수익, 비용, 자산 및 부채에 대한 보고금액과 우발부채에 대한 주석공시사항에 영향을 미칠 수 있는 판단, 추정 및 가정을 하여야 합니다. 그러나 이러한 추정 및 가정의 불확실성은 향후 영향을 받을 자산 및 부채의 장부금액에 중요한 조정을 유발할 수 있습니다.&cr;&cr;당사가 노출된 위험 및 불확실성에 대한 기타 공시사항으로 재무위험 관리의 목적 및 정책(주석 31)이 및 민감도 분석(주석 31)이 있습니다.&cr;&cr;3-1 회계추정 및 가정&cr;다음 회계연도 내에 자산과 부채의 장부금액에 중요한 조정을 유발할 수 있는 중요한 위험을 내포한 보고기간말 현재의 미래에 대한 중요한 가정 및 추정의 불확실성에 대한 기타 주요 원천은 다음과 같습니다. 가정 및 추정은 재무제표를 작성하는 시점에 입수가능한 변수에 근거하고 있습니다. 현재의 상황과 미래에 대한 가정은 시장의 변화나 당사의 통제에서 벗어난 상황으로 인해 변화할 수 있습니다. 그러한 변화가 발생시 이를 가정에 반영하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">3-1-1 비금융자산의 손상&cr;당사는 매 보고기간말에 모든 비금융자산에 대하여 손상징후의 존재여부를 평가합니다. 영업권과 비한정 내용연수의 무형자산에 대해서는 매년 또는 손상징후가 있는 경우에 손상검사를 수행하며 기타 비금융자산에 대해서는 장부금액이 회수가능하지 않을 것이라는 징후가 있을 때 손상검사를 수행합니다. 사용가치를 계산하기 위하여 경영자는 해당 자산이나 현금창출단위로부터 발생하는 미래기대현금흐름을 추정하고 동 미래기대현금흐름의현재가치를 계산하기 위한 적절한 할인율을 선택하여야 합니다.</P>
<PGBRK></PGBRK>
<P USERMARK="F-11">3-1-2 퇴직급여제도&cr;확정급여채무의 현재가치는 보험수리적 평가방법을 통해 결정됩니다. 보험수리적 평가방법의 적용을 위해서는 다양한 가정을 세우는 것이 필요합니다. 이러한 가정의 설정은 할인율, 미래임금상승률 및 사망률의 결정 등을 포함합니다. 평가방법의 복잡성과 기본가정 및장기적인 성격으로 인해 확정급여채무는 이러한 가정들에 따라 민감하게 변동됩니다. 모든 가정은 매 보고기간말마다 검토됩니다.&cr;</P>
<P USERMARK="F-11">적절한 할인율을 결정하기 위하여 경영진은 AA등급 이상의 회사채의 이자율을 참조하고 있습니다. 사망률은 공개적으로 활용가능한 표에 기초하고 있으며 미래임금상승률 및 미래연금상승률은 해당 국가의 기대인플레이션율에 기초하고 있습니다.</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">자세한 내역은 주석 19에서 기술하고 있습니다.&cr;</P>
<P USERMARK="F-11">3-1-3 개발비</P>

<P USERMARK="F-11">
<SPAN>당사는 주석 2-2 '중요한 회계정책'에 기술된 바에 따라 개발비를 자산으로 계상하고 있습니다. 자산으로 계상하는 개발비는 기술적 및 경제적 실현가능성이 있다는 경영자의 판단에 기초하고 있으며 이는 프로젝트 관리기법에 따라 선정된 일정 수준의 목표에 도달한 경우를 의미합니다. 자산화 대상 개발비는 해당 자산으로부터 미래기대현금흐름, 할인율 및 경제적효익이 지속되는 기간에 대한 경영자의 가정에 기초하여 산정되었습니다. 보고기간말 현재 최선의 추정치에 근거하여 자산으로 인식한 개발비의 장부금액은 5,244,052천원&cr;(전기말: 5,899,557천원)입니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
</P>
<P USERMARK="F-11">4. 공표되었으나 아직 시행되지 않은 회계기준</P>

<P USERMARK="F-11 0XEEAE00">
<SPAN USERMARK=" 0X000000">&cr;</SPAN>
<SPAN USERMARK=" 0X000000">제정 또는 공표되었으나 시행일이 도래하지 않아 적용하지 아니한 제ㆍ개정 기준서 및 해석서는 다음과 같습니다.&cr;</SPAN>
</P>
<P USERMARK="F-11">(1) 기업회계기준서 제1001호 유동부채와 비유동부채의 분류 개정</P>
<P USERMARK="F-11">보고기간말 현재 존재하는 실질적인 권리에 따라 유동 또는 비유동으로 분류되며, 부채의 결제를 연기할 수 있는 권리의 행사가능성이나 경영진의 기대는 고려하지 않습니다. 또한,부채의 결제에 자기지분상품의 이전도 포함되나, 복합금융상품에서 자기지분상품으로 결제하는 옵션이 지분상품의 정의를 충족하여 부채와 분리하여 인식된 경우는 제외됩니다. 동 개정사항은 2023년 1월 1일 이후 시작하는 회계연도부터 적용하며, 조기적용이 허용됩니다. 당사는 동 개정으로 인한 재무제표의 영향을 검토 중에 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">(2) 기업회계기준서 제1103호 '개념체계' 에 대한 참조 개정</P>
<P USERMARK="F-11">인식할 자산과 부채의 정의를 개정된 재무보고를 위한 개념체계를 참조하도록 개정되었으나, 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' 및 해석서 제2121호 '부담금'의 적용범위에 포함되는 부채 및 우발부채에 대해서는 해당 기준서를 적용하도록 예외를 추가하고, 우발자산이 취득일에 인식되지 않는다는 점을 명확히 하였습니다. 동 개정사항은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 당사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">(3) 기업회계기준서 제1016호 '유형자산' 개정</P>
<P USERMARK="F-11">기업이 자산을 의도한 방식으로 사용하기 전에 생산된 품목의 판매에서 발생하는 수익을 생산원가와 함께 당기손익으로 인식하도록 요구하며, 유형자산의 취득원가에서 차감하는 것을 금지하고 있습니다. 동 개정사항은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 당사는 동 개정으로 인한 재무제표의 영향을 검토 중에 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">(4) 기업회계기준서 제1037호 손실부담계약-계약이행원가 개정</P>
<P USERMARK="F-11">손실부담계약을 식별할 때 계약이행원가의 범위를 계약 이행을 위한 증분원가와 계약 이행에 직접 관련되는 다른 원가의 배분이라는 점을 명확히 하였습니다. 동 개정사항은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 당사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다. </P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-11">(5) 한국채택국제회계기준 연차개선 2018-2020</P>
<P USERMARK="F-11">한국채택국제회계기준 연차개선 2018-2020은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 회사는 동 개정으로 인해 재무제표에 중요한 영향은없을 것으로 예상하고 있습니다.</P>
<P USERMARK="F-11">- 기업회계기준서 제1101호 '한국채택국제회계기준의 최초 채택' : 최초채택기업인 종속기업</P>
<P USERMARK="F-11">- 기업회계기준서 제1109호 '금융상품' : 금융부채 제거 목적의 10% 테스트 관련 수수료</P>
<P USERMARK="F-11">- 기업회계기준서 제1116호 '리스' : 리스 인센티브</P>

<P USERMARK="F-11">- 기업회계기준서 제1041호 '농립어업' : 공정가치 측정
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN USERMARK=" B">5. 영업부문</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>&cr;5-1 영업부문의 식별&cr;</SPAN>
<SPAN></SPAN>
<SPAN>당사는 전략적인 영업단위를 5개의 보고부문으로 구분하였습니다. 전략적 영업단위들은 서로 다른 생산품과 용역을 제공하며 각 영업단위별로 요구되는 기술과 마케팅 전략이 다르므로 분리되어 운영되고 있습니다. </SPAN>
<SPAN>최고영업의사결정자는 각 전략적인 영업단위들에 대한 내부보고자료를 최소한 분기단위로 검토하고 있습니다. 한편, 부문별 정보 중 부문자산및 부문부채에 관한 사항은 최고영업의사결정권자에게 정기적으로 보고되지 않으므로 별도 공시하지 아니합니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>5-2 사업부문 및 제품유형&cr;당사의 사업부문 및 주요 제품 유형은 다음과 같습니다</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="609">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="396"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH USERMARK="F-BT" WIDTH="405" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제품유형</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EPO 의약품</TD>
<TD USERMARK="F-BT" WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">만성신부전환자의 빈혈치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기술이전(CDO)</TD>
<TD USERMARK="F-BT" WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">바이오의약품 개발기술 이전매출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">위탁생산(CMO)</TD>
<TD USERMARK="F-BT" WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">전임상 및 임상시료 위탁생산 서비스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">로열티</TD>
<TD USERMARK="F-BT" WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">바이오의약품 개발기술 이전 로열티</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타</TD>
<TD USERMARK="F-BT" WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">연구용역, Protein 및 KIT와 연구용 시약 판매</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN>5-3 부문별 매출액에 대한 정보</SPAN>
<SPAN>&cr;당기 및 전기 중 주요 사업부문에 대한 매출내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="612">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="304" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="612">

<COLGROUP>
<COL WIDTH="158"></COL>
<COL WIDTH="214"></COL>
<COL WIDTH="213"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="167" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="223" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="222" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">EPO 의약품</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,548,180 </TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">809,954 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">기술이전(CDO)</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,163,341 </TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">956,474 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">위탁생산(CMO)</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">898,673 </TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">862,927 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">로열티</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">449,524 </TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">84,728 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">기타</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">131,436 </TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">167,246 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">6,191,155 </TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,881,329 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN USERMARK="F-11">5-4 지역별 매출액에 대한 정보&cr;당기 및 전기 중 지역별 매출내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="612">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="304" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="612">

<COLGROUP>
<COL WIDTH="137"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="146" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" USERMARK="F-BT" ROWSPAN="2">구   분</TH>
<TH WIDTH="234" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT" COLSPAN="2">당   기</TH>
<TH WIDTH="232" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT" COLSPAN="2">전   기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">매출비중(%)</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">매출액</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">매출비중(%)</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">매출액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">국   내</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">57.7%</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,571,055 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">70.1%</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,019,404 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">해   외</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">42.3%</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,620,100 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">29.9%</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">861,925 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">100.0%</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">6,191,155 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">100.0%</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,881,329 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>5-5 주요 고객에 대한 정보&cr;</SPAN>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN> 중 당</SPAN>
<SPAN>사 매출액의 </SPAN>
<SPAN>10</SPAN>
<SPAN>%이상을 차지하는 주요 고객은 </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>3</SPAN>
<SPAN>개사</SPAN>
<SPAN>입니다. 해당 매출이 전체 매출에서 차지하는 비중은</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>71</SPAN>
<SPAN>.8</SPAN>
<SPAN>%</SPAN>
<SPAN>이며, </SPAN>
<SPAN>전기</SPAN>
<SPAN> 중 당사 매출액의 10%이상을 차지하는 고객은 </SPAN>
<SPAN></SPAN>
<SPAN>3</SPAN>
<SPAN>개사</SPAN>
<SPAN>로 해당 부문이 전체 매</SPAN>
<SPAN>출에서 차지하는 비중은 </SPAN>
<SPAN>69.7</SPAN>
<SPAN>%</SPAN>
<SPAN></SPAN>
<SPAN>입니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-11 B">6. 범주별 금융상품&cr;</SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
</P>

<P USERMARK="F-11">
<SPAN>6-1 </SPAN>
<SPAN></SPAN>
<SPAN>보고기간말</SPAN>
<SPAN> 현재 금융자산의 범주별 분류내역은 다음과 같습니다.&cr;&cr;</SPAN>
<SPAN><</SPAN>
<SPAN>당   기</SPAN>
<SPAN>></SPAN>
</P>

<TABLE BORDER="0" WIDTH="739" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="730"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="739" HEIGHT="33" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="739" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">과   목</P>
</TH>

<TH WIDTH="124" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">상각후원가측정</P>
<P USERMARK="F-BT">금융자산</P>
</TH>

<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">기타포괄손익</P>
<P USERMARK="F-BT">- 공정가치</P>
<P USERMARK="F-BT">측정금융자산</P>
</TH>

<TH WIDTH="123" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">당기손익</P>
<P USERMARK="F-BT">- 공정가치</P>
<P USERMARK="F-BT">측정금융자산</P>
</TH>
<TH WIDTH="123" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="86" HEIGHT="120" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT">유동자산</P>
</TD>

<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">현금및현금성자산</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">8,139,296 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">8,139,296 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">

<P USERMARK="F-BT">
<SPAN>매출채권및</SPAN>
<SPAN>기타</SPAN>
<SPAN>채권</SPAN>
</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">684,265 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">684,265 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">기타유동금융자산</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">10,640,908 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">10,640,908 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">소   계</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,464,470 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,464,470 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT">비유동자산</P>
</TD>

<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">

<P USERMARK="F-BT">
<SPAN> 기타비유동</SPAN>
<SPAN>금융</SPAN>
<SPAN>자산</SPAN>
</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">206,988 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">206,988 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="246" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">합   계</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,671,458 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,671,458 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11">전   기</SPAN>
<SPAN USERMARK="F-11">></SPAN>
</P>

<TABLE BORDER="0" WIDTH="739" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="730"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="739" HEIGHT="33" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="739" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">과   목</P>
</TH>

<TH WIDTH="124" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">상각후원가측정</P>
<P USERMARK="F-BT">금융자산</P>
</TH>

<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">기타포괄손익</P>
<P USERMARK="F-BT">- 공정가치</P>
<P USERMARK="F-BT">측정금융자산</P>
</TH>

<TH WIDTH="123" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">당기손익</P>
<P USERMARK="F-BT">- 공정가치</P>
<P USERMARK="F-BT">측정금융자산</P>
</TH>
<TH WIDTH="123" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="86" HEIGHT="120" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT">유동자산</P>
</TD>

<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">현금및현금성자산</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">4,363,335 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">4,363,335 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">

<P USERMARK="F-BT">
<SPAN>매출채권및</SPAN>
<SPAN>기타</SPAN>
<SPAN>채권</SPAN>
</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">100,983 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">100,983 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">기타유동금융자산</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">20,161,200 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">20,161,200 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">소   계</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">24,625,518 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">24,625,518 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT">비유동자산</P>
</TD>

<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">

<P USERMARK="F-BT">
<SPAN> 기타비유동</SPAN>
<SPAN>금융</SPAN>
<SPAN>자산</SPAN>
</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">295,157 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">295,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">합   계</P>
</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">24,920,675 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">24,920,675 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN>6-2 </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>보</SPAN>
<SPAN>고기간말 현재 금융부채의 범주별 분류내역은 다음과 같습니다.&cr;&cr;</SPAN>
<SPAN><</SPAN>
<SPAN>당   기</SPAN>
<SPAN>></SPAN>
</P>

<TABLE BORDER="0" WIDTH="743" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="734"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="743" HEIGHT="33" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="743" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="172"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">과   목</P>
</TH>

<TH WIDTH="159" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">상각후원가측정</P>
<P USERMARK="F-BT">금융부채</P>
</TH>

<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">당기손익-공정가치&cr;측정금융부채</P>
</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="85" HEIGHT="90" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">유동부채</P>
</TD>

<TD WIDTH="181" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">매입채무및기타채무</P>
</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">679,716 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">679,716 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">전환사채</P>
</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">18,398,863 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">18,398,863 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">소   계</P>
</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,078,579 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,078,579 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">비유동부채</TD>

<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<SPAN USERMARK="F-BT">기타비유동금융부채</SPAN>
</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">77,306 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">77,306 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="266" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">
<P USERMARK="F-BT">합   계</P>
</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,155,886 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,155,886 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11">전   기</SPAN>
<SPAN USERMARK="F-11">></SPAN>
</P>

<TABLE BORDER="0" WIDTH="743" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="734"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="743" HEIGHT="33" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="743" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="172"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구분</P>
</TH>

<TH WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">과목</P>
</TH>

<TH WIDTH="159" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">상각후원가측정</P>
<P USERMARK="F-BT">금융부채</P>
</TH>

<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">당기손익-공정가치&cr;측정금융부채</P>
</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="85" HEIGHT="90" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">유동부채</P>
</TD>

<TD WIDTH="181" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">매입채무및기타채무</P>
</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">878,296 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">878,296 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">전환사채</P>
</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">17,385,926 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">17,385,926 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">합   계</P>
</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">18,264,222 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">18,264,222 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN>6-3 </SPAN>
<SPAN>당기</SPAN>
<SPAN> 및 </SPAN>
<SPAN>전</SPAN>
<SPAN>기</SPAN>
<SPAN>의 금융상품의</SPAN>
<SPAN> </SPAN>
<SPAN>범주별 손익현황</SPAN>
<SPAN>은</SPAN>
<SPAN> 다음과 같습니다. </SPAN>
</P>

<P USERMARK="F-11">
<SPAN>&cr;<</SPAN>
<SPAN>당   기</SPAN>
<SPAN>></SPAN>
</P>

<TABLE BORDER="0" WIDTH="814" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="805"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="814" HEIGHT="33" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="813" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="125"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="114" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">상각후원가측정금융자산</P>
</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">당기손익-&cr;공정가치측정금융자산</P>
</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">기타포괄손익-공정가치측정금융자산</TH>
<TH WIDTH="116" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">상각후원가측정금융부채</TH>
<TH WIDTH="113" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">당기손익-&cr;공정가치측정금융부채</TH>

<TH WIDTH="113" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">합   계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">이자수익</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">255,537 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">255,537 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">외환차익</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">28,988 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">5,649 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">34,637 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">리스상환이익</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">930 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">930 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">수익 합계</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">285,455 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">5,649 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">291,104 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">이자비용</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,012,937 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,012,937 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">외환차손</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">37,686 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">38,814 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">76,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">외화환산손실</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">42,107 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">42,107 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">비용 합계</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">79,793 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,051,751 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,131,544 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">전   기</SPAN>
<SPAN USERMARK="F-11">></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
</P>

<TABLE BORDER="0" WIDTH="814" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="805"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="814" HEIGHT="33" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="813" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="125"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="114" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">상각후원가측정금융자산</P>
</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">당기손익-&cr;공정가치측정금융자산</P>
</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">기타포괄손익-공정가치측정금융자산</TH>
<TH WIDTH="116" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">상각후원가측정금융부채</TH>
<TH WIDTH="113" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">당기손익-&cr;공정가치측정금융부채</TH>

<TH WIDTH="113" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">합   계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">이자수익</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">519,972 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">519,972 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">외환차익</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">206 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">16,857 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">17,063 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">외화환산이익</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">4,987 </SPAN>
</TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT"> - </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,987 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">파생상품평가이익</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">233,424 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">233,424 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">수익 합계</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">520,178 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">21,844 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">233,424 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">775,447 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">
<P USERMARK="F-BT">이자비용</P>
</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,214,409 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,214,409 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">외환차손</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT"> 53 </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT"> - </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT"> - </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,595 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,648 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>외화환산손실</SPAN>
</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,410 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,410 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">

<P USERMARK="F-BT">
<SPAN>비용</SPAN>
<SPAN> 합계</SPAN>
</P>
</TD>

<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000"> 53</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,217,414 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,217,467 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11 B">7</SPAN>
<SPAN USERMARK="F-11 B">. </SPAN>
<SPAN USERMARK="F-11 B">현금및현금성자산</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>보</SPAN>
<SPAN>고</SPAN>
<SPAN>기간말 현재 현금및현금성자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="606">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="297"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" USERMARK="F-BT"></TD>
<TD WIDTH="306" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="609">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="145"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">거래처</TH>

<TH WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">보 유 현 금</TD>
<TD WIDTH="150" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,184 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">822 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">단 기 예 금</TD>
<TD WIDTH="150" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">기업은행 등</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,138,112 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,362,515 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="300" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">소  계</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,139,296 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,363,337 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="300" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">차감: 정부보조금</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="300" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">차감계</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,139,296 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,363,335 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11">&cr;</P>

<P USERMARK="F-11">
<SPAN USERMARK=" B">8</SPAN>
<SPAN USERMARK=" B">.</SPAN>
<SPAN USERMARK=" B"> </SPAN>
<SPAN USERMARK=" B">매출채권 및 기타</SPAN>
<SPAN USERMARK=" B">수취</SPAN>
<SPAN USERMARK=" B">채권&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P USERMARK="F-11">
<SPAN>8</SPAN>
<SPAN>-</SPAN>
<SPAN>1 </SPAN>
<SPAN>보</SPAN>
<SPAN>고기간말 현재 매출채권및기타수취채권의 내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="606">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="297"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" USERMARK="F-BT"></TD>
<TD WIDTH="306" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="609" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="152" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">과   목</P>
</TH>

<TH WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">

<P USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</P>
</TH>

<TH WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="9" WIDTH="153" HEIGHT="270" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">유동자산</P>
</TD>

<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">매출채권</P>
</TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">535,336 </TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">55,880 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">(손실충당금)</P>
</TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">- </TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">계약자산</TD>

<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT 0X0000FF" ALIGN="RIGHT">
<SPAN USERMARK=" 0X000000">49,734 </SPAN>
</TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">78,732 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">단기대여금</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">180,167 </TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">180,167 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">
<P USERMARK="F-BT">(손실충당금)</P>
</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(117,167)</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(117,167)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">미수금</P>
</TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">148,930 </TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">45,103 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">(손실충당금)</P>
</TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">- </TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">보증금</TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">49,968 </TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">가감계</TD>

<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT 0X0000FF" ALIGN="RIGHT">
<SPAN USERMARK=" 0X000000">846,967 </SPAN>
</TD>
<TD WIDTH="152" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">242,715 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="153" HEIGHT="90" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">비유동자산</P>
</TD>

<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">보증금</P>
</TD>

<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>206,988</SPAN>
<SPAN> </SPAN>
</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">295,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">(손실충당금)</P>
</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">
<SPAN USERMARK="F-BT">가감계</SPAN>
</TD>

<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">206,988 </SPAN>
</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">295,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="305" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">
<SPAN USERMARK="F-BT">합   계</SPAN>
</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,053,955 </TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">537,872 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"> </P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN>8</SPAN>
<SPAN>-2 당기 및 전기 중 기타수취채권에 대한 손실충당금의 증감내역은 다음과 같습니다.</SPAN>
<SPAN>&cr;&cr;<</SPAN>
<SPAN>당   기</SPAN>
<SPAN>></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="790">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="481"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" USERMARK="F-BT"></TD>
<TD WIDTH="490" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="792">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">과목</P>
</TH>

<TH COLSPAN="4" WIDTH="442" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">전체기간 기대신용손실</P>
</TH>

<TH ROWSPAN="2" WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">12개월 </P>
<P USERMARK="F-BT">기대신용손실</P>
</TH>

<TH WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">합계</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="111" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">매출채권</P>
<P USERMARK="F-BT">(개별평가)</P>
</TH>

<TH WIDTH="111" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">매출채권</P>
<P USERMARK="F-BT">(집합평가)</P>
</TH>

<TH WIDTH="110" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">신용위험 &cr;유의적 증가</P>
</TH>

<TH WIDTH="110" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">신용손상</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">기초 손실충당금</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   회계변경효과</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   위험대체(*1)</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   손상대체(*2)</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   상각(환입)</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   제거</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   기타변동</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">기말 손실충당금</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11 0XFF57C0">
<SPAN USERMARK=" 0X000000">(*1) 전체기간 기대신용손실과 12개월 기대신용손실간의 대체를 의미합니다.&cr;(*2) 신용위험의 유의적 증가가 있는 경우와 신용이 손상된 경우간의 대체를 의미합니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11"><전   기></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="790">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="481"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" USERMARK="F-BT"></TD>
<TD WIDTH="490" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="792">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">과목</P>
</TH>

<TH COLSPAN="4" WIDTH="442" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">전체기간 기대신용손실</P>
</TH>

<TH ROWSPAN="2" WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">12개월 </P>
<P USERMARK="F-BT">기대신용손실</P>
</TH>

<TH WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">합계</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="111" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">매출채권</P>
<P USERMARK="F-BT">(개별평가)</P>
</TH>

<TH WIDTH="111" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">매출채권</P>
<P USERMARK="F-BT">(집합평가)</P>
</TH>

<TH WIDTH="110" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">신용위험 &cr;유의적 증가</P>
</TH>

<TH WIDTH="110" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">신용손상</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">기초 손실충당금</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   회계변경효과</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   위험대체(*1)</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   손상대체(*2)</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   상각(환입)</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   제거</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">   기타변동</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30">
<P USERMARK="F-BT">기말 손실충당금</P>
</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">(*1) 전체기간 기대신용손실과 12개월 기대신용손실간의 대체를 의미합니다.&cr;(*2) 신용위험의 유의적 증가가 있는 경우와 신용이 손상된 경우간의 대체를 의미합니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-11 B">&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11 B">9</SPAN>
<SPAN USERMARK="F-11 B">. 계약자산과 계약부채&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P USERMARK="F-11">
<SPAN>9</SPAN>
<SPAN>-1 </SPAN>
<SPAN></SPAN>
<SPAN>보고기간말</SPAN>
<SPAN> 현재 고객과의 계약으로 인한 계약자산과 계약부채는 아래</SPAN>
<SPAN>와 같습니다.</SPAN>
</P>

<TABLE BORDER="0" WIDTH="618" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="618" HEIGHT="33" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원) </TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="620" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="341"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="350" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="135" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">

<P USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</P>
</TH>

<TH WIDTH="135" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="350" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">계약자산</P>
</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">49,734 </TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">78,732 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="350" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">계약부채</P>
</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">978,202 </TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">586,187 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="350" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">
<SPAN>이행되지 않은 수행의무에 배부된 거래가격</SPAN>
<SPAN></SPAN>
</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">978,202 </TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN>9</SPAN>
<SPAN>-2 </SPAN>
<SPAN>당기</SPAN>
<SPAN> 중 계약자산과 계약부채의 변동내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<TABLE BORDER="0" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="610" HEIGHT="33" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원) </TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="204" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="203" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">계약자산</P>
</TH>

<TH WIDTH="203" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">계약부채(*)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">기   초</P>
</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">78,732 </TD>
<TD WIDTH="203" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">586,187 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">증   가</P>
</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">1,069,850 </TD>
<TD WIDTH="203" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">1,498,266 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">감   소</P>
</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">1,098,848 </TD>
<TD WIDTH="203" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">1,106,251 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">기   말</P>
</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">49,734 </TD>
<TD WIDTH="203" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">978,202 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(*) 계약부채의 감소액은 전액 보고기간 중 수익으로 인식되었습니다.&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>9-3 </SPAN>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN> 중 계약자산에 대한 손실충당금의 변동내역은 </SPAN>
<SPAN>없습니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>9-4 </SPAN>
<SPAN>보</SPAN>
<SPAN>고기간말 현재 이행되지 않은 수행의무에 배부된 거래가격은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="610">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="610" HEIGHT="33" ALIGN="RIGHT">(단위: 천원) </TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="204" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="203" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">당기말</P>
</TH>
<TH WIDTH="203" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">위탁생산용역(CMO)</TD>
<TD USERMARK="F-BT" WIDTH="203" HEIGHT="30" ALIGN="RIGHT">978,202 </TD>
<TD USERMARK="F-BT" WIDTH="203" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN USERMARK=" B">10</SPAN>
<SPAN USERMARK=" B">. 재고자산&cr;</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>보</SPAN>
<SPAN>고기간말 현재 재고자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="738">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="429"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" USERMARK="F-BT"></TD>
<TD WIDTH="438" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="738">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구  분</P>
</TH>
<TH COLSPAN="3" WIDTH="305" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">당기말</TH>
<TH COLSPAN="3" WIDTH="303" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="102" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">취득원가</TH>
<TH WIDTH="102" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">평가손실&cr;충당금</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">장부금액</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">취득원가</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">평가손실&cr;충당금</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">원  재  료</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">355,347 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">355,347 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">66,031 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">66,031 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">부  재  료</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">445,267 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">445,267 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">159,542 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">159,542 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">재  공  품</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,639,749 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,639,749 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">574,208 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">574,208 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<SPAN USERMARK="F-BT">제       품</SPAN>
</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">323,524 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">323,524 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">합       계</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,763,887 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,763,887 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">799,781 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">799,781 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">11. 기타금융자산 및 기타금융부채</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>11-1 </SPAN>
<SPAN></SPAN>
<SPAN>보</SPAN>
<SPAN>고</SPAN>
<SPAN>기간말 현재 기타금융자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="612">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="304" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="613">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="176"></COL>
<COL WIDTH="175"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>

<TH WIDTH="185" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="184" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="613" HEIGHT="30" COLSPAN="3" USERMARK="F-BT">유동:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="244" HEIGHT="30" USERMARK="F-BT">단기금융상품</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">10,500,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">20,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="244" HEIGHT="30" USERMARK="F-BT">단기대여금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">180,167 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">180,167 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="244" HEIGHT="30" USERMARK="F-BT">  대손충당금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">(117,167)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">(117,167)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="244" HEIGHT="30" USERMARK="F-BT">미수수익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">27,940 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">98,200 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="244" HEIGHT="30">
<SPAN USERMARK="F-BT">임차보증금</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">49,968 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="244" HEIGHT="30" USERMARK="F-BT">소   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">10,640,908 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">20,161,200 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="613" HEIGHT="30" COLSPAN="3" USERMARK="F-BT">비유동:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="244" HEIGHT="30" USERMARK="F-BT">임차보증금</TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">
<SPAN>194,441 </SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">282,610 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="244" HEIGHT="30" USERMARK="F-BT">기타보증금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">12,547 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">12,547 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="244" HEIGHT="30" USERMARK="F-BT">소   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">206,988 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">295,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="244" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="185" HEIGHT="30" USERMARK="F-BT">10,847,896 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="184" HEIGHT="30" USERMARK="F-BT">20,456,357 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN>11-2 </SPAN>
<SPAN></SPAN>
<SPAN>보</SPAN>
<SPAN>고</SPAN>
<SPAN>기간말 현재 기타금융부채</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>의</SPAN>
<SPAN> 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="612">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="304" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="195"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="205" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>

<TH WIDTH="205" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="614" HEIGHT="30" COLSPAN="3" USERMARK="F-BT">유동:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" USERMARK="F-BT">전환사채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30" USERMARK="F-BT">18,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">18,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" USERMARK="F-BT">  상환할증금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30" USERMARK="F-BT">547,488 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">547,488 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" USERMARK="F-BT">  사채할인발행차금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30" USERMARK="F-BT">(148,625)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">(1,161,562)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="205" HEIGHT="30" USERMARK="F-BT">소   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30" USERMARK="F-BT">18,398,863 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">17,385,926 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" USERMARK="F-BT">비유동:</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30" USERMARK="F-BT"></TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" USERMARK="F-BT">임대보증금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30" USERMARK="F-BT">30,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" USERMARK="F-BT">장기미지급금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30" USERMARK="F-BT">47,306 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="205" HEIGHT="30" USERMARK="F-BT">소   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30" USERMARK="F-BT">77,306 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="205" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30" USERMARK="F-BT">18,476,169 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">17,385,926 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN USERMARK=" B">12. 기타자산 및 기타부채</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>12-1 </SPAN>
<SPAN></SPAN>
<SPAN>보</SPAN>
<SPAN>고</SPAN>
<SPAN>기간말 현재 기타자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="301" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="612">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="195"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>

<TH USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="612" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">유동:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="204" HEIGHT="30" VALIGN="MIDDLE">선급금(*)</TD>
<TD USERMARK="F-BT" WIDTH="204" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">748,877 </TD>

<TD USERMARK="F-BT 0X1814FF" WIDTH="204" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000">- </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">선급비용</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">15,490 </TD>

<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK="F-BT">8,159</SPAN>
<SPAN USERMARK="F-BT"> </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">합   계</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">764,367 </TD>

<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">8,159 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11">(*) 선급금은 당기 중 건설중인자산(특허권 관련)에서 선급금으로 대체된 금액이 포함되어 있습니다(주석 14. 참조).&cr;</P>

<P USERMARK="F-11">
<SPAN>1</SPAN>
<SPAN>2</SPAN>
<SPAN>-2 </SPAN>
<SPAN></SPAN>
<SPAN>보</SPAN>
<SPAN>고기간말 현재 기타부채의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="611">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="303" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="613">

<COLGROUP>
<COL WIDTH="196"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="195"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="205" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>

<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="613" HEIGHT="30" COLSPAN="3" USERMARK="F-BT">유동:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" USERMARK="F-BT">예수금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">34,131 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">27,074 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" USERMARK="F-BT">선수금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">30,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">합   계</TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">
<SPAN></SPAN>
<SPAN>34,131 </SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="204" HEIGHT="30" USERMARK="F-BT">57,074 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;&cr;</SPAN>
<SPAN USERMARK=" B">13. 투자부동산</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>13-1 </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>보고기간말 현재 유형자산의 구성내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="756">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="393"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="402" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="756">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" USERMARK="F-BT">구   분</TH>

<TH COLSPAN="3" WIDTH="318" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH COLSPAN="3" WIDTH="318" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">취득원가</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">감가상각&cr;누계액</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">장부금액</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">취득원가</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">감가상각&cr;누계액</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">토   지</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">127,244 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN></SPAN>
<SPAN>127,244 </SPAN>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">건   물</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">400,137 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(61,354)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">338,783 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">합   계</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">527,381 </TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>(61,354)</SPAN>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">466,027 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;13-2 당기 및 전기 중 당사의 투자부동산 장부가액의 변동내용은 다음과 같습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">당</SPAN>
<SPAN USERMARK="F-11">   기</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="781">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="418"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="427" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="782">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>초</SPAN>
</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">취   득</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">처   분</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">감가상각비</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>기타증감</SPAN>
<SPAN>(*)</SPAN>
</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<SPAN USERMARK="F-BT">당기</SPAN>
<SPAN USERMARK="F-BT">말</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">토   지</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">
<SPAN>127,244 </SPAN>
</TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">
<SPAN></SPAN>
<SPAN>127,244 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">건   물</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">(8,003)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">346,786 </TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">
<SPAN></SPAN>
<SPAN>338,783 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">
<SPAN>(8,003)</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">474,030 </TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">466,027 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>(*) 기타증감은 당기 중 유형자산에서 투자부동산으로 대체된 금액입니다(주석 14. 참조).&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN><전   기>&cr;전기 중 당사의 투자부동산 보유내역은 없습니다.&cr;&cr;13-3 당기 및 전기 중 투자부동산에서 발생한 손익의 내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="615">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="252"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="261" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="615">

<COLGROUP>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="205" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="205" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="205" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">임대수익</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">23,935 </TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">운영비용</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">9,611 </TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK=" B">&cr;&cr;14. 유형자산</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>14-1 </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>보</SPAN>
<SPAN>고기간말 현재 유형자산의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="756">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="393"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="402" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="756">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" USERMARK="F-BT">구   분</TH>

<TH COLSPAN="3" WIDTH="318" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH COLSPAN="3" WIDTH="318" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">취득원가</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">감가상각&cr;누계액</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">장부금액</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">취득원가</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">감가상각&cr;누계액</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">토            지</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,004,431 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,004,431 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,131,675 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,131,675 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">건            물</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,456,395 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(545,114)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,911,280 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,856,532 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(529,338)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,327,194 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">기  계  장  치</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,887,832 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(7,004,285)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,883,547 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,477,079 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(6,353,803)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,123,276 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">차 량 운 반 구</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">168,957 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(157,693)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">11,264 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">168,957 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(123,902)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">45,055 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">공 구 와 기 구</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,519 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(8,517)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,519 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(8,517)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">비            품</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">745,748 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(536,263)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">209,486 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">713,613 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(436,597)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">277,017 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<SPAN USERMARK="F-BT">사 용 권 자 산</SPAN>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">16,045 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(8,650)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">7,395 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">20,105 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(11,292)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,813 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">건설중인자산</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,110 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">1,110 </SPAN>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">98,094 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">98,094 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">합   계</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">14,289,037 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(8,260,523)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">6,028,515 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">14,474,575 </TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(7,463,449)</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">7,011,126 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>

<P USERMARK="F-11">
<SPAN>14-2 </SPAN>
<SPAN>당기</SPAN>
<SPAN> 및 전기 중 당사의 유형자산 장부가액의 변동내용은 다음과 같습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">당</SPAN>
<SPAN USERMARK="F-11">   기</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="892">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="529"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="538" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="893">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>기</SPAN>
<SPAN>   초</SPAN>
</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">취   득</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">대   체(*1)</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">폐   기</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">감가상각</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>기타증감</SPAN>
<SPAN>(*2)</SPAN>
</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<SPAN USERMARK="F-BT">기   </SPAN>
<SPAN USERMARK="F-BT">말</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">토            지</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">1,131,675 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">(</SPAN>
<SPAN USERMARK=" 0X000000">127,244</SPAN>
<SPAN USERMARK=" 0X000000">)</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">
<SPAN>1,004,431 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">건            물</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">3,327,194 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">(346,786)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(69,128)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">2,911,280 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">기  계  장  치</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">2,123,276 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">410,753 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(650,482)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">1,883,547 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">차 량 운 반 구</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">45,055 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(33,791)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">11,264 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">공 구 와 기 구</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">2 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">2 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">비            품</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">277,017 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">33,763 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">(4)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(101,290)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">209,486 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<SPAN USERMARK="F-BT">사 용 권 자 산</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">8,813 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">13,570 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(8,604)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(6,384)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">7,395 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">건설중인자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">98,094 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">402,801 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">(499,785)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">1,110 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">7,011,126 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">860,886 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">(973,815)</TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">
<SPAN>(4)</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(863,295)</TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">(6,384)</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">6,028,515 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">(*1) 당기 대체액 중 토지ㆍ건물은 투자부동산으로 대체된 것(주석 13. 참조)이며, 건설중인자산 대체액은 특허권과 선급금으로 대체된 것입니다.&cr;(*2)</SPAN>
<SPAN USERMARK="F-11"> </SPAN>
<SPAN USERMARK="F-11">사용권자산 기타증감은 리스계약 만기 전 해약으로 인한 감소액입니다.&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11">전   기</SPAN>
<SPAN USERMARK="F-11">></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="892">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="529"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="538" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="893">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>기</SPAN>
<SPAN>   초</SPAN>
</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">취   득</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">대   체</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">폐   기</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">감가상각</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>기타증감</SPAN>
<SPAN>(*)</SPAN>
</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<SPAN USERMARK="F-BT">기</SPAN>
<SPAN USERMARK="F-BT">   말</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">토            지</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">1,131,675 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">1,131,675 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">건            물</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">3,404,325 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(77,131)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">3,327,194 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">기  계  장  치</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">1,936,471 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">824,238 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">(13)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(637,420)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">2,123,276 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">차 량 운 반 구</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">78,847 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(33,791)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">45,055 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">공 구 와 기 구</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">2 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">2 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">비            품</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">321,150 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">54,945 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">(241)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(98,837)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">277,017 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<SPAN USERMARK="F-BT">사 용 권 자 산</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">3,772 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(11,292)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">16,333 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">8,813 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">건설중인자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">106,570 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">20,870 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">(29,346)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">98,094 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">6,979,039 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">903,825 </TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">(29,346)</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30" USERMARK="F-BT">(254)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">(858,471)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">16,333 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30" USERMARK="F-BT">7,011,126 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">(*) 사용권자산의 기타증감분은 기업회계기준서 제1116호 '리스' 적용으로 인하여 임차보증금에서 대체된 금액입니다.&cr;</SPAN>
<SPAN USERMARK="F-11">&cr;14-3 리스약정에 따라 인식한 리스계약별 사용권자산의 장부금액은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="300"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="300" HEIGHT="30"></TD>
<TD USERMARK="F-BT" WIDTH="309" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="203" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구    분</TH>
<TH WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당기말</TH>
<TH WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">토지 및 건물</TD>

<TD WIDTH="202" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">
<SPAN>7,395 </SPAN>
</TD>

<TD WIDTH="202" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">
<SPAN>8,813 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>14-</SPAN>
<SPAN>4</SPAN>
<SPAN> 당</SPAN>
<SPAN>기 및 전기 중 사용권자산과 관련하여 손익으로 인식된 금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="300"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="300" HEIGHT="30"></TD>
<TD USERMARK="F-BT" WIDTH="309" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="126"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="334" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT" COLSPAN="2">구    분</TH>
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당   기</TH>
<TH WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="120" USERMARK="F-BT" ROWSPAN="4">비용</TD>
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">사용권자산 감가상각비</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT"></TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">   건물</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">8,604 </TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">11,292 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">단기리스 관련 비용</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">49,964 </TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">1,964 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">소액자산리스 관련 비용</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">1,152 </TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">1,152 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" USERMARK="F-BT">비용 합계</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">59,720 </TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">14,408 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">수익</TD>
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">임차보증금 이자수익</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">8,055 </TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">10,715 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">14-5 당사가 단기리스료, 소액리스료 등 리스와 관련하여 당기 및 전기 중 인식한 총 현금유출금액은 </SPAN>
<SPAN USERMARK="F-11">51,116</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">천원</SPAN>
<SPAN USERMARK="F-11">과 3,116천원입니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">14-</SPAN>
<SPAN USERMARK="F-11">6</SPAN>
<SPAN USERMARK="F-11"> 보험가입자산</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="659">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="296"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="305" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="660">

<COLGROUP>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">보험종류</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">자   산</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">장부가액</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">부보액</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">보험회사명</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="132" HEIGHT="60" ALIGN="CENTER" USERMARK="F-BT">화재보험</TD>
<TD VALIGN="MIDDLE" WIDTH="132" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">건물</TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">2,911,280 </SPAN>
</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="60" USERMARK="F-BT">7,603,744 </TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="132" HEIGHT="60" ALIGN="CENTER" USERMARK="F-BT">KB손해보험㈜</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="132" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">기계장치</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30" USERMARK="F-BT">1.883.547 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">당사는 </SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11">말 현재 상기보험 이외에 </SPAN>
<SPAN USERMARK="F-11">가스사고배상책임보험(부보액 380,000천원)</SPAN>
<SPAN USERMARK="F-11">,</SPAN>
<SPAN USERMARK="F-11"> 영업배상책임보험(부보액 500,000천원) 및 </SPAN>
<SPAN USERMARK="F-11">생산물배상책임보험(부보액 </SPAN>
<SPAN USERMARK="F-11">1,810,000</SPAN>
<SPAN USERMARK="F-11">천원)</SPAN>
<SPAN USERMARK="F-11">, </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">임상1상 시험배상책임보험(</SPAN>
<SPAN USERMARK="F-11">부보액 100,000천원</SPAN>
<SPAN USERMARK="F-11">)</SPAN>
<SPAN USERMARK="F-11">에</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"> 가입하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11 B">&cr;15. 무형자산</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">15-1 </SPAN>
<SPAN USERMARK="F-11">보</SPAN>
<SPAN USERMARK="F-11">고</SPAN>
<SPAN USERMARK="F-11">기간말 현재 무형자산의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1022">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="659"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="668" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1023">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" USERMARK="F-BT">구   분</TH>

<TH COLSPAN="4" WIDTH="456" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH COLSPAN="4" WIDTH="453" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">취득원가</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">상각누계액</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">손상차손누계액</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">장부금액</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">취득원가</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">상각누계액</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">손상차손누계액</TH>
<TH WIDTH="108" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">특   허   권</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">359,227 </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(103,851)</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">255,375 </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">331,406 </TD>
<TD VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(81,107)</TD>
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">250,299 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">상   표   권</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">5,866 </TD>
<TD VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(5,863)</TD>
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">3 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">소프트웨어</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">33,126 </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(16,922)</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">16,204 </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">48,251 </TD>
<TD VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(28,846)</TD>
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,405 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">개   발   비</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">8,844,939 </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(1,747,468)</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(1,853,419)</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">5,244,052 </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">8,844,939 </TD>
<TD VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(1,091,963)</TD>
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(1,853,419)</TD>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">5,899,557 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">9,237,292 </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(1,868,241)</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(1,853,419)</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">5,515,631 </TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">9,230,462 </TD>
<TD VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(1,207,779)</TD>
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">(1,853,419)</TD>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">6,169,264 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11">15-2 </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">당</SPAN>
<SPAN USERMARK="F-11">기 및 전기 중 당사의 무형자산 장부가액의 변동내용은 다음과 같습니다.&cr;</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11">당   기</SPAN>
<SPAN USERMARK="F-11">></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="743">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="380"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="389" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="744" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">특허권</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">상표권</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">소프트웨어</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">개발비</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">합   계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">기초 장부금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">250,299 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">3 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">19,405 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">5,899,557 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">6,169,264 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">증가금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">   내부개발</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">   개별취득</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">39,883 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">3,105 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">42,988 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">감소금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">   상각</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">34,797 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">6,295 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">655,505 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">696,596 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">   손상차손</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="147" HEIGHT="30">
<SPAN USERMARK="F-BT">   </SPAN>
<SPAN USERMARK="F-BT">기타감소</SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">10 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">3 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">11 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">24 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">기말 장부금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">255,375 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">16,204 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">5,244,052 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">5,515,631 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>

<P>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11">전   기</SPAN>
<SPAN USERMARK="F-11">></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="743">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="380"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="389" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="744" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">특허권</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">상표권</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">소프트웨어</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">개발비</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">합   계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">기초 장부금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">245,132 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">3 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">12,549 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">7,247,657 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">7,505,341 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">증가금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">   내부개발</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">   개별취득</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">36,032 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">12,915 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">48,947 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">감소금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">   상각</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">30,866 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">6,059 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">758,135 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">795,060 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">   손상차손</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">
<SPAN>589,964 </SPAN>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">589,964 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" USERMARK="F-BT">기말 장부금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">250,299 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" USERMARK="F-BT">3 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">19,405 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">5,899,557 </TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" USERMARK="F-BT">
<SPAN>6,169,264 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>15-3 </SPAN>
<SPAN>당사가 </SPAN>
<SPAN>자체 개발한 바이오시밀러</SPAN>
<SPAN> </SPAN>
<SPAN>EPO 의약품</SPAN>
<SPAN> 개발</SPAN>
<SPAN> 프로젝트는 전임상, 임상1상, 임상3상 후 식약처에 품목허가(NDA)를 득한 후 제품 판매를 시작하게 됩니다. 당사는 EPO개발을 위하여 </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>말</SPAN>
<SPAN>레이시아 국영제약사인 DUOPHARMA BIOTECH BERHAD의 자회사인 </SPAN>
<SPAN>DUOPHAR</SPAN>
<SPAN>MA SDN BERHA</SPAN>
<SPAN>D</SPAN>
<SPAN></SPAN>
<SPAN>와</SPAN>
<SPAN> </SPAN>
<SPAN>공동으로 한국과 말레이시아에서 임상시험을 진행하였는 바, 보고기간말 현재</SPAN>
<SPAN> </SPAN>
<SPAN>말레이시아 식약청(NPRA)과 한국식약처로부터 품목허가</SPAN>
<SPAN>(NDA)</SPAN>
<SPAN>를 승인</SPAN>
<SPAN>받았</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>으</SPAN>
<SPAN>며</SPAN>
<SPAN>, 한</SPAN>
<SPAN>국</SPAN>
<SPAN>과</SPAN>
<SPAN> 말</SPAN>
<SPAN>레</SPAN>
<SPAN>이</SPAN>
<SPAN>시</SPAN>
<SPAN>아 시장에 판매 중에 있습니다.&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>15-4 </SPAN>
<SPAN>당기</SPAN>
<SPAN> 중 개발비의 변동 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="822">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="459"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="354" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD USERMARK="F-BT" WIDTH="468" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="822">

<COLGROUP>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>구   분</SPAN>
</TH>
<TH USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기   초</TH>
<TH USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증   가</TH>
<TH USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상   각</TH>
<TH USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손상차손</TH>
<TH USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">잔여상각기간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">세포주개발</TD>
<TD USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13 </TD>
<TD USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13 </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EPO개발</TD>

<TD USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>5,899,545 </SPAN>
</TD>
<TD USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">655,505 </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,244,039 </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합   계</TD>
<TD USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,899,557 </TD>
<TD USERMARK="F-BT" WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>

<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN></SPAN>
<SPAN>655,505 </SPAN>
</TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,244,052 </TD>
<TD USERMARK="F-BT" WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">15-5 </SPAN>
<SPAN USERMARK="F-11">EPO 개발과 관련하여 </SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11">까지 인식한 연구개발비 자산화 내역은 다음과 같습니다</SPAN>
<SPAN USERMARK="F-11">.</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1103">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="740"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="354" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD USERMARK="F-BT" WIDTH="749" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1104">

<COLGROUP>
<COL WIDTH="47"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="61"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="56" HEIGHT="83" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">분 류</TH>
<TH USERMARK="F-BT" WIDTH="71" HEIGHT="83" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">단 계</TH>
<TH USERMARK="F-BT" WIDTH="101" HEIGHT="83" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구 분</TH>
<TH USERMARK="F-BT" WIDTH="54" HEIGHT="83" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">자산명</TH>
<TH USERMARK="F-BT" WIDTH="494" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">자산화한 연구개발비 금액(누계액)</TH>
<TH USERMARK="F-BT" WIDTH="258" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">연구개발비</TH>
<TH USERMARK="F-BT" WIDTH="70" HEIGHT="83" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">잔여&cr;상각기간</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="83" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">前임상</TH>
<TH USERMARK="F-BT" WIDTH="83" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상1상</TH>
<TH USERMARK="F-BT" WIDTH="82" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상2상</TH>
<TH USERMARK="F-BT" WIDTH="82" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상3상</TH>
<TH USERMARK="F-BT" WIDTH="82" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">판매승인</TH>
<TH USERMARK="F-BT" WIDTH="82" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합 계</TH>
<TH USERMARK="F-BT" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>

<TH USERMARK="F-BT" WIDTH="86" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">

<P USERMARK="F-BT">
<SPAN>상각</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>누계액</SPAN>
<SPAN></SPAN>
</P>
</TH>

<TH WIDTH="86" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">
<P USERMARK="F-BT">손상차손</P>
<P USERMARK="F-BT">누계액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="56" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">개발비</TD>
<TD USERMARK="F-BT" WIDTH="71" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">개발완료</TD>
<TD USERMARK="F-BT" WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">바이오시밀러</TD>
<TD USERMARK="F-BT" WIDTH="54" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EPO</TD>
<TD USERMARK="F-BT" WIDTH="83" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,210,177 </TD>
<TD WIDTH="82" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>

<TD USERMARK="F-BT" WIDTH="82" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>7,263,843</SPAN>
<SPAN> </SPAN>
</TD>

<TD WIDTH="82" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN></SPAN>
<SPAN>- </SPAN>
</TD>
<TD WIDTH="82" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">8,474,020 </TD>
<TD USERMARK="F-BT" WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,244,039 </TD>
<TD USERMARK="F-BT" WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,376,561 </TD>

<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>1,853,419</SPAN>
<SPAN> </SPAN>
</TD>

<TD USERMARK="F-BT" WIDTH="70" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>8년</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">EPO는 신장투석환자(만성신부전증)의 투석 중 일어나는 급성 빈혈치료제로</SPAN>
<SPAN USERMARK="F-11">서 </SPAN>
<SPAN USERMARK="F-11">당사는 </SPAN>
<SPAN USERMARK="F-11">전기</SPAN>
<SPAN USERMARK="F-11"> 중 말레이시아 </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">식약청(NPRA)</SPAN>
<SPAN USERMARK="F-11">과 한국식약처로부터 품목허가(NDA)를 </SPAN>
<SPAN USERMARK="F-11">승인</SPAN>
<SPAN USERMARK="F-11">받아 </SPAN>
<SPAN USERMARK="F-11">제</SPAN>
<SPAN USERMARK="F-11">품(제품</SPAN>
<SPAN USERMARK="F-11">명: 말레이시아 ERYSAA, 한국: PANPOTIN)을</SPAN>
<SPAN USERMARK="F-11"> 출</SPAN>
<SPAN USERMARK="F-11">시하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11">15-6 </SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11"> 중 인식한 개발비 손상차손 내역은 다음과 같습니다</SPAN>
<SPAN USERMARK="F-11">.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="682">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="354" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD USERMARK="F-BT" WIDTH="328" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="682">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH USERMARK="F-BT" WIDTH="94" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">
<SPAN>구   분</SPAN>
</TH>
<TH USERMARK="F-BT" WIDTH="111" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">개발자산</TH>
<TH USERMARK="F-BT" WIDTH="110" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">장부금액</TH>
<TH USERMARK="F-BT" WIDTH="90" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">상각누계액</TH>
<TH USERMARK="F-BT" WIDTH="179" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">손상차손 금액</TH>
<TH USERMARK="F-BT" WIDTH="98" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">회수가능액&cr;평가방법</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당   기</TH>
<TH USERMARK="F-BT" WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">누계액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">개발비</TD>
<TD USERMARK="F-BT" WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EPO개발</TD>
<TD USERMARK="F-BT" WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,244,039 </TD>
<TD USERMARK="F-BT" WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,376,561 </TD>
<TD USERMARK="F-BT" WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>

<TD USERMARK="F-BT" WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN> </SPAN>
<SPAN>1,853,419 </SPAN>
</TD>
<TD USERMARK="F-BT" WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">사용가치</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11">15-7 </SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11"> 및 </SPAN>
<SPAN USERMARK="F-11">전기</SPAN>
<SPAN USERMARK="F-11"> 중 판매비와관리비에 포함하여 비용으로 인식한 연구개발비용은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="603">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="240"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="354" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD USERMARK="F-BT" WIDTH="249" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당   기</TH>
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">FACTORⅧ 개발</TD>
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">442,713 </TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">785,873 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EPO 개발</TD>
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">84,213 </TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">599,018 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">Aflibercept 개발</TD>
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,296,536 </TD>

<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>1,494,686 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="CENTER">기타연구개발</TD>
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,443,822 </TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,851,197 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="CENTER">차감: 정부보조금</TD>
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(591,716)</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">(208,237)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합   계</TD>
<TD USERMARK="F-BT" WIDTH="201" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,675,570 </TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">4,522,537 </TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11 B">16. 매입채무 및 기타채무</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">보</SPAN>
<SPAN USERMARK="F-11">고</SPAN>
<SPAN USERMARK="F-11">기간말 현재 매입채무 및 기타채무의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="614">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="251"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="260" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="616">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>

<TH WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="616" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3" USERMARK="F-BT">유동:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">매입채무</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">296,569 </TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">601,757 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">미지급금</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">383,147 </TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">276,539 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">합   계</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">679,716 </TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">878,296 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK="F-11 B">17. 전환사채</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P USERMARK="F-11">
<SPAN>17-1 당사는 2018년 2월 19일 이사회 결의에 따라 2018년 2월 21일 전환사채를 발행하였</SPAN>
<SPAN>으며, 상세 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="608" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="245"></COL>
<COL WIDTH="345"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="254" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구분</P>
</TH>

<TH WIDTH="354" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" HEIGHT="30">
<P USERMARK="F-BT">사채의 종류 및 명칭</P>
</TD>

<TD WIDTH="354" HEIGHT="30">
<P USERMARK="F-BT">(주)팬젠 제2회 무보증 사모 전환사채</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" HEIGHT="30">
<P USERMARK="F-BT">발행대상자</P>
</TD>

<TD WIDTH="354" HEIGHT="30">
<P USERMARK="F-BT">에이티넘성장투자조합2018 외 2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" HEIGHT="30">
<P USERMARK="F-BT">액면총액</P>
</TD>

<TD WIDTH="354" HEIGHT="30">
<P USERMARK="F-BT">18,000,000,000원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" HEIGHT="30">
<P USERMARK="F-BT">발행일</P>
</TD>

<TD WIDTH="354" HEIGHT="30">
<P USERMARK="F-BT">2018년 2월 21일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" HEIGHT="30">
<P USERMARK="F-BT">만기일</P>
</TD>

<TD WIDTH="354" HEIGHT="30">
<P USERMARK="F-BT">2023년 2월 21일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" HEIGHT="30">
<P USERMARK="F-BT">표면이자율</P>
</TD>

<TD WIDTH="354" HEIGHT="30">
<P USERMARK="F-BT">연 0%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="254" HEIGHT="30" USERMARK="F-BT">보장이자율</TD>
<TD WIDTH="354" HEIGHT="30" USERMARK="F-BT">분기단위 연복리 1%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">이자지급기일</P>
</TD>

<TD WIDTH="354" HEIGHT="30">
<P USERMARK="F-BT"> -</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="76">
<P USERMARK="F-BT">상환방법</P>
</TD>
<TD WIDTH="354" HEIGHT="76" USERMARK="F-BT">전환권이 행사되지 아니하여 만기까지 보유하고 있는 본 사채권에 대해 만기일에 권면금액의 105.1206%를 지급</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">전환시 발행할 주식의 종류 및 수</P>
</TD>

<TD WIDTH="354" HEIGHT="30">

<P USERMARK="F-BT">
<SPAN>기명식보통주</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>1,486,743</SPAN>
<SPAN>주</SPAN>
<SPAN>(Refixing 조항있음)</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">전환기간</P>
</TD>

<TD WIDTH="354" HEIGHT="30">
<P USERMARK="F-BT">2019년 2월 21일부터 2023년 1월 20일까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">
<P USERMARK="F-BT">전환가격</P>
</TD>

<TD WIDTH="354" HEIGHT="30">

<P USERMARK="F-BT">
<SPAN>1주</SPAN>
<SPAN>당 </SPAN>
<SPAN></SPAN>
<SPAN>12,107</SPAN>
<SPAN>원</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="53">
<P USERMARK="F-BT">채권자의 조기상환권</P>
</TD>

<TD WIDTH="354" HEIGHT="53">
<P USERMARK="F-BT">2019년 2월 21일 및 이후 매 3개월이 되는 날을 상환일로 하여, 만기 전 조기상환을 청구할 수 있음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="99">
<P USERMARK="F-BT">회사의 매도청구권</P>
</TD>

<TD WIDTH="354" HEIGHT="99">
<P USERMARK="F-BT">2019년 2월 21일 및 이후 매 3개월이 되는 날을 매매일로 하여 본 사채 최초 권면총액 중 30% 이내의 범위에서 본 사채를 회사 또는 회사가 지정하는 자에게 매도할 것을 투자자에게 청구할 수 있음</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"> </P>

<P>
<SPAN USERMARK="F-11">17-2 </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">당기말</SPAN>
<SPAN USERMARK="F-11"> 현재 전환사채의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="614">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="251"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="260" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="614" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="195"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="205" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="205" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="204" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-BT">발행일</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">발행가액</TD>
<TD WIDTH="205" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">18,000,000 </TD>
<TD WIDTH="204" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">18,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">   상환부채요소</TD>

<TD WIDTH="205" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">
<SPAN>18,398,863</SPAN>
<SPAN> </SPAN>
</TD>
<TD WIDTH="204" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">15,654,528 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">   전환권부채요소</TD>

<TD WIDTH="205" HEIGHT="30" USERMARK="F-BT 0XEEAE00" VALIGN="MIDDLE" ALIGN="RIGHT">
<SPAN USERMARK=" 0X000000">-</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>
<TD WIDTH="204" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">2,345,472 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">장부가액(부채요소)</TD>

<TD WIDTH="205" HEIGHT="30" USERMARK="F-BT 0X1814FF" VALIGN="MIDDLE" ALIGN="RIGHT">
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">18,398,863 </SPAN>
</TD>
<TD WIDTH="204" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">18,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE">
<SPAN USERMARK="F-BT">   전환권자본요소</SPAN>
</TD>

<TD WIDTH="205" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">
<SPAN>602,820</SPAN>
<SPAN> </SPAN>
</TD>
<TD WIDTH="204" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">- </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">전환사채의</SPAN>
<SPAN USERMARK="F-11"> 상환</SPAN>
<SPAN USERMARK="F-11">부채요소는 상각후원가로 측정</SPAN>
<SPAN USERMARK="F-11">하므로,</SPAN>
<SPAN USERMARK="F-11"> 상기 전환사채와 관련하여 유효이자율</SPAN>
<SPAN USERMARK="F-11"> </SPAN>
<SPAN USERMARK="F-11">5.81%</SPAN>
<SPAN USERMARK="F-11">을 적용하여</SPAN>
<SPAN USERMARK="F-11"> </SPAN>
<SPAN USERMARK="F-11">1,012,937</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">천원</SPAN>
<SPAN USERMARK="F-11">이 이</SPAN>
<SPAN USERMARK="F-11">자비용으로 반영되었으며, </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">당</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">기</SPAN>
<SPAN USERMARK="F-11">말 현재 전환된 주식은 없으며, 미전환된 잔여주</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">식수</SPAN>
<SPAN USERMARK="F-11">는 </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">1,486,743</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">주입니다.</SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11 B">18</SPAN>
<SPAN USERMARK="F-11 B">. 정부보조금</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11"> 및 전기 중 정부보조금의 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="254"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="263" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">기     초</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">5 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">총수령액</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">633,053 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">208,194 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">총사용액</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">593,110 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">208,237 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">기타증감</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(39,944)</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">39 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">기      말</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">&cr;당사는 상환의무가 있는 정부보조금은</SPAN>
<SPAN USERMARK="F-11"> </SPAN>
<SPAN USERMARK="F-11">장기미지</SPAN>
<SPAN USERMARK="F-11">급금</SPAN>
<SPAN USERMARK="F-11">(주석 11. 참조)</SPAN>
<SPAN USERMARK="F-11">으로</SPAN>
<SPAN USERMARK="F-11">, 상환의무가 없는 정부보조금은 사용시 관련 비용과 상계처리하고 있습니다.</SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11 B">19</SPAN>
<SPAN USERMARK="F-11 B">. 순확정급여부채</SPAN>
<SPAN USERMARK="F-11">&cr;&cr;당사는 종업원을 위하여 확정급여제도를 운영하고 있으며, 확정급여부채의 보험수리적 평가는 예측단위적립방식을 사용하였습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">19</SPAN>
<SPAN USERMARK="F-11">-1 </SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11"> 및 전기 중 순확정급여부채의 변동 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="253"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="262" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="405"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="414" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구    분</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당   기</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">기초 순확정급여부채</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>1,749,070 </SPAN>
</TD>

<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>1,237,615 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE" USERMARK="F-BT">급여비용(당기손익)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">  근무원가</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">344,727 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">259,363 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">  순이자비용</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">41,625 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">32,564 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">  소   계</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">386,352 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">291,927 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">퇴직급여지급액</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">(93,155)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">(66,213)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE" USERMARK="F-BT">순확정급여부채의 재측정요소(기타포괄손익)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">  재무적가정의 변동에서 발생하는 보험수리적손익</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">37,428 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">112,410 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">  인구통계학적 가정변경에서 발생하는 보험수리적손익</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">35,807 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">  경험조정</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">(150,195)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">137,524 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">  소   계</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">(112,767)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">285,741 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">기말 순확정급여부채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,929,501 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,749,070 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE" USERMARK="F-BT">재무상태표상 구성항목:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">확정급여채무의 현재가치</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN> </SPAN>
<SPAN>1,929,501 </SPAN>
</TD>

<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>1,749,070 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">사외적립자산의 공정가치</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">합   계</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN> </SPAN>
<SPAN>1,929,501 </SPAN>
</TD>

<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>1,749,070 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">19</SPAN>
<SPAN USERMARK="F-11">-2 </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">보고기간말 현재 보험수리적 평가를 위하여 사용된 주요 가정은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">할인율</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">2.250%</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">2.450%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">사외적립자산의 기대수익률</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">2.250%</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">2.450%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">미래임금상승률</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">7.376%</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">5.150%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11">19-3 당기 및 전기 중 확정급여제도 관련 비용의 계정과목별 금액은 다음과 같습니 다.</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">당   기</SPAN>
<SPAN USERMARK="F-11">></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="613">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="250"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="259" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="612" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="489" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당   기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">제조원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">판매비와관리비</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">경상연구개발비</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">합 계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT">당기근무원가</TD>
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">177,350 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">37,874 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">129,503 </TD>
<TD WIDTH="122" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">344,727 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT">순이자</TD>
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">20,259 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">4,959 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">16,408 </TD>
<TD WIDTH="122" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">41,625 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">197,609 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">42,832 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">145,911 </TD>
<TD WIDTH="122" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">386,352 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">전   기</SPAN>
<SPAN USERMARK="F-11">></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="613">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="250"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="259" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="612" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="489" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전   기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">제조원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">판매비와관리비</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">경상연구개발비</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">합 계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT">당기근무원가</TD>
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">128,557 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">32,253 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">98,553 </TD>
<TD WIDTH="122" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">259,363 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT">순이자</TD>
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">16,709 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">3,772 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">12,083 </TD>
<TD WIDTH="122" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">32,564 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">145,266 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">36,025 </TD>
<TD WIDTH="122" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">110,636 </TD>
<TD WIDTH="122" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">291,927 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">19-4 당기 및 전기 중 기타포괄손익(이익잉여금)으로 인식된 보험수리적 손익은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">구     분</P>
</TH>

<TH WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">당   기</P>
</TH>

<TH WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">전   기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="202" HEIGHT="30">
<P USERMARK="F-BT">법인세차감전 재측정요소</P>
</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">112,767 </TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(285,741)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="202" HEIGHT="30">
<P USERMARK="F-BT">법인세효과</P>
</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="202" HEIGHT="30">
<P USERMARK="F-BT">법인세차감후 재측정요소</P>
</TD>

<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0XEEAE00">
<SPAN USERMARK=" 0X000000">112,767 </SPAN>
</TD>

<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">
<SPAN USERMARK="F-BT">(285,741)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11">19-5 당기말 현재 다른 모든 가정이 유지될 때, 유의적인 보험수리적 가정이 발생가능한 합리적인 범위 내에서 변동할 경우 확정급여채무에 미치는 영향은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH ROWSPAN="2" WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">가정의 변동</P>
</TH>

<TH COLSPAN="2" WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">확정급여채무 변동</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">가정의 증가</P>
</TH>

<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">가정의 감소</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="151" HEIGHT="30">
<P USERMARK="F-BT">할인율</P>
</TD>

<TD WIDTH="151" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">1.0%</P>
</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(174,415)</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">209,416 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="151" HEIGHT="32">
<P USERMARK="F-BT">미래임금상승율</P>
</TD>

<TD WIDTH="151" ALIGN="CENTER" HEIGHT="32">
<P USERMARK="F-BT">1.0%</P>
</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="32" USERMARK="F-BT">205,751 </TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="32" USERMARK="F-BT">(174,942)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11">1</SPAN>
<SPAN USERMARK="F-11">9-6 당기말 현재 할인되지 않은 연금 급여지급액의 만기 분석은 아래와 같으며, 확정급여채무의 가중평균만기는 </SPAN>
<SPAN USERMARK="F-11">9.7년</SPAN>
<SPAN USERMARK="F-11">입니다.</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="605">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">1년미만</P>
</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">1년~3년미만</P>
</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">3년~5년미만</P>
</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">5년이상</P>
</TH>

<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">합   계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="101" HEIGHT="30">
<P USERMARK="F-BT">급여지급액</P>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">159,954 </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">73,338 </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">137,969 </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,558,240 </TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,929,501 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11 B">20</SPAN>
<SPAN USERMARK="F-11 B">. 우발사항 및 약정사항</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">당사는 당기말 현재</SPAN>
<SPAN USERMARK="F-11"> 서울보증보험㈜으로부터 </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">10,000</SPAN>
<SPAN USERMARK="F-11">천</SPAN>
<SPAN USERMARK="F-11">원</SPAN>
<SPAN USERMARK="F-11">의 이행보증을 제공</SPAN>
<SPAN USERMARK="F-11">받고 있</SPAN>
<SPAN USERMARK="F-11">습니다.</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11 B">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11 B">21</SPAN>
<SPAN USERMARK="F-11 B">. 특수관계자</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">21</SPAN>
<SPAN USERMARK="F-11">-1 </SPAN>
<SPAN USERMARK="F-11">보</SPAN>
<SPAN USERMARK="F-11">고</SPAN>
<SPAN USERMARK="F-11">기간말 현재 특수관계자 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="131"></COL>
<COL WIDTH="230"></COL>
<COL WIDTH="230"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="239" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">

<P USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</P>
</TH>

<TH WIDTH="239" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="140" HEIGHT="101" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">기타의 특수관계자</P>
</TD>

<TD WIDTH="239" HEIGHT="101">
<SPAN USERMARK="F-BT">와이비파트너스(주), 코에발코리아(주), </SPAN>
<SPAN USERMARK="F-BT">(주)엔키아, </SPAN>
<SPAN USERMARK="F-BT">(주)아시아바이오허브</SPAN>
<SPAN USERMARK="F-BT">, DUOPHARMA BIOTECH BERHAD,</SPAN>
<SPAN USERMARK="F-BT"> DUOPHARMA SDN BERHAD</SPAN>
</TD>

<TD WIDTH="239" HEIGHT="101">
<SPAN USERMARK="F-BT">와이비파트너스(주), 코에발코리아(주), </SPAN>
<SPAN USERMARK="F-BT">(주)엔키아, </SPAN>
<SPAN USERMARK="F-BT">(주)아시아바이오허브</SPAN>
<SPAN USERMARK="F-BT">, DUOPHARMA BIOTECH BERHAD,</SPAN>
<SPAN USERMARK="F-BT"> DUOPHARMA SDN BERHAD</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">21</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">-2 특수관계자와의 거래내역</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="873" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="864"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="873" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="873">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="3" WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="90">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH ROWSPAN="3" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="90">
<P USERMARK="F-BT">특수관계자명</P>
</TH>

<TH WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="4">
<P USERMARK="F-BT">당   기</P>
</TH>

<TH WIDTH="300" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="4">
<P USERMARK="F-BT">전   기</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">
<P USERMARK="F-BT">매출등</P>
</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT" COLSPAN="2">매입등</TH>

<TH WIDTH="150" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">
<P USERMARK="F-BT">매출등</P>
</TH>
<TH WIDTH="150" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT" COLSPAN="2">매입등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">매출</TH>
<TH WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">기타</TH>
<TH WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">매입</TH>
<TH WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">기타</TH>
<TH WIDTH="75" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">매출</TH>
<TH WIDTH="75" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">기타</TH>
<TH WIDTH="75" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">매입</TH>
<TH WIDTH="75" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">기타</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P USERMARK="F-BT">기타의</P>
<P USERMARK="F-BT">특수관계자</P>
</TD>

<TD WIDTH="188" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<SPAN USERMARK="F-BT">DUOPHARMA SDN BERHAD</SPAN>
</TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">2,540,860</TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">- </TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">- </TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">220 </TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">809,954 </TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">8,736 </TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">- </TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">46,054 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11">21-3 특수관계자와의 채권ㆍ채무내역</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="618" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="618" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="78"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH ROWSPAN="2" WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">특수관계자명</P>
</TH>

<TH WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">

<P USERMARK="F-BT">
<SPAN>당</SPAN>
<SPAN>기말</SPAN>
</P>
</TH>

<TH WIDTH="175" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">
<P USERMARK="F-BT">전기말</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">채권</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">채무</TH>
<TH WIDTH="88" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">채권</TH>
<TH WIDTH="87" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P USERMARK="F-BT">기타의&cr;특수관계자</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<SPAN USERMARK="F-BT">DUOPHARMA SDN BERHAD</SPAN>
</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">184,960 </TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">- </TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">5,219 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">임직원</TD>
<TD WIDTH="183" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">김지태 외 1명</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">63,000 </TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">63,000 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">상기 임직원과의 자금 대여거래는 단기대여금으로 당사는 '임직원대출규정'에 따라 퇴직급여충당금 범위내에서 대여할 수 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">21</SPAN>
<SPAN USERMARK="F-11">-4 제공받은 지급보증&cr;</SPAN>
<SPAN USERMARK="F-11">당사는 </SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11">말 </SPAN>
<SPAN USERMARK="F-11">현재 법인카드와 관련하여 대표이사로부터 지급보증(한도 30백만원)을 제공받고 있습니다.</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11 B">&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11 B">22</SPAN>
<SPAN USERMARK="F-11 B">. 자본</SPAN>
<SPAN USERMARK="F-11">&cr;&cr;</SPAN>
<SPAN USERMARK="F-11">22</SPAN>
<SPAN USERMARK="F-11">-1 자본금&cr;&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">22</SPAN>
<SPAN USERMARK="F-11">-1-1 </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">보고기간말 현재 당사가 발행할 주식 총수와 발행한 주식수 및 1주당 금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="305"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="314" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 원, 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>

<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">수권주식수</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">50,000,000 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">50,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">1주의 금액</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">500 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">발행 주식수</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">9,641,781 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">9,641,781 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">보통주자본금</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,820,890,500 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,820,890,500 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK="F-11 0X000000"></SPAN>
<SPAN USERMARK="F-11 0X000000">22</SPAN>
<SPAN USERMARK="F-11 0X000000">-1-2 </SPAN>
<SPAN USERMARK="F-11 0X000000"></SPAN>
<SPAN USERMARK="F-11 0X000000">당</SPAN>
<SPAN USERMARK="F-11 0X000000">기</SPAN>
<SPAN USERMARK="F-11 0X000000">와 전기 </SPAN>
<SPAN USERMARK="F-11 0X000000">중 보통주자본금 변동내역은 없</SPAN>
<SPAN USERMARK="F-11 0X000000">습니다.</SPAN>
</P>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN>22</SPAN>
<SPAN>-2 자본잉여금&cr;</SPAN>
<SPAN></SPAN>
<SPAN>보고기간말 현재 당사의 자본잉여금의 내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="603">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="301" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>

<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">주식발행초과금</TD>

<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>47,237,256 </SPAN>
<SPAN></SPAN>
</TD>

<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>47,237,256 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">22</SPAN>
<SPAN USERMARK="F-11">-3 기타자본항목&cr;</SPAN>
<SPAN USERMARK="F-11">보고기간말 현재 당사의 기타자본항목의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="603">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="301" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="605">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>

<TH WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT" ALIGN="CENTER">전환권대가</TD>
<TD WIDTH="202" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">602,820 </TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">602,820 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT" ALIGN="CENTER">
<SPAN>주식</SPAN>
<SPAN>매수</SPAN>
<SPAN>선택권</SPAN>
</TD>
<TD WIDTH="202" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">229,890 </TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">201,900 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT" ALIGN="CENTER">합 계</TD>
<TD WIDTH="202" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">832,710 </TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">804,720 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK=" B"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11">22-4 결손금처리계산서</SPAN>
<SPAN USERMARK="F-11">(안)&cr;</SPAN>
<SPAN USERMARK="F-11">당기 및 전기의 결손금처리계산서(안)는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="690" BORDER="0">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="60" USERMARK="F-BT">제 11(당) 기</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" USERMARK="F-BT">2020년 01월 01일</TD>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" USERMARK="F-BT">부터</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="60" USERMARK="F-BT">제 10(전) 기</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30" USERMARK="F-BT">2019년 01월 01일</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" USERMARK="F-BT">부터</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" USERMARK="F-BT">2020년 12월 31일</TD>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" USERMARK="F-BT">까지</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30" USERMARK="F-BT">2019년 12월 31일</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" USERMARK="F-BT">까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">처리예정일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" USERMARK="F-BT">2021년 03월 29일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="30" USERMARK="F-BT">처리확정일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30" USERMARK="F-BT">2020년 03월 24일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="801" BORDER="0">

<COLGROUP>
<COL WIDTH="792"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="801" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="803" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="248"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="257" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">과   목</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">제 11(당) 기</TH>

<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="272" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">
<SPAN>제 10</SPAN>
<SPAN>(전)</SPAN>
<SPAN> 기</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30" USERMARK="F-BT">Ⅰ.미처리결손금</TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT">38,679,693,380 </TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT"></TD>

<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT">
<SPAN></SPAN>
<SPAN>34,436,479,820 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30" USERMARK="F-BT P16">  1. 전기이월미처리결손금</TD>

<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT">
<SPAN>34,436,479,820 </SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT">25,213,168,612 </TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="257" HEIGHT="30">
<SPAN USERMARK="F-BT">     2. 회계변경의 누적효과</SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30" USERMARK="F-BT">     3. 순확정급여채무의 재측정요소</TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT">(112,766,755)</TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT">285,740,528 </TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30" USERMARK="F-BT P16">  4. 당기순손실</TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT">4,355,980,315 </TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT"></TD>

<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT">
<SPAN>8,937,570,680 </SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">합   계</TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT"></TD>

<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">38,679,693,380 </SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT"></TD>

<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT 0XEEAE00">
<SPAN USERMARK=" 0X000000">34,436,479,820 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="257" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">Ⅱ.</SPAN>
<SPAN USERMARK=" 0X000000">결손금처리액</SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="257" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">Ⅲ.</SPAN>
<SPAN USERMARK=" 0X000000">차기이월미처리결손금</SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT"></TD>

<TD ALIGN="RIGHT" WIDTH="137" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">38,679,693,380 </SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT"></TD>

<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" USERMARK="F-BT 0XEEAE00">
<SPAN USERMARK=" 0X000000">34,436,479,820 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P USERMARK="F-11">
<SPAN USERMARK=" B">2</SPAN>
<SPAN USERMARK=" B">3. 매</SPAN>
<SPAN USERMARK=" B">출&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-11">23-1 </SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11"> 및</SPAN>
<SPAN USERMARK="F-11"> </SPAN>
<SPAN USERMARK="F-11">전기</SPAN>
<SPAN USERMARK="F-11"> 중 매출의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="298"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="307" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">상 품 매 출</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,785 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">제 품 매 출</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">5,644,374 </TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,696,018 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">용 역 매 출</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">97,256 </TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">97,797 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">기술료매출</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">449,524 </TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">84,728 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">6,191,155 </TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,881,329 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
<SPAN>23-2 당사는 </SPAN>
<SPAN>바이오의약품의 수탁생산, 수탁검사 및 개발용역을 제공하고 있는 바, 그 주요 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="945" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="936"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="945" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="945" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="171"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="180" HEIGHT="62" USERMARK="F-BT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="388" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">계약금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="291" HEIGHT="31" USERMARK="F-BT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">매출인식액</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="62" USERMARK="F-BT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수주잔고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">기초금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="31" USERMARK="F-BT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신규수주액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="31" USERMARK="F-BT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타증감(*)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">기말금액</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="31" USERMARK="F-BT 0X1814FF" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">전기이전</P>
</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="31" USERMARK="F-BT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당   기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="31" USERMARK="F-BT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">누   계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30" USERMARK="F-BT">세포주 개발용역</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">773,500 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">773,500 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">393,957 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">379,543 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">   773,500 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30" USERMARK="F-BT">           - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30" USERMARK="F-BT">세포주 개발 및 공정개발</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">400,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">400,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">72,836 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">327,164 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">400,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30" USERMARK="F-BT">            - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30" USERMARK="F-BT">공정 개발용역</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">450,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT"> 480,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">930,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">19,149 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">   456,635 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">    475,784 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30" USERMARK="F-BT"> 454,216 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30" USERMARK="F-BT">위탁 생산용역</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">1,761,600 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT"> 2,103,344 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT"> 3,864,944 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">862,927 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">898,673 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">1,761,600 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30" USERMARK="F-BT">2,103,344 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30" USERMARK="F-BT">연구용역</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">20,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT"> 114,994 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT"> 809 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT"> 135,803 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">14,797 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">97,256 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">   112,053 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30" USERMARK="F-BT">   23,750 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="180" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">3,405,100 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT"> 2,698,338 </TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">
<SPAN>809 </SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT"> 6,104,247 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">1,363,666 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">2,159,271 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" USERMARK="F-BT">3,522,937 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30" USERMARK="F-BT">2,581,310 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11">(*) 기타증감은 외화 용역계약에 대한 원화 환산시 환율변동에 따른 차이 금액입니다.</P>

<P USERMARK="F-11">
<SPAN USERMARK=" B">&cr;&cr;24</SPAN>
<SPAN USERMARK=" B">. 비용의 성격별분류&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>24</SPAN>
<SPAN>-</SPAN>
<SPAN>1 </SPAN>
<SPAN>당기</SPAN>
<SPAN> 및 </SPAN>
<SPAN>전기</SPAN>
<SPAN> 중 발생한 비용(매출원가 및 판매비와관리비)을 성격별로 분류한 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="607">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="296"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="305" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="605">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당   기</TH>
<TH WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">원/부재료의 사용액</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,457,921 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,048,908 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">재고자산의 변동</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(1,459,799)</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(159,719)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">종업원급여</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,378,733 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,290,891 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">감가상각비</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">863,295 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">858,471 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">무형자산상각비</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">696,596 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">795,060 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">경상연구개발비(*)</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,675,570 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,522,537 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">기타</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,279,189 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,503,203 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">9,891,505 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">10,859,351 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>(*) 경상연구개발비에는 연구소,</SPAN>
<SPAN> 개발부서</SPAN>
<SPAN> 직원에 대한 인건비가 포함된 금액입니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>24</SPAN>
<SPAN>-2 종업원급여의 내역</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="298"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="307" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="196"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="205" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">급         여</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,979,484 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,920,508 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">퇴 직 급 여</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">240,441 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">181,291 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">복리후생비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">158,808 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">189,091 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,378,733 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,290,891 </TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN USERMARK=" B">25</SPAN>
<SPAN USERMARK=" B">. 판매비와관리비</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN> 및</SPAN>
<SPAN> </SPAN>
<SPAN>전기</SPAN>
<SPAN> 중 판매비와관리비의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="298"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="307" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">급         여</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">357,487 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">366,668 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">퇴 직 급 여</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">42,832 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">36,025 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">복리후생비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">81,082 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">106,899 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">여비교통비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">18,788 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">69,679 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">접   대   비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">11,815 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">14,123 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">세금과공과</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">34,253 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">34,778 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">감가상각비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">198,390 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">192,532 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">경상연구개발비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">3,675,570 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">4,522,537 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">운   반   비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">240,176 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">111,487 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">차량유지비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">19,967 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">17,109 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">보   험   료</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">47,447 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">36,668 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">무형자산상각비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">36,938 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">70,377 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">지급수수료</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">206,252 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">185,199 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">소 모 품 비</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">9,567 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">12,110 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">기         타</TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">92,891 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">104,472 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">5,073,456 </TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">5,880,662 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN USERMARK=" B">26</SPAN>
<SPAN USERMARK=" B">.</SPAN>
<SPAN USERMARK=" B"> 영업외손익&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>당기</SPAN>
<SPAN> 및</SPAN>
<SPAN> </SPAN>
<SPAN>전기</SPAN>
<SPAN> 중 영업외손익의 내역은 다음과 같습니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>26</SPAN>
<SPAN>-1 기타수익</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="599">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="288"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="297" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="187"></COL>
<COL WIDTH="186"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="196" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="195" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">임대료수익</TD>
<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">23,935 </TD>
<TD WIDTH="195" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">정부지원금</TD>
<TD WIDTH="196" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">155,944 </TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">71,439 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">잡이익</TD>
<TD WIDTH="196" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">13,011 </TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">4,468 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">합   계</TD>
<TD WIDTH="196" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">192,890 </TD>

<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">
<SPAN>75,906 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN>26</SPAN>
<SPAN>-2 기타비용</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="598">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="287"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="296" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="599">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="186"></COL>
<COL WIDTH="185"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="195" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="194" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">투자부동산감가상각비</TD>
<TD WIDTH="195" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,003 </TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">개발비손상차손</TD>
<TD WIDTH="195" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">589,964 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">유형자산처분손실</TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">4 </TD>
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">254 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">무형자산처분손실</TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">24 </TD>
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">잡손실</TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">32 </TD>
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">100 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">합   계</TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">8,062 </TD>

<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">
<SPAN>590,319 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>26</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>-3 금융수익</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="597">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="286"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="295" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="594">

<COLGROUP>
<COL WIDTH="205"></COL>
<COL WIDTH="181"></COL>
<COL WIDTH="181"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="214" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="190" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="190" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">이자수익</TD>
<TD WIDTH="190" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">255,537 </TD>
<TD WIDTH="190" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">519,972 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">파생상품평가이익</TD>
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="RIGHT">233,424 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="214" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">
<SPAN>외환차익</SPAN>
<SPAN>(*)</SPAN>
</TD>
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">34,637 </TD>
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">17,164 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="214" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">
<SPAN>외화환산이익</SPAN>
<SPAN>(*)</SPAN>
</TD>
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">4,987 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">리스상환이익</TD>
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">930 </TD>
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">합   계</TD>
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT">291,104 </TD>

<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK="F-BT">775,547 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN>(*) </SPAN>
<SPAN>외환차익, 외화환산이익은 전기까지 기타수익으로 분류하였으나, 당기부터 금융수익으로 분류하였습니다.</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN>26-4 금융원가</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="598">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="287"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="296" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="595">

<COLGROUP>
<COL WIDTH="208"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="217" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH WIDTH="189" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당   기</TH>
<TH WIDTH="189" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">이자비용</TD>
<TD WIDTH="189" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">1,012,937 </TD>

<TD WIDTH="189" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">1,214,409 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>외환차손</SPAN>
<SPAN></SPAN>
<SPAN>(*)</SPAN>
</TD>
<TD WIDTH="189" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">76,517 </TD>
<TD WIDTH="189" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">1,648 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>외화환산손실</SPAN>
<SPAN></SPAN>
<SPAN>(*)</SPAN>
</TD>
<TD WIDTH="189" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">42,107 </TD>
<TD WIDTH="189" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">1,410 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<SPAN USERMARK="F-BT">합   계</SPAN>
</TD>
<TD WIDTH="189" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">1,131,562 </TD>

<TD WIDTH="189" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">
<SPAN USERMARK="F-BT">1,217,467</SPAN>
<SPAN USERMARK="F-BT"> </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN>(*) </SPAN>
<SPAN>외환차손, 외화환산손실은 전기까지 기타비용으로 분류하였으나, 당기부터 금융원가로 분류하였습니다.&cr;&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11 B">27</SPAN>
<SPAN USERMARK="F-11 B">. 법인세</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11">당사는 전체 회계연도에 대해서 예상되는 최선의 가중평균 연간법인세율의 추정에 기초하여 법인세비용을 인식하고 있습</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">니다.</SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-11">27-1</SPAN>
<SPAN USERMARK="F-11"> </SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11"> 및 </SPAN>
<SPAN USERMARK="F-11">전기</SPAN>
<SPAN USERMARK="F-11"> 중 발생한 법인세비용(이익)의 주요 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="603">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="301" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="261"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="159"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="270" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당   기</TH>
<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">법인세부담액</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>-</SPAN>
</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">3,215 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">일시적차이로 인한 이연법인세 변동액</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">자본에 직접 가감할 법인세</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">회계변경효과로 인한 법인세</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">법인세비용</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>-</SPAN>
</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">3,215 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK=" B"></SPAN>
</P>
<P USERMARK="F-11">27-2 당기 및 전기 중 회계이익에 적용세율을 곱하여 산출한 금액과 법인세비용의 조정내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당   기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT">법인세비용차감전순손실</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">(4,355,980)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">(8,934,355)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT">적용세율에 따른 법인세</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">(958,316)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">(1,965,558)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT">
<SPAN>- 비공제비용</SPAN>
<SPAN></SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">25,975 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">156,977 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT">
<SPAN>- 비과세수익</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">(6,158)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">(62,863)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT">- 세액공제</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT">- 이연법인세미인식</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">1,048,407 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">1,928,060 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT">- 기타(세율차이 등)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">(109,908)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">(53,400)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT">법인세비용(이익)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK="F-BT">3,215 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">27-3 보고기간말 현재 이연법인세의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="186"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="195" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">재무상태표</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">손익계산서</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당기말</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전기말</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">당   기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">미지급금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">25,467 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">26,774 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(1,307)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">6,158 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">사채상환할증금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">120,447 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">120,447 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(82,328)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">파생상품부채</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(183,974)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">정부보조금</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">
<SPAN>- </SPAN>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">
<SPAN>- </SPAN>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">
<SPAN>- </SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">대손충당금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">23,904 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">25,124 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(1,219)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">2,009 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">확정급여부채</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">424,490 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">384,795 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">39,695 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">112,520 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">업무용승용차 감가상각비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">13,946 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">10,741 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">3,205 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">3,163 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">무형자산손상차손(개발비)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">407,752 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">407,752 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">129,792 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">사용권자산감가상각비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">1,903 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">2,484 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(581)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">2,484 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">현할차(임차보증금)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">1,670 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">2,066 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(396)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">2,066 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="195" HEIGHT="30" USERMARK="F-BT">사채할인발행차금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">(32,697)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(255,544)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">222,846 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">349,498 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="195" HEIGHT="30" USERMARK="F-BT">미수수익</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">(6,147)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(21,604)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">15,457 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">23,576 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="195" HEIGHT="30" USERMARK="F-BT">사용권자산</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">(3,530)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(4,423)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">893 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(4,423)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="195" HEIGHT="30" USERMARK="F-BT">이월결손금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">6,697,717 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">6,142,946 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">554,770 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">1,567,519 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="195" HEIGHT="30" USERMARK="F-BT">이월세액공제</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">3,806,544 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">3,616,308 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">190,236 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">546,987 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="195" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">11,481,466 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">10,457,868 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">1,023,598 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">2,475,046 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="195" HEIGHT="30" USERMARK="F-BT">미인식한 이연법인세자산</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">(11,481,466)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(10,457,868)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(1,023,598)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">(2,475,046)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="195" HEIGHT="30" USERMARK="F-BT">이연법인세자산(부채)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>
<P USERMARK="F-11">27-4 당사는 차기 이후 예상연평균이익이 각 회계연도에 소멸되는 이월결손금 및 세액공제이월액을 초과하는 부분에 대하여 이연법인세 자산의 실현가능성이 있는 것으로 판단하고 있습니다. 보고기간말 현재 당사가 미래에 실현될 가능성이 희박하여 법인세효과를 인식하지 아니한 일시적차이(이연법인세자산)는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="599" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="200" VALIGN="BOTTOM" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">당기말</P>
</TH>

<TH WIDTH="199" VALIGN="BOTTOM" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT">이월결손금이월액</P>
</TD>
<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">6,697,717 </TD>
<TD WIDTH="199" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">6,142,946 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-BT">
<P USERMARK="F-BT">세액공제이월액</P>
</TD>
<TD WIDTH="200" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">3,806,544 </TD>
<TD WIDTH="199" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="RIGHT">3,616,308 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK="F-11">27-5 당사는 당기법인세자산과 당기법인세부채를 상계할 수 있는 법적으로 집행가능한 권리를 가지고 있고 이연법인세자산과 이연법인세부채가 동일한 과세당국에 의해서 부과되는 법인세와 관련되어 있는 경우 법인세자산과 부채를 상계하고 있습니다.</SPAN>
<SPAN USERMARK="F-11 B">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11 B"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN USERMARK=" B">28</SPAN>
<SPAN USERMARK=" B">. 주식기준보상</SPAN>
<SPAN> &cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">28-1 당기</SPAN>
<SPAN USERMARK="F-11">말 현재 당사가 보유하고 있는 주식기준 보상약정은 다음과 같습니다.&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="829">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="148"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="201" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK="F-BT">구분</TH>
<TH WIDTH="157" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">3차부여</TH>
<TH WIDTH="157" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">4차부여</TH>
<TH WIDTH="157" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">5차부여</TH>
<TH WIDTH="157" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">6차부여</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="157" HEIGHT="30" USERMARK="F-BT">일반직원</TH>
<TH ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="157" HEIGHT="30" USERMARK="F-BT">일반직원</TH>
<TH ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="157" HEIGHT="30" USERMARK="F-BT">임원 및 일반직원</TH>
<TH ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="157" HEIGHT="30" USERMARK="F-BT">임원 및 일반직원</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" USERMARK="F-BT">부여일</TD>
<TD ALIGN="CENTER" WIDTH="157" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">2014년 03월 24일</TD>
<TD ALIGN="CENTER" WIDTH="157" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">2015년 03월 26일</TD>
<TD ALIGN="CENTER" WIDTH="157" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE">2015년 07월 20일</TD>
<TD ALIGN="CENTER" WIDTH="157" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT">2018년 10월 18일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" USERMARK="F-BT">부여수량</TD>
<TD ALIGN="RIGHT" WIDTH="157" HEIGHT="30" USERMARK="F-BT">8,000주</TD>
<TD ALIGN="RIGHT" WIDTH="157" HEIGHT="30" USERMARK="F-BT">14,500주</TD>
<TD ALIGN="RIGHT" WIDTH="157" HEIGHT="30" USERMARK="F-BT">115,000주</TD>
<TD ALIGN="RIGHT" WIDTH="157" HEIGHT="30" USERMARK="F-BT">97,000주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" USERMARK="F-BT">행사가격</TD>
<TD ALIGN="RIGHT" WIDTH="157" HEIGHT="30" USERMARK="F-BT">8,700원</TD>
<TD ALIGN="RIGHT" WIDTH="157" HEIGHT="30" USERMARK="F-BT">9,500원</TD>
<TD ALIGN="RIGHT" WIDTH="157" HEIGHT="30" USERMARK="F-BT">15,000원</TD>
<TD ALIGN="RIGHT" WIDTH="157" HEIGHT="30" USERMARK="F-BT">14,850원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="53" VALIGN="MIDDLE" USERMARK="F-BT">행사가능기간</TD>
<TD ALIGN="CENTER" WIDTH="157" HEIGHT="53" USERMARK="F-BT">2016.03.24&cr;~2021.03.23</TD>
<TD ALIGN="CENTER" WIDTH="157" HEIGHT="53" USERMARK="F-BT">2017.03.26&cr;~2022.03.25</TD>
<TD ALIGN="CENTER" WIDTH="157" HEIGHT="53" USERMARK="F-BT">2017.07.20&cr;~2022.07.19</TD>
<TD ALIGN="CENTER" WIDTH="157" HEIGHT="53" USERMARK="F-BT">2020.10.18&cr;~2025.10.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="53" VALIGN="MIDDLE" USERMARK="F-BT">가득조건</TD>
<TD WIDTH="157" HEIGHT="53" ALIGN="CENTER" USERMARK="F-BT">용역제공조건: &cr;부여일로부터 2년</TD>
<TD WIDTH="157" HEIGHT="53" ALIGN="CENTER" USERMARK="F-BT">용역제공조건: &cr;부여일로부터 2년</TD>
<TD WIDTH="157" HEIGHT="53" ALIGN="CENTER" USERMARK="F-BT">용역제공조건: &cr;부여일로부터 2년</TD>
<TD WIDTH="157" HEIGHT="53" ALIGN="CENTER" USERMARK="F-BT">용역제공조건: &cr;부여일로부터 2년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" USERMARK="F-BT">부여방법</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">신주발행교부</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">신주발행교부</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">신주발행교부</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">신주발행교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" USERMARK="F-BT">소멸된 주식수(*1)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">- </TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">3,500주</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>2,500</SPAN>
<SPAN>주</SPAN>
</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK="F-BT">44,000</SPAN>
<SPAN USERMARK="F-BT">주</SPAN>
<SPAN USERMARK="F-BT"></SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" USERMARK="F-BT">조정후 행사가능주식수(*2)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">16,000주</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">22,000주</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>225,000</SPAN>
<SPAN>주</SPAN>
</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK="F-BT">53,000</SPAN>
<SPAN USERMARK="F-BT">주</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" USERMARK="F-BT">조정후행사가격(*2)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">4,350원</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">4,750원</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">7,500원</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">14,850원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" USERMARK="F-BT">행사한주식수</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>12,400</SPAN>
<SPAN>주</SPAN>
</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>15,400주</SPAN>
</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>85,800</SPAN>
<SPAN>주</SPAN>
</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK="F-BT">-</SPAN>
<SPAN USERMARK="F-BT"> </SPAN>
<SPAN USERMARK="F-BT"></SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" USERMARK="F-BT">미행사주식수</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>3,600</SPAN>
<SPAN>주</SPAN>
</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>6,600</SPAN>
<SPAN>주</SPAN>
</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>139,200</SPAN>
<SPAN>주</SPAN>
</TD>

<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK="F-BT">53,000</SPAN>
<SPAN USERMARK="F-BT">주</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">(*1) 소멸된 주식수는</SPAN>
<SPAN USERMARK="F-11"> 부여일로부터 2년이내 퇴사로 인해 부</SPAN>
<SPAN USERMARK="F-11">여가 취소된 </SPAN>
<SPAN USERMARK="F-11">부분입</SPAN>
<SPAN USERMARK="F-11">니</SPAN>
<SPAN USERMARK="F-11">다.&cr;</SPAN>
<SPAN USERMARK="F-11">(*2) 조정후 주식수와 조정후 행사가격은 전기 이전에 무상증자로 인한 조정효과를 반영한 것입니다.&cr;</SPAN>
</P>
<P USERMARK="F-11">28-2 부여일 현재의 주식기준보상 공정가치를 측정하기 위하여 사용된 기초자료는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="637" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="628"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="637" HEIGHT="30" USERMARK="F-BT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="638" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="260"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">구분</P>
</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">3차부여분</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">4차부여분</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">5차부여분</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">6차부여분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" HEIGHT="30">
<P USERMARK="F-BT">부여일 현재 주가(공정가치)(*1)</P>
</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">5,301 </TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,580 </TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">14,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" HEIGHT="30">
<P USERMARK="F-BT">행사가격(*1)</P>
</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,700 </TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">9,500 </TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">15,000 </TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">14,850 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" HEIGHT="30">
<P USERMARK="F-BT">기대주가변동성(가중평균변동성)(*2)</P>
</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8.10%</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">31.30%</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">15.60%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" HEIGHT="30">
<P USERMARK="F-BT">기대 배당금(*3)</P>
</TD>

<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30">
<P USERMARK="F-BT">- </P>
</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" HEIGHT="30">
<P USERMARK="F-BT">무위험이자율(*4)</P>
</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2.02%</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2.30%</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2.27%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11">(*1) 부여일 현재 주가(공정가치) 및 행사가격은 각 회차별 부여일 현재를 기준으로 산정된 것이므로 전기 이전의 무상증자로 인한 조정효과가 반영되지 않은 것입니다.&cr;(*2) 4, 5차부여분은 상장되어 있는 유사 업종 기업군들의 평균 180영업일 기준 변동성 사용하였으며, 6차부여분은 평가기준일 이전 180영업일 기준의 당사의 변동성을 사용하였습니다.&cr;(*3) 주식선택권 부여일 현재 당사는 배당 이력이 없으므로 기대 배당은 없는 것으로 가정하였습니다.&cr;(*4) 무위험이자율은 평가기관이 시장에서 수집된 유통가격 정보를 바탕으로 Fama-Bliss 방식의 Strip & Bootstrapping 방법을 활용하여 무위험채권(국고채)의 Spot Curve에서 산출하여 적용하였습니다.&cr;</P>
<P></P>

<P USERMARK="F-11">
<SPAN USERMARK=" B">29</SPAN>
<SPAN USERMARK=" B">. 주당손익</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN>29</SPAN>
<SPAN>-1 </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN> 및 </SPAN>
<SPAN>전기</SPAN>
<SPAN>의 기본 및 희석주당손실의 산정내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="615">

<COLGROUP>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="615" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 원,주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="215" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH USERMARK="F-BT" WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당   기</TH>
<TH USERMARK="F-BT" WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">당기순이익(손실)</TD>
<TD USERMARK="F-BT" WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,355,980,315)</TD>

<TD USERMARK="F-BT 0X0000FF" WIDTH="199" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000">(8,937,570,680)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">차감: 우선주배당금</TD>
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">- </TD>
<TD USERMARK="F-BT" WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">보통주당기순이익(손실)</TD>

<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">
<SPAN>(4,355,980,315)</SPAN>
</TD>

<TD USERMARK="F-BT" WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">
<SPAN>(8,937,570,680</SPAN>
<SPAN>)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">가중평균유통보통주식수</TD>

<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">
<SPAN>9,641,781 </SPAN>
</TD>
<TD USERMARK="F-BT" WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">9,641,781 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">기본주당이익(손실)</TD>
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" USERMARK="F-BT">(452)</TD>

<TD USERMARK="F-BT" WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">
<SPAN>(927)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;29</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>-2 당기 및 전기 중 유통보통주식수의 변동이 없으므로 상기 기본 및 희석주당손실의 계산을 위한 가중평균유통보통주식수는 보고기간말 현재 유통보통주식수와 동일합니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">29</SPAN>
<SPAN USERMARK="F-11">-3 </SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11"> 및 </SPAN>
<SPAN USERMARK="F-11">전</SPAN>
<SPAN USERMARK="F-11">기</SPAN>
<SPAN USERMARK="F-11">의 희석주당</SPAN>
<SPAN USERMARK="F-11">손익은 잠재적 보통주의 반희석효과로 인하여 기본주당손익과 동일합니다. </SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11">말 현재 희석효과가 발생하지 않은 잠재적 보통주의 내역은 다음과 같습니다.&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="727">

<COLGROUP>
<COL WIDTH="135"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="227"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">청구기간</TH>
<TH WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">발행될 주식수</TH>
<TH WIDTH="236" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">조   건</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT" ALIGN="CENTER">주식기준보상</TD>

<TD WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>2016.03.24 ~ </SPAN>
<SPAN>2025.10.17</SPAN>
<SPAN></SPAN>
</TD>

<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>202,400</SPAN>
<SPAN>주</SPAN>
</TD>

<TD WIDTH="236" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>주당 </SPAN>
<SPAN>4,350</SPAN>
<SPAN>원 ~ </SPAN>
<SPAN>14,850원</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT" ALIGN="CENTER">전환사채</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">2019.02.21 ~ 2023.01.20</TD>

<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>1,486,743주</SPAN>
</TD>

<TD WIDTH="236" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN>주당</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>12,107</SPAN>
<SPAN>원</SPAN>
<SPAN></SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN USERMARK=" B">30</SPAN>
<SPAN USERMARK=" B">. 공정가치</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN>보</SPAN>
<SPAN>고기간말 현재 금융상품의 장부금액과 공정가치는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="599">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="288"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT"></TD>
<TD WIDTH="297" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="52"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" USERMARK="F-BT" COLSPAN="2">구  분</TH>

<TH COLSPAN="2" WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH COLSPAN="2" WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">장부금액</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">공정가치</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">장부금액</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="6" WIDTH="601" HEIGHT="30" USERMARK="F-BT">금융자산:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="61" HEIGHT="90" USERMARK="F-BT" ROWSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER">유동</TD>
<TD WIDTH="146" HEIGHT="30" USERMARK="F-BT">현금및현금성자산</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,139,296 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,139,296 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,363,335 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,363,335 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" USERMARK="F-BT">매출채권및기타채권</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">684,265 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">684,265 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">100,983 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">100,983 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" USERMARK="F-BT">기타유동금융자산</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">10,640,908 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">10,640,908 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">20,161,200 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">20,161,200 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="61" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">비유동</TD>
<TD WIDTH="146" HEIGHT="30" USERMARK="F-BT">기타비유동금융자산</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">206,988 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">206,988 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">295,157 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">295,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT" COLSPAN="2">금융자산 합계</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">19,671,458 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">19,671,458 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">24,920,675 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">24,920,675 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="6" WIDTH="601" HEIGHT="30" USERMARK="F-BT">금융부채:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="61" HEIGHT="60" USERMARK="F-BT" ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER">유동</TD>
<TD WIDTH="146" HEIGHT="30" USERMARK="F-BT">매입채무및기타채무</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">679,716 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">679,716 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">878,296 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">878,296 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" USERMARK="F-BT">전환사채</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,398,863 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,398,863 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">17,385,926 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">17,385,926 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="61" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">비유동</TD>
<TD WIDTH="146" HEIGHT="30" USERMARK="F-BT">기타비유동금융부채</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">77,306 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">77,306 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT" COLSPAN="2">금융부채 합계</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">19,155,886 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">19,155,886 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,264,222 </TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,264,222 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
<SPAN>경영진은 재무제표상 상각후원가로 측정된 금융자산과 금융부채의 장부금액은 공정가치와 근사하다고 판단하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK=" B">31</SPAN>
<SPAN USERMARK=" B">. 재무위험관리의 목적 및 정책</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>당사의 주요 금융부채는 매입채무및기타채무와 전환사채 및 기타비유동금융부채로 구성되어 있으며, 이러한 금융부채는 영업활동 및 재무활동으로 발생하였습니다. 또한 당사는 영업활동에서 발생하는 현금및현금성자산, 매출채권및기타채권 등과 같은 금융자산도 보유하고 있습니다.&cr;&cr;당사의 금융자산 및 금융부채에서 발생할 수 있는 주요 위험은 시장위험, 신용위험 및 유동성위험입니다. 당사의 주요 경영진은 아래에서 설명하는 바와 같이, 각 위험별 관리절차를 검토하고 정책에 부합하는지 검토하고 있습니다. 또한 당사는 투기 목적의 파생상품거래를 실행하지 않는 것이 기본적인 정책입니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>3</SPAN>
<SPAN>1</SPAN>
<SPAN>-1 시장위험&cr;시장위험은 시장가격의 변동으로 인하여 금융상품의 공정가치가 변동할 위험입니다. 시장위험은 이자율위험, 환위험 및 기타 가격위험의 세가지 유형으로 구성됩니다.&cr;&cr;다음의 민감도 분석은 당기말과 전기말에 관련되어 있습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P USERMARK="F-11 0XEEAE00">
<SPAN USERMARK=" 0X000000">(1) 이자율위험&cr;이자율위험은 시장이자율의 변동으로 인하여 금융상품의 공정가치나 미래현금흐름이 변동할 위험입니다. 당사는 내부적으로 이자율 1% 변동을 기준으로 이자율위험을 측정하고있으며, 상기의 변동비율은 합리적으로 발생가능한 이자율변동위험에 대한 경영진의 평가를 반영하고 있습니다.&cr;</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
</P>
<P USERMARK="F-11">당기말 현재 변동이자율이 적용되는 차입금은 없으므로, 이자율변동이 금융부채의 현금흐름에 미치는 영향은 없습니다.&cr;</P>

<P USERMARK="F-11">
<SPAN>(2) 환위험&cr;환위험은 환율의 변동으로 금융상품의 공정가치나 미래현금흐름이 변동할 위험입니다. 보고기간말 현재 기능통화 이외의 외화로 표시된 화폐성자산 및 부채의 장부금액은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="610">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="308" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="613">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" USERMARK="F-BT">구   분</TH>

<TH COLSPAN="2" WIDTH="246" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH COLSPAN="2" WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">자산</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">부채</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">자산</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">USD</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">657,988 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">175,369 </TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">451,848 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN>당사는 내부적으로 원화 환율 변동에 대한 환위험을 정기적으로 측정하고 있습니다. </SPAN>
<SPAN>보고기간말</SPAN>
<SPAN> 현재 각 외화에 대한 기능통화의 환율 5% 변동시 환율변동이 </SPAN>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN> 및 전기 손익에미치는 영향은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="612">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT"></TD>
<TD WIDTH="310" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" USERMARK="F-BT">구   분</TH>
<TH COLSPAN="2" WIDTH="246" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH COLSPAN="2" WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">5% 상승시</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">5% 하락시</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">5% 상승시</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">5% 하락시</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">USD</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">32,899 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(32,899)</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(13,824)</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">13,824 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>&cr;상기 민감도 분석은 </SPAN>
<SPAN>당기말과 전기말</SPAN>
<SPAN> 현재 기능통화 이외의 외화로 표시된 화폐성 자산 및부채를 대상으로 하였습니다.&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>(3) 기타 가격위험&cr;기타 가격위험은 이자율위험이나 환위험 이외의 시장가격의 변동으로 인하여 금융상품의 공정가치나 미래현금흐름이 변동할 위험이며, 당사는 </SPAN>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN>말 현재 금융상품 중 상장지분상품 등을 보유하고 있지 않습니다.</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>31</SPAN>
<SPAN>-2 신용위험&cr;신용위험은 거래상대방이 의무를 이행하지 않아 당사에 재무손실이 발생할 위험입니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P USERMARK="F-11">
<SPAN>당사는 신용위험을 관리하기 위하여 금융자산의 신용보강을 위한 정책과 절차를 마련하여운영하고 있으며, 회수가 지연되는 금융자산에 대하여는 회수지연 현황 및 회수대책이 보고된 후 지연사유에 따라 적절한 조치를 취하고 있습니다. 또한, 거래상대방의 신용에 따라 필요한 경우 담보 및 기타 신용보강을 요구하고 있습니다.</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK="F-11">
<SPAN>보고기간말</SPAN>
<SPAN> 현재 당사의 신용위험에 대한 최대노출정도는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="618" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="618" HEIGHT="30" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="618" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="268"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="161"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="277" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH WIDTH="171" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">

<P USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</P>
</TH>

<TH WIDTH="170" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="277" HEIGHT="30">
<P USERMARK="F-BT">현금및현금성자산</P>
</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,139,296 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,363,335 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="277" HEIGHT="30">
<P USERMARK="F-BT">매출채권및기타채권</P>
</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">684,265 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">100,983 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="277" HEIGHT="30" USERMARK="F-BT">계약자산</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">49,734 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">78,732 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="277" HEIGHT="30">
<P USERMARK="F-BT">기타유동금융자산</P>
</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">10,640,908 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">20,161,200 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="277" HEIGHT="30" USERMARK="F-BT">기타비유동금융자산</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">206,988 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">295,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="277" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">합   계</P>
</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">19,721,192 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">24,999,407 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>
<P USERMARK="F-11">당사는 매출채권과기타수취채권에 대해 손실충당금을 인식하였으며(주석 8. 참조), 이외의 금융자산에 대해서는 채무불이행위험이 없다고 판단하여 기대신용손실을 인식하지 않았습니다.</P>

<P USERMARK="F-11">
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">31</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">-3 유동성위험&cr;유동성위험은 만기까지 모든 금융계약상의 약정사항들을 이행할 수 있도록 자금을 조달하지 못할 위험입니다.&cr;&cr;당사는 유동성 전략 및 계획을 통하여 자금부족에 따른 위험을 관리하고 있으며, 금융상품의 만기와 영업현금흐름의 추정치를 고려하여 금융자산과 금융부채의 만기를 대응시키고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">보</SPAN>
<SPAN USERMARK="F-11">고기간말 현재 금융부채별 상환계획으로서 할인되지 않은 계약상의 금액은 다음과 같습니다.&cr;</SPAN>
<SPAN USERMARK="F-11">&cr;<</SPAN>
<SPAN USERMARK="F-11">당기</SPAN>
<SPAN USERMARK="F-11">말></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="298"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT"></TD>
<TD WIDTH="307" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="47"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT" COLSPAN="2">구   분</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">1년 이내</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">1년~5년</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">5년 이후</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="56" VALIGN="MIDDLE" HEIGHT="60" USERMARK="F-BT" ROWSPAN="2" ALIGN="CENTER">유동</TD>
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">매입채무및기타채무</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">679,716 </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">679,716 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">전환사채(*)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,398,863 </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,398,863 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="56" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT">비유동</TD>
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">기타비유동금융부채</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">77,306 </SPAN>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">77,306 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER" COLSPAN="2">합   계</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X1814FF">
<SPAN USERMARK=" 0X000000">679,716 </SPAN>
</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT"> 18,476,170 </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">19,155,886 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN>(</SPAN>
<SPAN>*) 상기 전환사채의 만기구조는 계약 만기까지 사채권자의 전환권이 행사되지 않을 경우를 가정한 것입니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11"><</SPAN>
<SPAN USERMARK="F-11">전기</SPAN>
<SPAN USERMARK="F-11">말></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="609">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="298"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT"></TD>
<TD WIDTH="307" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">1년 이내</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">1년~5년</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">5년 이후</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">매입채무및기타채무</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">878,296 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">878,296 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">전환사채(*)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,921,708 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,921,708 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">합   계</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">878,296 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,921,708 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">19,800,004 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>*) 상기 전환사채의 만기구조는 계약 만기까지 사채권자의 전환권이 행사되지 않을 경우를 가정한 것입니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;31</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>-4 자본관리&cr;자본관리의 주 목적은 당사의 영업활동을 유지하고 주주가치를 극대화하기 위하여 높은 신용등급과 건전한 자본비율을 유지하기 위한 것입니다.&cr;&cr;당사는 자본구조를 경제환경의 변화에 따라 수정하고 있으며, 이를 위하여 배당정책을 수정하거나 자본감소 혹은 신주발행을 검토하도록 하고 있습니다. 한편, </SPAN>
<SPAN>당기</SPAN>
<SPAN> 중 자본관리의목적, 정책 및 절차에 대한 어떠한 사항도 변경되지 않았습니다.&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>당사는 총부채를 자기자본으로 나눈 부채비율을 사용하고 있으며,</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>보고기간말 현재 총부채 및 자기자본은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="605">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT"></TD>
<TD WIDTH="303" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">구   분</TH>

<TH WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">총 부 채</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">22,097,719 </TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">20,656,553 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">자기자본</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">14,211,163 </TD>

<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>18,426,386 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT" ALIGN="CENTER">부채비율</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">155.50%</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">112.10% </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>
<PGBRK></PGBRK>

<P USERMARK="F-11 0XEEAE00">
<SPAN USERMARK=" 0X000000 B">32</SPAN>
<SPAN USERMARK=" 0X000000 B">. 현금흐름표</SPAN>
<SPAN USERMARK=" 0X000000">&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN>32</SPAN>
<SPAN>-1 현금흐름표상의 현금은 재무상태표상의 현금및현금성자산과 동일합니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>32</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>-2 </SPAN>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN> 및 </SPAN>
<SPAN>전기</SPAN>
<SPAN> 중 영업활동으로부터 창출된 현금흐름의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="607">

<COLGROUP>
<COL WIDTH="321"></COL>
<COL WIDTH="268"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="330" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT"></TD>
<TD WIDTH="277" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="608">

<COLGROUP>
<COL WIDTH="272"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="154"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="281" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="163" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">1.당기순손실</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,355,980 </TD>

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">8,937,571 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">2.비현금항목의조정</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,778,440 </TD>

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">3,102,409</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   감가상각비</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">863,295 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">858,471 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   투자부동산감가상각비</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,003 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   무형자산상각비</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">696,596 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">795,060 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   퇴직급여</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">386,352 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">291,927 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   주식보상비</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">27,990 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">106,079 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   외화환산이익</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(4,986)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   외화환산손실</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">42,107 </TD>

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>1,410</SPAN>
<SPAN> </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   유형자산처분손실</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">254 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   무형자산처분손실</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">24 </TD>

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">- </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   무형자산손상차손</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN USERMARK="F-BT">589,964 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   파생상품평가이익</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>(233,424)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   리스상환이익</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(930)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   잡이익</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(2,401)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   이자수익</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(255,537)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(519,972)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   이자비용</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,012,937 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,214,409 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT">   법인세비용(이익)</SPAN>
</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,215 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">3.운전자본의조정</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(3,467,021)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,596,602 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   매출채권</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(482,922)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">990,905 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   기타채권</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(103,827)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">4,029 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   계약자산</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">28,058 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(32,688)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   기타유동자산</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(14,636)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(3,306)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   재고자산</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(2,964,106)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(317,034)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   매입채무</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(305,188)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">415,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   기타채무</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">99,683 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,076 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   계약부채</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">392,015 </TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">569,611 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   기타유동부채</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(22,944)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">33,722 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">   퇴직금의지급</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(93,155)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(66,213)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="281" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">4.영업횔동으로부터 창출된 현금흐름</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(5,044,560)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(4,238,560)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>

<P USERMARK="F-11">
<SPAN>32-3 </SPAN>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN> 및 </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>전기</SPAN>
<SPAN> 중 현금의 유입과 유출이 없는 중요한 거래는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="667">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="356"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT"></TD>
<TD WIDTH="365" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="667">

<COLGROUP>
<COL WIDTH="428"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="437" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당   기</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">
<SPAN>건설중인자산에서 </SPAN>
<SPAN></SPAN>
<SPAN>유ㆍ무형자산으로 대체</SPAN>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0XEEAE00">
<SPAN USERMARK=" 0X000000">12,649</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>29,346</SPAN>
<SPAN> </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">선급급에서 무형자산으로 대체</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0XEEAE00">
<SPAN USERMARK=" 0X000000">13,605</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">
<SPAN>유ㆍ무형자산 취득 관련</SPAN>
<SPAN> 미지급금 증가</SPAN>
</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">91,672 </TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>84,747</SPAN>
<SPAN> </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">회계정책변경에 따른 사용권자산 증가</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>16,333 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">파생상품부채에서 전환권대가로 대체</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN> </SPAN>
<SPAN>602,820</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT">임차보증금에서 사용권자산으로 대체</SPAN>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0XEEAE00">
<SPAN USERMARK=" 0X000000">13,570</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT">임차보증금의 유동성 대체</SPAN>
</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">49,968 </TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">토지·건물의 투자부동산 대체</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0XEEAE00">
<SPAN USERMARK=" 0X000000">527,382</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">건물 감가상각누계액의 투자부동산 감가상각누계액으로 대체</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0XEEAE00">
<SPAN USERMARK=" 0X000000">53,352</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-BT">건설중인자산에서 선급금으로 대체</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0XEEAE00">
<SPAN USERMARK=" 0X000000">487,136</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT">보험수리적 평가에 따른 확정급여채무 </SPAN>
<SPAN USERMARK="F-BT">증가</SPAN>
</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN USERMARK="F-BT">285,741 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="437" VALIGN="MIDDLE" HEIGHT="30">
<SPAN USERMARK="F-BT">보험수리적 평가에 따른 확정급여채무 </SPAN>
<SPAN USERMARK="F-BT">감소</SPAN>
</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">112,767 </TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN USERMARK="F-BT">- </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-11">32-4 당기 및</SPAN>
<SPAN USERMARK="F-11"> 전기 중 재무활동에서 생기는 부채의 변동 상세내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-11">&cr;<당   기></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="757">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="446"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT"></TD>
<TD WIDTH="455" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="758" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH ROWSPAN="2" WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">당기초</P>
</TH>

<TH ROWSPAN="2" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">현금흐름</P>
</TH>

<TH COLSPAN="3" WIDTH="306" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">비현금거래</P>
</TH>

<TH ROWSPAN="2" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">

<P USERMARK="F-BT">
<SPAN>당기</SPAN>
<SPAN>말</SPAN>
</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">발    행</P>
</TH>
<TH WIDTH="102" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">상   각</TH>

<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">공정가치변동</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" USERMARK="F-BT">임대보증금</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">30,000 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">30,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" USERMARK="F-BT">전환사채</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,000,000 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" USERMARK="F-BT">사채상환할증금</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">547,488 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">547,488 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" USERMARK="F-BT">사채할인발행차금</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(1,161,562)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,012,937 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(148,625)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">17,385,926 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">30,000 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN></SPAN>
<SPAN>1,012,937 </SPAN>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,428,863 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-11"><전   기></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="961">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="650"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-BT"></TD>
<TD WIDTH="659" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="962" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">구   분</P>
</TH>

<TH ROWSPAN="2" WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">전기초</P>
</TH>

<TH ROWSPAN="2" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P USERMARK="F-BT">현금흐름</P>
</TH>

<TH COLSPAN="5" WIDTH="510" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">비현금거래</P>
</TH>

<TH ROWSPAN="2" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">

<P USERMARK="F-BT">
<SPAN>전기</SPAN>
<SPAN>말</SPAN>
</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">발    행</P>
</TH>
<TH WIDTH="102" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">상   각</TH>

<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P USERMARK="F-BT">공정가치변동</P>
</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">추정변경</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-BT">재분류(*)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" USERMARK="F-BT">전환사채</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,000,000 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" USERMARK="F-BT">사채상환할증금</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">921,708 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>(374,220)</SPAN>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">547,488 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" USERMARK="F-BT">사채할인발행차금</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(2,750,191)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,214,409 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>374,220 </SPAN>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(1,161,562)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" USERMARK="F-BT">파생상품부채(*)</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">836,244 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(233,424)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(602,820)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">합   계</P>
</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">17,007,761 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>1,214,409 </SPAN>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(233,424)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">- </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(602,820)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">17,385,926 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11">(*) 전기말 현재 전환사채에 내재된 전환권이 자본요건을 충족하게 되어 자본항목으로 재분류되었습니다.&cr;&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11 B">3</SPAN>
<SPAN USERMARK="F-11 B">3</SPAN>
<SPAN USERMARK="F-11 B">. 재무제표의 승인</SPAN>
<SPAN USERMARK="F-11">&cr;&cr;</SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11">재무제표는 </SPAN>
<SPAN USERMARK="F-11">2021년 03월 29일</SPAN>
<SPAN USERMARK="F-11">에 개최될 정기주주총회에서 확정될 예정입니다.</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
</P>
<P></P>
</SECTION-2>
</LIBRARY>
</INSERTION>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 기타 재무에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 재무제표 재작성 등 유의사항&cr;</SPAN>
<SPAN>&cr;(1) 당사는 본 보고서 작성기준일 현재 재무제표를 재작성한 사항이 없습니다.</SPAN>
</P>
<P>(2) 당사는 최근 3사업연도 중 합병, 분할, 자산양수도, 영업양수도 사항이 없습니다.</P>

<P>
<SPAN>(3) 당사는 최근 3사업연도 중 자산유동화와 관련한 자산매각의 회계처리 및 우발채무 </SPAN>
<SPAN>등에 관한 사항이 없습니다.   &cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">나. 대손충당금 설정현황&cr;</SPAN>
<SPAN>&cr;(1) 계정과목별 대손충당금 설정내역                                      (단위 : 천원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="549" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT" VALIGN="MIDDLE">구 분</TD>
<TD WIDTH="102" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT" VALIGN="MIDDLE">계정과목</TD>
<TD WIDTH="107" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT" VALIGN="MIDDLE">채권 총액</TD>
<TD WIDTH="107" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT" VALIGN="MIDDLE">대손충당금</TD>
<TD WIDTH="118" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">대손충당금&cr;설정률</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<SPAN USERMARK="F-BT">제11기</SPAN>
<SPAN USERMARK="F-BT">&cr;(2020년</SPAN>
<SPAN USERMARK="F-BT">)</SPAN>
</TD>
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">매출채권</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">535,336</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">대여금</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">180,167</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(117,167)</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">65.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">미수금</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">148,930</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">864,433</TD>

<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>(117,167)</SPAN>
</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">13.6%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<SPAN USERMARK="F-BT">제10기&cr;(2019년</SPAN>
<SPAN USERMARK="F-BT">)</SPAN>
</TD>
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">매출채권</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">55,880</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">대여금</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">180,167</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(117,167)</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">65.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">미수금</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">45,103</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">281,150</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(117,167)</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">41.7%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120" USERMARK="F-BT">
<SPAN>제9기 &cr;(2018년</SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">매출채권</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,046,785</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">대여금</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">167,167</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(117,167)</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">70.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">미수금</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">49,345</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" USERMARK="F-BT" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,263,297</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(117,167)</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">9.3%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 대손충당금 변동현황                                                         (단위 : 천원)</P>

<TABLE BORDER="1" WIDTH="550" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="228"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">구     분</TD>

<TD WIDTH="107" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">
<SPAN>제11기</SPAN>
<SPAN>&cr;(2020년)</SPAN>
</TD>
<TD WIDTH="102" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">제10기 &cr;(2019년)</TD>
<TD WIDTH="104" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">제9기&cr;(2018년)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30" USERMARK="F-BT">1. 기초 대손충당금 잔액합계</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30" USERMARK="F-BT">2. 순대손처리액(①－②±③)</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30" USERMARK="F-BT">① 대손처리액(상각채권액)</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30" USERMARK="F-BT">② 상각채권회수액</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30" USERMARK="F-BT">③ 기타증감액</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30" USERMARK="F-BT">3. 대손상각비 계상(환입)액</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30" USERMARK="F-BT">4. 기말 대손충당금 잔액합계</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">117,167 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>3) 매출채권관련 대손충당금 설정방침&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN> </SPAN>
<SPAN>당사의 대손충당금 설정은 </SPAN>
<SPAN> </SPAN>
<SPAN>매출채권 전체기간 기대신용손실에 해당하는 금액을 손실충당금으로 측정하고 최초인식시점에 신용이 손상된 금융자산은 </SPAN>
<SPAN>최초 인식 후 전체기간 기대신용손실</SPAN>
<SPAN>의 누적변동분만을 손실충당금으로 계상합니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(4) 당해 경과기간별 매출채권 잔액 현황                                    (단위 : 천원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">구분</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">6월이하</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">6개월 초과&cr;1년이하</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">1년 초과&cr;3년 이하</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">3년 초과</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">금  액</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">535,336</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>

<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>535,336</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구성비율</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">100.0%</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="98" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">100.0%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK=" B">다. 재고자산의 현황&cr;&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>(1) 재고자산의 보유현황                                                           (단위 : 천원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="617" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="59"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">사업부문</TD>

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">계정과목</P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">제11기</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">제10기</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">제9기</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P USERMARK="F-BT">비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120" USERMARK="F-BT">제    조</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">제품</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">323,524</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">원부재료</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">800,614</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">225,573</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">417,225</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">재공품</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,639,749</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">574,208</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">65,522</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합 계</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,763,887</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">799,781</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">482,747</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="331" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">총자산대비 재고자산 구성비율(%)</P>
<P USERMARK="F-BT">[재고자산합계÷기말자산총계×100]</P>
</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">10.37%</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">2.05%</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">1.06%</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="331" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P USERMARK="F-BT">재고자산회전율(회수)</P>
<P USERMARK="F-BT">[연환산 매출원가÷{(기초재고+기말재고)÷2}]</P>
</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">2.11회</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">7.76회</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">20.32회</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK="F-BT">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>2) 재고자산의 실사현황&cr;</SPAN>
<SPAN></SPAN>
<SPAN>1) 재고실사일 &cr;   </SPAN>
<SPAN>- 자체재고조사 : 1분</SPAN>
<SPAN>기: </SPAN>
<SPAN> 2020. 4. 1 ~  4. 3</SPAN>
<SPAN>, </SPAN>
<SPAN> 2분기 : 2020.  7. 1 ~  7. 3&cr;                            3분기:  2020. 9.25 ~ 9.30,  4분기 : 2020. 12.28 ~ 2021. 1. 4&cr;   - 회계사 입회 재고조사 : 2021. 1. 18&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>2) </SPAN>
<SPAN>당사는 매분기별로 자체 재고실사를 진행하고 있습</SPAN>
<SPAN>니다.&cr;3) 재고실사내용 :제품,원부재료등&cr;</SPAN>
<SPAN>4) 실사 방법 : </SPAN>
<SPAN>재고실사기준일(</SPAN>
<SPAN>2020. 12. 31</SPAN>
<SPAN>) </SPAN>
<SPAN>장부상 재</SPAN>
<SPAN>고 수량과 실지재고수량을 &cr;                    확인하였으며, 중요한 차이가 발생되지 않았습니다.</SPAN>
</P>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(3) 장기체화재고등 현황&cr;재고자산의 시가가 취득원가보다 하락한 경우에는 시가를 재무상태표가액으로 하고 있으며, 재고자산에 대한 평가내역은 다음과 같습니다.&cr; </SPAN>
</P>

<P>
<SPAN>                                                                                  (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="616">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">계정과목</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">취득원가</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">보유금액</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">당기평가손실</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">기말잔액</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">제품</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">323,524</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">323,524</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">323,524</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT 0X0000FF">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">원부재료</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">800,614</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">800,614</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">800,614</TD>
<TD WIDTH="107" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT 0X0000FF" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">재공품</TD>

<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">2,639,749</SPAN>
</TD>

<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">2,639,749</SPAN>
</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>

<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">2,639,749</SPAN>
</TD>
<TD WIDTH="107" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT 0X0000FF" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>

<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">3,763,887</SPAN>
</TD>

<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK=" 0X000000">3,763,887</SPAN>
</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>

<TD WIDTH="107" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">
<SPAN>3,763,887</SPAN>
</TD>
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-BT 0X0000FF">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(4) 재고자산의 담보제공&cr;당사는 보고서 기준일 현재 재고자산을 담보로 제공한 사실이 없습니다.&cr;&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">라. 공정가치평가 내역</SPAN>
</P>
<P></P>
<P>당사는 매도가능금융자산 등과 같은 금융상품을 보고기간말 현재의 공정가치로 평가하고 있습니다. 공정가치로 측정되거나 공정가치가 공시되는 금융상품과 비금융상품의 공정가치에 대한 공시는 다음의 주석에 설명되어 있습니다.&cr;</P>
<P>공정가치는 측정일에 시장참여자 사이의 정상거래에서 자산을 매도하면서 수취하거나 부채를 이전하면서 지급하게 될 가격입니다. 공정가치측정은 자산을 매도하거나 부채를 이전하는 거래가 다음 중 어느 하나의 시장에서 이루어지는 것으로 가정하고 있습니다.&cr;</P>
<P>- 자산이나 부채의 주된 시장</P>
<P>- 자산이나 부채의 주된 시장이 없는 경우에는 가장 유리한 시장&cr;</P>
<P>당사는 주된 (또는 가장 유리한) 시장에 접근할 수 있어야 합니다.</P>
<P>&cr;자산이나 부채의 공정가치는 시장참여자가 경제적으로 최선의 행동을 한다는 가정하에 시장참여자가 자산이나 부채의 가격을 결정할 때 사용하는 가정에 근거하여 측정하고 있습니다.</P>
<P></P>
<P>비금융자산의 공정가치를 측정하는 경우에는 시장참여자가 경제적 효익을 창출하기 위하여 그 자산을 최고 최선으로 사용하거나 혹은 최고 최선으로 사용할 다른 시장참여자에게 그 자산을 매도하는 시장참여자의 능력을 고려하고 있습니다.&cr;</P>
<P>당사는 상황에 적합하며 관련된 관측가능한 투입변수의 사용을 최대화하고 관측가능하지 않은 투입변수의 사용을 최소화하면서 공정가치를 측정하는 데 충분한 자료가 이용가능한가치평가기법을 사용하고 있습니다.&cr;</P>
<P>재무제표에서 공정가치로 측정되거나 공시되는 모든 자산과 부채는 공정가치 측정에 유의적인 가장 낮은 수준의 투입변수에 근거하여 다음과 같은 공정가치 서열체계로 구분됩니다.&cr;</P>
<P>수준 1 - 동일한 자산이나 부채에 대한 접근가능한 활성시장의 (조정되지 않은) 공시가격</P>
<P>수준 2 - 공정가치측정에 유의적인 가장 낮은 수준의 투입변수가 직접적으로 또는 간접적으로 관측가능한 투입변수를 이용한 공정가치</P>
<P>수준 3 - 공정가치측정에 유의적인 가장 낮은 수준의 투입변수가 관측가능하지 않은 투입변수를 이용한 공정가치</P>
<P>  </P>
<P>재무제표에 반복적으로 공정가치로 측정되는 자산과 부채에 대하여 당사는 매 보고기간 말 공정가치측정에 유의적인 가장 낮은 수준의 투입변수에 기초한 분류에 대한 재평가를 통해 서열체계의 수준 간의 이동이 있는지 판단합니다.</P>
<P>&cr;공정가치 공시 목적상 당사는 성격과 특성 및 위험에 근거하여 자산과 부채의 분류를 결정하고 공정가치 서열체계의 수준을 결정하고 있습니다.</P>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>당기</SPAN>
<SPAN>말과 전기말 현재 금융상품의 장부금액과 공정가치는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="599">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="288"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT"></TD>
<TD WIDTH="297" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM" USERMARK="F-BT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="52"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="60" COLSPAN="2" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>

<TH USERMARK="F-BT" WIDTH="198" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN USERMARK="F-GL">당기</SPAN>
<SPAN USERMARK="F-GL">말</SPAN>
</TH>
<TH WIDTH="196" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" HEIGHT="30" COLSPAN="6">금융자산:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="61" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">유동</TD>
<TD WIDTH="146" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">8,139,296 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">8,139,296 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">4,363,335 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">4,363,335 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30">매출채권및기타채권</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">684,265 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">684,265 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">100,983 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">100,983 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30">기타유동금융자산</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">10,640,908 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">10,640,908 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">20,161,200 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">20,161,200 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="61" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비유동</TD>
<TD WIDTH="146" HEIGHT="30">기타비유동금융자산</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">206,988 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">206,988 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">295,157 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">295,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">금융자산 합계</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">19,671,458 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">19,671,458 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">24,920,675 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">24,920,675 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" HEIGHT="30" COLSPAN="6">금융부채:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="61" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">유동</TD>
<TD WIDTH="146" HEIGHT="30">매입채무및기타채무</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">679,716 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">679,716 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">878,296 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">878,296 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30">전환사채</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">18,398,863 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">18,398,863 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">17,385,926 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">17,385,926 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="61" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비유동</TD>
<TD WIDTH="146" HEIGHT="30">기타비유동금융부채</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">77,306 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">77,306 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">금융부채 합계</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">19,155,886 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">19,155,886 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">18,264,222 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">18,264,222 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>

<INSERTION ABASISNUMBER="SE2" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『진행률적용 수주계약 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*진행률적용수주계약현황*.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="747" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="445"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="454" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="3">(단위 : 백만원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="984" BORDER="1">

<COLGROUP>
<COL WIDTH="182"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="191" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="72" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급&cr;(평가기관)</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환&cr;여부</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="191" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_CMPY">(주)팬젠&cr;제2회무기명사모전환사채</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_STC" AUNITVALUE="2">사모</TU>
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_DAT" AUNITVALUE="20180221">2018.02.21</TU>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_MON">18,000</TE>
<TE WIDTH="72" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_RATE">표면 0%&cr;만기 1%</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_LAS" AUNITVALUE="20230221">2023.02.21</TU>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_REC">미상환</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="191" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">18,000</TE>
<TE WIDTH="72" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『사채관리계약 주요내용 및 충족여부 등』 삽입</COMMENT>
<LIBRARYLIST>11011#*사채관리계약주요내용.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과&cr;20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>
<P>&cr;</P>

<P>
<SPAN USERMARK=" 0XFF1200">1. 예측정보에 대한 주의사항&cr;</SPAN>
<SPAN>&cr;- 당사가 동 사업보고서에서 미래에 발생할 것으로 예측되는 경영활동 및 사건, 현상 등은 당해 공시서류 작성시점의 재무성과 등에 대하여 회사의 견해를 반영한 것입니다. 동 예측정보는 미래 경영환경과 관련된 다양한 가정에 기초하고 있으며, 동 예측정보는 결과적으로 부정확한 것으로 판명될 수 있습니다. 또한 이러한 가정들에는 예측정보에서 기재한 예상치와 실제 결과 간에 중요한 차이를 초래할 수 있는 위험, 불확실성 등을 포함하고 있습니다. 이러한 중요한 차이를 초래할 수 있는 요인에는 회사 내부경영과 관련된 요인과 외부환경에 관한 요인이 포함되어 있으며 이에 한하지 않습니다. 당사는 동 예측정보작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다. 따라서 동 보고서에 기재된 예측정보는 동 보고서를 작성하는 시점을 기준으로 작성한 것이며, 회사가 이러한 위험요인이나 예측정보를 추가적으로 업데이트 할 계획이 없음을 유의하시기 바랍니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200">2. 개요&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;- </SPAN>
<SPAN>당사는 2010년 1월 29일에 분할 설립된 이후  바이오의약품 생산용 GMP시설과, 당사의 원천기술인 PanGen CHO-TECH</SPAN>
<SPAN>™ </SPAN>
<SPAN>기술, 바이오의약품 제품화 기술을 활용하여 바이오시밀러 EPO의약품 생산 및 판매, 바이오의약품 개발 사업, 바이오의약품(전임상,임상시료포함) 위탁생산(CMO) 및  개발기술 이전서비스</SPAN>
<SPAN>(CDO)</SPAN>
<SPAN> 사업을 수행하고 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> - 바이오시밀러 의약품  생산  및 판매사업 :&cr;   · EPO의약품(만성 신부전 환자의 빈혈치료제)&cr;&cr; - 바</SPAN>
<SPAN>이오 의약품 개발사업 :&cr;   ·혈우병A치료제 Factor VIII&cr;  </SPAN>
<SPAN> </SPAN>
<SPAN>·항암치료보조제 G-CSF</SPAN>
<SPAN>&cr;   </SPAN>
<SPAN>·황반변성,황반부종등 치료제 Aflibercept</SPAN>
<SPAN>&cr;   </SPAN>
<SPAN>·중증열성 혈소판 감소 증후군 치료제  항SFTS</SPAN>
<SPAN>V항체&cr;&cr;</SPAN>
<SPAN> - 바이오 의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산</SPAN>
<SPAN></SPAN>
<SPAN>(CMO) 및 개발 기술 이전 서비스&cr;   사업(CDO) :&cr;  · CDMO</SPAN>
<SPAN>(Contract Development and Manufacturing Organization)&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>자체 개발에 성공한 만성 신부전 환자의 빈혈 치료제인 바이오시밀러 EPO의약품은 </SPAN>
<SPAN>2019년 1월에 말레이시아 식약청으로부터 </SPAN>
<SPAN>제품명 Erysaa로</SPAN>
<SPAN></SPAN>
<SPAN> 품목허가를 받아  2019년 3월부터 말레이시아 시장에 판매중에 있으며</SPAN>
<SPAN>,</SPAN>
<SPAN> </SPAN>
<SPAN> </SPAN>
<SPAN>한국은</SPAN>
<SPAN> </SPAN>
<SPAN>2019년 11월에 제품명 팬포틴으로 품목허가를 받</SPAN>
<SPAN>아  </SPAN>
<SPAN></SPAN>
<SPAN>2020년 2월부터 국내 판매를 시작 하였습니다&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>개발중인 바이오의약품 제품에는</SPAN>
<SPAN>  혈우병A 치료제인</SPAN>
<SPAN> FactorVIII(</SPAN>
<SPAN>임상1상 완료)</SPAN>
<SPAN>, </SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>황반변성,황반부종등</SPAN>
<SPAN> 치료제인 바이오시밀러 </SPAN>
<SPAN>Aflibercept(</SPAN>
<SPAN>전임상완료)</SPAN>
<SPAN>, 항암치료 보조제인 바이오시밀러 G-CSF (전임상 완료), </SPAN>
<SPAN>중증열성혈소판감소증후군치료제</SPAN>
<SPAN>인 항SFTSV항</SPAN>
<SPAN>체(</SPAN>
<SPAN>생산세포주 및 공정기술 개발완료)</SPAN>
<SPAN>등이 있으며 </SPAN>
<SPAN>순차적으로 제품개발 중에 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>바이오의약품</SPAN>
<SPAN>(전임상,임상시료포함)</SPAN>
<SPAN> 위탁생산 및 바이오의약품 개발 기술 이전 서비스는 생산용 세포주 및 생산 공정 기술 이전 서비스(CDO)와 위</SPAN>
<SPAN>탁생산</SPAN>
<SPAN>서비스(</SPAN>
<SPAN>(</SPAN>
<SPAN>CMO)</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>등으로 설립 이후부터</SPAN>
<SPAN> </SPAN>
<SPAN>현재까지 항체 치료제 12종을 포함한 바이오의약품 생산용 세포주를 41종 구축하였고 </SPAN>
<SPAN>수십건의 항체치료제 및 단백질 치료제 기술이전</SPAN>
<SPAN>과  </SPAN>
<SPAN>위탁생산(CM</SPAN>
<SPAN>O)</SPAN>
<SPAN>사업을 </SPAN>
<SPAN>성공적으로 수행하였습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="987">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="207"></COL>
<COL WIDTH="246"></COL>
<COL WIDTH="244"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="263" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>사업부분</P>
</TH>

<TH WIDTH="216" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>해당기술</P>
</TH>

<TH WIDTH="255" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요(개발)제품 및 서비스</P>
</TH>
<TH WIDTH="253" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">진행사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">바이오시밀러의약품생산및판매</TD>

<TD WIDTH="216" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">
<P>PanGen CHO-TECH™기술 및</P>

<P>
<SPAN>바이오의약품,</SPAN>
<SPAN>제품화 기술</SPAN>
<SPAN>등</SPAN>
</P>
</TD>

<TD WIDTH="255" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">
<P>바이오시밀러 EPO</P>
<P>(만성 신부전 환자의 빈혈치료제)</P>
</TD>

<TD WIDTH="253" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">

<P>
<SPAN>자</SPAN>
<SPAN>체제</SPAN>
<SPAN>품개</SPAN>
<SPAN>발성공&cr;한</SPAN>
<SPAN>국,말레이시아 제품판매중</SPAN>
<SPAN>&cr;필리핀,베트남,태국,사우디아라비아</SPAN>
<SPAN> </SPAN>
<SPAN>품목허가신청</SPAN>
<SPAN></SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="263" HEIGHT="258" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>바이오의약품</P>

<P>
<SPAN></SPAN>
<SPAN>개발사업등</SPAN>
</P>
</TD>

<TD WIDTH="216" HEIGHT="258" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>PanGen CHO-TECH™기술 및</P>

<P>
<SPAN>바이오의약품,</SPAN>
<SPAN>제품화 기술</SPAN>
<SPAN>등</SPAN>
</P>
</TD>

<TD WIDTH="255" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">
<P>재조합 Factor VIII</P>
<P>(혈우병A 치료제) </P>
</TD>

<TD WIDTH="253" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">

<P>
<SPAN>전임상완료(17년 7월)&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>한국 IND제출 (18년10월)&cr;한국임상1상 시험승인(19년 3월)&cr;</SPAN>
<SPAN></SPAN>
<SPAN>한국 임상1상 완료</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>바이오시밀러 G-CSF</P>
<P>(항암치료 보조제)</P>
</TD>
<TD WIDTH="253" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전임상 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="255" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>바이오시밀러 </SPAN>
<SPAN> </SPAN>
<SPAN>Aflibercept</SPAN>
<SPAN>&cr;(황반변성,황반부종등 치료제)</SPAN>
</TD>
<TD WIDTH="253" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전임상 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="255" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">항SFTSV항체&cr;(중증열성혈소판감소증후군치료제)</TD>
<TD WIDTH="253" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">생산세포주 및 공정기술개발완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="263" HEIGHT="106" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>바이오의약품 위탁생산 및 개발 기술</P>

<P>
<SPAN>이전 서비스(CDMO)</SPAN>
</P>
</TD>

<TD WIDTH="216" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>PanGen CHO-TECH™기술</P>
</TD>

<TD WIDTH="255" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>생산용세포주 및 </P>

<P>
<SPAN>생산공정 기술이전 서비스&cr;</SPAN>
<SPAN>(CDO)</SPAN>
</P>
</TD>

<TD WIDTH="253" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>사업화</P>
<P>(기술이전)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>바이오의약품 제품화 기술</P>
</TD>

<TD WIDTH="255" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위탁생산서비스(CMO)</P>
</TD>

<TD WIDTH="253" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>사업화</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200">3. 재무상태 및 영업실적&cr;</SPAN>
<SPAN>&cr;가. 재무상태&cr;                                                                                                (단위:백만원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="599" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">과     목</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제11기&cr;(2020년)</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제10기&cr;(2019년)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">증감</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">증감율</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">유동자산</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">24,092</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">25,607</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-1,515</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-5.92%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비유동자산</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">12,217</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">13,475</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-1,258</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-9.34%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자 산 총 계</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">36,309</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">39,082</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-2,773</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-7.10%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">유동부채</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">20,091</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">18,907</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,184</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">6.26%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비유동부채</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,007</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,749</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">258</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">14.75%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">부 채 총 계</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">22,098</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">20,656</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,442</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">6.98%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자본금</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,821</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,821</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">0</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">주식발행초과금</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">47,237</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">47,237</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">0</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기타자본</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">833</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">804</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">29</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3.61%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">이월결손금</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">38,680</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">34,436</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,244</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">12.32%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자본 총계</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">14,211</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">18,426</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-4,215</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-22.88%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">부채와 자본총계</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">36,309</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">39,082</TD>
<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-2,773</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-7.10%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF">&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN>- 2020년말 자산총계는 363억원으로 2019년말  대비 약 7.1% 감소하고  부채총계는 2020년말  약 221억원으로 2019년말 대비 약 7% 증가하였습니다.   또한 2020년말 자본총계는 142억원으로 2019년 말 대비 약 23% 감소하였습니다.  2020년말 자산  총계중 현금,예금자산은 186억원이며 자산총계의 51%를 차지하고 있습니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>
<P>나. 영업실적&cr;                                                                                                (단위:백만원)</P>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="85"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">과목</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제11기&cr;(2020년)</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제10기&cr;(2019년)</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">증감</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">증감율</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">매출액</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">6,191</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">2,881</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">3,310</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">114.89%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">매출원가</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">4,818</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">4,978</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">-160</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">-3.21%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">매출총이익</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">1,373</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-2,097</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">3,470</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">흑자전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">판매비와 일반관리비</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">5,073</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">5,881</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">-808</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">-13.74%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(연구개발비)</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">3,675</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">4,523</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">-848</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">-18.75%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">영업이익</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">-3,700</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-7,978</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">4,278</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">53.62%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">법인세비용차감전순이익</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">-4,356</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-8,934</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">4,578</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">51.24%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">당기순이익</TD>
<TD WIDTH="104" ALIGN="RIGHT" HEIGHT="30">-4,356</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-8,938</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">4,582</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">51.26%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF">&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>*품목별 매출 내역&cr;                                                                                                 (단위:백만원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="167"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>품 목</P>
</TD>
<TD COLSPAN="2" WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매  출  액</TD>
<TD ROWSPAN="2" WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">증감</TD>
<TD ROWSPAN="2" WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">증감율</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020년</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">EPO</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,548</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">810</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,738</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">338.02%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">기술이전(CDO)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="37">1,163</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="37">956</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="37">207</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="37">21.65%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">위탁생산(CMO)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">899</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">863</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.17%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">로열티</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">450</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">365</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">429.41%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-33</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-20.12%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">상품</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-3</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-100.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,191</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,881</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,310</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">114.89%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>- 2020년 매출증가(전년대비 약 115%증가)로 매출총이익은 2019년 적자에서 흑자로 전환 하였고 특히 EPO 제품 매출이 전년대비 338% 증가 하였습니다.  2019년 판매비와 일반관리비는 약 51억원으로 전년대비 약  8억원 감소 하였습니다</SPAN>
<SPAN>. </SPAN>
<SPAN>매출증가 및 판매비와일반관리비 감소로 인하여 2020년 영업손실은 전년대비 약 54억원 감소한 37억원이며 당기순손실은 전년대비 약 51% 감소한  약 44억원이 발생하였습니다&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>매출증가의 주 원인은 EPO부분의 매출로  2019년대비 약 27억원 증가하였으며, 2019년 3월 부터 판매를 시작한 말레이시아 시장에서 2020년 EPO 매출이 큰 폭으로 증가 하였고 또한  2020년 2월에는 국내 시장에 신규로 EPO판매를 시작하였습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>EPO 제</SPAN>
<SPAN>품</SPAN>
<SPAN>은 2017년 3월에 말레이시아 식약청에 NDA를 신청하여</SPAN>
<SPAN> 2019년 1월에 </SPAN>
<SPAN>말레이시아 식약청으로부터 </SPAN>
<SPAN>품목허가(제품명:ERYSAA)를 받아 말레이시아 시장에 판매중에 있으며</SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>한국은</SPAN>
<SPAN> 2018년 5월에 한</SPAN>
<SPAN>국 식약처에 NDA(품목허가)</SPAN>
<SPAN>제출하여 </SPAN>
<SPAN></SPAN>
<SPAN> 2019년 11월에 품목허가(제품명:팬포틴)를 받았</SPAN>
<SPAN>고  2020년 2월에 판매를 시작하였습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>EPO 판매시장 확대를 위해 2020년에  필리핀, 베트남, 태국, 사우디아라비아등에  품목허가 신청서(NDA)를 제출 하였으며 해당 시장에 2021~2022년중에 신규 진출을 준비중에 있습니다.  &cr;</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>다. 개발비 손상차손&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>당사가 </SPAN>
<SPAN>자체 개발한 바이오시밀러</SPAN>
<SPAN> </SPAN>
<SPAN>EPO 의약품</SPAN>
<SPAN> 개발</SPAN>
<SPAN> 프로젝트는 전임상, 임상1상, 임상3상 후 식약처에 품목허가(NDA)를 득한 후 제품 판매를 시작하게 됩니다. 당사는 EPO개발을 위하여 </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>말</SPAN>
<SPAN>레이시아 국영제약사인 DUOPHARMA BIOTECH BERHAD의 자회사인 </SPAN>
<SPAN>DUOPHAR</SPAN>
<SPAN>MA SDN BERHA</SPAN>
<SPAN>D</SPAN>
<SPAN></SPAN>
<SPAN>와</SPAN>
<SPAN> </SPAN>
<SPAN>공동으로 한국과 말레이시아에서 임상시험을 진행하였는 바, 보고기간말 현재</SPAN>
<SPAN> </SPAN>
<SPAN>말레이시아 식약청(NPRA)과 한국식약처로부터 품목허가</SPAN>
<SPAN>(NDA)</SPAN>
<SPAN>를 승인</SPAN>
<SPAN>받았</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>으</SPAN>
<SPAN>며</SPAN>
<SPAN>, 한</SPAN>
<SPAN>국</SPAN>
<SPAN>과</SPAN>
<SPAN> 말</SPAN>
<SPAN>레</SPAN>
<SPAN>이</SPAN>
<SPAN>시</SPAN>
<SPAN>아 시장에 판매 중에 있습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>
<P>- 당기 중 개발비의 변동 내역은 다음과 같습니다.&cr;                                                                                                    (단위:천원)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="582">

<COLGROUP>
<COL WIDTH="82"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="52"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH USERMARK="F-BT" WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>구   분</SPAN>
</TH>
<TH USERMARK="F-BT" WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기   초</TH>
<TH USERMARK="F-BT" WIDTH="61" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증   가</TH>
<TH USERMARK="F-BT" WIDTH="74" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상   각</TH>
<TH USERMARK="F-BT" WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손상차손</TH>
<TH USERMARK="F-BT" WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH USERMARK="F-BT" WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">잔여상각기간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">세포주개발</TD>
<TD USERMARK="F-BT" WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13 </TD>
<TD USERMARK="F-BT" WIDTH="61" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="74" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13 </TD>
<TD USERMARK="F-BT" WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EPO개발</TD>

<TD USERMARK="F-BT" WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>5,899,545 </SPAN>
</TD>
<TD USERMARK="F-BT" WIDTH="61" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="74" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">655,505 </TD>
<TD USERMARK="F-BT" WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,244,039 </TD>
<TD USERMARK="F-BT" WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합   계</TD>
<TD USERMARK="F-BT" WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,899,557 </TD>
<TD USERMARK="F-BT" WIDTH="61" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>

<TD USERMARK="F-BT" WIDTH="74" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN></SPAN>
<SPAN>655,505 </SPAN>
</TD>
<TD USERMARK="F-BT" WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,244,052 </TD>
<TD USERMARK="F-BT" WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X0000FF">&cr;&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN> - </SPAN>
<SPAN>EPO 개발과 관련하여 </SPAN>
<SPAN>당기</SPAN>
<SPAN>까지 인식한 연구개발비 자산화 내역은 다음과 같습니다</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>                                                                                                        (단위:천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1104">

<COLGROUP>
<COL WIDTH="47"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="61"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="56" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분 류</TH>
<TH USERMARK="F-BT" WIDTH="71" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단 계</TH>
<TH USERMARK="F-BT" WIDTH="101" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH USERMARK="F-BT" WIDTH="54" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산명</TH>
<TH USERMARK="F-BT" WIDTH="494" HEIGHT="30" COLSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산화한 연구개발비 금액(누계액)</TH>
<TH USERMARK="F-BT" WIDTH="258" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연구개발비</TH>
<TH USERMARK="F-BT" WIDTH="70" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">잔여&cr;상각기간</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="83" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">前임상</TH>
<TH USERMARK="F-BT" WIDTH="83" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상1상</TH>
<TH USERMARK="F-BT" WIDTH="82" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상2상</TH>
<TH USERMARK="F-BT" WIDTH="82" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상3상</TH>
<TH USERMARK="F-BT" WIDTH="82" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">판매승인</TH>
<TH USERMARK="F-BT" WIDTH="82" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합 계</TH>
<TH USERMARK="F-BT" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>

<TH USERMARK="F-BT" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">

<P USERMARK="F-BT">
<SPAN>상각</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>누계액</SPAN>
<SPAN></SPAN>
</P>
</TH>

<TH USERMARK="F-BT" WIDTH="86" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT">손상차손</P>
<P USERMARK="F-BT">누계액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="56" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">개발비</TD>
<TD USERMARK="F-BT" WIDTH="71" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">개발완료</TD>
<TD USERMARK="F-BT" WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">바이오시밀러</TD>
<TD USERMARK="F-BT" WIDTH="54" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EPO</TD>
<TD USERMARK="F-BT" WIDTH="83" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD USERMARK="F-BT" WIDTH="83" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,210,177 </TD>
<TD USERMARK="F-BT" WIDTH="82" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>

<TD USERMARK="F-BT" WIDTH="82" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>7,263,843</SPAN>
<SPAN> </SPAN>
</TD>

<TD USERMARK="F-BT" WIDTH="82" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN></SPAN>
<SPAN>- </SPAN>
</TD>
<TD USERMARK="F-BT" WIDTH="82" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,474,020 </TD>
<TD USERMARK="F-BT" WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,244,039 </TD>
<TD USERMARK="F-BT" WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,376,561 </TD>

<TD USERMARK="F-BT" WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>1,853,419</SPAN>
<SPAN> </SPAN>
</TD>

<TD USERMARK="F-BT" WIDTH="70" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>8년</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;- </SPAN>
<SPAN></SPAN>
<SPAN>당기 중 인식한 개발비 손상차손 내역은 다음과 같습니다.&cr;                                                                                                       (단위:천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="682">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH USERMARK="F-BT" WIDTH="94" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>구   분</SPAN>
</TH>
<TH USERMARK="F-BT" WIDTH="111" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개발자산</TH>
<TH USERMARK="F-BT" WIDTH="110" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH USERMARK="F-BT" WIDTH="90" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액</TH>
<TH USERMARK="F-BT" WIDTH="179" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손상차손 금액</TH>
<TH USERMARK="F-BT" WIDTH="98" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회수가능액&cr;평가방법</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-BT" WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당   기</TH>
<TH USERMARK="F-BT" WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">누계액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT" WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">개발비</TD>
<TD USERMARK="F-BT" WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EPO개발</TD>
<TD USERMARK="F-BT" WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,244,039 </TD>
<TD USERMARK="F-BT" WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,376,561 </TD>
<TD USERMARK="F-BT" WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>

<TD USERMARK="F-BT" WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN> </SPAN>
<SPAN>1,853,419 </SPAN>
</TD>
<TD USERMARK="F-BT" WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">사용가치</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"> </SPAN>
<SPAN></SPAN>
<SPAN>EPO개발비 손상검사와 관련하여 회수가능금액을 사용가치로 측정하여 EPO개발비와 관련 있는 자산과 부채의 장부금액을 비교하여 결정 하였습니다.  사용가치 측정을 위한 미래현금흐름은 회사의 과거 영업성과와 미래 사업계획을 근거로 하여 향후 5개년를 추정하고, 이후의 현금흐름은 바이오 제약산업의 미래 불확실성을 고려하여 </SPAN>
<SPAN>0%의</SPAN>
<SPAN> 영구성장율을 적용하여 추정하였고 </SPAN>
<SPAN>사용가치 측정을 위한 할인율은 자산의 특유한 위험을 반영하여 조정한 가중평균자본비용인</SPAN>
<SPAN> </SPAN>
<SPAN>18.86%</SPAN>
<SPAN>로</SPAN>
<SPAN> 추정하였습니다</SPAN>
<SPAN>. 손</SPAN>
<SPAN>상</SPAN>
<SPAN>검사 결과 사용가치가 장부금액을</SPAN>
<SPAN> 초과하여 당기중 손상차손 인식은 없습니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>
<P>-당기와 전기 중 판매비와관리비에 포함하여 비용으로 인식한 연구개발비용은 다음과 같습니다.&cr;                                                                                                     (단위:천원)</P>

<TABLE BORDER="1" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">구   분</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">당기</TD>
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">FACTORⅧ 개발</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">442,713 </TD>
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">785,873 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">EPO 개발</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">84,213 </TD>
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">599,018 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">Aflibercept개발</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,296,536 </TD>
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,494,686 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">기타연구개발</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">2,443,822 </TD>
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,851,197 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">차감: 정부보조금</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">(591,716)</TD>
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(208,237)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합   계</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">3,675,570 </TD>
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,522,537 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200">4. 유동성 및 자금조달&cr;</SPAN>
<SPAN>&cr;가. 유동성에 관한 사항&cr;                                                                                                   (단위:백만원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT">구   분</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT">제11기&cr;(2020년)</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT">제10기&cr;(2019년)</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT">증  감</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" USERMARK="F-BT">유동자금</TD>
<TD WIDTH="131" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,639</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">24,363</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-5,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" USERMARK="F-BT">유동차입금(전환사채)</TD>
<TD WIDTH="131" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,399</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">17,386</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,013</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" USERMARK="F-BT">Net Cash(유동자금-차입금)</TD>
<TD WIDTH="131" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">240</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">6,977</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-6,737</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>당사는 2020년말 18,639백만원의 유동자금을 보유하고 있으며 2019년 대비 유동자금은 약 57억원 감소 하였습니다. 2020년 기준 유동자금은  자산총계의 51%에 해당하는 규모로  보유하고  있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" U"></SPAN>
<SPAN>나. 유동성관리지표&cr;당사는 유동성관리지표로 유동비율 및 부채비율을 이용하고 있습니다. 당사의 유동비율 및 부채비율의 추세는 아래와 같습니다. 전년대비 유동비율 감소 및 부채비율이증가하였습니다..&cr;</SPAN>
<SPAN>                                                                                                 (단위:백만원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">구   분</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">제11기&cr;(2020년)</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">제10기&cr;(2019년)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">증   감</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" USERMARK="F-BT">유동자산</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">24,092</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">25,607</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-1,515</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" USERMARK="F-BT">유동부채</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">20,091</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,907</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,184</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" USERMARK="F-BT">유동비율</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">119.91%</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">135.44%</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-15.53%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" USERMARK="F-BT">부채</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">22,098</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">20,656</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">1,442</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" USERMARK="F-BT">자본</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">14,211</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">18,426</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-4,215</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" USERMARK="F-BT">부채비율</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">155.50%</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">112.10%</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">43.40%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>다. 자금조달  &cr;                                                                                               (단위:백만원)</P>

<TABLE BORDER="1" WIDTH="595" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="185"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">구     분</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">제11기&cr;(2020년)</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK="F-BT">제10기&cr;(2019년)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" USERMARK="F-BT">자금조달</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">전환사채 발행</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">BW 행사</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">주식매수선택권행사</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">합      계</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF">&cr;</SPAN>
<SPAN></SPAN>
<SPAN>2</SPAN>
<SPAN>0</SPAN>
<SPAN>19~2020년 중에는 별도의 자금조달은 없었으며,  2018년 2월 21일에  바이오벤처 합작법인 설립과 제품생산을 위한 운영자금조달을 위해 전환사채 180억원을 조달하였 습니다. 전환사채 만기는 5년으로 2023년 2월 21이며  2019년 2월 21일을 시작으로 2022년 11월 21일까지 매 3개월마다 투자자가 조기상환 청구를 할 수 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200">5. 부외거래&cr;</SPAN>
<SPAN>부외거래에 관한 사항은 해당 없습니다.  "XI. 그 밖에 투자자 보호를 위하여 필요한 사항중  2. 우발채무 등" 을 참조하시기 바랍니다.&cr;</SPAN>
</P>
<P USERMARK=" 0XFF1200">6. 그 밖에 투자의사결정에 필요한 사항&cr;</P>

<P>
<SPAN>가. 중요한 회계정책 및 추정에 관한 사항&cr;당사의 중요한 회계정책 및 추정에 관한 사항은  "Ⅲ. 재무에 관한 사항중 5. 재무제    표 주석"을 참조하시기 바랍니다.&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF">&cr;</SPAN>
<SPAN>나. 환경 및 종업원 등에 관한 사항&cr;환경관련 제재사항이나 행정조치 등에 관한 사항은 "XI. 그밖에 투자자 보호를 위하여필요한 사항 중 3. 제재현황 등 그 밖의 사항" 을 참조하시기 바랍니다. 그리고 당기중 주요 핵심인력 이동사항 등 유의한 종업원 관련 변동사항은 없습니다.&cr;&cr;다. 법규상의 규제에 관한 사항&cr;당사의 사업과 관련된 법규상 주요 규제내용은 "XI. 그밖에 투자자 보호를 위하여 필요한 사항 중 3. 제재현황 등 그 밖의 사항" 을 참조하시기 바랍니다.&cr;&cr;라. 파생상품 및 위험관리정책에 관한 사항&cr;파생상품 및 위험관리정책에 관한 사항은  "Ⅲ. 재무에 관한 사항중 5. 재무제표 주석"을 참조하시기 바랍니다.&cr;</SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 감사인의 감사의견 등</TITLE>
<P></P>
<WARNING>※ 회계감사인의 감사(검토)의견, 회계감사인과의 감사/비감사 용역 체결현황이 있을 경우&cr;    아래 『회계감사인의 감사의견』단위서식을 클릭하여 삽입하신 후 입력하세요.</WARNING>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『회계감사인의 감사의견』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인의감사의견.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">25_회계감사인의감사의견</FILENAME>
<P USERMARK=" 0XFF1200 B">1. 회계감사인의 명칭 및 감사의견</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="184"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="193" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제11기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR1" VALIGN="MIDDLE">한울회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT1" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_EMP1" VALIGN="MIDDLE">해당사항없음</TE>
<TE WIDTH="193" HEIGHT="30" ACODE="OPN_POT1" VALIGN="MIDDLE">내부창출 개발비 손상평가</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제10기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR2" VALIGN="MIDDLE">한울회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT2" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_EMP2" VALIGN="MIDDLE">해당사항없음</TE>
<TE ALIGN="CENTER" WIDTH="193" HEIGHT="30" ACODE="OPN_POT2" VALIGN="MIDDLE">해당사항없음</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제9기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR3" VALIGN="MIDDLE">한울회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT3" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_EMP3" VALIGN="MIDDLE">해당사항없음</TE>
<TE ALIGN="CENTER" WIDTH="193" HEIGHT="30" ACODE="OPN_POT3" VALIGN="MIDDLE">해당사항없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" 0XFF1200 B">2. 감사용역 체결현황</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="681" BORDER="1">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="172" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">제11기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR1" VALIGN="MIDDLE">한울회계법인</TE>
<TE ALIGN="CENTER" WIDTH="172" HEIGHT="30" ACODE="SIGK_CNT1" VALIGN="MIDDLE">재무제표(K-IFRS) 감사</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">50,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">631</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">50,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">620</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">제10기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR2" VALIGN="MIDDLE">한울회계법인</TE>
<TE ALIGN="CENTER" WIDTH="172" HEIGHT="30" ACODE="SIGK_CNT2" VALIGN="MIDDLE">재무제표(K-IFRS) 감사</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">45,500,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">576</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">45,500,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">578</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">제09기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR3" VALIGN="MIDDLE">한울회계법인</TE>
<TE ALIGN="CENTER" WIDTH="172" HEIGHT="30" ACODE="SIGK_CNT3" VALIGN="MIDDLE">재무제표(K-IFRS) 감사</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">43,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">43,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">538</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" 0XFF1200 B">3. 회계감사인과의 비감사용역 계약체결 현황</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="632" BORDER="1">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGL_YEAR1" VALIGN="MIDDLE">제11기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">2020년 04월</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">법인세</TE>
<TE ALIGN="CENTER" WIDTH="140" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">2021.01.01~03.31</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">7,000,000</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">한울회계법인</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGL_YEAR2" VALIGN="MIDDLE">제10기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">2019년 02월</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">법인세</TE>
<TE ALIGN="CENTER" WIDTH="140" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">2020.01.01~03.31</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">6,500,000</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">한울회계법인</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGL_YEAR3" VALIGN="MIDDLE">제09기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">2018년 04월</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">법인세</TE>
<TE ALIGN="CENTER" WIDTH="140" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">2019.03.01~03.31</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">6,500,000</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">한울회계법인</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『내부감사기구가 회계감사인과 논의한 결과』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인과논의한결과.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">46_회계감사인과논의한결과</FILENAME>
<P USERMARK=" 0XFF1200 B">4. 재무제표 중 이해관계자의 판단에 상당한 영향을 미칠 수 있는 사항에 대해 내부감사기구가 회계감사인과 논의한 결과</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="730" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="257"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="266" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="201" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20200424" VALIGN="MIDDLE">2020.04.24</TU>
<TE ALIGN="CENTER" WIDTH="266" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측: 감사 및 재무담당임원 외 2명&cr;감사인측: 업무수행이사 외 2명</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="201" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">감사계획논의</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20200723" VALIGN="MIDDLE">2020.07.23</TU>
<TE ALIGN="CENTER" WIDTH="266" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측: 감사 및 재무담당임원 외 2명&cr;감사인측: 업무수행이사 외 2명</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="201" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">반기검토 결과</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="76" ACODE="DIS_DIV" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="DIS_DATE" AUNITVALUE="20201118" VALIGN="MIDDLE">2020.11.18</TU>
<TE ALIGN="CENTER" WIDTH="266" HEIGHT="76" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측: 감사 및 재무담당임원 외 1명&cr;감사인측: 업무수행이사 외 2명</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="201" HEIGHT="76" ACODE="DIS_CONT" VALIGN="MIDDLE">감사계획, 외부감사인의 독립성, 내부회계관리제도 검토결과, 핵심감사사항 결정</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="99" ACODE="DIS_DIV" VALIGN="MIDDLE">4</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="DIS_DATE" AUNITVALUE="20210205" VALIGN="MIDDLE">2021.02.05</TU>
<TE ALIGN="CENTER" WIDTH="266" HEIGHT="99" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측: 감사 및 재무담당임원 외 1명&cr;감사인측: 업무수행이사 외 2명</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="201" HEIGHT="99" ACODE="DIS_CONT" VALIGN="MIDDLE">회계감사 결과</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<P>
<SPAN USERMARK=" 0XFF1200 B">5. 내부통제에 관한 사항&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">회계감사인의 내부회계관리제도 검토의견</SPAN>
</P>

<TABLE BORDER="1" WIDTH="794" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="425"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사업연도</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">감사인</TD>
<TD WIDTH="434" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">회계감사인의 검토의견</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지적사항</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제11기(당기)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">한울회계법인</TD>
<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="99">경영자의 운영실태보고 내용이 중요성의 관점에서 내부회계관리제도 모범규준 제5장 '중소기업에 대한 적용'의 규정에 따라작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였습니다.</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">해당사항 없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제10기(전기)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">한울회계법인</TD>
<TD WIDTH="434" HEIGHT="99">경영자의 운영실태보고 내용이 중요성의 관점에서 내부회계관리제도 모범규준 제5장 "중소기업에 대한 적용"의 규정에 따라 작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였습니다.</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">해당사항 없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">제9기(전전기)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">한울회계법인</TD>
<TD WIDTH="434" HEIGHT="76">경영진의 운영실태보고 내용이 중요성의 관점에서 내부회계관리제도 모범규준의 규정에 따라 작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였습니다. </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">해당사항 없음</TD>
</TR>
</TBODY>
</TABLE>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『조정협의회내용 및 재무제표 불일치정보』 삽입</COMMENT>
<LIBRARYLIST>11011#*조정협의회내용및재무제표불일치정보.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>
<P>&cr;</P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P></P>
<P></P>

<P>
<SPAN USERMARK=" B">가. 이사회의 구성</SPAN>
<SPAN>&cr;당사의 이사회는 이사로 구성되고 법령 또는 정관에 정하여진 사항, 주주총회로부터 위임받은 사항, 회사의 기본방침 및 업무집행에 관한 주요사항을 의결하며 이사 및 경영진의 직무집행을 감독하고 있습니다. 본 보고서 작성기준일 현재 당사의 이사회는</SPAN>
<SPAN> 5명의 이사(사내이사 3명, 기타비상무이사 2명)로 구성되어 있으며</SPAN>
<SPAN>, 당사의 이사회 의장은 당사 정관 제35조 3항에 의거 대표이사가 의장을 겸직하고 있습니다.  당사는이사회 내 별도의 위원회는 구성되어 있지 않습니다.&cr;&cr;- 사내이사 : 윤재승(이사회의장), 김영부, 장재홍&cr;- 기타비상무이사 : 백광희, 레오나르드아리프빈압둘샤타&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">나. 이사회의 중요 의결사항</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1177">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="344"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="129" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">회차</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="129" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">
<P>개최일자</P>
</TH>

<TH WIDTH="353" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="129" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">
<P>의안내용</P>
</TH>

<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="129" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">
<P>가결 여부</P>
</TH>
<TH WIDTH="600" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">이사의 성명</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김영부&cr;(출석율:100 %)</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">윤재승&cr;(출석율:100 %)</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장재홍&cr;(출석율:100 %)</TH>

<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">백광희&cr;
<SPAN>(</SPAN>
<SPAN>출석율:25%</SPAN>
<SPAN>)</SPAN>
</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">레오나르드아리프빈압둘샤타&cr;(출석율:0 %)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">1</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.02.10</TD>
<TD WIDTH="353" HEIGHT="53">- 제10기 결산재무제표 승인의 건&cr;- 정기주주총회 소집 및 의안 결정의 건</TD>

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>가결</P>
</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.06.30</TD>
<TD WIDTH="353" HEIGHT="53" VALIGN="MIDDLE">- 주식매수선택권 부여취소의 건</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">3</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.08.10</TD>
<TD WIDTH="353" HEIGHT="53" VALIGN="MIDDLE">- 주식매수선택권 부여취소의 건</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">4</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.11.03</TD>
<TD WIDTH="353" HEIGHT="53" VALIGN="MIDDLE">- 주식매수선택권 부여취소의 건</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">다. 이사회에서의 사외이사 주요 활동내역</SPAN>
</P>

<P>
<SPAN>당사는 사외이사가  선임되어 있지 않아 해당사항 없습니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">라 이사회내의 위원회 구성현황과 그 활동내역&cr;</SPAN>
<SPAN>당사는  이사회내에 위원회가 구성되어 있지 않습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">마. 이사의 독립성&cr;</SPAN>
<SPAN>이사는 주주총회에서 선임하며, 주주총회에서 선임할 이사 후보자는 이사회가 선정하여 주주총회에 제출할 의안으로 확정하고 있습니다. 이사의 선임과 관련하여 관련법규에 의거한 주주제안이 있는 경우 이사회는 적법한 범위 내에서 이를 주주총회에 의안으로 제출하고 있습니다.&cr;&cr;회사 경영의 중요한 의사결정과 업무집행은 이사회의 심의 및 결정을 통하여 이루어지고 있습니다. 또한 당사는 대주주 등의 독단적인 경영과 이로 인한 소액주주의 이익 침해가 발생하지 않도록 이사회 운영규정 제정하여 성실히 준수하고 있습니다&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(기준일 : 2020년 12월 31일)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="831" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">담당직무</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">성명</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">활동분야&cr;(담당업무)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">추천인</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">상근여부</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사와의&cr;거래</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">최대주주와의&cr;이해관계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연임횟수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대표이사</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김영부</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경영총괄</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이사회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">상근</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주본인</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3회</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대표이사</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">윤재승</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경영총괄</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이사회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">상근</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3회</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사내이사</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">장재홍</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">C F O</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이사회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">상근</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2회</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타비상무이사</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">백광희</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경영전반</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이사회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비상근</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2회</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타비상무이사</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">레오나르드아리프빈압둘샤타</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경영전반</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이사회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비상근</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2회</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P USERMARK=" B">바. 사외이사 및 그 변동현황&cr;
<SPAN USERMARK=" !B">당사는 사외이사가  선임되어 있지 않아 해당사항 없습니다.</SPAN>
</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK=" B">사. 사외이사의 전문성</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>당사는 사외이사가  선임되어 있지 않아 해당사항 없습니다.</SPAN>
<SPAN>&cr;</SPAN>&cr;
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『사외이사 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_사외이사_교육_*.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P></P>
<P></P>
<P USERMARK=" B">가. 감사위원회 설치여부</P>
<P>당사는 본 보고서 작성기준일 현재 감사위원회를 별도로 설치하고 있지 않으며, 주주총회 결의로 선임된 비상근 감사 1명(김두표감사)이 당사 정관 제44조에서 규정하고 있는 감사의 직무에 따라 감사업무를 충실히 수행하고 있습니다.&cr;</P>

<P>
<SPAN USERMARK=" B">나. 감사의 독립성</SPAN>
<SPAN>&cr;감사는 회계와 업무를 감사하며 이사회 및 타 부서로부터 독립된 위치에서 업무를 수행하고 있습니다. 또한 당사는 감사의 감사업무에 필요한 경영정보접근을 위하여 당사 정관에 다음과 같은 조항을 두고 있습니다.&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="582">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="467"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>관련조항</P>
</TH>
<TH WIDTH="476" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내    용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="352">정관제 44 조&cr;(감사의 직무)</TD>

<TD WIDTH="476" VALIGN="MIDDLE" HEIGHT="352">
<P>① 감사는 회사의 회계와 업무를 감사한다.</P>
<P>② 감사는 이사회에 출석하여 의견을 진술할 수 있다.</P>
<P>③ 감사는 회의의 목적 사항과 소집의 이유를 기재한 서면을 이사회에 제출하여 임시총회의 소집을 청구할 수 있다.</P>
<P>④ 감사는 그 직무를 수행하기 위하여 필요한 때에는 자회사에 대하여 영업의 보고를 요구할 수 있다. 이 경우 자회사가 지체없이 보고를 하지 아니할 때 또는 그 보고의 내용을 확인할 필요가 있는 때에는 자회사의 업무와 재산 상태를 조사할 수 있다.</P>
<P>⑤ 감사에 대해서는 정관 제34조 2의 제3항의 규정을 준용한다.</P>
<P>⑥ 감사는 회사의 비용으로 전문가의 도움을 구할 수 있다. </P>
<P>⑦ 감사는 필요하면 회의의 목적사항과 소집이유를 적은 서면을 이사(소집권자가 있는 경우에는 소집권자)에게 제출하여 이사회 소집을 청구할 수 있다. </P>
<P>⑧ 제7항의 청구를 하였는데도 이사가 지체 없이 이사회를 소집하지 아니하면 그 청구한 감사가 이사회를 소집할 수 있다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P USERMARK=" B">다. 감사의 인적사항</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="585">

<COLGROUP>
<COL WIDTH="67"></COL>
<COL WIDTH="296"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="55"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성명</P>
</TH>

<TH WIDTH="305" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요 경력</P>
</TH>

<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>결격요건 여부</P>
</TH>

<TH WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>김두표</P>
</TD>

<TD WIDTH="305" VALIGN="MIDDLE" HEIGHT="168">
<P>73.02 서울대 법학과 졸업</P>
<P>76.02 서울대학원 법학과 수료</P>
<P>99.08 연세대 경영대학원 증권금융 석사</P>
<P>77.11~86.12 삼성물산 선물거래 과장</P>
<P>87.01~98.01 동서증권 이사대우</P>
<P>01.03~08.08 개인사업</P>
<P>13.03~14.02 경성대학교 부교수</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>해당사항 없음</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;&cr;</SPAN>
<SPAN USERMARK=" B">라. 감사의 주요 활동내역&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="586">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="347"></COL>
<COL WIDTH="81"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회차</TH>

<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개최일자</P>
</TH>

<TH WIDTH="356" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>활  동  내  용</P>
</TH>
<TH WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="92" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2020.01.22</TD>
<TD WIDTH="356" HEIGHT="53" VALIGN="MIDDLE">- 내부회계관리제도 운영실태 보고 및  평가 &cr;  보고의 건</TD>
<TD WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">보고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.01.31</TD>
<TD WIDTH="356" HEIGHT="30" VALIGN="MIDDLE">- 외부감사인과 커뮤니케이션 : 회계감사결과 논의</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">서면회의</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="92" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2020.02.10</TD>
<TD WIDTH="356" HEIGHT="53" VALIGN="MIDDLE">- 제10기 결산재무제표 승인의 건&cr;- 정기주주총회 소집 및 의안 결정의 건</TD>
<TD WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.24</TD>
<TD WIDTH="356" HEIGHT="30" VALIGN="MIDDLE">- 제10기 정기 주주총회 참석 및 감사보고</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">보고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.04.24</TD>
<TD WIDTH="356" HEIGHT="30" VALIGN="MIDDLE">- 외부감사인과 커뮤니케이션 : 감사계획 논의</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대면회의</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.07.23</TD>
<TD WIDTH="356" HEIGHT="30" VALIGN="MIDDLE">- 외부감사인과 커뮤니케이션 : 반기검토 결과</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대면회의</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.11.18</TD>
<TD WIDTH="356" HEIGHT="30" VALIGN="MIDDLE">- 내부회계관리제도 검토결과</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대면회의</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회 위원의 인적사항 및 사외이사 여부』 삽입</COMMENT>
<LIBRARYLIST>11011#*감사위원현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">41_02_감사_교육_실시현황</FILENAME>
<P>감사 교육실시 현황</P>

<TABLE-GROUP ACLASS="ADT_EDU" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="351"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">교육일자</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">교육실시주체</TH>
<TH WIDTH="360" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 교육내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="ADT_EDU_DT" AUNITVALUE="20201117">2020.11.17</TU>
<TE WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_EDU_MA">코스닥협회</TE>
<TE WIDTH="360" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADT_EDU_DTL">코스닥 내부 감사 포럼</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">42_02_감사_지원조직_현황</FILENAME>
<P>감사 지원조직 현황</P>

<TABLE-GROUP ACLASS="ADT_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADT_OGN_NM">경영지원팀</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADT_OGN_CNT">2</TE>

<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="76" ACODE="ADT_OGN_PST" ALIGN="CENTER">
<SPAN>이사1명,</SPAN>
<SPAN>대리1명</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(평균 15년)</SPAN>
</TE>
<TE WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" ACODE="ADT_OGN_DTL">재무제표, 이사회등 경영전반에 관한 감사직무 수행지원</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>감사 지원조직은 별도로 없으며 경영지원 회계팀에서 감사 관련 업무 지원을&cr;하고 있습니다.</P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『준법지원인 등 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_준법지원인등_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">43_02_준법지원인등_지원조직_해당사항없음</FILENAME>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>지원조직이 없는 경우에는 그 사실을 기재한다.</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK=" B">마. 준법지원인 및 지원조직 현황 </P>

<P>
<SPAN>당사는 본 보고서 작성일 현재 선임된 준법 지원인이 없어 해당사항 없습니</SPAN>
<SPAN>다..</SPAN>
</P>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주의 의결권 행사에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 집중투표제의 채택여부</SPAN>
</P>
<P>당사는 본 보고서 작성기준일  현재 집중투표제를 채택하고 있지 않습니다.</P>
<P></P>
<P USERMARK=" B">나. 서면투표제 또는 전자투표제의 채택여부</P>

<P>
<SPAN>당사는 본 보고서 작성기준일 현재 서면투표제 또는 전자투표제를 채택하고 있지 않습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">다. 소수주주권의 행사여부</SPAN>
</P>
<P>당사는 본 보고서 작성기준일 현재 소수주주권이 행사된 사실이 없습니다.</P>
<P></P>
<P USERMARK=" B">라. 경영권 경쟁 여부</P>
<P>당사는  본 보고서 작성기준일 현재 경영권과 관련하여 경쟁이 발생한 사실이 없습니다&cr;</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P>&cr;</P>
<P USERMARK="F-16 0XFF1200 B">1.최대주주 및 특수관계인의 주식소유 현황</P>
<P></P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="619" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="308" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="615" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="297" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="28" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김영부</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="28" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-10">최대주주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="28" ACODE="STK_KND" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="28" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-10">1,263,880</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-10">13.11</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="28" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-10">1,203,880</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-10">12.49</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="28" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="28" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">윤재승</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="28" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-10">등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="28" ACODE="STK_KND" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="28" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-10">906,360</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-10">9.40</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="28" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-10">846,360</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-10">8.78</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="28" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="28" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">백광희</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="28" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-10">등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="28" ACODE="STK_KND" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="28" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-10">508,440</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-10">5.27</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="28" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-10">448,440</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-10">4.65</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="28" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="28" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김재영</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="28" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-10">자녀</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="28" ACODE="STK_KND" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="28" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-10">81,420</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-10">0.84</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="28" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-10">81,420</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-10">0.84</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="28" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="28" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김나연</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="28" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-10">자녀</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="28" ACODE="STK_KND" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="28" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-10">81,420</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-10">0.84</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="28" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-10">81,420</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-10">0.84</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="28" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="28" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">장재홍</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="28" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-10">등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="28" ACODE="STK_KND" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="28" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-10">27,600</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-10">0.29</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="28" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-10">27,600</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="28" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-10">0.29</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="28" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">와이비파트너스(주)</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-10">특수관계인</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-10">264,100</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-10">2.74</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-10">264,100</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-10">2.74</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">황현옥</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-10">처</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-10">0</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-10">0</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-10">60,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-10">0.62</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE" USERMARK="F-10">3,133,220</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE" USERMARK="F-10">32.49</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE" USERMARK="F-10">3,013,220</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE" USERMARK="F-10">31.25</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN>주1) 위의 표 기말</SPAN>
<SPAN>지분율은</SPAN>
<SPAN> </SPAN>
<SPAN>2020.12.31</SPAN>
<SPAN>일 발행주</SPAN>
<SPAN>식</SPAN>
<SPAN> 총수 9,641,781주</SPAN>
<SPAN>를</SPAN>
<SPAN> 기준으로 작성하였습니다.</SPAN>
<SPAN></SPAN>
</P>
<P></P>
<P USERMARK=" B">최대주주의 주요경력 및 개요</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="651">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="298"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성명</P>
</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직책</TH>

<TH WIDTH="307" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요경력</P>
</TH>
<TH WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">김영부</TD>
<TD WIDTH="101" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">대표이사&cr;(상근/등기)</TD>

<TD WIDTH="307" HEIGHT="145" VALIGN="MIDDLE">
<P>연세대. 경영학 석사</P>
<P>와이비파트너스㈜ 대표이사</P>
<P>와이비파트너스㈜ 기타비상무이사&cr;와이비파트너스(주) 대표이사</P>
<P>㈜팬젠 대표이사&cr;㈜엔키아 대표이사</P>
</TD>
<TD WIDTH="142" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">-&cr;00.04 ~ 15.03&cr;15.03 ~ 16.05&cr;16.05 ~ 현 재&cr;00.03 ~ 현 재&cr;18.03 ~ 현 재</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주가 법인 또는 투자조합 등 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P>&cr;</P>

<P>
<SPAN USERMARK=" B">[최대주주의 변동을 초래할 수 있는 특정거래]&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
<SPAN>(기준일 : 2020.12.31)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="985">

<COLGROUP>
<COL WIDTH="35"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="79"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="44" VALIGN="MIDDLE" HEIGHT="56" USERMARK="F-10" ALIGN="CENTER">NO </TD>
<TD ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" HEIGHT="56" USERMARK="F-10" ALIGN="CENTER">채권자 (담보권자) </TD>
<TD ROWSPAN="2" WIDTH="132" VALIGN="MIDDLE" HEIGHT="56" USERMARK="F-10" ALIGN="CENTER">채무자 </TD>
<TD ROWSPAN="2" WIDTH="70" VALIGN="MIDDLE" HEIGHT="56" USERMARK="F-10" ALIGN="CENTER">차입목적 </TD>
<TD ROWSPAN="2" WIDTH="119" VALIGN="MIDDLE" HEIGHT="56" USERMARK="F-10" ALIGN="CENTER">담보설정금액(원) </TD>
<TD ROWSPAN="2" WIDTH="87" VALIGN="MIDDLE" HEIGHT="56" USERMARK="F-10" ALIGN="CENTER">담보권 종류 </TD>
<TD ROWSPAN="2" WIDTH="80" VALIGN="MIDDLE" HEIGHT="56" USERMARK="F-10" ALIGN="CENTER">담보제공&cr;주식수(주) </TD>
<TD ROWSPAN="2" WIDTH="66" VALIGN="MIDDLE" HEIGHT="56" USERMARK="F-10" ALIGN="CENTER">보호예수&cr;여부 </TD>
<TD COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">담보제공기간 </TD>
<TD ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" HEIGHT="56" USERMARK="F-10" ALIGN="CENTER">계약체결일 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">시작일 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">종료일 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="44" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">1</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">페퍼저축은행 </TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">와이비파트너스(주) </TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">운영자금 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="RIGHT">944,400,000</TD>
<TD WIDTH="87" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">질권 </TD>
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="RIGHT">178,572 </TD>
<TD WIDTH="66" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">미해당 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2018-03-26 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2021-07-20</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2018-03-26 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="44" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">페퍼저축은행 </TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">와이비파트너스(주) </TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">운영자금 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="RIGHT">1,857,600,000</TD>
<TD WIDTH="87" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">질권 </TD>
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="RIGHT">350,400 </TD>
<TD WIDTH="66" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">미해당 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2018-06-21</TD>
<TD WIDTH="86" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2021-06-21</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2018-06-21 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="44" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">3</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">유안타증권</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">김영부 </TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">운영자금 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="RIGHT">1,000,000,000</TD>
<TD WIDTH="87" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">질권 </TD>
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="RIGHT">200,000 </TD>
<TD WIDTH="66" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">미해당 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2020-08-24</TD>
<TD WIDTH="86" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2021-02-22</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">2020-08-24 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10" COLSPAN="2" ALIGN="CENTER">합   계</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10" ALIGN="CENTER">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10"></TD>
<TD WIDTH="119" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10" ALIGN="RIGHT">3,802,000,000</TD>
<TD WIDTH="87" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10" ALIGN="CENTER">-</TD>
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10" ALIGN="RIGHT">728,972 </TD>
<TD WIDTH="66" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10" ALIGN="CENTER">-</TD>
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10" ALIGN="CENTER">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10" ALIGN="CENTER">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-10" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>공</SPAN>
<SPAN>시서류 작성기준일 현재 </SPAN>
<SPAN>총 </SPAN>
<SPAN></SPAN>
<SPAN>728,972</SPAN>
<SPAN>주의</SPAN>
<SPAN> 주식이 담보로 제공되어 있고 담보권 전부 실행시 </SPAN>
<SPAN>최대주주의 지분율은</SPAN>
<SPAN> </SPAN>
<SPAN>4.93</SPAN>
<SPAN>%</SPAN>
<SPAN> 입니</SPAN>
<SPAN>다</SPAN>
<SPAN>.  자세한 </SPAN>
<SPAN>내용은 기공시한 최대주주 변경을 수반하는 주식담보 제공 계약체결을 참조하시기 바랍니다. </SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주의 최대주주(최대출자자)가 법인 또는 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주의최대출자자가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『최대주주 변동내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주변동내역.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-16 0XFF1200 B">2. 최대주주 변동내역</SPAN>
<SPAN USERMARK=" 0XFF1200 B"></SPAN>
<SPAN USERMARK=" 0XFF1200">&cr;</SPAN>
<SPAN>당사는 공시대상 기간 중 최대주주가 변동되었던 경우가 없습니다.</SPAN>
<SPAN>&cr;&cr;</SPAN>
</P>
<P USERMARK="F-16 0XFF1200 B">3.주식 소유현황</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM" USERMARK="F-10">김영부</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT" USERMARK="F-10">1,203,880</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT" USERMARK="F-10">12.49</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM" USERMARK="F-10">윤재승</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT" USERMARK="F-10">846,360</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT" USERMARK="F-10">8.78</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM" USERMARK="F-10">Duopharma Biotech Berhad</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT" USERMARK="F-10">806,450</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT" USERMARK="F-10">8.36</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK="F-16 0XFF1200 B">4. 소액주주현황</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『소액주주현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*소액주주현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">10_소액주주현황</FILENAME>

<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N">소액주주현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="697" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="206"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="223" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="215" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNT">4,723</TE>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNTT">4,734</TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_RT">99.77</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNT">5,499,392</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNTT">9,641,781</TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_RT">57.04</TE>
<TE WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE">발행주식 총수의 100분의 1에&cr;미달하는 주식을 보유한 주주</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-16 0XFF1200 B">5. 주식사무&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="277"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" HEIGHT="904" ALIGN="CENTER" VALIGN="MIDDLE">
<P>정관상&cr;신주인수권의&cr;내용</P>
</TD>

<TD WIDTH="477" HEIGHT="904" COLSPAN="3" VALIGN="MIDDLE">
<P>제 10 조 (신주인수권)</P>
<P>① 주주는 그가 소유한 주식의 수에 비례하여 신주의 배정을 받을 권리를 갖는다. </P>
<P>② 회사는 제1항의 규정에도 불구하고 다음 각 호의 어느 하나에 해당하는 경우 이사회의 결의로 주주 외의 자에게 신주를 배정할 수 있다.</P>
<P>1. 자본시장과 금융투자업에 관한 법률 제9조에서 정한 “유가증권시장 또는 코스닥시장(코넥스시 장 포함)”에 주권을 신규상장하기 위하여 신주를 모집하거나 인수인에게 인수하게 하는 경우 </P>
<P>2. 발행주식총수의 100분의 50을 초과하지 않는 범위 내에서 자본시장과 금융투자업에 관한 법률 제165조의6에 따라 일반공모증자 방식으로 신주를 발행하는 경우 </P>
<P>3. 상법 제542조의3에 따른 주식매수선택권의 행사로 인하여 신주를 발행하는 경우 </P>
<P>4. 발행하는 주식총수의 100분의 20 범위 내에서 우리사주조합원에게 주식을 우선배정하는 경우 </P>
<P>5. [근로복지기본법] 제39조의 규정에 의한 우리사주매수선택권의 행사로 인하여 신주를 발행하는 경우 </P>
<P>6. 발행주식총수의 100분의 50을 초과하지 않는 범위 내에서 경영상의 필요로 또는 긴급한 자금조달을 위하여 국내외 투자자에게 신주를 발행하는 경우 </P>
<P>7. 발행주식총수의 100분의 50을 초과하지 않는 범위 내에서 사업상 중요한 기술도입, 연구개발, 생산,판매,자본제휴를 위하여 그 상대방에게 신주를 발행하는 경우 </P>
<P>8. 발행주식총수의 100분의 50을 초과하지 않는 범위내에서 주식예탁증서(DR)발행에 따라 신주를 발행하는 경우</P>
<P>③ 제2항 각 호 중 어느 하나의 규정에 의해 신주를 발행할 경우 발행할 주식의 종류와 수 및 발행 가격 등은 이사회의 결의로 정한다. 다만, 일반공모 증자의 경우에는 자본시장과 금융투자업에 관한 법률 시행령 제176조의8과 증권의 발행 및 공시 등에 관한 규정 제5-18조 제1항에 따라, 제3자배정증자의 경우에는 증권의 발행 및 공시 등에 관한 규정 제5-18조 제1항에 따라 발행가격을 산정한다.</P>
<P>④ 신주인수권의 포기 또는 상실에 따른 주식과 신주배정에서 발생한 단주에 대한 처리방법은 이사 회의 결의로 정한다.</P>
<P>⑤ 제2항에 따라 주주 외의 자에게 신주를 배정하는 경우 회사는 상법 제416조제1호, 제2호, 제2호의2, 제3호 및 제4호에서 정하는 사항을 그 납입기일의 2주 전까지 주주에게 통지하거나 공고 하여야 한다. 다만, 자본시장과 금융투자업에 관한 법률 제165조의 9에 따라 주요사항보고서를 금융위원회 및 거래소에 그납입일1주전까지 공시함으로써 그통지 및 공고를 갈음할 수 있다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>결산일</P>
</TD>

<TD WIDTH="110" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>12월 31일</P>
</TD>

<TD WIDTH="81" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>정기주주총회</P>
</TD>

<TD WIDTH="286" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>매 사업연도 종료 후 3개월 이내  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>주주명부폐쇄시기</P>
</TD>

<TD WIDTH="477" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">
<P>매년 1월 1일부터 1월 15일까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>주권의 종류</P>
</TD>
<TD WIDTH="477" HEIGHT="53" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">주식ㆍ사채 등의 전자등록에 관한 법률 시행에 따라 권종 삭제&cr;(시행일 2019.9.16)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>명의개서대리인</P>
</TD>

<TD WIDTH="477" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국민은행 증권대행부</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>주주의 특전</P>
</TD>

<TD WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>해당사항 없음</P>
</TD>

<TD WIDTH="81" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>공고게재</P>
</TD>

<TD WIDTH="286" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>홈페이지(www.pangen.com) </P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK="F-16 0XFF1200 B">6. 주가 및 주식 거래 실적&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">한국거래소 코스닥 시장 - 보통주(222110)  </SPAN>
<SPAN>                    (단위:원, 주)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="705" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="138" ALIGN="CENTER" HEIGHT="30">구   분</TD>
<TD WIDTH="96" ALIGN="CENTER" HEIGHT="30">2020년 7월</TD>
<TD WIDTH="96" ALIGN="CENTER" HEIGHT="30">2020년 8월</TD>
<TD WIDTH="96" ALIGN="CENTER" HEIGHT="30">2020년 9월</TD>
<TD WIDTH="93" ALIGN="CENTER" HEIGHT="30">2020년10월</TD>
<TD WIDTH="93" ALIGN="CENTER" HEIGHT="30">2020년11월</TD>
<TD WIDTH="93" ALIGN="CENTER" HEIGHT="30">2020년12월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">주  가</TD>
<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30">최 고</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">8,480</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">11,450</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">11,650</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">12,000</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">11,300</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">10,250</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30">최 저</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">7,260</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">8,150</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">8,700</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">8,740</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,700</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,480</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30">평 균</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">7,882</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">10,111</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,712</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">10,183</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">10,164</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,864</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">거래량</TD>
<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30">최고(일)</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">240,966</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">729,505</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">476,243</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,835,790</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">705,276</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">131,483</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30">최저(일)</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,435</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">32,156</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">18,458</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">18,817</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">25,327</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">16,590</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30">월간</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,595,850</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,387,293</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,652,700</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">5,862,128</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,751,785</TD>
<TD WIDTH="93" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,224,655</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 주가의 최고가, 최저가는 종가 기준입니다.</P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P></P>
<P USERMARK=" B">임원 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="931" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="582"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="591" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1181" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당&cr;업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="218" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="166" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기&cr;만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김영부</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="196004" VALIGN="MIDDLE">1960.04</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">대표이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">경영총괄</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">연세대. 경영학 석사&cr;와이비파트너스㈜ 대표이사&cr;㈜팬젠 대표이사&cr;(주)엔키아 대표이사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">1,203,880</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">최대주주본인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2010.02.26&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="20220326" VALIGN="MIDDLE">2022.03.26</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">윤재승</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="196102" VALIGN="MIDDLE">1961.02</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">대표이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">경영총괄</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">Purdue Univ. 생물학 박사&cr;㈜팬젠 대표이사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">846,360</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2010.01.29&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="20220326" VALIGN="MIDDLE">2022.03.26</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">변태호</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="195808" VALIGN="MIDDLE">1958.08</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">부사장</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">COO</TE>

<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE">
<SPAN USERMARK="F-10">고려대 생식발생학 박사&cr;</SPAN>
<SPAN USERMARK="F-10">㈜팬젠 부사장</SPAN>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">85,606</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2010.01.29&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="70" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">장재홍</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="70" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="70" AUNIT="SH5_BIH" AUNITVALUE="196608" VALIGN="MIDDLE">1966.08</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="70" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">전무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="70" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="70" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="70" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">CFO</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="70" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">강원대 회계학과 학사&cr;와이비파트너스㈜ 기타비상무이사&cr;㈜팬젠 임원</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">27,600</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="70" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="70" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2010.12.01&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="70" AUNIT="SH5_FIH" AUNITVALUE="20220326" VALIGN="MIDDLE">2022.03.26</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김지태</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="196408" VALIGN="MIDDLE">1964.08</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">전무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">공장장</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">고려대 배양공학 석사&cr;㈜팬젠 임원</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">26,619</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2010.01.29&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">이종민</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="196701" VALIGN="MIDDLE">1967.01</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">개발부서장</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">고려대 유전공학 석사&cr;㈜팬젠 임원</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">27,470</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2010.01.29&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">오한규</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="196907" VALIGN="MIDDLE">1969.07</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">품질부서장</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">수원대 생물학 석사&cr;㈜팬젠 임원</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">25,600</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2010.01.29&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">박정수</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="197011" VALIGN="MIDDLE">1970.11</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">연구소&cr;부소장</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">경희대 분자유전학 박사&cr;㈜팬젠 임원</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">49,220</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2010.01.29&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">박홍열</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="197311" VALIGN="MIDDLE">1973.11</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">공시,IR</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">경희대 유전공학과 석사&cr;(주)팬젠 임원</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">25,310</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2020.01.01&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">조창범</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="197011" VALIGN="MIDDLE">1970.11</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">회계,재무</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">경희대 무역학과 학사&cr;와이비파트너스(주)</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2020.01.01&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">이승희</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="197310" VALIGN="MIDDLE">1973.10</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">연구소</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">경희대 유전공학과 석사&cr;(주)팬젠 임원</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">25,280</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2020.01.01&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="70" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">백광희</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="70" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="70" AUNIT="SH5_BIH" AUNITVALUE="195812" VALIGN="MIDDLE">1958.12</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="70" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">기타&cr;비상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="70" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="70" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="70" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">기타&cr;비상무이사</TE>

<TE ALIGN="CENTER" WIDTH="218" HEIGHT="70" ACODE="SH5_SKL" VALIGN="MIDDLE">
<SPAN USERMARK="F-10">Univ. of Chicago, 분자생물학 박사&cr;경희대 교수&cr;</SPAN>
<SPAN USERMARK="F-10">㈜팬젠 기타비상무이사</SPAN>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">448,440</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="70" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="70" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2010.01.29&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="70" AUNIT="SH5_FIH" AUNITVALUE="20230324" VALIGN="MIDDLE">2023.03.24</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="93" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">레오나르드&cr;아리프&cr;빈압둘샤타</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="93" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="93" AUNIT="SH5_BIH" AUNITVALUE="196412" VALIGN="MIDDLE">1964.12</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="93" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">기타&cr;비상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="93" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="93" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="93" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">기타&cr;비상무이사</TE>

<TE ALIGN="CENTER" WIDTH="218" HEIGHT="93" ACODE="SH5_SKL" VALIGN="MIDDLE">
<SPAN USERMARK="F-10">Monash Univ. 경제학/법학 학사&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN>Duopharma biotech </SPAN>
<SPAN></SPAN>
<SPAN USERMARK="F-10"> CEO&cr;</SPAN>
<SPAN USERMARK="F-10">CCMB 그룹 대표이사&cr;</SPAN>
<SPAN USERMARK="F-10"></SPAN>
<SPAN USERMARK="F-10">㈜팬젠 기타비상무이사</SPAN>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="93" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="93" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="93" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="93" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2014.03.24&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="93" AUNIT="SH5_FIH" AUNITVALUE="20230324" VALIGN="MIDDLE">2023.03.24</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김두표</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="195007" VALIGN="MIDDLE">1950.07</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">감사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">감사</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">연세대 경영학 석사&cr;㈜팬젠 감사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2013.03.06&cr;~</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="20220326" VALIGN="MIDDLE">2022.03.26</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『등기임원후보자 및 해임대상자』 삽입</COMMENT>
<LIBRARYLIST>11011#*등기임원후보자및해임대상자.dsl</LIBRARYLIST>
</INSERTION>
<P>&cr;</P>

<P>
<SPAN USERMARK=" B">등기임원의 겸직현황</SPAN>
<SPAN USERMARK=" 0X1814FF B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>(기준일 : 2020.12.31)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="771">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="336" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">겸 직 자</TD>
<TD COLSPAN="3" WIDTH="435" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">겸 직 회 사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">성 명</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">직 위</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">회사명</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">직 위</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">재직기간</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">김영부</TD>
<TD ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">대표이사</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">와이비파트너스(주)</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대표이사</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.05 ~ 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">엔키아</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대표이사</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018.03 ~ 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">윤재승</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대표이사</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경희대학교</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대학교수</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1992.03 ~ 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">백광희</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타비상무이사</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경희대학교</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대학교수</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1989.09 ~ 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">레오나르드아리프빈압둘샤타</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타비상무이사</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Duopharma Biotech Berhad </TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CEO</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018 ~ 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김두표</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비상근감사</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">와이비파트너스</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">감사</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2003.03 ~ 현재</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>직원 등 현황</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="748" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="381"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="390" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="793" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="646" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외&cr;근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="287" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균&cr;근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여&cr;총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균&cr;급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이&cr;없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제&cr;근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">전체</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">42</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">42</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">4.87</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">1,798,704</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">42,826</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">전체</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">38</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">38</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">4.44</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">1,261,348</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">33,193</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="126" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">80</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">80</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">4.66</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE">3,060,052</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE">38,251</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 직원 현황 표는 미등기임원을 포함하여 작성한다</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P></P>
<P>미등기임원 보수 현황</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="787" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="420"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="429" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="786" BORDER="1">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_CNT">8</TE>
<TE WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT">625,678</TE>
<TE WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR">78,210</TE>
<TE WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">1. 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">등기이사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">5</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">700,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">등기감사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">100,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">2. 보수지급금액</P>
<P USERMARK=" B">2-1. 이사ㆍ감사 전체</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">6</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUM">81,900</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_VIC">13,650</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">2-2. 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당&cr;평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사&cr;(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_NUM">5</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_SUM">81,900</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_VIC">16,380</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사&cr;(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK="F-16 0XFF1200 B">3. 이사 및 감사의 보수지급기준&cr;&cr;</SPAN>
<SPAN>회사 등기임원의 보수 지급기준은 주주총회에서 승인받은 한도금액 내에서 지급되며퇴직급여는 주주총회 결의를 거친 임원 퇴직금지급규정에 따라 지급되고 있습니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『주식매수선택권의 부여 및 행사현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*주식매수선택권의부여및행사현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">14_주식매수선택권의부여및행사현황</FILENAME>
<P USERMARK=" B"><주식매수선택권의 부여 및 행사현황></P>
<P><표1></P>

<TABLE-GROUP ACLASS="SUB_SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="232"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="241" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주식매수선택권의 공정가치 총액</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">등기이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="RRT_PAY_NUM">5</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="RRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사외이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ORT_PAY_NUM">0</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ORT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">감사위원회 위원 또는 감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_NUM">1</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">6</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P><표2></P>

<TABLE-GROUP ACLASS="SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="882" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="488"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="153" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="497" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="947" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="65"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여&cr;받은자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여일</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여방법</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최초&cr;부여&cr;수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기변동수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총변동수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기말&cr;미행사수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사&cr;가격</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">변태호</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150720">2015.07.20</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">8,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">12,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.07.20 ~&cr;2022.07.19</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">7,500</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">장재홍</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150720">2015.07.20</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">18,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">7,200</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">10,800</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.07.20 ~&cr;2022.07.19</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">7,500</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">김지태</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150720">2015.07.20</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">18,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">18,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.07.20 ~&cr;2022.07.19</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">7,500</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">이종민</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150720">2015.07.20</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">14,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">14,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.07.20 ~&cr;2022.07.19</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">7,500</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">오한규</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150720">2015.07.20</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">14,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">5,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">8,400</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.07.20 ~ &cr;2022.07.19</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">7,500</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">박정수</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150720">2015.07.20</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">14,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">14,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.07.20 ~&cr;2022.07.19</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">7,500</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM">박홍열</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150720">2015.07.20</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">6,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.07.20 ~&cr;2022.07.19</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">7,500</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM">조창범</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20181018">2018.10.18</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">7,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">7,500</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2020.10.18 ~&cr;2025.10.17</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">14,850</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM">이승희</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150720">2015.07.20</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">6,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.07.20 ~&cr;2022.07.19</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">7,500</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">송OO외1</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20140324">2014.03.24</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">16,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">12,400</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">3,600</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2016.03.24 ~&cr;2021.03.23</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">4,350</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">김OO외4</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150326">2015.03.26</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">29,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">15,400</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">7,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">6,600</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.03.26 ~&cr;2022.03.25</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">4,750</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">이OO외24</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20150720">2015.07.20</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">112,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">57,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">50,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2017.07.20 ~&cr;2022.07.19</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">7,500</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="49" ACODE="SH5_NM" USERMARK="F-10">진OO외19</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="49" AUNIT="SH5_GV_DT" AUNITVALUE="20181018">2018.10.18</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="49" ACODE="SH5_MTH" USERMARK="F-10">신주발행</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_STK_KNDD" USERMARK="F-10">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="49" ACODE="SH5_START_CNT" USERMARK="F-10">89,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="49" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_MCNL_CNT">18,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="49" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="49" ACODE="SH5_CNL_CNT">44,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="49" ACODE="SH5_NEXE_CNT">45,500</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="49" ACODE="SH5_PER" USERMARK="F-10">2020.10.18 ~&cr;2025.10.17</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="49" ACODE="SH5_PRC" USERMARK="F-10">14,850</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="SH5_NM">계</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="-">-</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_START_CNT" USERMARK="F-10">372,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">18,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">113,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">56,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">202,400</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="30" ACODE="SH5_PER">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_PRC">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN>주1) 행사가격은 2015년 8월 10일 무상증자로 인하여 조정된 행사가격입니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>주2) 주식매수선택권부여후 2년이내 퇴사한 직원의 주식매수선택권 </SPAN>
<SPAN>56,000</SPAN>
<SPAN></SPAN>
<SPAN>주</SPAN>
<SPAN>에 대</SPAN>
<SPAN>해 이사회결의로 취소하였습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>주3)</SPAN>
<SPAN></SPAN>
<SPAN> 2020년</SPAN>
<SPAN>  12</SPAN>
<SPAN>월 31일</SPAN>
<SPAN>  종가는</SPAN>
<SPAN> </SPAN>
<SPAN>10,150</SPAN>
<SPAN>원</SPAN>
<SPAN>입</SPAN>
<SPAN>니다</SPAN>
<SPAN>.&cr;주4) 2021년 1월 15일 이사회 결의로 임직원 29명에게 108,500주의 주식매수선택권을 부여 하였으며 위 부여현황에는 포함되어 있지 않습니다.(세부내역 2021.1.15일자 주식매수선택권부여에관한 신고 공시 참조)</SPAN>
</P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P>당사는 보고서 작성 기준일 현재 계열회사 및  타법인 출자가 없어 해당사항이 없습니다.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『타법인출자 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*타법인출자현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 이해관계자와의 거래내용</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-16 0XFF1200 B">1. 대주주등에 대한 신용공여등</SPAN>
<SPAN USERMARK="F-14 0XFF1200 B">&cr;</SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">2. 대주주와의 자산양수도 등&cr;</SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">3. 대주주와의 영업거래&cr;</SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">4. 대주주이외의 이해관계자와의 거래&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">(1) 거래내역       </SPAN>
<SPAN>                                                     (단위:천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1271">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">특수관계구분</TD>
<TD WIDTH="115" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">거래상대방</TD>
<TD WIDTH="312" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">제11기 </TD>
<TD WIDTH="312" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">제10기</TD>
<TD WIDTH="312" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="4">제9기</TD>
<TD WIDTH="97" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">매출등</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">매입등</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">매출등</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">매입등</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">매출등</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">매입등</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매      출</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타거래</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매      입</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타거래</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매      출</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타거래</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매      입</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타거래</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매      출</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타거래</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매      입</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타거래</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">기타이해관계자</TD>

<TD WIDTH="115" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>Duopharma &cr;SDN Berhad</SPAN>
</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,540,860</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">220</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">809,954</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">8,736</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">46,054</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">209,872</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">91,211</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">53,583</TD>
<TD WIDTH="97" HEIGHT="53" VALIGN="MIDDLE">주1,주2,주3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">임직원</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">김OO외1명</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK=" 0X0000FF">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK=" 0X0000FF">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK=" 0X0000FF">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK=" 0X0000FF">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,000</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,000</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE">주4</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>주</SPAN>
<SPAN>1) </SPAN>
<SPAN>Duopharma SDN Berhad</SPAN>
<SPAN>는</SPAN>
<SPAN> 당사의 지분</SPAN>
<SPAN> 8.36%</SPAN>
<SPAN>를 소유하고 있는</SPAN>
<SPAN> Duopharma Biotech Berhad</SPAN>
<SPAN>(말레이시아법인)의 자회사 입니다.&cr;주2)</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>Duopharma SDN Berhad</SPAN>
<SPAN>사는</SPAN>
<SPAN> 당사가 개발중인 바이오시밀러 EPO 임상3상 비용을 공동 부담하고 있으며 </SPAN>
<SPAN> EPO 제품에 대한 말레이시아, 싱가폴, </SPAN>
<SPAN>브루나이 </SPAN>
<SPAN>3개국의 판권을 </SPAN>
<SPAN>보유하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>주3) 기타거래는 EPO 공동임상비용 정산등과 관련된 거래 입니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>주4) 기타거래는 임직원 단기대여금액이며 당사는 "임직원가계대출규정"에 따라&cr; 퇴직급여충당금 범위내에서 단기대여를 하였습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">(2) 채권 채무 내역   </SPAN>
<SPAN>                                                  (단위: 천원)</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="769" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60">특수관계구분</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="60">회사명&cr;(성명)</TD>
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">제11기</TD>
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">제10기</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" COLSPAN="2">제9기 </TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="60">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">채권</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="77" HEIGHT="30">채무</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">채권</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="77" HEIGHT="30">채무</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="77" HEIGHT="30">채권</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30">채무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="53">기타이해관계자</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="53">
<SPAN>Duopharma &cr;SDN Berhad</SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53">184,960</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="77" HEIGHT="53">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53">5,219</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="77" HEIGHT="53">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="77" HEIGHT="53">49,345</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="53">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">임직원</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">김OO외1명</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">63,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="77" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">63,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="77" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="77" HEIGHT="30">50,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30">주1)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>주1) 상기 채권은 </SPAN>
<SPAN>임직원에</SPAN>
<SPAN> 대한 단기대여금으로  회사의 "임직원가계대출규정"에 따라  퇴직급여충당금 범위내에서 대여를 진행하며 대여이자율은 국세청 인정이자율을 적용하고 있습니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>
<P></P>
<P></P>

<P>
<SPAN USERMARK=" 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">1. </SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">공시사항의 진행, 변경상황&cr;</SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">2. </SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">주주총회 의사록 요약</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="648">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="407"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>
<TH WIDTH="416" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">안건</TH>
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가결여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">제10기정기주총&cr;(2020.03.24)</TD>
<TD WIDTH="416" HEIGHT="168" VALIGN="MIDDLE">제1호의안 : 제10기 재무제표 승인의 건&cr;제2호의안 : 이사 선임의 건&cr;   제2-1호 의안 기타비상무이사 백광희 재선임의 건&cr;   제2-2호 의안 기타비상무이사 레오나르드아리프빈&cr;                      압둘샤타 재선임의 건&cr;제3호의안 : 이사 보수한도 승인의 건 (이사보수한도 7억원)&cr;제4호의안 : 감사보수한도 승인의 건  (감사보수한도 1억원)</TD>
<TD WIDTH="108" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">원안대로승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="237" ALIGN="CENTER" VALIGN="MIDDLE">제9기정기주총&cr;(2019.03.26)</TD>
<TD WIDTH="416" HEIGHT="237" VALIGN="MIDDLE">제1호의안 : 제9기 재무제표 승인의 건&cr;제2호의안 : 이사 선임의 건&cr;   제2-1호 의안 사내이사 윤재승 재선임의 건&cr;   제2-2호 의안 사내이사 김영부 재선임의 건&cr;   제2-3호 의안 사내이사 장재홍 재선임의 건&cr;제3호의안 : 감사(비상근)  김두표 선임의 건&cr;제4호의안 : 정관 변경의 건&cr;제5호 의안: 주식매수선택권 부여 승인의 건 &cr;제6호의안 : 이사 보수한도 승인의 건 (이사보수한도 7억원)&cr;제7호의안 : 감사보수한도 승인의 건  (감사보수한도 1억원)</TD>
<TD WIDTH="108" HEIGHT="237" ALIGN="CENTER" VALIGN="MIDDLE">원안대로승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">제8기정기주총&cr;(2018.03.30)</TD>
<TD WIDTH="416" HEIGHT="99" VALIGN="MIDDLE">제1호의안 : 제8기 재무제표 승인의 건&cr;제2호의안 : 이사 보수한도 승인의 건 (이사보수한도 7억원)&cr;제3호의안 : 감사보수한도 승인의 건  (감사보수한도 1억원)&cr;제4호의안 : 정관 일부 변경의 건</TD>
<TD WIDTH="108" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">원안대로승인</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">3. </SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">우발채무 등</SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">&cr;</SPAN>
<SPAN USERMARK="F-16 B">&cr;</SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK=" B">가. 중요한 소송사건 등&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다</SPAN>
<SPAN>.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">나. 견질 또는 담보용 어음,수표 현황&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다.</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN USERMARK=" B">다. 채무보증 현황&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다</SPAN>
<SPAN>.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">라. 채무인수약정 현황</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">마. 그 밖의 우발채무 등&cr;</SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다.</SPAN>
<SPAN>&cr;&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">4. </SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">제재현황 등 그 밖의 사항</SPAN>
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK=" 0XFF1200">&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">가. 제재현황</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다</SPAN>
<SPAN>.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">나. 작성 기준일 이후 발생한 주요사항&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>본 보고서 작성기준일  현재 해당사항이 없습니다.</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN USERMARK=" B">다. </SPAN>
<SPAN USERMARK=" B">중소기업 기준 검토표</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">중소기업검토표.jpg</IMG>
<IMG-CAPTION ATOC="N">중소기업검토표</IMG-CAPTION>
</IMAGE>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『신용보강 제공 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*신용보강제공현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『장래매출채권 유동화 현황 및 채무비중』 삽입</COMMENT>
<LIBRARYLIST>11011#*장래매출채권유동화현황및채무비중.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『단기매매차익 미환수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*단기매매차익미환수현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『공모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*공모자금의사용내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『사모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*사모자금의사용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">19_사모자금의사용내역</FILENAME>
<P USERMARK="F-16 0XFF1200 B">5. 사모자금의 사용내역</P>

<TABLE-GROUP ACLASS="FUND_SA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="641" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="341" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="840" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="203" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="171" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">주요사항보고서의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="203" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">(주)팬젠제2회무기명무보증&cr;사모전환사채</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20180221">2018년 02월 21일</TU>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">타법인증권&cr;취득자금외</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">18,000</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">타법인증권&cr;취득자금외</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">8,000</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1),주2)</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN>주1) 팬젠 제2회 사모전환사채 180억원의 세부 자금사용 목적은 바이오벤처 사업을 영위하는 합작법인 설립에 100억원과 제품생산을 위한 원재료구매등의 운영자금 80</SPAN>
<SPAN>억원입니다.  </SPAN>
<SPAN></SPAN>
<SPAN>합작법인 설립과 관련하여 2020년 7월에 말레이시아 국영제약사인 Duopharma사, 말레이시아 정부기관인 벤처테크(VentureTECH)와 업무협약(MOU)을 체결하였으며 투자시기는 미 확정이며 최종 투자금액은 변동될 수 있습니다.&cr;</SPAN>
<SPAN>주2) </SPAN>
<SPAN>사모자금중 사용후 남</SPAN>
<SPAN>은 자금</SPAN>
<SPAN> </SPAN>
<SPAN>10,000</SPAN>
<SPAN>백만</SPAN>
<SPAN>원은</SPAN>
<SPAN> </SPAN>
<SPAN>기업은행(중금채)과 한국투자증권(RP외)등에 1년이하 단기금융상품에 예치하여 운용하고 있습니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">사모자금 사용 세부내역        </SPAN>
<SPAN>                                (단위:백만원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="589">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="81"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">구      분</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 </TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018년</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합    계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">타법인증권&cr;취득자금</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소계</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="106" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">운영자금</TD>
<TD WIDTH="138" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">인건비&cr;원재료구매자금등&cr;연구개발비</TD>
<TD WIDTH="89" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">&cr;333&cr;1,881</TD>
<TD WIDTH="87" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">451&cr;1,005&cr;1,123</TD>
<TD WIDTH="92" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">875&cr;2,332&cr;-</TD>
<TD WIDTH="90" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">1,326&cr;3,670&cr;3,004</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소계</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,214</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,579</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,207</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">합      계</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,214</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,579</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,207</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,000</TD>
</TR>
</TBODY>
</TABLE>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『미사용자금의 운용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*미사용자금의운용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">53_미사용자금의운용내역</FILENAME>
<P USERMARK=" B">미사용자금의 운용내역</P>

<TABLE-GROUP ACLASS="UNS_HIY" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="598" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="231"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="240" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금융상품명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">운용금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">실투자기간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="53" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="53" ACODE="UNS_NAM" VALIGN="MIDDLE">중금채</TE>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="53" ACODE="UNS_MNY" VALIGN="MIDDLE">4,000</TE>
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="53" AUNIT="UNS_PER" AUNITVALUE="202010-202101" VALIGN="MIDDLE">2020년 10월 ~ 2021년 01월</TU>
<TE ALIGN="CENTER" WIDTH="119" HEIGHT="53" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="53" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="53" ACODE="UNS_NAM" VALIGN="MIDDLE">중금채</TE>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="53" ACODE="UNS_MNY" VALIGN="MIDDLE">4,000</TE>
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="53" AUNIT="UNS_PER" AUNITVALUE="202010-202102" VALIGN="MIDDLE">2020년 10월 ~ 2021년 02월</TU>
<TE ALIGN="CENTER" WIDTH="119" HEIGHT="53" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="53" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="53" ACODE="UNS_NAM" VALIGN="MIDDLE">RP</TE>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="53" ACODE="UNS_MNY" VALIGN="MIDDLE">2,000</TE>
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="53" AUNIT="UNS_PER" AUNITVALUE="202012-202101" VALIGN="MIDDLE">2020년 12월 ~ 2021년 01월</TU>
<TE ALIGN="CENTER" WIDTH="119" HEIGHT="53" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="240" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="30" ACODE="UNS_MNY_SUM" VALIGN="MIDDLE">10,000</TE>
<TD ALIGN="CENTER" WIDTH="239" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" AUPDATECONT="N">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P>※미사용 자금은 1년 이하의 단기금융상품에 예치하여 운용하고 있습니다.&cr;</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『합병등 전후의 재무사항 비교표』 삽입</COMMENT>
<LIBRARYLIST>11011#*합병등전후의재무사항비교표.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『보호예수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*보호예수현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『특례상장기업 관리종목 지정유예 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*특례상장기업관리종목지정유예현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">52_특례상장기업관리종목지정유예현황</FILENAME>
<P USERMARK=" B">특례상장기업 관리종목 지정유예 현황</P>

<TABLE-GROUP ACLASS="SPE_MAG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="711" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="405"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020.12.31</TU>
<TD VALIGN="MIDDLE" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="414" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="896" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="211"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="210" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">관리종목 지정요건</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="408" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">요건별 회사 현황</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">관리종목&cr;지정유예 여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="146" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">항목별&cr;지정유예 &cr;종료시점</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">항목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">미해당</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="210" HEIGHT="53" VALIGN="MIDDLE" AUPDATECONT="N">최근 사업연도말&cr;매출액 30억미만</TD>
<TD ALIGN="CENTER" WIDTH="220" HEIGHT="53" VALIGN="MIDDLE" AUPDATECONT="N">최근 사업연도말 매출액(별도)</TD>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="SPE_LAT_YER" VALIGN="MIDDLE">2020</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="53" ACODE="SPE_LAT_AMO" VALIGN="MIDDLE">6,191</TE>
<TE ALIGN="CENTER" WIDTH="64" HEIGHT="53" ACODE="SPE_LAT_ISY" VALIGN="MIDDLE">O</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="53" ACODE="SPE_LAT_ISN" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="146" HEIGHT="53" AUNIT="SPE_LAT_OFF" AUNITVALUE="20201231" VALIGN="MIDDLE">2020.12.31</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="210" HEIGHT="120" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="4">최근 4사업연도 연속 영업손실 발생</TD>
<TD ALIGN="CENTER" WIDTH="220" HEIGHT="120" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="4">최근 4사업연도 &cr;각 영업손익&cr;(별도)</TD>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SPE_FOR_YER1" VALIGN="MIDDLE">2020</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="SPE_FOR_AMO1" VALIGN="MIDDLE">-3,700</TE>
<TE ALIGN="CENTER" WIDTH="64" HEIGHT="120" ACODE="SPE_FOR_ISY" VALIGN="MIDDLE" ROWSPAN="4">O&cr;(주2)</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="120" ACODE="SPE_FOR_ISN" VALIGN="MIDDLE" ROWSPAN="4">-</TE>
<TU ALIGN="CENTER" WIDTH="146" HEIGHT="120" AUNIT="SPE_FOR_OFF" AUNITVALUE="-" VALIGN="MIDDLE" ROWSPAN="4">-</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SPE_FOR_YER2" VALIGN="MIDDLE">2019</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="SPE_FOR_AMO2" VALIGN="MIDDLE">-7,978</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SPE_FOR_YER3" VALIGN="MIDDLE">2018</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="SPE_FOR_AMO3" VALIGN="MIDDLE">-3,044</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SPE_FOR_YER4" VALIGN="MIDDLE">2017</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="30" ACODE="SPE_FOR_AMO4" VALIGN="MIDDLE">-3,891</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="210" HEIGHT="122" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="3">자기자본 50%이상(10억원 이상에 한함)의 법인세차감전계속사업손실이 최근 3년간 2회 이상 및 최근 사업연도 법인세차감전계속사업손실 발생</TD>
<TD ALIGN="CENTER" WIDTH="220" HEIGHT="122" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="3">최근&cr;3사업연도&cr;각 법인세차감전&cr; 계속사업손익&cr;(연결)</TD>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="SPE_LOS_YER1" VALIGN="MIDDLE">2020</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="34" ACODE="SPE_LOS_AMO1" VALIGN="MIDDLE">-4,356</TE>
<TE ALIGN="CENTER" WIDTH="64" HEIGHT="122" ACODE="SPE_LOS_ISY" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="122" ACODE="SPE_LOS_ISN" VALIGN="MIDDLE" ROWSPAN="3">O</TE>
<TU ALIGN="CENTER" WIDTH="146" HEIGHT="122" AUNIT="SPE_LOS_OFF" AUNITVALUE="20181231" VALIGN="MIDDLE" ROWSPAN="3">2018.12.31</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="38" ACODE="SPE_LOS_YER2" VALIGN="MIDDLE">2019</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="38" ACODE="SPE_LOS_AMO2" VALIGN="MIDDLE">-8,934</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="50" ACODE="SPE_LOS_YER3" VALIGN="MIDDLE">2018</TE>
<TE ALIGN="RIGHT" WIDTH="110" HEIGHT="50" ACODE="SPE_LOS_AMO3" VALIGN="MIDDLE">-1,454</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P>(주1) 당사는 코스닥시장 상장규정 제2조 제31항에서 정하는 기술성장기업으로서, 동 규정 제7조 제2항의 신규상장심사요건 특례 요건을 적용하여 2016년 3월 11일 코스닥시장에 상장하였습니다.&cr;(주2) 기술성장기업의 경우에는 해당 요건을 적용받지 않습니다.</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P>본 보고서 작성기준일 현재 해당사항이 없습니다.&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P>본 보고서 작성기준일 현재 해당사항이 없습니다.&cr;</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>